as a PDF - Forschungszentrum Borstel
Transcription
as a PDF - Forschungszentrum Borstel
Jahresbericht 2007-2008 Forschungszentrum Borstel – Leibniz-Zentrum für Medizin und Biowissenschaften Fo r s c h u n g s z e n t r u m Bo r s t e l Fo r s c h u n g s z e n t r u m Bo r s t e l Leibniz-Zentrum für Medizin und Biowissenschaften Parkallee 1-40 23845 Borstel Tel. +49 (0)4537.188 0 E-mail. fzb@fz-borstel.de www.fz-borstel.de Impressum/Imprint Herausgeber/Editorial Board Prof. Dr. Dr. Silvia Bulfone-Paus Prof. Dr. P. Peter Zabel Prof. Dr. U. E. Schaible Koordination/Coordination Dr. Bettina C. Brand Design/Layout Stil.3 Designbüro AGD www.stil-punkt-3.de Hamburg Jahresbericht 2007-2008 Forschungszentrum Borstel – Leibniz-Zentrum für Medizin und Biowissenschaften Wissenschaftlicher Jahresbericht 2007-2008 Fo r s c h u n g s z e n t r u m Bo r s t e l Verstärkung fuer die Wissenschaft (von li. nach re.) S. Ehlers, Professor für Molekulare Entzündungsmedizin, Kiel; Ulrich E. Schaible, Direktor am FZB & Professur für Biochemische Mikrobiologie, Lübeck; Heinz Fehrenbach, Professur für Experimentelle Pneumologie, Lübeck. Strengthening science (left to right): S. Ehlers, Chair, Molecular Inflammation Medicine, Kiel; Ulrich E. Schaible, Director at the Research Center Borstel & Chair, Biochemical Microbiology, Lübeck; Heinz Fehrenbach, Chair, Experimental Pneumology, Lübeck. Inhalt/Content Vorwort/Preface . . . . . . . . . . . . . . . . . . . 6 Abteilung Klinische Medizin Organe des FZB/Boards of the FZB Stiftungsversammlung . . . Kuratorium . . . . . . . . . . Direktorium . . . . . . . . . . Kollegium . . . . . . . . . . . Wissenschaftlicher Beirat . Betriebsrat . . . . . . . . . . Zentrale Verwaltung . . . . Organigramm . . . . . . . . Department of Clinical Medicine . . . . . 130 . . . . . . . . . . . . . . 10 Zusammenfassung/Summary . . . . . . . . . . . 132 . . . . . . . . . . . . . . 10 Research Reports . . . . . . . . . . . . . . 10 Division of Clinical Immunpharmacology . . . . . 143 . . . . . . . . . . . . . . 11 Division of Clinical and Experimental Pathology . . 149 . . . . . . . . . . . . . . 11 Division of Mycobacteriology and National . . . . . . . . . . . . . . 11 Reference Center (NRC) for Mycobacteria . . . . 157 . . . . . . . . . . . . . . 11 Division of Molecular Mycobacteriology . . . . . . 164 . . . . . . . . . . . . . . 12 Division of Molecular and Clinical Allergology . . 175 Division of Cellular Allergology . . . . . . . . . . . 180 Division of Mucosaimmunology . . . . . . . . . . . 184 Division of Clinical Infectious Abteilung für Immunchemie und Biochemische Mikrobiologie Department of Immunochemistry and Biochemical Microbiology Diseases and Clinical Studies . . . . . . . . . . . . 191 Publikationen/Publications . . . . . . . . 14 Peer reviewed papers . . . . . . . . . . . . . . . . 204 Zusammenfassung/Summary . . . . . . . . . . . . . 16 Research Reports Book chapters and reviews . . . . . . . . . . . . . 224 Division of Medical and Biochemical Microbiology . . 32 Division of Structural Biochemistry . . . . . . . . . . 36 Ernennungen/Appointments Division of Immunochemistry . . . . . . . . . . . . . 45 Auszeichnungen/Awards Division of Biophysics . . . . . . . . . . . . . . . . . 52 Preise . . . . . . . . . . . . . . . . . . . . . . . . . . . 230 Jennifer Debarry, best PhD graduation 2007 Emmy-Noether Junior Research Group Ehrungen . . . . . . . . . . . . . . . . . . . . . . . . . 232 Immunobiophysics . . . . . . . . . . . . . . . . . . . 59 Division of Molecular Infection Biology . . . . . . . 62 Berufungen . . . . . . . . . . . . . . . . . . . . . . . . 232 Junior Research Group Molecular Ernennungen. . . . . . . . . . . . . . . . . . . . . . . 232 Infection Biology . . . . . . . . . . . . . . . . . . . . 69 Research Group of Cellular Pneumology . . . . . . 74 Wissenschaftliche Veranstaltungen Colloquia and Symposia Abteilung Immunologie und Zellbiologie Department of Immunology and Cell Biology . . . . . . . . . . Zentrumsseminare . . . . . . . . . . . . . . . . . . . 236 Weiterbildungsseminare der Klinik . . . . . . . . 242 Symposien und Workshops . . . . . . . . . . . . . 244 . . . . . . . . . 78 Zusammenfassung/Summary . . . . . . . . . . . . . 80 Research Reports Division of Immunbiology . . . . . . . . . . . . . . . 88 Lehre/Teaching . . . . . . . . . . . . . . . . . . . . 250 Ausbildung/Training . . . . . . . . . . . . . . . . 256 Division of Cellular Immunology . . . . . . . . . . . 92 Division of Molecular Immunology . . . . . . . . . 97 Division of Immune Cell-Analytics . . . . . . . . . . 99 Chronik/Chronicle . . . . . . . . . . . . . . . . . . 260 Division of Biological Chemistry . . . . . . . . . . 102 Division of Tumor Biology . . . . . . . . . . . . . . 106 Neue Entwicklungen Division of Veterinary Infectiology New Developments . . . . . . . . . . . . . . . . . 266 and Immunology . . . . . . . . . . . . . . . . . . . 109 Division of Biochemical Immunology . . . . . . . . 119 Haushaltsplan/Budget . . . . . . . . . . . . . . 273 Division of Innate Immunity . . . . . . . . . . . . . 125 Personenregister/Register of Persons . . . 274 5 Jennifer Debarry, Promotionspreis 2007 Vorwort Preface Fo r s c h u n g s z e n t r u m Bo r s t e l Vorwort Preface Das Forschungszentrum Borstel (FZB), Leibniz-Zen- The Research Center Borstel (RCB), Leibniz Center trum für Medizin und Biowissenschaften, sieht sei- for Medicine and Biosciences, sees its scientific ne gesellschaftspolitisch und gesamtstaatlich be- mission in the field of pneumology with the main deutsame wissenschaftliche Mission in der emphases on infectious diseases, allergy, and in- grundlagen-, krankheits- und patientenorientier- flammation. ten Forschung auf dem Gebiet der Pneumologie mit den Schwerpunkten Infektiologie, Allergologie und Entzündung. The members of Borstel may look back upon a number of impressive and pioneering events during 2007 and 2008. During this time of financial cri- In den Jahren 2007 und 2008 können die Borste- sis, we may look back upon two years during which ler auf eine Reihe prägender und wegweisender the RCB turned out to be a very respectable motor Ereignisse zurückblicken. Der sich abzeichnenden of scientific excellence in the North. Finanzkrise trotzend, erwies sich das Forschungszentrum Borstel auch in den vergangenen beiden Reopening of the Manor House as a science and communication center Jahren alles andere als krisengeschüttelt. Wir One of the emblems of the Center is our manor können auf zwei Jahre zurückblicken, in denen house, which could finally be reopened in June sich das FZB als grundsolider Motor wissen- 2007 as a science and communication centre after schaftlicher Exzellenz im Norden erwiesen hat. five years of renovation and restauration activities. Since then it has anew become the Center within the Center. Dreh- und Angelpunkt des Zentrums ist unser Herrenhaus, das nach fünf-jährigen Renovierungs- Zentrum im Zentrum: das wiedereröffnete Herrenhaus und Restaurierungsarbeiten im Juni 2007 als Wis- Although financial conditions have become more sens -und Kommunikationszentrum endlich wie- difficult on the whole, the acquisition of non-public dereröffnet wurde. Seitdem ist es wieder Zentrum funds could once more be increased. This applies im Zentrum. also to research funds which are especially significant for a gain in prestige and could be acquired from the EU, the BMBF, and the DFG. During the Die Drittmitteleinwerbung konnte trotz der hierfür last years, the RCB was again a spearhead of cre- insgesamt härter gewordenen Bedingungen er- ative biomedical research in the North and ac- neut gesteigert werden. Dies gilt auch für beson- tively participated in new initiatives for research ders prestigereiche Forschungsmittel, die von der cooperations such as Transregios and Collabora- EU, dem BMBF und der DFG eingeworben werden tive Research Centers. konnten. So war in den vergangenen Jahren das FZB wieder eine Speerspitze kreativer biomedizinischer Forschung im Norden und beteiligte sich As part of the Pact for Innovation and Research the aktiv an neuen Initiativen für Forschungsverbünde RCB was again successful in gaining funds from wie Transregios und Sonderforschungsbereichen. the Leibniz-Association. Because of this success, the financing for the group “Barrier Integrity“, a cooperation project together with the Christian-Al- Auch die Antragstellung im „Pakt für Forschung 6 brechts-University of Kiel, was guaranteed. In col- Wissenschaftlicher Jahresbericht 2007-2008 Vorwort Preface und Innovation“ der Leibniz-Gemeinschaft war laboration with the “Leibniz-Center for Infection zum wiederholten Male erfolgreich. Zum einen Research “, i.e the Bernhard-Nocht-Institute and the hat das die Finanzierung für die Gruppe „Barrie- Heinrich-Pette-Institute (both in Hamburg), funds re-Integrität“, ein gemeinsames Kooperationspro- for a graduate school were raised. The “Leibniz jekt mit der Christian-Albrechts Universität Kiel, si- Graduate School – Model Systems for Infectious chern können. Zum anderen konnte mit den Diseases“ will start its training program in spring Partnern des „Leibniz-Zentrum für Infektionsfor- 2009. Leibniz Graduate School schung“, dem Bernhard-Nocht-Institut und dem Heinrich-Pette-Institut (beide Hamburg) Gelder für eine Graduiertenschule eingeworben werden. Die Communication and transfer of research results „Leibniz-Graduate School – Modellssystem für In- play an especially important role in life of the Re- fektionskrankheiten“ wird im Frühjahr 2009 ihr an- search Center. National and international meet- spruchsvolles Ausbildungsprogramm starten. ings were organised on the part of the Center within the framework of several scientific events in Die Kommunikation und der Transfer von For- 2007 and 2008. The “Second Joint German Allergy Congress” and the “14th European Carbohydrate schungsergebnissen haben einen besonders ho- Symposium” (2007) as well as the “49th Annual hen Stellenwert im Zentrum. Dafür wurden in 2007 Congress of the German Society for Pneumology und 2008 seitens des Zentrums im Rahmen zahl- and Ventilation Medicine” and the “Symposium of reicher wissenschaftlicher Veranstaltungen natio- the European Respiratory Society, State of the Art nale und internationale Diskussionsforen organi- in Tuberculosis” in 2008 come to mind . siert. Besonders hervorzuheben sind der „2. Gemeinsamen Deutschen Allergie-Kongress“ und das „14th European Carbohydrate Symposium“ Another new development is the new “Manor (2007), sowie der „49. Kongress der Deutschen House Lecture” of the Excellence Cluster “Inflam- Gesellschaft für Pneumologie und Beatmungsme- mation at Interfaces”, in which outstanding scien- dizin e.V.“ und das „Symposium der European Re- tists from all over the world are invited to present spiratory Society, State of the Art in Tuberculosis“ their scientific knowledge and their expertise in the in 2008. field of inflammation. Ein weiteres Aushängeschild ist die neue „Manor Scientists at the RCB have appeared in highest- House Lecture“ des Exzellenzclusters „Entzündung ranking journals such as Nature Medicine, Nature an Grenzflächen“, die einmal im Monat heraus- Immunology, Journal of Experimental Medicine, ragende Kolleginnen und Kollegen aus aller Welt New England Journal of Medicine demonstrating einlädt, ihre wissenschaftliche Erkenntnisse und the scientific quality of the RCB. Scientific success ihre Vision der Forschungsentwicklung im Bereich is also shown by scientific prizes, awards and hon- Entzündung darzustellen. ours to people working at the RCB. Zur wissenschaftlichen Bilanz des FZB trägt auch In 2008 Ulrich Schaible succeeded Ernst Rietschel die beeindruckende Publikationsleistung der Mit- as head of the department “Immunochemistry and arbeiterinnen und Mitarbeiter des FZB in höch- Biochemical Microbiology”. Meanwhile he has re- strangigen Journalen wie Nature Medicine, Na- named it into “Molecular Infection Biolology”, re- Wissenschaftlicher Jahresbericht 2007-2008 7 Manor House Lecture Vorwort Preface ture Immunology, J Exp. Medicine, New England structured and extended it and is on his way to lit- J. of Medicine bei. Wissenschaftlicher Erfolg zeigt erally become a “Borsteler”. Fo r s c h u n g s z e n t r u m Bo r s t e l sich aber auch in der Vergabe wissenschaftlicher Preise, Auszeichnungen und Ehrungen an FZB-Mitarbeiterinnen und -Mitarbeiter. In the summer of 2008 Heinz Fehrenbach took up his work as the new professor for Experimental Pneumology (Lübeck). From now on, the Experi- Ulrich Schaible ist neuer Direktor der Abtl. Molekulare Infektiologie Das wichtigste Borsteler Ereignis des Jahres 2008 mental Pneumology will be part of the department war der Amtsantritt von Ulrich Schaible als Nach- of Clinical Medicine as an independent section folger von Ernst Rietschel im August. Inzwischen which comprises several groups. hat er seine Abteilung „Immunchemie und Biochemische Mikrobiologie“ umbenannt in „Molekulare Infektiologie“, umstrukturiert und erweitert PD Dr. Thomas Gutsmann, a colleague in the divi- und ist im besten Sinne dabei, ein Borsteler zu sion of Biophysics for many years, received a call werden. for the W3 professorship for Nanobiomechanics at the University of Ulm, for which we warmly congratulate him. Heinz Fehrenbach leitet den Bereich 'Experimentelle Pneumologie' Im Sommer 2008 hat auch Heinz Fehrenbach seine Tätigkeit als neuer Professor für Experimentelle Pneumologie (Lübeck) aufgenommen. Die Ex- In 2007, a Medical Treatment Center (MVZ) was perimentelle Pneumologie wird zukünftig als started at the Medical Clinic in Borstel after long eigenständiger Bereich in der Abteilung Klinische negotiations, which organisationally unites the Medizin stehen und mehrere Gruppen umfassen. Pathology (E. Vollmer) and Bronchopulmonary Medicine (U. Greinert) and therefore guarantees out patient care in Borstel. This new structure is PD Dr. Thomas Gutsmann, langjähriger Mitarbei- able to ensure the execution of the multiple clini- ter in der Biophysik, erhielt einen Ruf auf eine W3- cal studies at the Medical Clinic in Borstel togeth- Professur für Nanobiomechanik an der Univer- er with the Clinical Study Center (head: C. Lange) sität Ulm, zu dem wir ihm herzlichst gratulieren. existing since 2005. Im Jahr 2007 konnte an der Medizinischen Klinik Our sincere thanks for the support and solidarity Borstel nach langen Verhandlungen endlich ein goes to the trustee of the RCB, Secretary of State Medizinisches Versorgungszentrum (MVZ) ge- de Jager. We are also especially obliged to the gründet werden, das die Praxen für Pathologie representative trustee, Senior Government Official (E. Vollmer) und Lungen- und Bronchialheilkunde PD Dr. L. Schaade (Federal Ministry for Health, (U. Greinert) organisatorisch zusammenführt und Bonn), the head of the administrative district of eine Sicherung der ambulanten Krankenversor- Bad Segeberg, G. Gorrisen, the chairman of the gung in Borstel bedeutet. Diese neue Versor- Scientific Advisory Board, Prof. Dr. Seeger, Gießen, gungsstruktur kann zusammen mit dem seit 2005 his representative Prof. Dr. B. Wollenberg, Lübeck, bestehenden Klinischen Studienzentrum (Leiter: the chairman of the Foundation Board, Senior Gov- C. Lange) an der Medizinischen Klinik Borstel die ernment Official M. Wagner (Schleswig-Holstein Durchführung der vielfältigen klinischen Studien Ministry of Science, Economy and Traffic), the rep- gewährleisten. resentative chairman of the Foundation Board, As- 8 Wissenschaftlicher Jahresbericht 2007-2008 Vorwort Preface Herzlicher Dank für die zuverlässige Unterstüt- sistant Secretary Franz J. Bindert (Federal Ministry zung und Solidarität, ohne die wir in Borstel nicht for Health, Bonn) as well as the Circle of Friends arbeiten könnten, gilt Herrn Staatssekretär de Ja- of the Research Center. ger, dem Kurator des FZB. Unser besonderer Dank für vielfältige Unterstützungen und freundschaftliche Verbundenheit gilt auch dem stellver- The Board of Directors is most obliged to all sci- tretenden Kurator, Herrn Oberregierungsrat PD entists, doctors, members of the clinical staff, grad- Dr. L. Schaade (Bundesministerium für Gesund- uate students and laboratory assistants, adminis- heit, Bonn), dem Landrat des Kreises Segeberg, trative officials, the technical staff and all other Herrn G. Gorrissen, dem Vorsitzenden des Borstel colleagues, who actually made the above Wissenschaftlichen Beirates, Prof. Dr. Seeger, mentioned successes possible. Giessen, dessen Stellvertreterin Prof. Dr. B. Wollenberg, Lübeck, dem Vorsitzenden der Stiftungs- Silvia Bulfone-Paus versammlung, Herrn Ministerialrat M. Wagner Peter Zabel (Ministerium für Wissenschaft, Wirtschaft und Ver- Ulrich Schaible kehr des Landes Schleswig-Holstein) und dem stellvertretenden Vorsitzenden, Ministerialdirigent Franz J. Bindert (Bundesministerium für Gesundheit, Bonn), sowie dem Freundeskreis des Forschungszentrums. Es ist dem Direktorium ein ganz besonderes Anliegen, an dieser Stelle allen Wissenschaftlerinnen und Wissenschaftlern, Ärzten, Krankenpflegemitarbeitern, Doktoranden und Laborassistenten, Verwaltungsangestellten, Mitarbeitern des technischen Dienstes und allen anderen Borsteler Mitarbeitern und Mitarbeiterinnen, welche die oben genannten Erfolge erst ermöglicht haben, unsere Hochachtung und unseren Dank auszusprechen. Silvia Bulfone-Paus Peter Zabel Ulrich Schaible Wissenschaftlicher Jahresbericht 2007-2008 9 Organe des FZB Boards of the FZB Fo r s c h u n g s z e n t r u m Bo r s t e l Die Organe der Stiftung Forschungszentrum Borstel Stiftungsversammlung/ Foundation Board Kuratorium/ Board of Curators Ministerialrat Michael Wagner Staatssekretär Jost de Jager Ministerium für Wissenschaft, Wirtschaft und Verkehr Ministerium für Wissenschaft, Wirtschaft und Verkehr des Landes Schleswig-Holstein, Kiel Schleswig-Holstein (Vorsitzender) (Vorsitzender) oder Oberregierungsrat PD Dr. Lars Schaade Oberregierungsrat Klaus-Eckhard von Unruh Bundesministerium für Gesundheit Ministerium für Wissenschaft, Wirtschaft und Verkehr (stv. Vorsitzender) des Landes Schleswig-Holstein, Kiel Referatsleiterin Maria Becker Bundesministerium für Gesundheit Ministerialdirigent Franz J. Bindert Infektions- und Gesundheitsschutz Bundesministerium für Gesundheit, Bonn Mathias Diener-Sonnenberg (stv. Vorsitzender) Finanzministerium, Land Schleswig-Holstein oder Referatsleiterin Hanna Fangohr Dr. Renée Buck Außeruniversitäre Forschungseinrichtungen Ministerium für Soziales, Gesundheit, Familie, Behörde für Wissenschaft und Forschung Jugend und Senioren, Schleswig-Holstein Hochschulamt, Freie und Hansestadt Hamburg Landrätin Jutta Hartwieg Kreis Segeberg Landrätin Jutta Hartwieg Kreis Segeberg Prof. Dr. Werner Seeger Abteilungsdirektor Dr. Ulrich Reineke Direktor der Klinik Innere Medizin, Justus von Deutsche Rentenversicherung, Berlin Liebig Universität Gießen oder Verwaltungsoberrat Uwe Wilhelm Prof. Dr. Barbara Wollenberg Deutsche Rentenversicherung, Berlin Direktorin der Klinik für Hals-, Nasen- und Ohrenheilkunde, Universität zu Lübeck Dr. Ingrid Künzler Direktorium/Scientific Directors Deutsche Rentenversicherung Nord, Lübeck Prof. Dr. med. Dr. rer. nat. Silvia Bulfone-Paus Abteilungsdirektor Helmut Josten (Geschäftsführende Direktorin) Deutsche Rentenversicherung Nord Direktorin der Abteilung ‚Immunologie und Zell- Freie und Hansestadt Hamburg biologie’ Landesverwaltungsdirektor Peter-Oliver Weber Prof. Dr. rer. nat. Ulrich E. Schaible Deutsche Rentenversicherung Oldenburg-Bremen Direktor der Abteilung ‚Immunchemie und Biochemische Mikrobiologie’ 10 Wissenschaftlicher Jahresbericht 2007-2008 Organe des FZB Boards of the FZB Prof. Dr. med. Peter Zabel Prof. Dr. Thomas Hünig Direktor der Abteilung ‚Klinische Medizin’ Institutsvorstand des Institutes für Virologie und Ärztlicher Direktor der Medizinischen Klinik Bor- Immunologie, stel und der Medizinischen Klinik III, Universitäts- Bayerische Julius-Maximilians-Universität, Würzburg klinikum Schleswig-Holstein/Campus Lübeck Prof. Dr. Erika Jensen-Jarolim Kollegium/Scientific Council Head of the Department of Pathophysiology, Prof. Dr. med. Dr. rer. nat. Silvia Bulfone-Paus Center for Physiology and Pathophysiology, (Geschäftsführende Direktorin) Medical University of Vienna Direktorin der Abteilung ‚Immunologie und Zellbiologie’ Prof. Dr. Thisbe Lindhorst Direktorin des Institutes für Organische Chemie, Prof. Dr. rer. nat. Ulrich E. Schaible Christian-Albrechts-Universität zu Kiel Direktor der Abteilung ‚Immunchemie und Biochemische Mikrobiologie’ Prof. Dr. Klaus Dieter Pfeffer Direktor des Institutes für Medizinische Mikrobio- Prof. Dr. med. Peter Zabel logie und Krankenhaushygiene, Direktor der Abteilung ‚Klinische Medizin’ Universität Düsseldorf Ärztlicher Direktor der Medizinischen Klinik Borstel und Betriebsrat/Working Council der Medizinischen Klinik III, Universitätsklinikum Heiko Käßner (Vorsitzender) Schleswig-Holstein/Campus Lübeck Manfred Richter (stv. Vorsitzender) Prof. Dr. rer. nat. Heinz Fehrenbach Zentrale Verwaltung/ Administration Bereichsleiter ‚Experimentelle Pneumologie’ Susann Schrader Prof. Dr. med. Stefan Ehlers Verwaltungsdirektorin Bereichsleiter ‚Mikrobielle Entzündungsforschung’ Sybille Lenkeit Wissenschaftlicher Beirat/ Scientific Advisory Board Haushalt-, Kassen- und Rechnungswesen Prof. Dr. Werner Seeger Bernd Poetzing Direktor der Klinik für Innere Medizin II, Finanz- und Patientenwesent Justus von Liebig Universität Gießen (Vorsitzender) Karl-Heinz Lemm Personalwesen Prof. Dr. Barbara Wollenberg Direktorin der Klinik für Hals-, Nasen- und Ohren- Heinz-Jürgen Wefel heilkunde, Wirtschaftsdienst Universität zu Lübeck (stv. Vorsitzende) Dirk Grünes Prof. Dr. Christoph Dehio Technischer Dienst Infection Biology, Biozentrum, Universität Basel Wissenschaftlicher Jahresbericht 2007-2008 11 Organigramm des Forschungszentrums Borstel Structural Plan of the Research Center Borstel Fo r s c h u n g s z e n t r u m Bo r s t e l Headline Subline deutsch Fo r s c h u n g szentrum Bo r s t e l Headline Direktorium (Vorstand) Subline englisch Prof. Dr. Dr. S. Bulfone-Paus (geschäftsführende Direktorin) Prof. Dr. P. Zabel Prof. Dr. U. E. Schaible Zentrale Verwaltung Verwaltungsdirektorin S. Schrader Tel -220 Fax -721 Abteilung Immunchemie und Biochemische Mikrobiologie Prof. Dr. rer. nat. Ulrich E. Schaible Tel -600 Fax -403 Abteilung Immunologie und Zellbiologie Prof. Dr. med. Dr. rer. nat. S. Bulfone-Paus Tel -200 Fax -403 Medizinische Klinik Abteilung Klinische Medizin Prof. Dr. med. P. Zabel zugleich Ärztlicher Direktor der Medizinischen Klinik Tel -300 Fax -603 Tel -370 Oberärzte PD Dr. C. Lange Dr. U. Greinert Dr. E. Müller PD Dr. H.-P. Hauber Ambulanzen Umweltmedizin Pneumologie Päd. Allergologie Fax -313 Tel -332 Tel -384 Tel -323 Tel -371 Dr. E. Müller Prof. Dr. P. Zabel Dr. G. Berger Tel -351 Tel -351 Tel -351 Zentrale Einrichtungen 12 Wissenschaftlicher Jahresbericht 2007-2008 Organigramm des Forschungszentrums Borstel Structural Plan of the Research Center Borstel Telefon: Zentrale 0 45 37-1 88 - 0 Durchwahl 0 45 37-1 88 - ... Wissenschaftsreferat Dr. B. Brand Tel -439 Fax -403 Tel = Telefon-Durchwahl Fax = Telefax-Durchwahl LG = Laborgruppe AG = Arbeitsgruppe EU-Forschungsreferat Dr. K. Loetzer Tel -309 Fax -403 Haushalts-, Kassen- und Rechnungswesen Finanz- und Patientenwesen Wirtschaftsdienst S. Lenkeit Tel -271 B. Poetzing Tel -338 H.-J. Wefel Tel -278 Fax -324 Personalwesen K.-H. Lemm Tel -325 Fax -313 Fax -243,743 Technischer Dienst Fax -626 D. Grünes Tel -277 Fax -244 LG Immunchemie LG Medizinische und Biochemische Mikrobiologie LG Strukturbiochemie Prof. Dr. U. Zähringer Tel -462 Prof. Dr. H. Brade Tel -474 Prof. Dr. O. Holst Tel -472 Fax -745 LG Molekulare Infektiologie LG Biophysik Prof. Dr. S. Ehlers Tel -481 PD Dr. T. Gutsmann Tel -291 Fax -686 Juniorprofessur für Molekulare Infektiologie Emmy-Noether-NG Immunbiophysik Prof. Dr. C. Hölscher Tel -586 PD Dr. A. Schromm Tel -296 Fax -775 Fax -419 Fax -745 AG Zelluläre Pneumologie Fax -632 PD Dr. C. Stamme Tel -581 Fax -725 Fax -632 LG Immunbiologie LG Zell. Immunologie Prof. Dr. Dr. S. Bulfone-Paus Tel -200 Fax -403 Prof. Dr. A. J. Ulmer Tel -448 Immunzell-Analytik LG Biologische Chemie LG Tumorbiologie Dr. M. Ernst Tel -453 Prof. Dr. E. Brandt Tel -444 Prof. Dr. J. Gerdes Tel -424 Fax -608 LG Molekulare Immunologie Fax -435 Fax -645 Dr. K.-H. Lee Tel -585 Fax -403 Fax -724 LG Vet.-Infektiologie und -Immunologie LG Biochem. Immunologie LG Angeborene Immunität Prof. Dr. J. Ahmed Tel -428 PD Dr. F. Petersen Tel -451 PD Dr. H. Heine Tel -420 Fax -627 Fax -645 Fax -697 LG Klin. u. Experim. Pathologie LG Mykobakteriologie u. Nat. Referenzzentrum LG Molekulare und Klinische Allergologie Prof. Dr. Dr. E.Vollmer Tel -250 o. -278 Dr. S. Rüsch-Gerdes OA Dr. U. Greinert Dr. W.-M. Becker Dr. G. Berger Fax -229 T. -213/F. -311 T. -384/F. -313 T. -337/F. -328 T. -351/F. -313 LG Zelluläre Allergologie AG Molekulare Mykobakteriologie LG Klin. Immunpharmakologie PD Dr. H. Haas Tel -440 PD Dr. S. Niemann Tel -762 Prof. Dr. P. Zabel Tel -300 Fax -608 Fax -311 LG Klinische Infektiologie u. Studienzentrum LG Mukosaimmunologie PD Dr. C. Lange Tel -332 PD Dr. A. Frey Tel -562 Fax -313 Fax -603 Fax -693 Tierhaltung Laborantenausbildung Bibliothek und Dokumentation Dr. I. Monath Tel -742 Dr. S. Zähringer Tel -381 PD Dr. N. Reiling C. Engler, K. Geschuhn Tel -276/Fax -260 Fax -403 Fax -647 EDV-Zentrale Dr. K. Visser Tel -605 Wissenschaftlicher Jahresbericht 2007-2008 Fax -745 13 Abteilung Immunchemie und Biochemische Mikrobiologie Fo r s c h u n g s z e n t r u m Bo r s t e l 14 Department of Immunochemistry and Biochemical Microbiology Wissenschaftlicher Jahresbericht 2007-2008 Abteilung Immunchemie und Biochemische Mikrobiologie Department of Immunochemistry and Biochemical Microbiology Abteilung Immunchemie und Biochemische Mikrobiologie Department of Immunochemistry and Biochemical Microbiology Wissenschaftlicher Jahresbericht 2007 -2008 15 Zusammenfassung Summary Fo r s c h u n g s z e n t r u m Bo r s t e l new: Department for Molecular Infection Biology neu: Abteilung für Molekulare Infektiologie Abteilung für Immunchemie und Biochemische Mikrobiologie Department of Immunochemistry and Biochemical Microbiology Leiter Head Prof. Dr. rer. nat. Ulrich E. Schaible Prof. Dr. rer. nat. Ulrich E. Schaible Sekretariat Secretary Maike Kohlmorgen Maike Kohlmorgen Für die Abteilung Immunchemie und Biochemi- The Department of Immunochemistry and Biochem- sche Jahre ical Microbiology went through a transitional phase 2007/2008 eine Phase des Umbruchs. Professor in 2007/2008. Professor Dr. Dr. Ernst Th. Rietschel, Dr. Dr. Ernst Th. Rietschel, der die Abteilung (und who directed the department (and as acting direc- als Geschäftsführender Direktor immer wieder tor the Research Center during several periods) su- auch das Forschungszentrum) in beeindrucken- perbly through many challenging times and estab- der Weise durch oft schwierige Zeiten führte und lished its excellent international standing, retired ihr hervorragendes internationales Ansehen mit- but took over the even greater task to lead the Leib- begründete, wurde emeritiert, übernahm aber niz Association as its President. As Professor Ri- die ungleich größere Aufgabe des Präsidenten etschel’s successor in 2008, I took over the fasci- der Leibniz-Gemeinschaft. Als Nachfolger von nating assignment to lead this outstanding Prof. Rietschel übernahm ich 2008 die faszinie- Department to future challenges. The change in di- Mikrobiologie bedeuteten die rende Aufgabe, diese hervorragende Abteilung rectorship went along with a new name, Depart- zu neuen Aufgaben zu führen. Die Übernahme ment of Molecular Infection Biology (MIB), to ac- dieser Position ging einher mit einer Umbenen- commodate the interdisciplinary and holistic nung der Abteilung in Abteilung für Molekulare orientation study infectious diseases. Infektiologie (MI), um die interdisziplinäre und ganzheitliche Orientierung der Abteilung zu unterstreichen. MIB combines research on the many facets of bacterial infections to study them in their entirety. The research agenda covers from basic molecular anal- MI kombiniert Forschung an den unterschiedlich- ysis of bacterial structures and their genetic basis, sten Facetten bakterieller Infektionen, um diese in studies on pathogen and host interactions and the ihrer Ganzheit zu erforschen. Das Forschungspro- resulting immune responses as well as translation- gramm der MI deckt verschiedene Bereiche von al approaches in collaboration with the Clinical De- der molekularen Analyse bakterieller Strukturen partment. The prime foci of MIB are on pulmonary und ihrer genetischen Grundlagen, Studien zu Er- pathogens, in particular those, which cause Tuber- reger-Wirt-Wechselwirkungen und den daraus re- culosis and Cystic Fibrosis, but also on Chlamydia sultierenden Immunantworten bis hin zu transla- and other Gram-negative ones including environ- tionalen Ansätzen in Zusammenarbeit mit der mental bacteria and their influence on lung immu- Abteilung Klinische Medizin ab. Den Hauptfokus nity such as allergic reactions. Tuberculosis research 16 Wissenschaftlicher Jahresbericht 2007-2008 Zusammenfassung Summary der Abteilung bilden Krankheitserreger der Lun- comprises studies ge, insbesondere diejenigen, die Tuberkulose cell/pathogen interactions and anti-tuberculosis im- und Zystische Fibrose verursachen, aber auch munity. Chlamydien und andere Gram-negative Erreger, pathogenicity - primarily in infections with Gram- wie auch Umweltkeime und deren Einfluss auf die negative bacteria - are studied with respect to their Immunität der Lunge, wie beispielsweise auf all- structural, genetic and functional characteristics ergische Reaktionen. Die Tuberkuloseforschung with a focus on immune modulation by bacterial betreibt Studien zur Genetik des Wirtes, zu Wirts- compounds and membrane biophysics of receptor- Zell-Erreger-Interaktionen und der Immunität ge- ligand interactions. Factors on host determining genetics, virulence host and gen die Tuberkelbazillen. Faktoren, die die Virulenz und Pathogenität bestimmen – insbesondere bei Infektionen mit Gram-negativen Bakterien – MIB assembles a broad range of state of the art tech- werden bezüglich ihrer strukturellen, genetischen niques as well as the expertise and interdisciplinary und funktionellen Charakteristika untersucht, wo- approach of MIB’s excellent scientific staff. This al- bei der Schwerpunkt auf der Immunmodulation lows for a detailed but global analysis of a pathogen durch bakterielle Moleküle und die Membran- and the disease it causes, i.e. the infectious process biophysik in its entirety from the characterization of individual von Rezeptor-Ligand-Interaktionen liegt. bacterial molecules and their interactions with host cell structures to their effect on the host and the resulting defence responses. Nuclear magnet reso- MI vereinigt ein breites Spektrum an hochmoder- nance (NMR) and mass spectroscopy (MS) are used nen Techniken mit der Expertise und interdiszi- for structural analysis of bacterial compounds. Atom- plinären Ausrichtung seiner exzellenten wissen- ic force microscopy (AFM) and micro calorimetry al- schaftlichen Mitarbeiterinnen und Mitarbeiter. low assessment of molecular interactions between Das erlaubt eine detaillierte und umfassende pathogen and host molecules. Using advanced life Analyse eines Krankheitserregers und der durch cell imaging and other microscopy techniques com- ihn ausgelösten Krankheit, z.B. den Prozess einer bined with experimental tissue culture, in vitro organ Infektion in seiner Ganzheit von der Charakteri- and animal models the host-pathogen interplay can sierung eines einzelnen bakteriellen Moleküls be dissected. Our large collection of gene knock-out und seiner Interaktion mit Wirtszell-Strukturen bis and transgenic mouse models paired with safety lev- hin zu seinem Effekt auf den Wirt und die daraus el 3 labs for work with tubercle bacilli (Mycobacteri- resultierenden Abwehrmechanismen. Kernspin- um tuberculosis) provides the great opportunity to Magnet-Resonanz (Nuclear Magnet Resonance; study the host response to tuberculosis, one of the NMR) und Massenspektroskopie (MS) werden für most important human infections world-wide. Finally, die strukturelle Analyse von bakteriellen Be- in collaboration with other groups within the Clinical standteilen genutzt. Atomare Kraftmikroskopie and Immunology/Allergy departments of the Re- (Atomic Force Microscopy; AFM) und Mikrokalori- search Center Borstel, we direct our research to- metrie erlauben die Bestimmung molekularer In- wards translational approaches. The allocation of teraktionen zwischen Krankheitserregern und novel findings and inventions to benefit medical Wirtsmolekülen. Durch die Verwendung von Mi- progress is facilitated by their translation into patents kroskopie an lebenden Zellen (Advanced Life and clinical applicability, by which we hope to con- Cell Imaging) und anderer mikroskopischer und tribute to the development of novel diagnostics and bildgebender Verfahren in Kombination mit ex- therapeutics including anti-tuberculosis and anti-al- perimentellen Gewebekulturen können in vitro lergy drugs. Wissenschaftlicher Jahresbericht 2007-2008 17 NMR, MS, AFM, micro calorimetry, life cell imaging NMR, MS, AFM, Mikrokalorimetrie, Life Cell Imaging Zusammenfassung Summary Organ- und Tiermodelle der Wirts-Erreger-Wech- At the intersection between infection and allergy re- selwirkung analysiert werden. Unsere große search, the Division of Structural Biochemistry lead Sammlung von Gen Knock-Out und transgenen by Prof. Dr. Otto Holst, unfolded structures of bac- Mausmodellen und das Vorhandensein von La- terial origin which are protective against allergic re- boratorien der Sicherheitsstufe 3 für die Arbeit mit actions. Several epidemiological studies revealed Tuberkulosebakterien (Mycobacterium tuberculo- an allergy protective effect of farm life in early child- sis) bieten die großartige Möglichkeit, die Tuber- hood. Children grown up on traditional farms in the kulose, eine der wichtigsten Infektionskrankheiten south of Germany presented with significantly re- des Menschen weltweit, genauer zu untersuchen. duced occurrence of asthmatic symptoms, hay fever Schließlich arbeiten wir zusammen mit anderen and atopic sensitization in comparison to other chil- Gruppen immunologi- dren living in the same area. The division’s earlier schen/allergologischen Bereiche am Forschungs- studies provided insight to the protective effect of zentrum Borstel an translationalen Forschungs- cowshed dusts. Recently, Otto Holst and his col- ansätzen. Wir hoffen, zur Entwicklung neuer leagues analysed the microbial flora of protective Diagnostika und Therapeutika (u. a. auch Medi- cowshed dusts including the most prominent bac- kamente gegen Tuberkulose und Allergien) bei- terial spores. Of a number of bacterial species iden- tragen zu können, auch indem wir neue Ent- tified in cowsheds, two were selected, isolated, and Fo r s c h u n g s z e n t r u m Bo r s t e l Acinetobacter lwoffii & Lactococcus lactis: reduce allergic reactions der klinischen und deckungen und Erfindungen durch Patente characterized, namely Acinetobacter lwoffii F78 klinisch anwendbar machen. and Lactococcus lactis G121. The isolates were investigated with regard to their activation through pattern recognition receptors and subsequent in- Acinetobacter lwoffii & Lactococcus lactis: Verringerung der allergischen Reaktion An der Schnittstelle zwischen Infektion und Aller- duction of human monocyte-derived dendritic cells gie hat die von Prof. Dr. Otto Holst geleitete For- maturation, inflammatory cytokines, T-helper cell 1 schergruppe Strukturbiochemie Strukturen bakteriellen Ursprungs entschlüsselt, die gegen (TH1) polarizing Notch ligand expression and their effect on the allergic phenotype. It was found that allergische Reaktionen schützen. Verschiedene both bacterial isolates were capable to reduce al- epidemiologische Studien zeigten, dass ein Le- lergic reactions in mice and induce a T-helper 1 cell ben auf einem Bauernhof in früher Kindheit ge- polarizing program in dendritic cells. These data gen Allergien schützt. Kinder, die auf traditionel- strongly support the hygiene hypothesis, i.e. that an len Bauernhöfen in Süddeutschland aufwachsen, environment rich in microbiological structures such entwickeln deutlich seltener asthmatische Sym- as the farming environment can protect from aller- ptome, Heuschnupfen oder atopische Erkrankun- gies. Furthermore, it was found that bacterial spores gen im Vergleich zu anderen Kindern, die in der in contrast to vegetative bacteria stimulated a TH1 gleichen Gegend leben. Frühere Untersuchungen biasing cytokine profile. Application of Bacillus dieser Forschergruppe erlaubten Einblicke in den licheniformis spores prevented allergy-associated Schutzeffekt von Stäuben aus Kuhställen. Kürzlich eosinophilia and goblet cell hyperplasia in mice. analysierten Otto Holst und seine Kollegen die mi- This suggests that bacterial spores from a farming krobielle Flora von schützenden Stäuben aus Kuh- environment can suppress development of allergic ställen inklusive der häufigsten Bakteriensporen. asthma focusing the hygiene hypothesis to the func- Aus einer Vielzahl von Bakterien, die in Kuhstäl- tion of bacterial spores in allergy protection. len gefunden wurden, wurden zwei ausgewählt, isoliert und charakterisiert, nämlich Acinetobac- ter lwoffii F78 und Lactococcus lactis G121. Die The historically strong engagement of the Research Isolate wurden auf ihren Effekt hin untersucht, den Center in analysing the biological properties and 18 Wissenschaftlicher Jahresbericht 2007-2008 Zusammenfassung Summary sie auf Strukturerkennungsrezeptoren haben und structural entities of the main cell wall glycolipid of auf in der Folge ablaufende Aktivierungssignale: Gram-negative bacteria, lipopolysaccharide (LPS) Reifung menschlicher dendritischer Zellen, Aus- was still a main topic in 2007/2008. The Division of schüttung entzündlicher Zytokine, Polarsierung Structural Biochemistry found that the hexasaccha- hin zu T-Helfer 1 Zellen durch Notch-Liganden Pro- ride of the outer core (OC) region of Yersinia ente- duktion und Effekt auf allergische Reaktionen. Es rocolitica serotype O:3 is essential for the integrity wurde festgestellt, dass beide bakteriellen Isola- of the outer membrane and virulence during early te in der Lage waren, allergische Reaktion in phases of infection. This hexasaccharide is most Mäusen zu verringern und dass sie ein T-Helfer 1 likely involved in Yersinia’s resistance against (TH1) Zellpolarisierungsprogramm in dendriti- cationic antimicrobial peptides (AMP). It was found schen Zellen anregen. Diese Daten stützen nach- that the proximal sugar residue of the OC hexas- haltig die Hygienehypothese, also, dass eine Um- accharide is a 2-acetamido-2,6-dideoxy-D-xylo-hex- gebung, 4-ulopyranose but not a 2-acetamido-2,6-dideoxy-D- die reich an mikrobiologischen (D-FucpNAc, N-acetyl-D-fuco- Strukturen ist, wie z.B. ein Bauernhof, vor Allergi- galactopyranose en schützen kann. Weiterhin wurde herausgefun- samine) as previously published. It was also demon- den, dass Bakteriensporen im Gegensatz zu ve- strated that WbcP is the biosynthetic enzyme con- getativen förderndes verting UDP-2-acetamido-2-deoxy-D-glucopyranose Zytokinprofil auslösen. Die Anwendung von Spo- (UDP-D-GlcpNAc, UDP-N-acetyl-D-glucosamine) to ren des Bacillus licheniformis verhinderte die mit UDP-2-acetamido-2,6-dideoxy-D-xylo-hex-4-ulopyra- Allergien assoziierte Eosinophilie und Hyperpla- nose. Furthermore, evidence was provided that the sie der Goblet Zellen in Mäusen. Dies lässt ver- keto/diol-character of the sugar residue is crucial for muten, dass Bakteriensporen von Bauernhöfen the biological role of OC, i.e. recognition by bacte- die Entwicklung von allergischem Asthma unter- riophage, enterocoliticin and specific monoclonal drücken können, was das Augenmerk der Hygie- antibodies. Bakterien ein TH1 Hexasaccharide may be involved in Yersinia resistance against antimicrobial peptides nehypothese auf die Funktion von Bakteriensporen im Schutz gegen Allergien lenkt. The Division of Biophysics headed by PD Dr. Thomas Gutsmann established a system to analyse the inDas historisch gewachsene große Engagement teraction between AMP and other host proteins and des Forschungszentrums Borstel bei der Analyse model membranes. Atomic force microscopy was der biologischen Eigenschaften und strukturellen used to define the localization of the LPS binding Eigenheiten des Hauptzellwandglykolipids Gram- protein (LBP), essential for LPS-signalling, to choles- negativer Bakterien, Lipopolysaccharid (LPS), terol-rich domains in reconstituted lipid membranes. war auch in den Jahren 2007/2008 ein Hauptthe- Through the collaborative research centre SFB 617 ma der MI. Die Forschergruppe Strukturbioche- and the Fond for Innovation of Schleswig-Holstein, mie fand heraus, dass das Hexasaccharid der a novel biosensor and fluorescence spectrometry äußeren Kernregion von Yersinia enterocolitica system, respectively, became available in order to Serotyp O:3 unerlässlich ist für die Integrität der study receptor-ligand binding and membrane in- äußeren Membran und die Virulenz während der teractions with tremendously improved sensitivity frühen Phase der Infektion. Dieses Hexasaccharid and resolution. These techniques allowed studies ist wahrscheinlich an der Resistenz von Yersinia on the microbicidal effectiveness of AMP against a gegen kationische antimikrobielle Peptide (AMP) number of bacterial species including mycobacte- beteiligt. Der proximale Zucker der äußeren Kern- ria and the underlying molecular mechanism. It region des Hexasaccharids ist ein 2-Acetamido- should be mentioned that Arenicin-1, an AMP de- Wissenschaftlicher Jahresbericht 2007-2008 19 Resistenz von Yersinia gegen kationische antimikrobielle Peptide Zusammenfassung Summary 2,6-Dideoxy-D-xylo-hex-4-Ulopyranose und nicht rived from the marine sand worm Arenicola areni- ein 2-Acetamido-2,6-Dideoxy-D-Galactopyranose cola, is of special therapeutic interest due to its re- (D-FucpNAc, N-acetyl-D-Fucosamine) wie ursprüng- quirements in temperature and salt concentrations. lich beschrieben. WbcP ist das biosynthetisch re- In cooperation with the novel Division of Cellular Mi- levante Enzym, das UDP-2-Acetamido-2-deoxy-D- crobiology (Prof. Dr. Ulrich Schaible), a simple re- Glucopyranose (UDP-D-GlcpNAc, UDP-N-acetyl- constituted membrane model of the outer mem- D-glucosamine) in UDP-2-Acetamido-2,6- dideoxy- brane of the tubercle bacillus was established, D-xylo-hex-4-Ulopyranose umwandelt. Es konnte which demonstrated that AMP effectiveness was auch gezeigt werden, dass der Keton/Diol-Cha- hampered by mycobacterial cell wall lipids. This ex- rakter des Zuckeranteils für die biologische Rolle plains the surprisingly low anti-mycobacterial activ- der äußeren Kernregion, z.B. für die Erkennung ity of such AMP. The Division of Biophysics works in durch Bakteriophagen, Enterocoliticin und spezi- close association with the Emmy-Noether-Junior Re- fische monoklonale Antikörper, wichtig ist. search Group of Immunobiophysics headed by PD Fo r s c h u n g s z e n t r u m Bo r s t e l Dr. Andra Schromm. This group characterized the biological activity of bacterial lipopeptides in both vir- The concept of 'endotoxic conformation' may be also applicable to lipopeptides Die von PD Dr. Thomas Gutsmann geleitete For- ulence and immune stimulation. Physicochemical schergruppe Biophysik hat ein System etabliert, and biological characterisation of synthetic mit dem die Wechselwirkung zwischen AMP und lipopeptides modelled by bacterial blue prints re- anderen Wirtsproteinen sowie Modellmembra- vealed that the concept of ‘endotoxic conformation’, nen analysiert werden kann. Atomic Force Mikro- i.e. the physicochemical information of the skopie wurde benutzt, um mit Hilfe von rekonsti- molecules is also applicable to lipopeptides. This tuierten Lipidmembranen die Lokalisation des concept, which has originally been developed for LPS-bindenden Proteins (LBP), welches essentiell lipopolysaccharides, constitutes a general principle für die Zellaktivierung durch LPS ist, Cholesterol- for the molecular basis of cell activation by am- reichen Bereichen zuzuordnen. Mit Mitteln aus phiphilic molecules. Collaborative studies together dem Sonderforschungsbereich 617 und dem In- with the group of PD Dr. Cordula Stamme (Cellular novationsfond Schleswig-Holstein konnten ein Pneumology) revealed mechanisms of lung-specific neues Biosensorsystem und ein Fluoreszenz Spek- immune regulation as executed by pulmonary C- trometrie System angeschafft werden, mit dem type lectins. Rezeptor-Ligand-Bindungen und Membran-Wechselwirkungen mit enorm verbesserter Sensitivität und Auflösung untersucht werden können. Diese Also highly active in LPS research, the Division of Im- Techniken erlauben Untersuchungen der anti-bak- munochemistry headed by Prof. Dr. Ulrich Zähringer teriellen Aktivität von AMP gegen eine Anzahl pioneered the usage of nuclear magnetic reso- von Bakterienspezies, u.a. auch Mykobakterien, nance (NMR) to analyse the structures and dynam- und der zugrunde liegenden molekularen Me- ics of endotoxins, the molecular principle of sepsis chanismen. Es sollte nicht unerwähnt bleiben, resulting from exaggerated innate immune re- dass Arenicin-1, ein aus dem Wattwurm Arenico- sponses to bacterial endotoxins. Sepsis remains a la arenicola gewonnenes AMP, aufgrund seiner global health threat with high risk of morbidity and Anforderungen an Temperatur und Salzgehalt mortality. LPS of Gram-negative bacteria is the pro- von besonderem therapeutischem Interesse ist. In totypic inducer of sepsis based on its activation of Zusammenarbeit mit der neuen Forschergruppe haematopoietic immune cells through the Toll-like Zelluläre Mikrobiologie wurde ein einfaches re- receptor (TLR) 4/MD-2 complex and subsequent re- konstituiertes Membranmodell der äußeren Mem- lease of pro- and anti-inflammatory mediators. 20 Wissenschaftlicher Jahresbericht 2007-2008 Zusammenfassung Summary bran des Tuberkelbazillus etabliert, welches zeig- However, the molecular interaction between the LPS te, dass die Effektivität bestimmter AMPs durch and the TLR4/MD-2 complex is still undefined on a mykobakterielle Zellwandlipide gehemmt wurde. structure-function relationship. Gaining insight into Dies erklärt die überraschend niedrige antimyko- this interaction will hopefully improve therapeutic bakterielle Aktivität solcher AMPs. Die Forscher- regimens against sepsis. In cooperation with the gruppe Biophysik arbeitet eng mit der von PD Dr. group of Stephan Grzesiek, NMR Structural Biology, Andra Schromm geleiteten Emmy-Noether-Nach- Biozentrum Basel, Switzerland, the Division of Im- wuchsgruppe Immunbiophysik zusammen. Diese munochemistry successfully developed a novel nu- Gruppe hat die biologische Aktivität von bakteri- clear magnetic resonance (NMR) approach to de- ellen Lipopeptiden sowohl in der Virulenz wie auch in der Immunstimulation charakterisiert. Die termine structure and dynamics of LPS in aqueous solution. This was achieved by uniformly 13C,15N-la- physikochemische und biologische Charakterisie- belling of LPS in genetically well-defined Es- rung von synthetischen Lipopeptiden, die den cherichia coli strains and keeping isolated LPS in so- bakteriellen Vorlagen nachgebaut wurden, ha- lution by di-hexanoyl-phosphatitdylcholine (DHPC) ben gezeigt, dass das Konzept der endotoxi- as a mimetic of the bacterial membrane. These LPS schen Konformation, also die physikochemische preparations showed well-resolved NMR spectra, Information der Endotoxinmoleküle (LPS), auch which made LPS amenable to analysis by modern auf Lipopeptide übertragbar ist. Dieses Konzept, heteronuclear NMR methods for the first time to welches ursprünglich für LPS entwickelt wurde, study conformation and dynamics of LPS as a key- stellt damit ein allgemeines Prinzip für die mole- event in LPS-TLR4/MD-2 interaction. Moreover, this kulare Basis der Zellaktivierung durch amphiphi- NMR approach proved to be applicable to analyse le Moleküle dar. Studien, die in Zusammenarbeit a broad panel of complex LPS and lipid A structures mit der Gruppe von PD Dr. Cordula Stamme (Zel- under natural conditions resembling the bacterial luläre Pneumologie) durchgeführt wurden, deck- membrane. Within the Division of Immunochemistry, ten Mechanismen Lungen-spezifischer Immunre- the group of PD Dr. Buko Lindner, specialized in dif- gulation auf, die von pulmonaren C-Typ Lektinen ferent methods of mass spectrometry, used capil- ausgeführt wurden. lary electrophoresis coupled to Fourier-transform ion cyclotron resonance mass spectrometry to separate and analyse complex mixtures of glycolipids. Auch die von Prof. Dr. Ulrich Zähringer geleitete Native glycolipid preparations (glycosphingolipid, Forschergruppe Immunchemie ist sehr aktiv in der lipopolysaccharides) are inherently highly hetero- LPS-Forschung. Sie war wegbereitend für die Nut- geneous with respect to numbers and types of fat- zung von NMR für die Analyse der Struktur der ty acids, oligosaccharides and non-stoichiometric Endotoxine (LPS) und ihrer Dynamik. Endotoxine substituents (P, P-Etn, and Ara4N), which hamper stellen das molekulare Prinzip der Sepsis dar, die their structural characterisation. In the past, chro- aus der überbordenden angeborenen Immun- matographic separation of highly amphiphilic com- antwort gegen bakterielle Endotoxine entsteht. pounds by HPLC or TLC for subsequent chemical Sepsis bleibt eine globale Gesundheitsbedro- analyses failed. To overcome these problems, cap- hung mit einem hohen Krankheits- und Sterblich- illary electrophoresis (CE) was linked online to a keitsrisiko. LPS von Gram-negativen Bakterien ist Fourier-transform ion cyclotron resonance mass der prototypische Verursacher einer Sepsis, da- spectrometer (FT-ICR MS) using a sheath liquid in- durch, dass es haematopoetische Immunzellen terface. This novel technique allowed for the first über den Toll-like Rezeptor (TLR) 4/MD-2 Komplex time separation and online mass analyses of com- aktiviert und dadurch zur Freisetzung von pro- ponents within non-derivatized R-Form LPS and lipid Wissenschaftlicher Jahresbericht 2007-2008 21 Physikochemische Information des LPS auch auf Lipopeptide übertragbar Zusammenfassung Summary und anti-inflammatorischen Mediatoren führt. Al- A as well as more complex mixtures with detection lerdings sind die Struktur-Funktion-Zusammen- limits in the low fmol range. Fo r s c h u n g s z e n t r u m Bo r s t e l hänge der molekularen Interaktion zwischen LPS und TLR4/MD-2 noch immer unverstanden. Die NMR Methode zur Bestimmung der Struktur und der Dynamik von LPS in wässriger Lösung Aufdeckung dieser Zusammenhänge wird hof- The Division of Medical and Biochemical Microbi- fentlich die therapeutischen Möglichkeiten gegen ology headed by Prof. Dr. Helmut Brade generated Sepsis verbessern. In Kooperation mit der Grup- and characterized antibodies against LPS of Gram- pe von Stephan Grzesiek, NMR Structural Biology, negative bacteria. The aim was to get hold of anti- Biozentrum Basel, Schweiz, entwickelte die For- bodies which can neutralize LPS of sepsis agents schergruppe Immunchemie erfolgreich eine neue such as Escherichia coli. As previous approaches us- NMR-Methode, mit der Struktur und Dynamik von ing neoglycoconjugates for immunization failed, a LPS in wässriger Lösung bestimmt werden kön- novel strategy through vaccination with anti-idio- nen. Dies wurde dadurch erreicht, dass LPS in ge- typic antibodies was successful in inducing LPS-neu- netisch gut definierten Escherichia coli Stämmen einheitlich mit 13C,15N gekennzeichnet wurden. tralizing antibodies. The single chain technique is Isoliertes LPS wurde dann durch Di-Hexanoyl- which represent as putative therapeutics against Phosphatitdylcholine (DHPC) quasi zur Nachah- sepsis. Of special interest was the LPS of intracellu- mung der bakteriellen Membran in Lösung ge- lar Chlamydia pathogens. The crystal structure of halten. Diese LPS-Präparationen zeigten gut antibodies specific for Chlamydia LPS complexed aufgelöste NMR-Spektren, die es zum ersten Mal with natural oligosaccharides lead to the rational ermöglichten, LPS mit modernen heteronuklearen design of a synthetic neoglycoconjugate. This con- Methoden zu analysieren, um so Konformation jugate was used to generate specific antibodies und Dynamik des LPS als Schlüsselereignis in der against Chlamydophila psittaci but not other LPS-TLR4/MD-2 Interaktion zu untersuchen. Außer- Chlamydia species, which proved to be a useful tool dem zeigte sich, dass diese NMR-Methode auf to specifically diagnose C. psittaci. Successful co- die Analyse eines breiten Spektrums komplexer crystallization of antibodies and Chlamydia-LPS- de- LPS und Lipid A Strukturen unter natürlichen Be- rived oligosaccharides revealed that specificities to dingungen ähnlich der bakteriellen Membran an- 3-Desoxy-d-manno- oct-2-ulosonacid (Kdo) are germ wendbar ist. Innerhalb der Forschergruppe Im- line determined. Studies using synthetic oligosac- munchemie hat sich die Gruppe von PD Dr. Buko charide ligands therefore revealed that KDO-spe- Lindner auf verschiedene Methoden der Mas- cific antibodies expose a high flexibility with re- senspektrometrie spezialisiert. Die Gruppe ent- spect to their species specificity, which is due to low wickelte eine Kapillarelektrophorese Methode in affine cross reactivity allowing affinity maturation Kombination mit Fourier-Transform Ion Cyclotron and specification upon antigen encounter. currently used to generate recombinant antibodies, Resonanz Massenspektrometrie, um komplexe Mixturen von Glykolipiden trennen und analysie- Phage display to identify a novel single chain antibody specific for Man6P on glycoproteins ren zu können. Natürliche Glykolipid-Präparatio- Within the Division of Medical and Biochemical Mi- nen (Glykosphingolipide, Lipopolysaccharide) crobiology, PD Dr. Sven Müller-Loennies in cooper- sind grundsätzlich höchst heterogen bezüglich ation with Prof. Dr. Thomas Braulke, University Clin- Anzahl und Art von Fettsäuren, Oligosacchariden ics Hamburg-Eppendorf, employed phage display und nicht-stoichiometrischen Bestandteilen (P, P- to identify a novel single chain antibody specific for Etn, und Ara4N), welche die strukturelle Charak- mannose-6-phosphate (Man6P) on glycoproteins. terisierung behindern. In der Vergangenheit As a proof-of-principle, this antibody fragment can scheiterte die chromatographische Auftrennung be used to diagnose certain lysosomal storage dis- 22 Wissenschaftlicher Jahresbericht 2007-2008 Zusammenfassung Summary von hoch amphiphilen Bestandteilen durch HPLC eases and to purify Man6P-carrying proteins to im- oder TLC für die anschließende chemische Ana- prove enzyme supplementation therapy which will lyse. Um dieses Problem zu umgehen, wurde die gain lead to translational approaches. Kapillarelektrophorese (KE) online mit einem Fourier-Transform Ion Cykolotron Resonanz Massenspektrometer (FT-ICR MS) verbunden, wofür ein Beneath structural analyses of Gram-negative cell Sheath-Liquid-Interface genutzt wird. Diese neue wall glycolipids, the prime focus of MIB in Technik erlaubt zum ersten Mal sowohl die Tren- 2007/2008 laid in tuberculosis research. In the Divi- nung und Online-Massenanalyse von Bestandtei- sion of Molecular Infection Biology (Prof. Dr. Stefan len im nicht-derivatisierten R-Form LPS und im Li- Ehlers), the model of aerosol tuberculosis in mice pid A wie auch von komplexeren Mixturen mit was employed to define host- and pathogen-de- Nachweisgrenzen im niedrigen fmol Bereich. pendent determinants of tuberculosis pathogenesis with a focus on innate receptors. Using a humanized mouse model to investigate the role of the C-type Die von Prof. Dr. Helmut Brade geleitete For- lectin DC-SIGN, novel data suggest that instead of schergruppe Medizinische und Biochemische favouring the immune evasion of mycobacteria, hu- Mikrobiologie hat Antikörper gegen LPS von man DC-SIGN may have evolved as a pathogen re- Gram-negativen Bakterien entwickelt und cha- ceptor promoting protection by limiting TB-induced rakterisiert. Das Ziel war, einen Antikörper zu er- pathology. Focusing on the relative role of Toll-like halten, der LPS von Sepsiskeimen wie Escherichia receptors and the common adapter molecule coli neutralisieren kann. Erste Versuche mit Neo- MyD88, recent work demonstrates that Toll-like re- glykokonjugaten als Immunisierung schlugen fehl. ceptors are not essential for effective immunity to M. Hingegen war eine neue Strategie der Vakzinati- tuberculosis in mice. However, MyD88 is essential on mit anti-idiotypischen Antikörpern erfolgreich for protective host defense in tuberculosis, which is und induzierte LPS-neutralisierende Antikörper. however not due to signal transduction from TLR 2, Die Einzelkette - (Single-Chain) Technik wird der- 4 or 9. Of interest, adaptive immunity to M. tuber- zeit genutzt, um rekombinante Antikörper zu ge- culosis is largely TLR/MyD88-independent. Studies nerieren, die möglicherweise für die Therapie ge- using M. tuberculosis gene deletion mutants re- gen Sepsis eingesetzt werden könnten. Von vealed that inflammasome activation and IL-1beta besonderem Interesse war das LPS der intrazel- processing depends on a putative Zn(2+) metallo- lulären Bakterien aus der Chlamydien Familie. protease. Although nitrate reductase and arginine Die Kristallstruktur von Antikörpern, die charakte- deaminase ristisch für Chlamydien-LPS sind, zusammen mit metabolism of M. tuberculosis, mutants deficient in natürlichen Oligosacchariden führte zum Design these enzymes were not defective in persistence. eines synthetischen Neoglykokonjugates. Dieses This prompted a thorough investigation of the phys- Konjugat wurde benutzt, um spezielle Antikörper iological status of granulomatous lesions in animal gegen Chlamydophila psittaci, aber nicht gegen models. These studies revealed that tuberculosis le- andere Chlamydien-Spezies, herzustellen, was sions in the murine lung were not hypoxic, which sich als nützliches Werkzeug bei der Diagnose was however in sharp contrast to necrotizing gran- von C. psittaci erwies. Die erfolgreiche Ko-Kristal- ulomas in guinea pigs showing a hypoxic environ- lisation von Antikörpern und Oligosacchariden ment. In contrast to M. tuberculosis, the opportunist are important for anaerobic aus dem Chlamydien-LPS ließ erkennen, dass die M. avium induces necrotizing granulomas in mice. Antikörperspezifität gegen 3-Desoxy-d-manno-oct- These lesions, which develop in an IFN-γ and IRF-1- 2-Ulosonsäure (Kdo) von den Keimzellen deter- dependent manner, were also hypoxic. To further Wissenschaftlicher Jahresbericht 2007-2008 23 DC-SIGN may have evolved as a pathogen receptor Induktion von LPS neutralisierenden Antikörpern Zusammenfassung Summary miniert ist. In Untersuchungen, bei denen synthe- address the microenvironment in which mycobac- tische Oligosaccharide verwendet wurden, zeig- teria reside in vivo, a new technique was estab- te sich, dass Kdo- spezifische Antikörper eine ho- lished to isolate mycobacteria-containing phago- he Flexibilität bezüglich ihrer Spezies- Spezifität somes from primary macrophages based on zeigten, was durch eine niedrige affine Kreuzre- immunomagnetic labelling. Fo r s c h u n g s z e n t r u m Bo r s t e l aktivität verursacht wird. Diese erfahren allerdings nach Antigenerkennung eine mit der AffiThe Divison of Infection Biology (Junior Professor) nitätsreifung einhergehenden Spezifizierung. lead by Prof. Dr. Christoph Hölscher focused on the cytokine milieu essential for protective immunity in tuInnerhalb der Forschergruppe Medizinische und berculosis. This group revealed that alternative Biochemische Mikrobiologie hat PD Dr. Sven Mül- macrophage activation is associated with reactiva- ler-Loennies in Kooperation mit Prof. Dr. Thomas tion and lung pathology in tuberculosis. Reactivation Braulke, Universitätsklinikum Hamburg-Eppen- and granuloma necrosis are pivotal events of post- dorf, Phage Display eingesetzt, um einen neuen primary tuberculosis. In patients with pulmonary tu- Single Chain Antikörper zu herzustellen, der für berculosis from Ghana, a structural variant of the in- Mannose-6-Phosphat- (Man6P) auf Glycoprotei- terleukin (IL)-4 receptor-alpha (Rα) was found to be nen spezifisch ist. Dieses Antikörperfragment associated with an increased transcription of the kann genutzt werden, um bestimmte lysosomale gene and increased cavity size indicating a promi- Speicherkrankheiten zu diagnostizieren und um nent role of the IL-4Rα in human granuloma necrosis. Man6P-tragende Proteine zur Verbesserung der Detailed analysis in mice overexpressing IL-4Rα-me- Enzym-Ergänzungs-Therapie zu reinigen. Diese Er- diated signals revealed that alternative macrophage gebnisse zeigen interessante Ansätze für die activation is associated with M. tuberculosis re- translationale Forschung auf. crudescence and granuloma necrosis independent of overt effects on anti-mycobacterial T cell immunity. These studies demonstrated the contribution of IL- Therapeutic interference with IL-17-dependent pathways holds the risk of reactivating latent tuberculosis Neben der strukturellen Analyse Gram-negativer 4Rα-dependent mechanisms to the pathogenesis of Zellwandglykolipide lag der Schwerpunkt der Ab- post-primary tuberculosis. In recent years, the cy- teilung Molekulare Infektiologie in den Jahren tokine IL-17 attracted the attention of tuberculosis re- 2007/2008 in der Tuberkuloseforschung. Die For- search. The Group of Christoph Hölscher could schergruppe Molekulare Infektionsbiologie (Prof. demonstrate that IL-17 is essential to maintain pro- Dr. Stefan Ehlers) nutzt insbesondere das Maus- tective immunity during M. tuberculosis infection. A modell der Inhalationstuberkulose, um Wirts- und variety of autoimmune disorders have been shown to Erreger abhängige Determinanten der Krankheit- depend on IL-17-producing T helper (TH) 17 cells. sentwicklung zu definieren. Untersuchungen an Therapeutic blockade of TH17 development may pro- für das menschliche C-Typ Lectin DC-SIGN trans- vide a novel approach to avoid adverse conse- genen Mäusen lassen vermuten, dass dieser Re- quences of anti-inflammatory strategies such as re- zeptor vor allem zum Schutz vor der infektions- activation of latent tuberculosis as a result of vermittelten Gewebepathologie beiträgt. Bei der gezielten Analyse einzelner Toll-like Rezeptoren anti-autoimmune therapies. Their findings, however, revealed that IL-17 is essential for maintaining CD4+ (TLR) und deren gemeinsamen Signal-Adapter- TH1 cell-dependent protection during the chronic moleküls MyD88 fiel auf, dass TLRs und MyD88 für stage of tuberculosis. In conclusion, therapeutic in- die Entwicklung der anti-tuberkulösen T-Zell-Im- terference with IL-17-dependent pathways holds the munität nicht essentiell sind. Hingegen ist intaktes risk of reactivating latent tuberculosis. 24 Wissenschaftlicher Jahresbericht 2007-2008 Zusammenfassung Summary MyD88 unabdingbar für den antibakteriellen The new division of Cellular Microbiology headed Schutz, jedoch nicht aufgrund seiner Funktion als by Prof. Dr. Ulrich Schaible is also primarily focusing Adaptermolekül für TLRs. Gezielte Deletionsmu- on tuberculosis research. The main interests are the tanten in M. tuberculosis haben gezeigt, dass die role of micronutrients and innate immune players in Aktivierung des Inflammasoms und die IL-1beta- host defence against M. tuberculosis and the intra- Prozessierung durch eine Zn(2+) Metalloprotease cellular survival strategies of tubercle bacilli. Recent des Erregers moduliert werden. Obwohl die Akti- studies of this group revealed the importance of vität der Nitratreduktase und der Arginin-Deami- iron for exaggeration of tuberculosis and lead to the nase für den anaeroben Metabolismus von M. generation of novel iron sensors to measure cellu- tuberculosis wichtig sind, war die Persistenz- lar iron status in collaboration with Prof Dr. Robert fähigkeit von Mutanten, in denen diese Enzyme Hider, Kings College London. Innate immune play- inaktiviert waren, im Mausmodell nicht einge- ers such as IL-18 and neutrophils seem to contribute schränkt. Dieser Befund war der Auslöser für um- to protective host defence in a yet underappreciat- fangreiche vergleichende Untersuchungen zur ed manner. Moreover, apoptotic cell death has Physiologie des Granuloms in Tiermodellen: Hier- been demonstrated to facilitate cross-presentation bei erwiesen sich TB-Läsionen in der Maus als of mycobacterial antigens to properly prime pro- nicht schwer hypoxisch, während nekrotisierende tective T cell responses, which will be of importance Granulome in Meerschweinchen quasi anaerob for rational vaccine design against tuberculosis. Fi- waren. Die experimentelle Infektion mit M. avium nally, the mycobacterial cell wall glycolipid, tre- induziert auch in Mäusen nekrotisierende Granu- halose dimycolate, was identified as a key factor in lome - diese Läsionen, die sich abhängig von IFN- inhibiting phagosome maturation by M. tuberculo- gamma und IRF-1 entwickeln, erwiesen sich eben- sis, a hallmark of mycobacterial virulence. Howev- falls als hypoxisch. Um das Mikromilieu, in dem er, Mykobakterien intrazellulär leben, näher zu cha- macrophages is able to chemically inactivate this rakterisieren, wurde daraufhin eine neue Metho- virulence factor. These studies reveal a complex in- de entwickelt, die die Isolierung Mykobakterien- terplay between the tubercle bacillus and the host, haltiger Phagosome aus primären Makrophagen which ultimately determine either latency or dis- mittels eines immunmagnetischen Verfahrens er- ease progression. nitric oxide generated by activated laubt. The year 2007 was marked by the successful grantDie Forschergruppe Juniorprofessur Molekulare ing of the initiative for a Cluster of excellence “In- Infektionsbiologie unter der Leitung von Prof. Dr. flammation at Interfaces” between the universities Christoph Hölscher beschäftigt sich mit der Zyto- Kiel, Lübeck and the Research Centre Borstel. The kin-vermittelten Interaktion verschiedener Immun- cluster bundles research on the various aspect of in- zellen des unspezifischen und spezifischen Im- flammation in human diseases caused by infec- munsystems während der Infektion mit M. tions, allergies and autoimmunity in all three loca- tuberculosis. Das Labor fand heraus, dass eine tions. MIB with its expertise in infection research is durch den Interleukin (IL)-4 Rezeptor-alpha (Ra) an integral part of the Cluster providing structural vermittelte alternative Aktivierung von Makro- analyses and infection models. As a consequence phagen mit der Reaktivierung und der für die of the establishment of the cluster, Prof. Dr. Stefan post-primäre Tuberkulose typischen Pathologie Ehlers accepted the new Chair of Molecular In- assoziiert ist. In Patienten mit einer pulmonalen flammation Medicine at Kiel University. In the fol- Tuberkulose aus Ghana wurde eine strukturelle lowing, the novel section of Microbial Inflammation Wissenschaftlicher Jahresbericht 2007-2008 25 Isolierung Mykobakterien-haltiger Phagosome mittels eines immunmagnetischen Verfahrems Zusammenfassung Summary Variante des IL-4Ra gefunden, welche zu einer er- Research headed by Prof. Dr. Stefan Ehlers was es- höhten Signalweiterleitung führt und mit einer ver- tablished within MIB and now encompasses three stärkten Pathologie verbunden ist. Somit scheint independent divisions: Microbial Interface Biology die IL-4Ra Untereinheit von großer Bedeutung für headed by PD Dr. Norbert Reiling, Infection Im- die Ausbildung zentral nekrotisierender Granulo- munology headed by Prof. Dr. Christoph Hölscher me zu sein. Detaillierte funktionelle Analysen in and Molecular Inflammation Medicine headed by Mäusen, Prof. Dr. Stefan Ehlers. Fo r s c h u n g s z e n t r u m Bo r s t e l welche IL-4Ra-vermittelte Signale überexprimieren, zeigten, dass eine alternative Makrophagen Aktivierung involviert ist in die Therapy of infectious diseases with a special focus on bacterial sepsis Reaktivierung und Granulomnekrose einer M. tu- However, further numerous grants were awarded to berculosis Infektion ohne die anti-mykobakteriel- the researchers within MIB. The final period of fund- le T-Zell-vermittelte Immunantwort zu beeinträch- ing was granted to the Emmy-Noether Junior Re- tigen. eine search Group Immunobiophysics headed by PD Dr. bedeutsame Beteiligung von IL-4Ra-vermittelten Andra Schromm. The excellent research output of Mechanismen an der Pathogenese der post- this group lead to the decision to continue Im- primären Tuberkulose. In den vergangenen Jah- munobiophysics as an inherent part of MIB. The fi- ren zog das Zytokin IL-17 die Aufmerksamkeit der nal period of the collaborative research centre (SFB Tuberkuloseforschung auf sich. Die Forschergrup- 470) “Glycostructures in Biosystems” ending in 2009, pe um Christoph Hölscher konnte belegen, dass was highly successful and a novel initiative is under IL-17 für den Immunschutz während einer Tuber- way to hopefully continue this important research in kulose-Infektion notwendig ist. Da die Pathoge- a wider collaborative manner. Prof. Dr. Branden- nese zahlreicher autoimmuner und chronisch burg and PD Dr. Thomas Gutsmann were awarded entzündlicher Erkrankungen von IL-17-produzie- a grant by the support program of the German Min- renden T-Helfer (TH)17 Zellen abhängt, wird die istry of Education and Research (BMBF) “Innovative Inhibierung einer TH17 Entwicklung als neuartige molecular and cellular therapeutic approaches”. anti-entzündliche Therapie-Strategie diskutiert. The project “Therapy of infectious diseases with a Die Forschergruppe fand nun allerdings heraus, special focus on bacterial sepsis”, a cooperative en- dass IL-17 essentiell ist für die Aufrechterhaltung des CD4+ TH1 Zell-vermittelten Schutzes während deavour with Prof. Dr. M. Hornef (Medizinische der chronischen Phase einer Tuberkulose. Daher (Rheinisch-Westfälische Technische Hochschule birgt eine Neutralisierung von IL-17-abhängigen Aachen), will combine basic research and preclini- Mechanismen im Rahmen einer anti-entzündli- cal studies representing a fine example of transla- chen Therapie das Risiko der Reaktivierung einer tional research in the Department of MIB. Prof. Dr. latenten Tuberkulose. Otto Holst and PD Dr. Buko Lindner were also suc- Diese Studien belegen also Hochschule Hannover) and Dr. T. Schürholz cessfully involved in the collaborative research centre SFB-TR 22 between the universities of Marburg, Die neue Forschergruppe Zelluläre Mikrobiolo- Munich and Borstel. gie unter der Leitung von Prof. Dr. Ulrich Schaible richtet ihr Augenmerk ebenfalls auf die Tuberkuloseforschung. Das Hauptinteresse gilt der Rolle In November 2007, scientists from the Universities of bestimmter Nährstoffe und angeborener Be- Kiel, Lübeck, Hamburg, and Bremen, as well from standteile des Immunsystems in der Abwehr des the GKSS, the EMBL (DESY, Hamburg), and the Re- Wirtes gegen M. tuberculosis und den intrazel- search Centre Borstel came together to discuss lulären Überlebensstrategien der Tuberkulose- membrane biophysics and structural biology in the 26 Wissenschaftlicher Jahresbericht 2007-2008 Zusammenfassung Summary bakterien. Jüngere Studien der Gruppe zeigten, first Meeting of Northern Biophysicists, which was dass Eisen eine wichtige Rolle bei der Verschlim- held at the Manor House in Borstel. This novel con- merung der Tuberkulose spielt, und führten zu der vention will hopefully develop into a platform for Entwicklung von neuen Eisensensoren für die Mes- biophysicists with Borstel in its centre. In September sung des zellulären Eisenstatus (Kooperation mit 2007, the meeting „Scanning Probe Microscopy and Prof Dr. Robert Hider, Kings College London). An- Organic Materials XVI“ was organized by the Divi- geborene Bestandteile des Immunsystems wie IL- sion of Biophysics. Through such endeavours, MIB 18 und Neutrophile scheinen in einer bisher un- will become a centre of excellence for infection-fo- terschätzten Weise zur protektiven Wirtsabwehr cused biophysics. In 2008, PD Dr. Thomas Gutsmann gegen Tuberkulose beizutragen. Die Gruppe fand was appointed the new leader of the division of Bio- auch, dass der programmierte Zelltod die Kreuz- physics. He was offered a professorship at the Uni- präsentation mykobakterieller Antigene ermög- versity Ulm, which we were successfully in compet- licht und bei der Auslösung einer schützenden T- ing with and we are happy to keep Dr. Gutsmann Zellantwort eine Rolle spielt. Diese Ergebnisse as leader of the Division of Biophysics. Strategical- sind für das rationale Impfstoffdesign gegen die ly, this Division will synergize with the group of Im- Tuberkulose von Bedeutung. Schließlich wurde munobiophysics headed by PD Dr. Andra Schromm das mykobakterielle Zellwandglykolipid Trehalo- in order to strengthen focus in biophysics at the se-Dimycolat als Schlüsselfaktor bei der Hem- Borstel Research Center. mung der Phagosomreifung, eines zentralen Virulenzmechanismus des Tuberkuloseerregers, durch M. tuberculosis identifiziert. Allerdings ist In 2008, Prof. Dr. Ulrich E. Schaible accepted the Stickoxid, welches aktivierte Makrophagen pro- directorship of the Department of MIB and as duzieren, in der Lage, diesen Virulenzfaktor che- head of the division of Cellular Microbiology. This misch zu deaktivieren. Diese Studien enthüllen recruitment will further strengthen tuberculosis re- ein komplexes Zusammenspiel zwischen dem Tu- search within MIB and at the Borstel Research berkulosebazillus und seinem Wirt, was letztend- Centre. Part of this group is still placed for anoth- lich über Latenz- oder Krankheitsentwicklung ent- er two years at the London School of Hygiene and scheidet. Tropical Medicine, UK and strong links will be built between both institutions to facilitate research initiatives at the EU level and interchange expertises Das Jahr 2007 war durch die erfolgreiche Bewilli- from both partners, namely epidemiology and gung des Exzellenzclusters “Inflammation at In- structural biology. terfaces”, einer gemeinsamen Initiative der Universitäten Kiel und Lübeck und des Forschungszentrums Borstel, geprägt. Der Cluster The excellence of the present member groups of bündelt die Forschungsaktivitäten aller drei Stan- MIB forms the basis for the future development of dorte in verschiedenen Bereichen der Entzün- the department. New challenges of transition lay dungserkrankungen, die durch Infektionen, Aller- ahead of us. Outstanding and valued colleagues gien und Autoimmunitätserkrankungen verursacht will leave the department in the years to come and werden. Die Abteilung Molekulare Infektiologie adequate successors need to be recruited. This re- mit ihrer Expertise auf dem Gebiet der Infekti- quires maintaining state of the art technologies onsforschung ist integraler Bestandteil des Clu- within MIB. Continuing our excellence in structural sters und steuert Strukturanalysen und Infektions- biology requires upgrading the accoutrement in modelle bei. Im Rahmen der Etablierung des NMR and MS to remain technically up to date and Wissenschaftlicher Jahresbericht 2007-2008 27 Goal: Center of Excellence for infectionfocused biophysics Apoptose ermöglicht Kreuzpräsentation von Antigenen: Induktion einer schützenden T-Zellantwort. Zusammenfassung Summary Clusters wurde Prof. Dr. Stefan Ehlers auf die Pro- internationally competitive with respect to sensitivi- fessur Molekulare Entzündungsmedizin an der ty and resolution. The alarming menace of arising Universität Kiel berufen. Zugleich wurde inner- strains of the tubercle bacillus resistant to two and halb der Abteilung Molekulare Infektiologie der more antibiotics will require above category 3 safe- Bereich Mikrobielle Entzündungsforschung eta- ty levels in order to study such clinical isolates safe- bliert, der von Prof. Dr. Stefan Ehlers geleitet wird ly. Novel imaging technologies combined with ge- und zur Zeit drei Forschergruppen umfasst: Mi- netically tagged bacterial strains will provide the krobielle Grenzflächenbiologie unter der Leitung opportunity to study the infectious process in real von PD Dr. Norbert Reiling, Infektionsimmunolo- time in life animal models, an approach that is es- gie unter der Leitung von Prof. Dr. Christoph Höl- pecially challenging with respect to research in tu- scher und Molekulare Entzündungsmedizin unter berculosis. A future task will also be the recruitment der Leitung von Prof. Dr. Stefan Ehlers. of patient cohorts to translate our basic research in- Fo r s c h u n g s z e n t r u m Bo r s t e l Neu: Bereich Mikrobielle Entzündungsforschung to clinical studies. Thereby, we hope to contribute to novel diagnostics and therapeutics including anti-tuNeben dem Exzellenzcluster gab es noch weitere berculosis and anti-allergy drugs. These future tasks Bewilligungen von Forschungsmitteln für die Wis- will allow MIB to tackle the great challenges in in- senschaftlerinnen und Wissenschaftler der Abtei- fection research and human health. lung. Die letzte Förderperiode wurde für die Emmy-Noether-Nachwuchsgruppe Immunbiophysik, die von PD Dr. Andra Schromm geleitet wird, bewilligt. Die exzellenten Forschungsergebnisse dieser Gruppe führten zu der Entscheidung, die Immunbiophysik als inhärenten Teil der Abteilung zu erhalten. Die letzte Förderperiode des sehr erfolgreichen SFB 470 “Glykostrukturen in Biosystemen – Darstellung und Wirkung” endet 2009. Zur Zeit gibt es eine neue Initiative, die hoffentlich diese wichtige Forschung in einem breiteren kooperativen Rahmen fortsetzen wird. Prof. Dr. Klaus Brandenburg und PD Dr. Thomas Gutsmann erhielten die Bewilligung für das Projekt “Therapie von Infektionskrankheiten mit speziellem Bezug auf die bakterielle Sepsis“ im Förderprogramm des Bundesministeriums für Bildung und Forschung (BMBF) ‚Innovative Therapieverfahren auf molekularer und zellulärer Basis’. Das Projekt, eine Kooperation mit Prof. Dr. M. Hornef (Medizinische Hochschule Hannover) und Dr. T. Schürholz (Rheinisch-Westfälische Technische Hochschule Aachen), wird Grundlagenforschung und präklinische Studien kombinieren, was ein wunderbares Beispiel für die fachübergreifende Forschung der Abteilung Molekulare Infektiologie darstellt. Prof. Dr. Otto Holst und PD Dr. Buko Lindner wa- 28 Wissenschaftlicher Jahresbericht 2007-2008 Zusammenfassung Summary ren ebenfalls innerhalb des SFB-TR 22 erfolgreich, einer gemeinsamen Initiative der Universitäten Marburg und München und des Forschungszentrums Borstel. Im November 2007 diskutierten Wissenschaftler der Universitäten Kiel, Lübeck, Hamburg und Bremen gemeinsam mit Vertretern des GKSS, des EMBL (DESY, Hamburg) und des Forschungszentrums Borstel Themen der Membranbiophysik und der Strukturbiologie während des ersten Treffens der Norddeutschen Biophysiker im Herrenhaus des Forschungszentrums Borstel. Diese neue Zusammenkunft wird sich hoffentlich zu einer Plattform für Biophysiker entwickeln, in deren Zentrum Borstel steht. Im September 2007 organisierte die Forschergruppe Biophysik den Kongress „Scanning Probe Microscopy and Organic Materials XVI“. Mit Hilfe solcher Veranstaltungen wird sich die Abteilung Molekulare Infektiologie zu einem Exzellenzzentrum für Infektions-orientierte Biophysik entwickeln. 2008 wurde PD Dr. Thomas Gutsmann Thomas Gutsmann leitet die Biophysik zum Gruppenleiter der Forschergruppe Biophysik ernannt. Ihm wurde eine Professur an der Universität Ulm angeboten. Glücklicherweise konnten wir Dr. Gutsmann jedoch als Leiter der Biophysik in Borstel halten. Strategisch wird diese Forschergruppe mit der Gruppe Immunbiophysik, die von PD Dr. Andra Schromm geleitet wird, zusammenarbeiten, um den Schwerpunkt Biophysik am Forschungszentrum weiter zu stärken. 2008 übernahm Prof. Dr. Ulrich E. Schaible die Position des Direktors der Abteilung Molekulare Infektiologie und als Leiter den Bereich Mikrobiologie und Infektiologie und die Forschergruppe Zelluläre Mikrobiologie. Diese Berufung wird die Tuberkuloseforschung in der Abteilung und am Forschungszentrum Borstel weiter stärken. Ein Teil seiner Gruppe wird für die nächsten zwei Jahre weiterhin an der London School of Hygiene and Tropical Medicine angesiedelt sein. Dies wird da- Wissenschaftlicher Jahresbericht 2007-2008 29 Zusammenfassung Summary Fo r s c h u n g s z e n t r u m Bo r s t e l zu beitragen, eine enge Verbindung zwischen den Institutionen zu etablieren, um Forschungsinitiativen auf der EU-Ebene und den Austausch von Fachwissen zwischen den Partner, insbesondere in den Bereichen Epidemiologie und Strukturbiologie, zu erleichtern. Die Exzellenz der Gruppen innerhalb der Abteilung Molekulare Infektiologie bildet die Basis für die künftigen Entwicklungen der Abteilung. Neue Herausforderungen liegen vor uns. Herausragende und geschätzte Kollegen werden in den kommenden Jahren die Abteilung verlassen und würdige Nachfolger müssen rekrutiert werden. Dies erfordert die Etablierung von hochmodernen Technologien in der Abteilung. Für die Fortführung unserer exzellenten Arbeit in der Strukturbiologie müssen NMR und MS in Hinblick auf Sensitivität und Auflösung modernisiert werden, um technisch auf dem neuesten Stand zu bleiben und international kompetitiv sein zu können. Die Höhere Sicherheitssufen für die Untersuchung multiresistenter, klinischer Isolate in der Tuberkuloseforschung alarmierende Bedrohung durch neue, gegen zwei und mehr Antibiotika resistente Stämme des Tuberkelbazillus wird höhere Sicherheitsstufen als die Stufe 3 erfordern, um solche klinischen Isolate sicher untersuchen zu können. Neue bildgebende Technologien in Kombination mit genetisch markierten Bakterienstämmen werden die Möglichkeit bieten, den infektiösen Prozess in Echtzeit in lebenden Tiermodellen zu untersuchen, eine Vorgehensweise, die mit Blick auf die Tuberkuloseforschung eine besondere Herausforderung darstellt. Eine weitere Aufgabe in der Zukunft wird die Rekrutierung von Patientenkollektiven sein, um unsere Grundlagenforschung in klinischen Studien umzusetzen. Dabei hoffen wir, zu der Entwicklung neuer Diagnoseverfahren und Therapien insbesondere gegen Tuberkulose und Allergien beitragen zu können. Diese zukünftigen Aufgaben werden es der Abteilung erlauben, sich, in unserer Verantwortung für die Gesundheit der Menschheit, den großen Herausforderungen in der Infektionsforschung zu stellen. 30 Wissenschaftlicher Jahresbericht 2007-2008 Division of Medical and Biochemical Microbiology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l Division of Medical and Biochemical Microbiology Head (mAb) S69-4 which was able to differentiate C. Prof. Dr. Helmut Brade psittaci from C. pecorum, C. pneumoniae and C. tra- Principal Investigators infected cell monolayers and by ELISA. The epitope Dr. Lore Brade specificity of mAb S69-4 was determined by binding PD Dr. Sven Müller-Loennies and inhibition assays using bacteria, LPS, and chomatis in double labelling experiments of natural or synthetic Kdo oligosaccharides as free Staff Scientists and Postdoctoral Fellows ligands or conjugated to bovine serum albumin. The Prof. Satish Raina mAb bound preferentially Kdo(2→8)[Kdo(2→4)] Prof. Graciana Klein Kdo(2→4)Kdo with a KD of 10 µM as determined by Dr. Elder Pupo (recipient of an Alexander von Hum- surface plasmon resonance for the monovalent in- boldt grant) teraction using mAb or single chain Fv. Cross-reactivity was observed with Kdo(2→4)Kdo(2→4)Kdo Graduate and Diploma Students but not with Kdo(2→8)Kdo(2→4)Kdo, Kdo disac- Dipl. Biol. Sandra Gerstenbruch charides in 2→4- or 2→8-linkage or with Kdo Dipl. Biol. Lena Heinbockel monosaccharide. MAb S69-4 was able to detect LPS on thin layer chromatography plates in amounts of Technicians less than 10 ng by immuno-staining. Due to the high Ute Agge sensitivity achieved in this assay, the antibody also Nadine Harmel detected in-vitro products of cloned Kdo-transferas- Dagmar Meyer es of Chlamydia. The antibody can therefore be Christine Schneider used in medical and veterinarian diagnostics, gen- Veronika Susott eral microbiology, analytical biochemistry and stud- Irina von Cube ies of chlamydial LPS biosynthesis. Research Reports A monoclonal antibody against a carbohydrate epitope in lipopolysaccharide differentiates Chlamydophila psittaci from Chlamydophila pecorum, Chlamydophila pneumoniae and Chlamydia trachomatis Müller-Loennies S, Gronow S, Brade L, Brade H. Lipopolysaccharide (LPS) of Chlamydophila psittaci but not of Chlamydophila pneumoniae or Chla- mydia trachomatis contains a tetrasaccharide of 3-deoxy-α-D-manno-oct-2-ulosonic acid (Kdo) of the Fig. 1. Characterization of LPS from C. trachomatis and C. psittaci using monoclonal antibodies. Isolated LPS of C. trachomatis (lane 1-3) or C. psittaci (lane 4-6) in amounts of 100 ng (lane 1 and 4), 50 ng (lane 2 and 5) or 20 ng (lane 3 and 6) were separated by TLC and stained with mAb S67-27 recognizing a single Kdo residue, mAb S25-23 recognizing aKdo-(2→8)-αKdo-(2→4)-Kdo trisaccharide or mAb S69-4. sequence Kdo(2→8)[Kdo(2→4)]Kdo(2→4)Kdo. Af- Further contribution to the general understanding of ter immunization with the synthetic neoglycoconju- carbohydrate binding antibodies was obtained by a gate antigen Kdo(2→8)[Kdo(2→4)]Kdo(2→4)Kdo- comparison of the primary structure of mAb S69-4 to BSA, we obtained the mouse monoclonal antibody that of mAb S45-18 of which the crystal structure in 32 Wissenschaftlicher Jahresbericht 2007-2008 Division of Medical and Biochemical Microbiology Research Reports complex with its ligand has been elucidated recent- nation of the diffraction data revealed that the crys- ly [Nguyen, H. P., N. O. Seto, C. R. MacKenzie, L. tal was likely to be twinned and that the correct Brade, P. Kosma, H. Brade, and S. V. Evans. 2003. space group was P212121. Both translational pseu- Germline antibody recognition of distinct carbohy- dosymmetry and pseudo-merohedral twinning were drate epitopes. Nat. Struct. Biol. 10:1019-1025]. observed in one crystal of SAG506-01 and pseudomerohedral twinning was observed for a second crystal. The final R factor for SAG506-01 after refinement in P212121 was 20.5 %. Fig. 2. Detection of chlamydial inclusions in tissue culture by double labelling with monoclonal antibody S5-10 and S69-4. Tissue culture monolayers were infected with C. psittaci, C. pneumoniae or C. trachomatis, reacted with mAb S5-10 (IgG3) and S69-4 (IgG1) and developed with isotype specific second antibodies conjugated to FITC or HRP, respectively. Collaboration: Roger MacKenzie, Institute for Biological Sciences, National Research Council Ottawa, Canada; Paul Kosma, Department of Chemistry, University of Natural Resources and Applied Life Sciences, Vienna, Austria. Pseudo-symmetry and twinning in crystals of homologous antibody Fv fragments Fig. 3. Amino-acid sequence of the variable regions of SAG173-04 and SAG506-01 (top) and positions in the crystal structures (bottom). There are a total of three amino-acid differences in the two variable light-chain regions and four amino-acid differences in the two heavy-chain variable regions; however, only one of these differences lies in the hypervariable regions that potentially contact the antigen. The amino-acid sequence is numbered according to the Kabat numbering scheme. CDRs are indicated by grey shading. The magenta spheres represent the locations of the aminoacid differences, with the light chain in yellow and the heavy chain in white . A single molecule within the asymmetric unit of SAG50601 is shown alone for clarity. Müller-Loennies S, Gerstenbruch S, Brade H. A difference of seven conservative amino-acid substitutions between two single-chain antibodies (scFvs) specific for chlamydial lipopolysaccharide does not significantly affect their molecular structures or packing contacts, but dramatically affects their crystallization. The structure of the variable domain (Fv) of SAG173-04 was solved to 1.86 Å resolution and an Rcryst of 18.9 % in space group P212121. Crystals of the homologous SAG506-01 Collaboration: Stephen V. Evans, Cory L. Brooks, diffracted to 1.95 Å resolution and appeared at first Ryan J. Blackler, Department of Biochemistry and to have Patterson symmetry I4/m or P4/mmm; how- Microbiology, University of Victoria, Victoria, BC, ever, no solution could be found in space groups Canada; Paul Kosma, Department of Chemistry, belonging to the former and refinement in the only University of Natural Resources and Applied Life Sci- solution corresponding to the latter (in space group ences, Vienna, Austria. P43212) stalled at Rfree = 30.0 %. Detailed exami- Wissenschaftlicher Jahresbericht 2007-2008 33 Division of Medical and Biochemical Microbiology Research Reports Exploration of specificity in germline monoclonal Collaboration: Stephen V. Evans, Cory L. Brooks, De- antibody recognition of a range of natural and partment of Biochemistry and Microbiology Univer- synthetic epitopes sity of Victoria, Canada; Paul Kosma, Department of Müller-Loennies S, Brade L, Brade H. Chemistry, University of Natural Resources and Ap- Fo r s c h u n g s z e n t r u m Bo r s t e l plied Life Sciences, Vienna, Austria; Roger MacKenTo explore the molecular basis of antigen recogni- zie, Tomoko Hirama, Institute for Biological Sci- tion by germline antibodies, we have determined to ences, National Research Council Ottawa, Canada. high resolution the structures of the near-germline monoclonal antibody S25-2 in complex with seven distinct carbohydrate antigens based on the bacte- Recognition of heptoses and the inner core of rial sugar 3-deoxy-α-D-manno-oct-2-ulosonic acid bacterial lipopolysaccharides by surfactant pro- (Kdo). In contrast to previous findings, the inherited tein D germline Kdo monosaccharide binding site is not re- Müller-Loennies S, Brade H stricted to this bacterial sugar but is able to accommodate an array of substitutions and chemical mod- Lipopolysaccharides (LPS) of Gram-negative bacte- ifications of Kdo, including naturally occurring ria are important mediators of bacterial virulence antigens containing the related monosaccharide D- that can elicit potent endotoxic effects. Surfactant glycero-α-D-talo-oct-2-ulosonic acid as well as non- protein D (SP-D) shows specific interactions with terminal Kdo residues. However, we show by surface LPS, both in vitro and in vivo. These interactions in- plasmon resonance and ELISA how antibody S25-2 volve binding of the carbohydrate recognition do- specificity is so dependent on the context in which main (CRD) to LPS oligosaccharides (OS); however, the antigen is presented that a free disaccharide dis- little is known about the mechanisms of LPS recog- plays strong binding while the same lipid-A-bound nition. Recombinant neck+CRDs (NCRDs) provide disaccharide does not bind. These structures pro- an opportunity to directly correlate binding interac- vide insight into how inherited germline genes code tions with a crystallographic analysis of the binding for immunoglobulins of limited flexibility that are ca- mechanism. In these studies, we examined the in- pable of binding a range of epitopes from which teractions of wild-type and mutant trimeric NCRDs affinity-matured antibodies are generated. with rough LPS (R-LPS). Although rat NCRDs bound more efficiently than human NCRDs to Escherichia coli J-5 LPS, both proteins exhibited efficient binding to solid-phase Rd2-LPS and to Rd2-LPS aggregates presented in the solution phase. Involvement of residues flanking calcium at the sugar binding site was demonstrated by reciprocal exchange of lysine and arginine at position 343 of rat and human CRDs. The lectin activity of hNCRDs was inhibited by specific heptoses, including L-glycero-α-D-mannoheptose (L,D-heptose), but not by 3-deoxy-α-D-mannooct- 2-ulosonic acid (Kdo). Crystallographic analysis Fig. 4. Synthetic Kdo analogues crystallized with monoclonal antibody S25-2. The oligosaccharides (A) Kdo(2→4)Kdo(2→4)Kdo; (B) Ko; (C) Ko(2→4)Kdo; (D) 7-epi-Kdo; (E) 3,4-dehydro-3,4,5-trideoxyKdo(2→8)Kdo; (F) 5-deoxy-4-epi-2,3-dehydro-Kdo(4→8)Kdo; (G) Kdo(2→4)KdoC1red represent natural partial structures of bacterial LPS as well as artificial analogues of Kdo. of the hNCRD demonstrated a novel binding orientation for L,D-heptose, involving the hydroxyl groups of the side chain. Similar binding was observed for a synthetic α1→3-linked heptose disaccharide corresponding to heptoses I and II of the inner core 34 Wissenschaftlicher Jahresbericht 2007-2008 Division of Medical and Biochemical Microbiology region in many LPS. 7-O-Carbamoyl-L,D-heptose Research Reports Theses and D-glycero-α-D-manno-heptose were bound via ring hydroxyl groups. Interactions with the side Diploma chain of inner core heptoses provide a potential Lena Heinbockel mechanism for the recognition of diverse types of Struktur- und Wirkungsbeziehungen bei der Bindung LPS by SP-D. von Antikörpern an Lipopolysaccharide aus Salmo- nella enterica Technisch-Naturwissenschaftliche Fakultät Universität zu Lübeck, 2007. Fig. 5. Crystallographic complexes of the wild-type human NCRD with L,D- and D,D-heptose. (A) L,D-Heptose (red and green sticks) binds to Ca1 (green) by the 6- and 7-OH groups of its side chain. (B) D,D-Heptose (red and pink sticks) also interacts with Ca1 via the sugar ring. Fig. 6. Superimpositions of L,D- and D,D-heptose. (A) D,D-Heptose (pink sticks) and L,D-heptose (green sticks) crystal complexes illustrated in panels A and D of Figure 7 were aligned. The side chain OH groups of L,D-heptose show the same spatial distribution as the vicinal OH groups of the pyranose ring of D,D-heptose. (B) D,D-Heptose (pink sticks) was reoriented and superimposed on the L,D-heptose crystal structure (green sticks). The spatial distribution of the 6- and 7-OH groups of the side chain of D,D-heptose does not allow coordination with Ca1. Collaboration: Hua Wang, James Head, Tanya Cafarella, Barbara Seaton, Department Physiology and Biophysics, Boston University School of Medicine, Boston, USA; Sharmin Sheikh, Barbara McDonald, Kelly Smith, Erika Crouch, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, USA; Paul Kosma, Department of Chemistry, University of Natural Resources and Applied Life Sciences, Vienna, Austria. Wissenschaftlicher Jahresbericht 2007-2008 35 Division of Structural Biochemistry Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l Division of Structural Biochemistry Head and providing sufficient amounts of LPS precursors Prof. Dr. Otto Holst to support OM biogenesis. We now report the identification of an arginine to cysteine substitution at Principle Investigator position 134 of the conserved IM protein YhjD in Dr. Uwe Mamat KPM22 that acts as a compensatory suppressor mutation of the lethal DKdo phenotype. Further, the Staff Scientists and Postdoctoral Fellows yhjD400 suppressor allele renders the LPS trans- Dr. Katarzyna Duda Dr. Nestor Gonzalez Roldan porter MsbA dispensable for lipid IVA transmembrane trafficking. The independent derivation of a Dr. Anna Hanuszkiewicz series of nonconditional KPM22-like mutants from Dr. Patricia Sanchez-Carballo the Kdo-dependent parent strain TCM15 revealed a Dr. Kay Vogel second class of suppressor mutations localized to MsbA. Proline to serine substitutions at either Graduate Student residue 18 or 50 of MsbA relieved the Kdo growth Elena Ciliberti dependence observed in the isogenic wild-type strain. Technicians Rainer Bartels Collaboration: Meredith TC, Department of Micro- Helga Bartels biology and Molecular Genetics, Harvard Medical Petra Behrens School, Boston, USA; Woodard RW, Kirchhoff P, Kühl Sylvia Düpow A, Department of Medicinal Chemistry, College of Regina Engel Pharmacy, University of Michigan, Ann Arbor, USA; Volker Grote Aggarwal P, Nanotechnology Characterization Lab- Katharina Jakob oratory, Advanced Technology Program, SAIC-Fred- Gudrun Lehwark-Yvetot erick, Inc., Frederick, USA; Lindner B, Division of Im- Kerstin Viertmann munochemistry, Research Center Borstel. Research Reports Supported in part by: Deutsche Forschungsgemein- Single amino acid substitutions in either YhjD or schaft (Ma 1408/2-1 and Li-448/4-1). MsbA confer viability to 3-deoxy-D-manno-oct-2ulosonic acid-depleted Escherichia coli Mamat U, Hanuszkiewicz A, Holst O. Modification of lipopolysaccharide with colanic acid (M-antigen) repeats in Escherichia coli The Escherichia coli K-12 strain KPM22, defective in Mamat U, Holst O. synthesis of 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo), is viable with an outer membrane (OM) com- Colanic acid (CA) or M-antigen is an exopolysac- posed predominantly of lipid IVA, a precursor of li- charide produced by many enterobacteria, includ- popolysaccharide (LPS) biosynthesis that lacks any ing the majority of Escherichia coli strains. Unlike glycosylation. To sustain viability, the presence of a other capsular polysaccharides which have a close second-site suppressor was proposed for transport association with the bacterial surface, CA forms a of lipid IVA from the inner membrane (IM), thus relieving toxic side effects of lipid IVA accumulation loosely associated saccharide mesh that coats the 36 bacteria, often within biofilms. We show that a high- Wissenschaftlicher Jahresbericht 2007-2008 Division of Structural Biochemistry Research Reports ly mucoid strain of E. coli K-12 ligates CA repeats to early-life contact with cowsheds, farm animals, a significant proportion of lipopolysaccharide (LPS) and/or consumption of products like raw milk. Also, core acceptor molecules, forming the novel LPS gly- it had been indicated that microorganisms might coform we call MLPS. MLPS biosynthesis is dependent upon i) CA induction, ii) LPS core biosynthesis, have an important effect on the development of and iii) the O-antigen ligase WaaL. Compositional microbial organisms, their products, or both might analysis, mass spectrometry, and nuclear magnet- induce or influence allergy-protective mechanisms. ic resonance spectroscopy of a purified MLPS sam- We sought to gain further insight into the potential ple confirmed the presence of a CA repeat unit allergy-protective properties of microbes isolated identical in carbohydrate sequence, but differing at from the farming environment. Of a number of bac- multiple positions in anomeric configuration and terial species identified in cowsheds of farms, linkage, from published structures of extracellular 2 were selected, isolated, and characterized, name- CA. The attachment point was identified as O-7 of ly Acinetobacter lwoffii F78 and Lactococcus lactis allergies, and thus the question arose of which farm the L-glycero-D-manno-heptose of the outer LPS G121. The isolates were investigated with regard to core, the same position used for O-antigen ligation. their activation of pattern-recognition receptors, the When O-antigen biosynthesis was restored in the maturation of human monocyte-derived dendritic K-12 background and grown under conditions meet- cells, the upregulation of inflammatory cytokines, ing the above specifications, only MLPS was observed, suggesting E. coli can reversibly change its the TH1-polarizing Notch ligand expression, and proximal covalently linked cell surface polysaccha- that both bacterial isolates were able to reduce al- ride coat from O-antigen to CA in response to lergic reactions in mice, to activate mammalian certain environmental stimuli. The identification of cells in vitro, and to induce a TH1-polarizing pro- MLPS has implications for potential underlying gram in dendritic cells. Our data strongly support mechanisms coordinating the synthesis of various the hygiene hypothesis, which states that an envi- surface polysaccharides. ronment rich in microbiologic structures, such as a their influence on the allergic phenotype. It is shown farming environment, might protect against the Collaboration: Meredith TC, Woodard RW; Depart- development of allergies. ment of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, USA; Kaczynski Z, Collaboration: Debarry J, Dickgreber N, Heine H, Faculty of Chemistry, University of Gdansk, Gdansk, Division of Innate Immunity, Research Center Bors- Poland; Lindner B, Division of Immunochemistry, Re- tel; Garn H, Blümer N, Renz H, Department of Clini- search Center Borstel. cal Chemistry and Molecular Diagnostics, Medical Faculty, Philipps University, Marburg; von Mutius E, Dr von Hauner Children’s Hospital, Ludwig-Maxim- Acinetobacter lwoffii and Lactococcus lactis ilians-University of Munich; Bufe A, Experimental strains isolated from farm cowsheds possess Pneumology, BGFA-XU18, Ruhr-University Bochum; strong allergy-protective properties Gatermann S, Institute for Hygiene and Microbiolo- Hanuszkiewicz A, Holst O. gy, Department of Medical Microbiology, Ruhr-University Bochum, Bochum. Children who grow up in a farming environment show lower levels of atopic sensitization, hay fever, Supported in part by: Deutsche Forschungsgemein- and asthma than children of the same age not liv- schaft (SFB-TR22, Project A2). ing in such an environment. A number of investigations provided good evidence that this is due to an Wissenschaftlicher Jahresbericht 2007-2008 37 Division of Structural Biochemistry Research Reports Investigation of the chemical structure and bio- non-virulent smooth-opaque (SmO) type. From both logical activity of oligosaccharides isolated from morphotypes we separated a non-acylated arabi- rough-type Xanthomonas campestris pv. cam- nomannan (AM) from an acylated polysaccharide pestris B100 lipopolysaccharide fraction by affinity chromatography, of which the Kaczynski Z, Holst O. AMs were structurally characterised. The AMs from Fo r s c h u n g s z e n t r u m Bo r s t e l the virulent morphotype in contrast to that from the The rough-type lipopolysaccharide (LPS) of the phy- non-virulent form possessed a larger mannan chain topathogenic bacterium Xanthomonas campestris and a shorter arabinan chain. Incubation of murine pv. campestris B100 was isolated utilizing the hot bone marrow derived macrophages and human phenol-water method and successively deacylated dendritic cells showed that the acylated polysac- by treatment with hydrazine and hot potassium charide fractions were potent inducers of TNF-α, hydroxide. Four compounds were separated by IL-12 and IL-10, compared to non-acylated AMs preparative high-performance anion-exchange which only led to a marginal cytokine release. Fur- chromatography and studied by sugar analysis and by 1D and 2D homonuclear and heteronuclear 1H, lated polysaccharide fractions as well as the non- 13C and 31P NMR spectroscopy as well as ESI FT- acylated AMs were able to induce in vitro anti-tumor MS. The two main products were a heptasaccharide cytotoxicity of human peripheral blood mononucle- ther in vitro experiments showed that both, the acy- and a pentasaccharide of the structures α-D-Manp- ar cells. Thus, morphotype specific structural differ- (1→3)-α-D-Manp-(1→3)-β-D-Glcp-(1→4)-α-D-Manp- ences in capsular AMs of M. avium do not correlate 3 P -(1→5)-α-Kdo-(2→6)-β-D-Glc pN -4 P -(1→6)-α-D- with biological activity, however, their acylation is a GlcpN-1P (1) and β-D-Glcp-(1→4)-α-D-Manp-3P- prerequisite for effective stimulation of murine (1→5) -α- Kdo-(2→6)-β-D-GlcpN-4P-(1→6)-α-D-GlcpN- macrophages and human dendritic cells. 1P (2), respectively. The products in smaller amounts were a heptasaccharide and pentasaccharide pos- Collaboration: Mittelstädt J, Brandau S, Division of sessing the above structures plus a phosphate Immunotherapy, Research Center Borstel; Reiling N, group at C-4 of the Kdo residue (compounds 3 and Division of Molecular Infectiology, Research Center 4). Both, heptasaccharide 1 and pentasaccharide 2 Borstel; Lindner B, Division of Immunochemistry, Re- were able to induce an oxidative burst in cell cul- search Center Borstel; Torrelles J, Brennan PJ, De- tures of the non-host plant tobacco. partment of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Collaboration: Lindner B, Division of Immunochemi- Biomedical Sciences, Colorado State University, Fort stry, Research Center Borstel; Braun, S, Niehaus, K, Collins, CO, USA. Abt. 7, Proteom- und Metabolomforschung, Fakultät für Biologie, Universität Bielefeld, Bielefeld. Supported in part by: Deutsche Forschungsgemeinschaft (SFB 470, Project B1). Capsular arabinomannans from Mycobacterium avium with morphotype specific structural differ- The structure of the O-specific polysaccharide of ences but identical biological activity the lipopolysaccharide from Pantoea agglomer- Wittkowski M, Holst O. ans strain FL1 Hanuszkiewicz A, Holst O. The capsules of two colony-morphotypes of My- cobacterium avium strain 2151 were investigated, A neutral O-specific polysaccharide consisting of D- i.e. of the virulent smooth-transparent (SmT) and the rhamnose was obtained by mild acid hydrolysis of 38 Wissenschaftlicher Jahresbericht 2007-2008 Division of Structural Biochemistry Research Reports the lipopolysaccharide of the plant pathogenic bac- tetrasaccharidic repeating unit containing a high terium Pantoea agglomerans strain FL1, a common number of acidic monosaccharides. It was hypoth- epiphyte of many plant species, and associated esized that the carboxylate groups might serve as with Pseudomonas savastanoi pv. savastanoi in a protective buffer for bacterium under the extreme young and apparently intact olive knots. By means life conditions. To provide insight into the relation- of compositional and methylation analyses, and ship and interactions between the environmental NMR spectroscopy, the chemical repeating unit of factors and microbial life, the core structure was al- the polymer was identified as a linear tetrasaccha- so characterized. The LPS was hydrolyzed under ride of the structure both mild acid and strong alkaline conditions. This last treatment was the best one to →2)-a-D-Rhap-(1→2)-β-D-Rhap-(1→3)-a-D-Rhap-(1→2)-a-D-Rhap-(1→ obtain the whole core backbone and to gain information about the phosphates poCollaboration: Cimmino A, Evidente A, Dipartimen- sition. Moreover, the strong alkaline treatment prod- to di Scienze del Suolo, della Pianta, dell’ Ambien- uct allowed us to identify the linkage between the te e delle Produzioni Animali, Universitá Degli Studi O-chain and the core structure. Two core oligosac- di Napoli Federico II, I-80055 Portici (NA), Italy; Mar- charides were found and their structures were de- chi G, Surico G, Dipartimento di Biotecnologie Agra- termined by FTICR MS and NMR spectroscopy. To rie-Patologia Vegetale, Università di Firenze, I-50144 the best of our knowledge, this represents the first Firenze, Italy. description of the core structure of a lipopolysaccharide of an extremophile bacterium. Structural characterization of the core region of Collaboration: Pieretti G, Corsaro MM, Lanzetta R, the lipopolysaccharide from the haloalkaliphilic Parrilli M, Dipartimento di Chimica Organica e Halomonas pantelleriensis: Identification of the Biochimica, Università Federico II di Napoli, Napoli, biological O-antigen repeating unit Italy; Nicolaus B, Gambacorta A, Istituto di Chimica Holst O. Biomolecolare ICB-CNR, Pozzuoli, Italy; Lindner B, Division of Immunochemistry, Research Center Borstel. Halomonas pantelleriensis is an extremophile, haloalkaliphilic microorganism that requires strictly aerobic conditions for growth. It is able to optimally The structure of the O-specific polysaccharide grow in media containing 3–15 % (w/v) total salt at from the lipopolysaccharide of Pseudomonas sp. a pH value between 9 and 10. To survive in these OX1 cultivated in the presence of the Azo Dye Or- harsh conditions the extremophiles have developed ange II several strategies that allow the microorganism to Holst O. thrive. These adaptative strategies probably concern the bacteria outer membrane, which is a bar- The Gram-negative bacterium Pseudomonas sp. rier regulating the exchange with the environment. OX1, previously known as P. stutzeri OX1, is en- In such a context, the lipopolysaccharides (LPSs), dowed with a great metabolic versatility and is which are among the major constituent of the Gram- able to utilize a wide range of toxic organics as the negative outer membrane, are thought to contribute only source of carbon and energy for its growth. It to restrictive membrane permeability properties. has been recently observed that Pseudomonas sp. Previous studies concerning the structure of the O- OX1 can reduce azo dyes, ubiquitous pollutants ex- chain repeating unit of the lipopolysaccharide from hibiting resistance toward chemical and physical this bacterium showed that it is constituted of a degradation, with this azoreduction being a pro- Wissenschaftlicher Jahresbericht 2007-2008 39 Division of Structural Biochemistry Research Reports cess able to generate enough energy to sustain etamido-2,6-dideoxy-α- and β-D-glucopyranosides Fo r s c h u n g s z e n t r u m Bo r s t e l bacterial survival. When such culture conditions oc- and N-(5-hydroxy-6-methyl-4-oxo-4H-pyran-3-yl) acet- cur, modifications in the primary structure of the O- amide as side-products. specific polysaccharide (OPS) within the lipoto Collaboration: Borowski S, Michalik D, Reinke H, Vo- remarkable changes both in the monosaccharide gel C, University of Rostock, Institute of Chemistry, composition and in the architecture of the repeat- Rostock; Duda KA, Department of Microbiology, Uni- ing unit, with respect to the polysaccharide pro- versity of Silesia, Katowice, Poland. polysaccharides are observed, leading duced under standard culture conditions. In the present paper, we present the complete structure of the O-specific polysaccharide being 3)-β-D-QuiNAc4NBuOH(1→4)-α-D-GalNASer-(1→4)-α-D-ManNAcA-(1→4)-α-L-GulNAcA-(1 3 β-D-Glc-(1 This structure is profoundly different from the one Activation of pro-matrix metalloproteinase-9 and isolated from Pseudomonas sp. OX1 grown on rich degradation of gelatin by the surface protease medium. PgtE of Salmonella enterica serovar Typhimurium. Holst O. Collaboration: Leone S, Lanzetta R, Scognamiglio R, Alfieri F, Parrilli M, Molinaro A, Dipartimento di Chi- Mammalian matrix metalloproteinases (MMPs) de- mica Organica e Biochimica, Università degli Studi grade collagen networks in extracellular matrices di Napoli Federico II, Napoli, Italy; Izzo V, Di Dona- by cleaving collagen and its denatured form to A, Dipartimento di Biologia Strutturale e Funzio- gelatin, and thus enhance migration of mammalian nale, Università degli Studi di Napoli Federico II, cells. The gastrointestinal pathogen Salmonella en- Napoli, Italy. terica survives and grows within host macrophages and dendritic cells, and can disseminate in the host by travelling within infected host cells. Here, we re- αSynthesis of methyl 2-acetamido-2,6-dideoxy-α port that S. enterica serovar Typhimurium activates and β-D-xylo-hexopyranosid-4-ulose, a keto sugar proMMP-9 (gelatinase B) secreted by human pri- which misled the analytical chemists mary macrophages, and degrades gelatin after Hanuszkiewicz, Holst O. growth within J774A.1 murine macrophage-like cells. Both proMMP-9 activation and gelatin degradation To understand the contradictory results on the struc- were due to expression of the Salmonella surface ture of the lipopolysaccharide isolated from a Yer- protease PgtE. Following intraperitoneal infection in sinia enterocolitica O:3, both anomers of methyl 2- BALB/c mice, the amount of a pgtE deletion deriva- acetamido-2,6-dideoxy-D-xylo-hexopyranosid-4-ulos tive was nearly ten-fold lower in the livers and e were prepared. The key steps of the synthetic spleens of mice than the amount of wild-type S. en- pathway were the selective acetylation of the terica, suggesting that PgtE contributes to dissemi- methyl 2-acetamido-2,6-dideoxy-α,β-D-glucopyrano- nation of Salmonella in the host. PgtE belongs to the sides, the oxidation of the 4-position to form the ke- omptin family of bacterial beta-barrel transmem- to-sugars, and deacetylation to provide the target brane proteases. The ortholog of PgtE in Yersinia compound. Surprisingly, the last step was accom- pestis, Pla, which is central for bacterial virulence in panied by a disproportionation to give methyl 2-ac- plague, was poor in proMMP-9 activation and in 40 Wissenschaftlicher Jahresbericht 2007-2008 Division of Structural Biochemistry Research Reports gelatin degradation. To model the evolution of ing infection with either strain. Aerosol challenge of these activities in the omptin barrel, we performed mice showed that wild type and Rv1500 mutant a substitution analysis in Pla and genetically modi- strains had identical growth rates in infected organs fied it into a PgtE-like gelatinase. Our results indi- over time. We verified mRNA expression of Rv1500 cate that PgtE and Pla have diverged in substrate in H37Rv and conclude that Rv1500 must serve a re- specificity, and suggest that Salmonella PgtE has dundant role in viability and virulence of M. tuber- evolved to functionally mimic mammalian MMPs. culosis. Collaboration: Ramu P, Lobo LA, Kukkonen M, Bjur Collaboration: Malm S, Bange F-C, Department of E, Suomalainen M, Raukola H, Miettinen M, Medical Microbiology and Hospital Epidemiology, Julkunen I, Rhen M, Korhonen TK, Lähteenmäki K, Medical School Hannover, Hannover; Walter K, General Microbiology, Department of Biological Maass S, Pfau S, Ehlers S, Division of Molecular In- and Environmental Sciences, Faculty of Biosciences, fection Biology, Research Center Borstel, Borstel; University of Helsinki, Helsinki, Finland. Hübner G, Lindner B, Division of Immunochemistry, Research Center Borstel, Borstel. In vitro and in vivo characterization of a Mycobacterium tuberculosis mutant deficient in gly- Animal shed Bacillus licheniformis spores possess cosyltransferase Rv1500 allergy-protective as well as inflammatory prop- Engel R, Holst O. erties Vogel K, Holst O. In Mycobacterium marinum the homologue of Rv1500 of Mycobacterium tuberculosis encodes a Numerous epidemiological studies have demon- glycosyltransferase. Initially, it was suggested that strated an allergy-protective effect of farm life early this gene is involved in the synthesis of phos- in childhood. It has been hypothesized that environ- phatidylinositol mannosides (PIM), generating mental exposure to microbes may at least in part Ac2PIM7 from Ac2PIM5. PIM and its related compounds lipomannan (LM) and lipoarabinomannan contribute to this effect. Due to their small size and (LAM) have been shown to modulate the host re- of small children bacterial spores may be candi- thereby their potential for deposition in lower airways sponse to an infection with M. tuberculosis. Here, dates for such allergy protective effects. To investi- we generated a deletion mutant of Rv1500 in My- gate immune responses elicited by exposure to Bacil- cobacterium tuberculosis H37Rv, and analyzed the lus spores in experimental settings. Animal shed and mutant using a biochemical approach as well as in mattress dusts were analyzed for bacteria and fungi vitro and in vivo infection models. Inactivation of by aerobic and anaerobic growth. Bacillus licheni- Rv1500 did not lead to an altered expression pat- formis 467, the most prominent microorganism found tern of PIMs in M. tuberculosis H37Rv. We found in these samples, was investigated with respect to phophatidylinositol (PI), AcPIM2, Ac2PIM2, and AcPIM6 in both strains, but were unable to detect spore specific stimulation of pattern recognition re- Ac2PIM7 or Ac2PIM5 either in the wild type or the mutant strain. Uptake and growth of H37Rv and ceptors, monocyte derived dendritic cells and TH-cell polarization in vitro as well as to the prevention of asthma development in a mouse model of allergic Rv1500 mutant strains in murine bone marrow-de- asthma. In vitro, Bacillus licheniformis spores acti- rived macrophages was identical, and TNF IL-12p40 production in mouse macrophages and vated a TH1 cytokine expression profile. In vivo application of these spores resulted in less spore-spe- dendritic cells was induced to similar levels follow- cific but long lasting immune activation preventing and Wissenschaftlicher Jahresbericht 2007-2008 41 Division of Structural Biochemistry Research Reports eosinophilia and goblet cell hyperplasia, however troscopy and mass spectrometry, the structure of the they provoked an influx of neutrophils in lung tissue rough lipopolysaccharide (LPS) isolated from Acine- of asthmatic mice. Bacterial spores may contribute to tobacter lwoffii F78 was elucidated. As a prominent the allergy-protective properties of farming environ- feature, the core region of this LPS contained the ments, but their persistence in the lung causes on- disaccharide α-Kdo-(2→8)-α-Kdo which so far has going immune activation in mouse experiments. been identified only in chlamydial LPS. In serologi- Fo r s c h u n g s z e n t r u m Bo r s t e l cal investigations, the anti-chlamydial LPS monoCollaboration: Blümer N, Garn H, Renz H, Depart- clonal antibody S25-2 which is specific for the epi- ment of Clinical Chemistry and Molecular Diagnos- tope α-Kdo-(2→8)-α-Kdo reacted with A. lwoffii F78 tics, Medical Faculty, Philipps University, Marburg; Ko- LPS. Thus, for the first time an LPS was identified out- rthals M, Schwaiger K, Bauer J, Chair of Animal side Chlamydiaceae which contains a Chlamydia- Hygiene, Faculty of Life and Food Sciences, Technis- specific LPS epitope in its core region. che Universität München, Freising-Weihenstephan; Mittel- städt J, Brandau S, Division of Immunotherapy, Research Center Borstel; Ege M, von Mutius E, Dr. von Hauner Children’s Hospital, Ludwig-Maximilians-University of Munich, Munich; Gatermann S, Institute for Hygiene and Microbiology, Department of Medical Microbiology, Ruhr-University Bochum, Bochum; Bufe A, Department of Pneumology, Experimental Ruhr-University Bochum, Bochum; Goldmann T, Division of Clinical and Experimental Pathology, Research Center Borstel; Heine H, Division of Innate Immunity, Fig. 7 Research Center Borstel. Collaboration: Hübner G, Lindner B, Division of Supported in part by: Deutsche Forschungsgemein- Immunochemistry, Research Center Borstel; Vino- schaft (SFB-TR22, Project A1). gradov E, National Research Council, Institute for Biological Sciences, Ottawa, Canada; Brade L, Brade H, Division of Biochemical Microbiology, Structural and immunochemical analyses of the Research Center Borstel; Debarry J, Heine H, Divi- lipopolysaccharide (LPS) from Acinetobacter sion of Innate Immunity, Research Center Borstel. lwoffii F78 – the first LPS outside Chlamydiaceae carrying a Chlamydia-specific LPS epitope Supported in part by: Deutsche Forschungsgemein- Hanuszkiewicz A, Holst O. schaft (SFB-TR22, Project A2). ´ By the means of chemical analyses, NMR spec- 42 Wissenschaftlicher Jahresbericht 2007-2008 Division of Structural Biochemistry Research Reports Modulation of dendritic cell function by cowshed The structural analysis of the capsular polysac- dust extract charide from Acinetobacter lwoffii F78 Holst O. Hanuszkiewicz A, Holst O. We have shown previously that inhalation of The capsular polysaccharide from Acinetobacter cowshed dust extract (CDE) resulted in decreased lwoffii F78 was isolated and purified, and its struc- airway reactivity, eosinophilic inflammation and ture was elucidated by the means of chemical anal- sensitization in a mouse model of allergic asthma. yses, NMR spectroscopy and mass spectrometry. Our data suggested down regulation of allergic The presence of a capsule on this bacterium was immune response rather than activation of a Th1 confirmed by transmission electron microscopy ex- response towards the model allergen. However, the periments and utilization of anti-lipid A monoclonal precise mechanism of allergy protection is not antibody proved non-endotoxin origin of the isolat- understood in detail until now. To get deeper in- ed material. The structure represents a novel non- sides into CDE induced immune modulation we branched amino-polysaccharide, with high hetero- have analysed effects of CDE on dendritic cell biol- geneity of amino groups substituents: ogy. Dendritic cells were generated from murine bone marrow →3)-α-L-FucNAc-(1→3)-β-D-QuiNR14NR2-(1→4)-β-L-GlcNR33NR4A-(1→ (BMDC). Cells were stimulated via the airways. Our results showed that cells were where R1 represents 3-hydroxybutyric acid (3-HBA) or N-acetylated alanine (AlaNAc); R2 - AlaNAc or 3- not able to prime mice for allergic immune re- HBA; R3 - acetyl or 3-HBA; and R4 - 3-HBA or acetyl. with CDE and subsequently used to sensitize mice sponse when they were treated with CDE two days before pulsing with allergen whereas cells that Collaboration: Kaczynski Z, Faculty of Chemistry, were stimulated with CDE simultaneously to OVA University of Gdansk, Gdansk, Poland; Lindner B, Di- pulsing induced a fully developed allergic immune vision of Immunochemistry, Research Center Borstel; response. Surprisingly CDE treated cells that were Goldmann T, Vollmer E, Division of Clinical and Ex- not able to prime mice for allergic immune re- perimental Pathology, Research Center Borstel; De- sponse exhibit an activated phenotype with high ex- barry J, Heine H, Division of Innate Immunity, Re- pression of costimulatory surface molecule CD86. search Center Borstel. Moreover CDE treated cells transiently produced high amounts of cytokines like IL-10, IL-12p70 and Supported in part by the Deutsche Forschungsge- TNF-0. Interestingly, blocking of autocrine produced meinschaft (SFB-TR22, Project A2). IL-10 in vitro partially restored allergy inducing capacity of CDE exposed cells. Thus we conclude that prolonged contact to CDE reduces allergy inducing Host and non-host plant response to the capacity of dendritic cells. Furthermore we present lipopolysaccaride evidence that an autocrine IL-10 dependent mech- solanacearum, a causal agent of a devastating anism seems to be involved in down regulation of disease of potato dendritic cell function due to stimulation with CDE. Ovchinnikova OG, Holst O. Collaboration: Gorelik L, Kauth M, Gehlhar K, Bufe Ralstonia solanacearum is one of the most devas- A, Peters M, Department of Experimental Pneumol- tating phytopatogenic bacteria, in particular its ogy, Ruhr-University Bochum, Bochum. race 3. This microorganism is the causative agent isolated from Ralstonia of destructive diseases of different agrarian crops Wissenschaftlicher Jahresbericht 2007-2008 43 Division of Structural Biochemistry Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l including tomato and potato. An important aspect of the interaction between this pathogen and the host and non-host plants was its biochemical and molecular basis. Thus, the lipopolysaccharides (LPS) were extracted from the R. solanacearum cell wall, purified, and the O-specific polysaccharide (OPS) was isolated and chemically characterized by compositional analyses and NMR spectroscopy. The OPS was constituted of two linear polymers of an approximate ratio of 3:1, both of which were built up from three rhamnose and one N-acetylglucosamine residues and differed only in the substitution of one rhamnose residue. Also, traces of branched repeating units arising from nonstoichiometric xylosylation of the linear structure were present. The LPS inhibited the hypersensitivity reaction (HR) in non-host tobacco plants and induced localized resistance in host potato plants, both of which were pre-treated with the LPS before being inoculated with the pathogen. Collaboration: Esposito N, Barone A, Evidente A, Dipartimento di Scienze del Suolo, della Pianta, dell’ Ambiente e delle Produzioni Animali, Universitá di Napoli Federico II, Portici, Italy; Zoina A, Dipartimento di Arboricoltura, Botanica e Patologia Vegetale, Universitá di Napoli Federico II, Portici, Italy. Theses Dissertation Hanuszkiewic, Anna Isolation and structural as well as immunological characterization of the cell wall components from cowshed bacteria. Technisch-Naturwissenschaftliche Fakultät Universität zu Lübeck, 2008. Vogel, Kay Microbial spores from farming environments and their role in allergy protection. Technisch-Naturwissenschaftliche Fakultät Universität zu Lübeck, 2008. 44 Wissenschaftlicher Jahresbericht 2007-2008 Division of Immunochemistry Research Reports Division of Immunochemistry Head Research Reports Prof. Dr. Ulrich Zähringer Structure and dynamics of 13C,15N-labeled lipid A in a membrane mimetic Principle Investigators Zähringer U. PD Dr. Buko Lindner Dr. Christian Alexander After successful setup of a new approach to investigate intact deep rough type 13C,15N-labelled LPS Postdoctoral Fellows (Re LPS) from a heptosyltransferase deficient mutant Dr. Carola Funk (since July 2007) (WBB01) of Escherichia coli K-12 conformational Dr. Sandra Albrecht analysis of LPS in water became accessible (Re- Dr. Göran Hübner (since August 2008). search Report 2006). This gives access to the anal- Dr. Catharina Crone (till September 2007) ysis of conformation and dynamics of LPS, which is believed to be the key-event of understanding how Technicians LPS and TLR4/MD-2 molecules interact. This method Nina Grohmann is also useful not only for different LPS but also for Heiko Käßner lipid A structures, independent of its acylation pat- Brigitte Kunz tern (Fig UZ1). The results of these investigations Helga Lüthje have been published in Angew Chem Intl Ed Hermann Moll 2008;47:9870-9874. Ursula Schombel Simone Thomsen Birte Wegner Guests and Trainees Dr. Evelyna Zdorovenko, N.D. Zelinsky Institute, Moscow, Russia 03-05/07, and 09/07- 10/07, supported by SFB470, Project B4 Dr. Anna Kondakova, N.D. Zelinsky Institute of Organic Chemistry Moscow, Russia 10 - 11/07, and 10/08 - 11/08 Hrkac’ Stjepan and Ankatrin Stange, graduate students University Kiel voluntary MS trainee-coarse (08/08) Ruth Kläver, master course student, Molecular Life Sciences, University of Münster voluntary internship (09/08 - 10/08) Jakob Hufschmidt voluntary student’s internship (08/08) Wissenschaftlicher Jahresbericht 2007-2008 45 Division of Immunochemistry Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l bacteria. For further clarification, we aimed to isolate and characterize a TLR2-activating lipoprotein from Staphylococcus aureus as a representative lipoprotein of Gram-positive bacteria. Since the bacterial cell wall of S. aureus contains over 60 lipoproteins, we concentrated on lipoprotein sitC, a staphylococcal iron transporter. This lipoprotein was over-expressed by a S. aureus mutant, thus facilitating the isolation of the single lipoprotein. A new approach to isolate sitC was enabled by another S. aureus mutant over-expressing the hisFig. 8. Structure of E. coli lipid A (left) and part of the 2D contour plot (right) of a 1H,13C HSQC-spectrum (800MHz) of 13C,15N-labelled penta-acylated (red) and hexa-acylated (blue) lipid A from LPS (F515 and WBB01) in 3 % DHPC-d15 at 310K. tagged sitC. Isolation of the nearly pure lipoprotein The well resolved carbon signals of the fatty acids 100-fold higher than that of sitC isolated by other in the HSQC, together with complex 3D HCCH -TOC- methods such as electroelution. The TLR2-depen- SY experiments allowed the unequivocal assign- dent activity of the isolated his-tagged lipoprotein, ment of all signals, which is a prerequisite for fur- determined using HEK293 cells was significant. Our ther conformational analyses. NOESY spectra finally studies demonstrated the recognition of a single showed distinct differences in both lipid A’s, sug- lipoprotein by TLR2 for the first time was achieved by using Ni-NTA-chromatography. The amount of sitC-his isolated by this method was over gesting that the conformation of the lipid A-backbone has a significant impact on the reduced endotoxic activity of penta- vs. hexa-acylated lipid A. Collaboration: Grzesiek S, Wang W, Sass HJ, Division of Structural Biology, Biozentrum, University of Basel, Basel, Switzerland. Isolation and structural characterization of TLR2 activating lipoproteins from Staphylococcus aureus Funk C, Alexander C, Zähringer U. Recognition so called pathogen-associated molecular patterns (PAMPs), by Toll-like receptors (TLRs) initiates signal transduction pathways of the innate immune system. As a specific structure-function-relationship between PAMP and TLR is well established for most of the TLRs the structure of TLR2-lig- Fig. 9. TLR2-dependent activity of cell wall extracts from S. aureus SA113 Dlgt (lacking lipoproteins) SA113W TpTX sitC-His (overexpressing His-tagged lipoprotein sitC), and the His-tagged lipoprotein sitcC, isolated by Ni-NTA chromatography. ands published till date is under dispute. This project aims at defining a clear structure-activity Collaboration: Götz F, Anstett M, Stoll H, Depart- based relationship for TLR2. Previous studies of our ment of Microbial Genetics, University of Tübingen; group indicated that lipoproteins are the major if Heine H, Division of Innate Immunity, Research Cen- not sole TLR2-activating molecules of Gram positive ter Borstel. 46 Wissenschaftlicher Jahresbericht 2007-2008 Division of Immunochemistry Research Reports Supported in part by: Deutsche Forschungsgemein- chemistry. Grzesiek S, Wang W, Division of Structural schaft, Schwerpunktprogramm 1110. Biology, Biozentrum, University of Basel, Basel, Switzerland. Study of the pseudomonas LPS core region and Supported in part by: Deutsche Forschungsgemein- its binding to a Pseudomonas-specific monoclon- schaft, SFB 470 B4 and C1. al antibody Albrecht S, Zähringer U. Peptidoglycan in innate immunity: structure-funcThe inner core of the lipopolysaccharide (LPS) of all tion relationship Pseudomonas species contains a unique carbohy- Zähringer U, Lindner B. drate structure which we identified to be a highly phosphorylated 7-O-carbamoyl L-glycero-D-manno- During the last year we successfully established two heptopyranose (7-O-Cm-L,D-Hep). Recent studies on different projects which are devoted to the isolation clinical isolates from patients suffering from Pseu- and structural characterization of well defined and domonas infections showed a significant specificity highly purified peptidoglycan (PG) and PG-frag- of mAb S60-4-14 for Pseudomonas strains isolated ments. Both projects aim at isolation and character- from the lung of cystic fibrosis patients (Annual Re- ization of biological active peptidoglycan fragments port 2006). For a detailed characterization of the an- which are known to act as specific ligands for the so tibody-LPS interaction we pursued two approaches. called Nod-like receptors Nod1 and Nod2 within the On the one hand we isolated the mAb S60-4-14 from integrated research network (IRN) of nod-like recep- culture supernatants, prepared Fab-fragments by tors within the cluster of excellence “Inflammation at papain-cleavage and purified appropriate scFv Interfaces”. First interesting results further support from an extract of a scFv S60-4-14-overexpressing E. our hypothesis that besides muramic acid also the coli strain. The binding of scFv S60-4-14 was ana- stem-peptide of PG but not the glycan part in S. au- lyzed by Western Blot analysis and showed the reus PG is indispensible for the expression of Nod-2 same substrate. On the other hand we grew 13C,15N-labeled as well as unlabeled oligosaccha- activity. The other PG-project, which is also devoted rides from P. aeruginosa PAO1- to DalgC. Native and non-purified 13C,15N-LPS from P. aeruginosa PAO1- of Staphylococcus aureus, is a collaborative project DalgC as analyzed by NMR (800 MHz) was shown schmidt, University of Greifswald. This project aims at to express structural heterogeneity differing in acy- the characterization of the glycan part of PG which lation, phosphorylation and, as we found, potential- is known to act as a ligand of Thrombospondin-1 ly conformational features which may have an im- (TSP-1). Our current hypothesis is that only the glycan pact on the epitope structural analysis. Based on the and not the peptide part of the PG is involved in the availability of mAb, Fab and scFv as well as LPS and specific interaction of TSP-1, which we hypothesize to its substructures we are now able to investigate the act as a lectin involved and mediating staphylococ- epitopes involved in the binding by methods such as cal adherence during infection. to the chemical analysis of PG and PG-subfragments which we started together with Prof. S. Hammer- STD-NMR and Surface Plasmon Resonance. Collaboration: H. Heine, Division of Innate immuniCollaboration: Müller-Loennies S, Brade L, Brade H, ty, P. Rosenstiel and A. Till, CAU. Division of Medical and Biochemical Microbiology; Supported in part by: Excellence Cluster “Inflam- Goldmann T, Division of Clinical and Experimental mation at Interfaces” (Lübeck, Borstel, Kiel) and Pathology; Mamat U, Division of Structural Bio- DFG (SH, UZ, BL). Wissenschaftlicher Jahresbericht 2007-2008 47 Division of Immunochemistry Research Reports Application of capillary electrophoresis – Fourier- With an optimized CE electrolyte based on water, transform ion cyclotron resonance mass spec- isopropyl alcohol, triethylamine and acetic acid at trometry to the separation of R-form lipopolysac- pH 8.9 and short uncoated fused silica capillaries charide and lipid A species. we could for the first time separate and online mass Hübner G, Lindner B. analyse the different components of underivatized Fo r s c h u n g s z e n t r u m Bo r s t e l R-Form LPS and lipid A even of complex mixtures Native isolates of LPS comprise a high inherent het- (Fig. 10 bottom). Measurements with well defined erogeneity with respect to the number and type of LPS standards revealed detection limits of single fatty acids and core oligosaccharides and of non- constituents in the low fmol range. Comparison of stoichiometric substituents (P, P-Etn, and Ara4N) MS and CE-MS measurements under equal condi- which hamper their structural characterisation. So tions enabled the investigation of ion suppression far, chromatographic separation (e.g. by HPLC or effects within heterogeneous LPS samples. TLC) of these highly amphiphilic compounds for subsequent chemical analyses failed. Thus, high reso- Supported in part by: SFB-TR 22 Project Z01 and lution mass spectrometry is the method of choice for DFG (Li 448/4-1). the detailed analysis of these compounds. However, ion suppression effects within the complex sample mixture during electrospray ionisation can influ- LipID – a software tool for automated assignment ence the detection sensitivity of individual of lipids in mass spectra compounds dramatically. To overcome these prob- Hübner G, Lindner B. lems we coupled a home-made capillary electrophoresis (CE) online to a Fourier-transform ion Gangliosides and phospholipids determine the bio- cyclotron resonance mass spectrometer (FT-ICR MS) physical properties of membrane structures (e.g. using a sheath liquid interface (Fig.10 top). transmembrane permeability, formation of microdomains) and are involved in many essential biological functions e.g. cell signaling or energy storage. Furthermore, defects in lipid metabolism may play an essential role in many diseases. The analysis of lipids and especially those of subcellular membrane compartments (e.g. phagosomes, lipid rafts) is challenging because of the low amounts of material available for analysis and the wide molecular diversity of this class of compounds and their relative insolubility in aqueous systems. Using multiple stage mass spectrometry, ion species may be Fig. 10. Details of the sheath liquid online coupling of the homemade CE to the high resolution Qe FT-ICR MS (top) and the extracted ion chromatogram with respective mass spectra of different species of an R-form LPS isolated from an Rb-mutant of Salmonella enterica. 48 unambiguously classified. However, this procedure is time consuming. Our approach for detailed lipid analysis is based on normal phase HPLC separation cou- Wissenschaftlicher Jahresbericht 2007-2008 Division of Immunochemistry Research Reports pled online to high resolution MS analysis. Due to the Structural studies of lipopolysaccharides of med- high mass accuracy (> 2ppm) of the FT-ICR MS in- ically important Gram-negative bacteria by high- strument the lipids can be unequivocally be identified resolution ESI ICR-FT mass spectrometry taking into account the HPLC retention time and the Kondakova A, Lindner B. exact mass of a lipid species. For the evaluation of the huge amount of experimental data a new soft- LPS plays a role in the activation of the host immune ware tool called lipID was developed, which supports system and alterations in its chemical structure may the identification of glycerophospholipids, glycosph- significantly influence biological activity of the bac- ingolipids and fatty acids in mass spectra. The user- terial strains. In the recent years we have devel- extendable software is a Microsoft (MS) Excel Add-In oped an efficient approach to structural studies of and is compatible with all versions of MS Excel. It pro- core oligosaccharide and lipid A parts of LPS cesses singly given mass-to-charge values as well as molecule based on high-resolution mass spectrom- mass lists provided by the mass spectrometer con- etry, which allows us to overcome the intrinsic het- sidering a broad range of user-defined options. The erogeneity of the sample and provide important mode of operation is demonstrated in Fig 11. show- structural information even when only limited ing the mass spectrum of the total phospholipid ex- amount of material is available. We applied this ap- tract from a Gram-negative bacterium and the results proach for the studies of LPS isolated from the bac- produced by the lipID program giving information teria of Yersinia pestis (causative agent of plague), concerning the lipid headgroup, the total chain Yersinia pseudotuberculosis (cause of broad range lengths and the degree of saturation of the fatty acids. of acute and chronic gastrointestinal disorders and evolutionary predecessor of Y. pestis,) and Shigel- Supported in part by: SFB-TR 22 Project Z01. la (causative agent of gastrointestinal diseases, including shigellosis). While the structure of LPS in Y. pestis has been studied extensively over last years, most of the work has been done on specifically constructed mutant strains and little is known about the biological diversity of LPS structures in wild type strains. We have investigated the structure of LPS in five wild type strains and found it to be in agreement with the structures reported earlier, but the variety of core oligosaccharide glycoforms and lipid A acylation patterns was higher, e.g. in LPS of Y. pestis A-1249, which produce mostly triacylated form of lipid A, instead of more common tetraacylated one, but is not able to incorporate a residue of galactose in the outer core. The structures of LPS in Y. pseudotuberculosis strains were found to be similar to those in Y. pestis strains. Studies of Fig. 11. Example demonstrating the capability of the lipid identification program lipID. 27 out of 46 ion peaks in the detail of a mass spectrum from a lipid extract from an E. coli mutant could be assigned with lipID, using an expected experimental mass accuracy of 3 ppm. Besides several PE (or PC) species, also PG and PS species were identified. All assigned signals in the mass spectrum are depicted with an arrow. oligosaccharide and lipid A fractions isolated from eight Y. pseudotuberculosis strains, representing serovars 1 to 4, revealed the following structure of core oligosaccharide, with minor portion of core molecules including phosphoethanolamine residue at the unknown position. Wissenschaftlicher Jahresbericht 2007-2008 49 Division of Immunochemistry Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l LPS in a catalytic manner, thus enhancing the immunoactivating properties of these endotoxin preparations. In the second project aqueous extracts of paraffin-embedded non small cell lung Fig. 12 cancer-tissues conserved by the HOPE (Hepes-gluSimilarly, the mass spectrometric screening of LPS tamic acid buffer mediated organic solvent protec- samples isolated from 25 Shigella strains has shown tion effect) fixation technique have been shown for them to be structurally similar of the LPS of closely- the first time also to be generally applicable to 2- related bacteria Escherichia coli, but further investi- DE-based proteome analysis and a set of four se- gations are necessary to define significant structural lected protein spots has been identified including differences. the keratin group that represents a highly expressed marker protein fraction of lung adenocarcinoma. Collaboration: Knirel Y, ND Zelinski Institute of Organic Chemistry RAS, Moscow, Russia. Collaborations: Otto A, Berlin Max-Delbrück Center of Molecular Medicine, Berlin, Germany; Goldmann Supported in part by: DFG (Li 448/4-1). T, Kähler D, Division of Clinical and Experimental Pathology; Ulmer AJ, Division of Cellular Immunology; Gorczynski RM, Departments of Surgery and Im- Proteomic analysis of clinically-relevant tissue munology, University Health Network, Toronto, preparations based on two-dimensional gel elec- Canada; Mach JP, Institute de Biochimie, University trophoresis de Lausanne, Lausanne, Switzerland; Rietschel ET, Alexander C, Lindner B, Zähringer U. Waelli T, Clinique La Prairie, Clarens-Montreux, Switzerland. The proteomes of multiple tissue-derived samples were analyzed by the high resolution two-dimen- Supported in part by: Clinique La Prairie, Clarens- sional gel electrophoresis (2-DE) system WITAVISIONä (WITA GmbH, Teltow, Germany) and subse- Montreux, Switzerland. quent identification of selected protein spots by mass fingerprinting of tryptic peptides in two ma- Theses jor projects: In the first project within the research network funded by the swiss clinic: Clinique La Dissertation Prarie (CLP) two major immunoactivating chro- Crone, Catharina matographic fractions of a fetal sheep liver extract Aufbau einer quantitativen massenspekrtometri- have been characterized by 2-DE-based proteomics schen Analytik zur Untersuchung der Lipidzusam- and a total of 30 different proteins including the pro- mensetzung zellulärer Membranen und ihre An- inflammatory cytokines macrophage-migration in- wendung auf Membranmikrodomänen. hibitory factor (MIF) and interleukin 1b (IL-1b) could Technisch-Naturwissenschaftliche Fakultät be identified. Moreover, fetal hemoglobin (HbF) Universität Lübeck, 2007. and the corresponding heme-free globin a and g (supervisor PD Dr. Buko Lindner) chains were shown to display LPS-binding activities and to promote the disaggregation of S- and R-type Hübner, Göran Aufbau und Kopplung einer Kapillarelektrophorese 50 Wissenschaftlicher Jahresbericht 2007-2008 Division of Immunochemistry Research Reports an ein hochauflösendes Massenspektrometer zur Analyse amphiphiler Zellmembrankomponenten. Mathematisch-Naturwissenschaftliche Fakultät Christian-Albrechts-Universität zu Kiel, 2008. (supervisor PD Dr. Buko Lindner) Patents Alexander C, Zähringer U, Division of Immunochemistry; Ulmer AJ, Division of Immunology and Cell Biology, Research Center Borstel, and members of the Clinique La Prairie Research. Sa, L-1528 Luxembourg (LU). International (Non EU) extension of the following European patent: Compositions comprising Fetal Hemoglobin and Bacterial Endotoxin and optionally Additional Fetal Liver Components. International Publication Number: WO/2004/073728, International Application No.: PCT/EP2004/001553. Wissenschaftlicher Jahresbericht 2007-2008 51 Division of Biophysics Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l Division of Biophysics Head thermore, the sepsis shock syndrome, which in many PD Dr. Thomas Gutsmann cases is a result of the fact that antibiotics may kill bacteria, but do not inactivate bacterial virulence Principle Investigators factors such as endotoxins (lipopolysaccharides), is Prof. Dr. Klaus Brandenburg worldwide of increasing importance regarding the very high death rate (40 to 50 %). Therefore, the de- Staff Scientists and Postdoctoral Fellows velopment of suitable antimicrobial drugs is ur- PD Dr. Jörg Andrä gently requested. In recent years, various groups focus on the use of antimicrobial peptides (AMP) Graduate and Diploma Students derived from natural, innate immunity proteins, Arne Böhling (until July 2007) which in vivo bind to the virulence factors. Such bind- Gesa Helms (until February 2008) ing proteins are, for example, lactoferrin, the Limu- Ahmed Jaber (until March 2008) lus anti-LPS-factor, and the family of saposin-like Malte Hammer (until August 2008) proteins (NK-lysins, granulysins), which all have par- Nico Grimm (until Oktober 2008) ticular binding domains for example for bacterial Annemarie Brauser endotoxin. Furthermore, an alternative approach to Jörg Howe combat infections is the use of cyclooxygenase and Yani Kaconis lipoxygenase inhibitors. From the reviewed litera- Lingyi LI ture the mechanisms of action of antiinfective compounds on bacteria, on pathogenicity factors of the Technicians bacteria, and on viruses are summarized. In the last Gerold von Busse years, considerable progresses have been made in Sabine Dabelstein the fight against infections, specially also to over- Nina Hahlbrock come bacterial resistance. Christine Hamann Collaboration: Garidel P, Universität Halle Kerstin Stephan Guests and Trainees Dr. Satoshi Fukuoka Mechanism of interaction of optimized Limulus- Health Technology Research Center, National Insti- derived cyclic peptides with endotoxins. Thermo- tute of Advanced, Industrial Science and Technolo- dynamical, biophysical, and microbiological gy, Takamatsu analysis Andrä J, Howe J, Gutsmann T, Brandenburg K. Research Reports On the basis of formerly investigated peptides cor- Novel antiinflammatory and antiinfective agents responding to the endotoxin-binding domain from Andrä J, Howe J, Gutsmann T, Brandenburg K. the Limulus anti-lipopolysaccharide factor (LALF), a protein from L. polyphemus, we have designed and Despite the availability of antibiotics, infectious dis- synthesized peptides of different lengths with the eases become an even increasing threatening for aim to get potential therapeutic agents against the human health, in particular due to resistance de- septic shock syndrom. For an understanding of the velopment, for example in animal husbandry. Fur- mechanisms of action, we performed a profound 52 Wissenschaftlicher Jahresbericht 2007-2008 Division of Biophysics Research Reports physico-chemical and biophysical analysis of the in- ticular enterobacterial forms of LPS represent ex- teraction of rough mutant lipopolysaccharide (LPS) tremely strong activator molecules of the human im- with these peptides by applying Fourier-transform mune system causing a rapid induction of cytokine infrared spectroscopy (FTIR), small-angle X-ray scat- production in monocytes and macrophages. Vari- tering (SAXS), calorimetric techniques (differential ous mammalian blood proteins have been docu- scanning calorimetry DSC and isothermal titration mented to display LPS binding activities mediating calorimetry ITC), and freeze-fracture transmission normally decreasing effects in the biological activ- electron microscopy (FFTEM). Also, the action of the ity of LPS. In more recent studies, the essential sys- peptides on bacteria of different origin in microbial temic oxygen transportation protein hemoglobin assays was investigated. Using FTIR and DSC, our (Hb) has been shown to amplify LPS-induced cy- data indicated a strong fluidization of the lipid A tokine production on immune cells. The mechanism acyl chains due to peptide binding, with a decrease responsible for this effect is poorly understood. of the endothermic melting enthalpy change of the Here, we characterize the interaction of hemoglobin acyl chains down to a complete disappearance in with LPS by using biophysical methods. The data the 1:0.5 to 1:2 [LPS]:[peptide] molar ratio range. presented, revealing the changes of the type and Via ITC, it was deduced that the binding is a clear- size of supramolecular aggregates of LPS in the ly exothermic process which runs into saturation al- presence of Hb, allow a better understanding of the so at a [LPS]:[peptide] = 1:0.5 to 1:2 molar ratio. The hemoglobin-induced increase in bioactivity of LPS. data obtained with SAXS indicated a drastic change of the aggregate structures of LPS into a Collaboration: Garidel P, Universität Halle, Roessle multilamellar stack, which was visualized in electron M European Molecular Biology Laboratory, Alexan- micrographs as hundreds of lamellar layers. This der C, Div. of Immunochemistry, Fournier K and can be directly correlated with the inhibition of the Mach J.P. Universite Lausanne, Waelli T. Clinique La LPS-induced production of tumor-necrosis-factor-a in Prairie, Montreux, Gorczynski R University of Toron- human mononuclear cells, but not with the action of to, Ulmer AJ, Div. of Immunobiology, Zähringer U, the peptides on bacteria. Div. of Immunochemistry, Rietschel E Th, LeibnizGemeinschaft, Berlin. Collaboration: Garidel P, Universität Halle, Rössle M, European Molecular Biology Laboratory, Ham- Supported in part by: Clinique La Prairie, Switzer- burg, Richter W, Universität Jena, Leiva-León J and land. Moriyon I, Universidad de Navarra, Pamplona, Bartels R, Div. of Immunochemistry. Thermodynamic analysis of the lipopolysaccharide-dependent resistance of Gram-negative bacBiophysical characterization of the interaction of teria against polymyxin B endotoxins with hemoglobins Howe J, Andrä J, Gutsmann T, Brandenburg K. Howe J, Hammer M, Brandenburg K. Cationic antimicrobial cationic peptides (CAMP) Bacterial endotoxin (lipopolysaccharide, LPS) is the have been found in recent years to play a decisive major component of the outer leaflet of the outer role in host’s defence against microbial infection, membrane in Gram-negative bacteria. During se- but are also pharmaceutically developed as new vere infections, bacteria may reach the blood circuit therapeutic tool, necessary in particular due to the of humans, and endotoxins may be released from occurrence of resistance of microbiologic popula- the bacteria due to cell division or cell death. In par- tions to antibiotics. The structural basis of this phe- Wissenschaftlicher Jahresbericht 2007-2008 53 Division of Molecular Infection Biology Research Reports nomenon is only partially elucidated, and may com- mic reaction in the liquid crystalline phase (Fig. 13). prise quite different mechanism at the site of the In contrast, for resistant LPS the binding enthalpy bacterial cell membranes or in their cytoplasm. change remains endothermic in both phases. As in- Polymyxin B (PMB) is a well-studied representative frared data show, these differences can be ex- of a CAMP in particular against Gram-negative bac- plained by sterical changes in the head group re- teria to understand the interaction with the outer gion of the respective LPS. Fo r s c h u n g s z e n t r u m Bo r s t e l membrane or isolated membrane compounds such as lipopolysaccharide (LPS) and to define the mech- Collaboration: Conde R, Iriarte M, and Moriyón I., anism by which the peptides kill bacteria or neu- Universidad de Navarra, Pamplona, Garidel P, Uni- tralize LPS. Since PMB-resistance of bacteria is a versiät Halle, Koch MHJ European Molecular Biolo- long-known phenomenon and is attributed to struc- gy Laboratory, Hamburg. tural changes in the LPS moiety of the respective bacteria, we have performed a thermodynamic and biophysical analysis of the mechanisms of various Rationale for the design of shortened derivatives LPS:PMB interactions in comparison to LPS from sen- of the NK-lysin derived antimicrobial peptide NK- sitive strains. 2 with improved activity against gram-negative pathogens Andrä J, Brandenburg K. The peptide NK-2 is an effective antimicrobial agent with low hemolytic and cytotoxic activities and is thus a promising candidate for clinical applications. It comprises the a-helical, cationic core region of porcine NK-lysin a homolog of human granulysin and of amoebapores of pathogenic amoeba. Here we visualized the impact of NK-2 on E. coli by electron microscopy and used NK-2 as a template for sequence variations to improve the peptide stability and activity and to gain insight into the structure/function relationships. We synthesized 18 new peptides and tested their activities on 7 Gram-negative and one Gram-positive bacterial strains, human erythrocytes and HeLa cells. Although all peptides appeared unordered in buffer, those active Fig. 13. Isothermal calorimetric titration of LPS (0.05 mM) from P. mirabilis R45 (top) and S. minnesota R595 (bottom) with PMB (3 mM) at 37 °C. For this, the LPS dispersion in the calorimetric cell was titratetd every 5 min with 3 ml of PMB. The increase in the feedback power indicates an endothermic, the decrease an exothermic process. against bacteria adopted an a-helical conformation in membrane-mimetic environments like triflouroethanol and negatively charged phosphatidylglycerol (PG) liposomes that mimick the cytoplasmic membrane of bacteria. This conforma- In isothermal titration calorimetric experiments we tion was not observed in the presence of liposomes have found considerable differences of PMB bind- consisting of zwitterionic phosphatidylcholine (PC) ing to sensitive and resistant LPS, for sensitive LPS typical for the human cell plasma membrane. The the endothermic enthalpy change in the gel phase interaction was paralleled by intercalation of these of the hydrocarbon chains converts into an exother- peptides into PG-liposomes as determined by FRET- 54 Wissenschaftlicher Jahresbericht 2007-2008 Division of Molecular Infection Biology Research Reports spectroscopy. A comparative analysis between biological activity and the calculated peptide parameters revealed that the decisive factor for a broad spectrum activity is not the peptide overall hydrophobicity or amphipathicity but the possession of a minimal positive net charge plus an highly amphipathic anchor point of only 7 amino acid residues (2 helical turns). Collaboration: Goldmann T, Clinical and Experimental Pathology, Bartels R, Immunochemistry, Research Center Borstel; Monreal D, Martinez de Tejada G, Sanchez Gomez S, Moriyon I, Universidad de Navarra, Pamplona, Spain; Olak C, Brezesinski B, Max-Planck-Institut für Kolloid- und Grenzflächenforschung, Potsdam. Supported in part by: SFB617, A17. Structure and mode of action of the antimicrobial Andrä J, Gutsmann T. Fig. 14. Effect on the morphology of bacteria upon arenicin treatment (I). AFM images of untretated E. coli WBB01 (A) and incubated with 10 µM arenicin (B) in LB medium at 37°C for 30 min. Images were taken in air in AC (tapping) mode. The solution structure and the mode of action of Collaboration: Goldmann T, Clinical and Experi- arenicin isoform 1, an antimicrobial peptide with a mental Pathology, Research Center Borstel; unique 18-residue loop structure, from the lugworm Jakovkin I, Hecht O, Grötzinger J, Institute of Bio- Arenicola marina were elucidated here. Arenicin chemistry; Leippe, M, Zoological Institute, Christian- folds into a two-stranded anti-parallel b-sheet. It ex- Albrechts-University, Kiel; Krasnosdembskaya AD, hibits high antibacterial activity at 37°C and 4°C St. Petersburg State University, St Petersburg, Russia. peptide arenicin against Gram-negative bacteria, including polymyxin B resistant Proteus mirabilis. Bacterial killing occurs Supported in part by: SFB617, A17. within minutes and is accompanied by membrane permeabilisation, membrane detachment, and release of cytoplasm. Interaction of arenicin with re- Surface acoustic wave biosensor as a tool to constituted membranes that mimic the lipopolysac- study the interaction of antimicrobial peptides charide-containing with phospholipid and lipopolysaccharide mod- outer membrane or the phospholipid-containing plasma membrane of Gram- el membranes negative bacteria exhibited no pronounced lipid Andrä J, Böhling A, Gutsmann T. specificity. Arenicin-induced current fluctuations in planar lipid bilayers correspond to the formation of short Surface acoustic wave biosensors are a powerful lived heterogeneously structured lesions. Our data tool for the study of biomolecular interactions. The strongly suggest that membrane interaction plays a modulation of a surface-confined acoustic wave is pivotal role in the antibacterial activity of arenicin. utilized here for the analysis of surface binding. Wissenschaftlicher Jahresbericht 2007-2008 55 Division of Molecular Infection Biology Research Reports Phase and amplitude of the wave correspond Collaboration: Gronewold TMA, Perpeet M, roughly to mass loading and viscoelastic properties Schlecht U, Biosensor GmbH, Bonn. Fo r s c h u n g s z e n t r u m Bo r s t e l of the surface, respectively. We established a procedure to reconstitute phospholipid and Supported in part by: SFB617, A17. lipopolysaccharide bilayers on the surface of a modified gold sensor chip to study the mode of action of membrane-active peptides. The procedure Physicochemical and biological analysis of syn- included the formation of a self-assembled mono- thetic bacterial lipopeptides: Validity of the con- layer of 11-mercaptoundecanol, covalent coupling cept of ’endotoxic conformation’ of carboxymethyl-dextran, and subsequent coating Howe J, Gutsmann T, Andrä J, Brandenburg K. with a poly-L-lysine layer. The lipid coverage of the surface is highly reproducible and homogenous as Lipoproteins from the outer or cytoplasmic mem- demonstrated in atomic force micrographs. branes of Gram-positive and Gram-negative bacte- Ethanol/triton treatment removed the lipids com- ria have been recognized increasingly to be im- pletely which provided the basis for continuous se- portant regarding their biological function and quences of independent experiments. The setup activity. They are, beside endotoxins (lipopolysac- was applied to investigate the binding of human charide, LPS) as main amphiphilic component of the cathelicidin-derived peptide LL32, as an example outer membrane of Gram-negative bacteria, es- for antimicrobial peptides, to immobilized phos- tablished as potent stimulants of the human innate phatidylserine membranes. The peptide-membrane immune system and elicit a variety of proinflamma- interaction results in a positive phase shift and an tory immune responses. Investigations of synthetic increase in amplitude, indicating a mass increase lipopeptides corresponding to N-terminal partial along with a loss in viscosity. This suggests that the structures of bacterial lipoproteins defined the bilayer becomes more rigid upon interaction with chemical prerequisites for their biological activity, LL32. especially with respect to the number and length of acyl chains and sequence of the peptide part. Here we present experimental data on the biophysical mechanisms underlying lipopeptide bioactivity. Investigation of selected synthetic diacylated and triacylated lipopeptides revealed, that the molecular geometry of these molecules, i.e. the measured molecular conformations and supramolecular aggregate structures and the preference for membrane intercalation allow an understanding of the biological activities of the different lipopeptides. This refers in particular to the agonistic or antagonistic activity, i.e., their ability to induce cytokines in mononuclear cells or to block this activity, respectively. The analytical data show that our concept of ‘endotoxic conformation’, originally developed for LPS, can be applied also to the investigated lipopeptides, and suggest that the molecular mech- Fig. 15. Schematics of biosensor and the functionalization of the gold surface by a self-assembled monolayer (SAM), a layer of CMdextran, Poly-L-lysine, and a phospholipid membrane. 56 anisms of cell activation by amphiphilic molecules are governed by a general principle. Wissenschaftlicher Jahresbericht 2007-2008 Division of Molecular Infection Biology Research Reports Collaboration: Schromm AB Div. of Immunobio- of an increase in LPS mediating endotoxicity due to physics, Ulmer AJ Div. of Immunobiology, Wies- the action of Hb. müller KH, EMC Microcollections, Tübingen, Seyberth T, Jung G, Universität Tübingen, Rössle M and Collaboration: Garidel P, Universität Halle, Roessle Koch MHJ, European Molecular Biology Laboratory, M European Molecular Biology Laboratory, Richter Hamburg. W Universität Jena, Christian Alexander Div. of Immunochemistry, Fournier k and Mach J.P. Universite Lausanne, Waelli T. Clinique La Prairie, Montreux, Structural investigations into the interaction of Gorczynski R University of Toronto, Ulmer AJ Div. of hemoglobin and part structures with bacterial en- Immunobiology, Zähringer U Div. of Immunochem- dotoxins istry, Hartmann A Clinique La Prairie, Montreux, Ri- Howe J, Brandenburg K. etschel E Th, Leibniz-Gemeinschaft, Berlin. The interaction of bacterial endotoxins (lipopolysac- Supported in part by: Clinique La Prairie, Montreux. charide, LPS) with the oxygen transport protein hemoglobin has been previously investigated, but a detailed understanding of the mechanisms in- Theses volved is still lacking. Here, a biophysical investigation into the endotoxin:hemoglobin interaction is Dissertation presented which comprises the use of various rough Böhling, Arne mutant LPS as well as free lipid A, and, in addition Biophysikalische Untersuchungen an bakteriellen to the complete hemoglobin from fetal sheep ex- Modellmembranen bezüglich ihrer lateralen Orga- tract also the partial structures a-chain and the nisation und der Interaktion mit humanen heme-free sample. The investigations comprise the sinen determination of the gel to liquid crystalline phase Mathematisch-Naturwissenschaftliche Fakultät behaviour of the acyl chains of LPS, the ultrastruc- Christian-Albrechts-Universität zu Kiel, 2007. -Defen- ture (type of aggregate structure and morphology) of the endotoxins, and the incorporation of the Hammer, Malte hemoglobins into artificial immune cell membranes Struktur-Wirkungsbeziehungen and into LPS. Our data allow to suggest a model of branaktiven Peptiden und bakteriellen Lipopoly- the interaction between Hb and LPS in that sacchariden hemoglobins do neither react strongly with the hy- Mathematisch-Naturwissenschaftliche Fakultät drophilic nor with the hydrophobic moiety of LPS, Christian-Albrechts-Universität zu Kiel, 2007. zwischen mem- but with the complete endotoxin. Hb is able to incorporate into LPS with the longitudinal direction Diploma parallel to the lipid A double-layer. Although this Brauser, Annemarie does not lead to a strong disturbance of the acyl Rasterkraftmikroskopische Untersuchungen zur In- chain packing, the change of the curvature leads to teraktion zwischen Phospholipidmembranen und a slightly conical molecular shape with a change of LBP (Lipopolysaccharid-bindendes Protein) the three-dimensional arrangement from unilamel- Fachbereich Angewandte Naturwissenschaften lar into cubic aggregates. Our previous results show Fachhochschule Lübeck, 2007. that cubic LPS structures exhibit strong endotoxic activity. The here observed property of Hb on the Helms, Gesa physical state of LPS may explain the observation Schichtdickenmessungen an rekonstituierten fest- Wissenschaftlicher Jahresbericht 2007-2008 57 Division of Molecular Infection Biology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l körperunterstützten Lipidmembranen Mathematisch-Naturwissenschaftliche Fakultät Christian-Albrechts-Universität zu Kiel, 2008. Grimm, Nico Aufbau und Programmierung einer Filmwaage zur biophysikalischen Untersuchung von Lipdmonoschichten Fachbereich Angewandte Naturwissenschaften Fachhochschule Lübeck, 2008. Jaber, Ahmed Spektroskopische und kalorimetrische Untersuchungen von Lipid-Peptid-Interaktionen Fachbereich Angewandte Naturwissenschaften Fachhochschule Lübeck, 2008. Patents Andrä, J., Blondelle, S. E., Brandenburg, K., Deutsch, G., Japelj, B., Jerala, R., Leiva Leon, J., Lohner, K., Majerle, A., Martinez de Tejada, G., Moriyon, I., Porro, M., Pristovsek, P., Zorko, M. and Zweytick, D. (2008) Antimicrobial Peptides. World Intellectual Property Organization (WO 2008/006125 A1) Brandenburg, K. Novel antimicrobial peptides. European patent office, P1712 EP. 58 Wissenschaftlicher Jahresbericht 2007-2008 Emmy-Noether Junior Research Group Immunobiophysics Research Reports Emmy-Noether Junior Research Group Immunobiophysics Head lipopeptides revealed, that the molecular geome- PD Dr. Andra Schromm try of these molecules, i.e. the molecular conformations and supramolecular aggregate structures de- Graduate Student termined Susanne Keese (since April 2008) measurements and the preference for membrane from small-angle X-ray diffraction intercalation allow an understanding of the biologTechnicians ical activities of the different lipopeptides. This Sabrina Groth refers in particular to the agonistic or antagonistic Nina Hahlbrock (until April 2008) activity, i.e., their ability to induce cytokines in mononuclear cells or to block this activity, respec- Trainees tively (Fig. 16). The analytical data show that our Kai Reichelt (Jan-März 2008) concept of ‘endotoxic conformation’, originally de- Thore Masekowitz (August-November 2008) veloped for LPS, can be applied also to the investigated lipopeptides, and suggest that the molecular mechanisms of cell activation by amphiphilic Research Reports molecules are governed by a general principle. Physicochemical and biological characterisation of synthetic bacterial lipopeptides: Validity of the concept of ’endotoxic conformation’ Schromm AB, Howe J*, Brandenburg K*. Lipoproteins from the outer or cytoplasmic membranes of Gram-positive and Gramnegative bacteria have been recognized increasingly to be important regarding their biological function and activity. They are, beside endotoxins (lipopolysaccharide, LPS) as main amphiphilic component of the outer membrane of Gram-negative bacteria, established as potent stimulants of the human innate immune system and elicit a variety of proinflammatory im- Fig. 16. Correlation between the molecular conformation of lipid A from E.coli, synthetic lipid A precursor IVa (“compound 406”), and synthetic lipopeptides determined from small-angle X-ray diffraction and biological activity in human macrophages. mune responses. Investigations of synthetic lipopeptides corresponding to N-terminal partial structures Collaboration: Howe J, Brandenburg K, *Divison of of bacterial lipoproteins defined the chemical pre- Biophysics; Ulmer AJ, Division of Cellular Immunol- requisites for their biological activity, especially with ogy; Wiesmüller K-H, Seyberth T, EMC microcollec- respect to the number and length of acyl chains and tions GmbH, Tübingen; Rössle M, European Molec- sequence of the peptide part. We obtained exper- ular Biology Laboratory c/o DESY, Hamburg. imental data on the biophysical mechanisms underlying lipopeptide bioactivity. Investigation of se- Supported in part by: This work was funded by DFG lected grants (SCHR 621/2-2, SCHR 621/2-3 and Ul 68/3-1), synthetic diacylated and triacylated Wissenschaftlicher Jahresbericht 2007-2008 59 Emmy-Noether Junior Research Group Immunobiophysics Research Reports the European Commission (ANEPID), and the Fed- that the lipopeptide represents an important stim- eral Ministry of Education and Research (project ulus of the innate immune response in the early Biochance no. 0312662). stages of infection. Fo r s c h u n g s z e n t r u m Bo r s t e l Collaboration: Reiling N, Division of Microbial InSerum-dependent immune recognition of a syn- terface Biology; Howe J, Brandenburg K, Division of thetic lipopeptide mimetic of the 19-kD lipopro- Biophysics; Wiesmüller KH, EMC microcollections, tein from Mycobacterium tuberculosis Tübingen; Roessle M, European Molecular Biology Groth S, Schromm AB. Laboratory c/o DESY, Hamburg. Host defense against invading pathogens is me- Supported in part by: This work was funded by DFG diated by the combined action of the innate and grants SCHR 621/2-2 and SCHR 621/2-3. the adaptive immune system. The innate immune response provides a critical first line defense against Mycobacterium tuberculosis, an intracel- Innate immune regulation by pulmonal collectins lular pathogen that represents a major health Stamme C*, Moulakakis C*, Keese S, Sender V*, threat worldwide. The 19-kDa lipoprotein is a cell- Schromm AB. wall-associated antigen expressed in M. tubercu- losis. A synthetic lipopeptide mimicking the lipid Pulmonary diseases caused by Gram-negative moiety of the 19-kDa lipoprotein from M. tubercu- bacteria are the leading cause of mortality from in- losis has recently been assigned an important role fectious diseases. The difficulties associated with in the induction of an antibacterial immune re- effective treatment of these diseases include the sponse in host macrophages. We have investigat- emergence of antibiotic-resistant pathogens, in- ed the biological activities and the biophysical creasing numbers of elderly individuals und im- mechanisms underlying cell activation by synthet- munocompromised patients. An attractive target ic 19-kDa M. tuberculosis-derived lipopeptide. In- for improving clinical outcomes is the modulation vestigation of the geometry of the lipopeptide (i.e. of the host pulmonary immune response itself. Sur- the molecular conformation and supramolecular factant protein A is one of the primary secreted aggregate structure) and the preference for mem- components of lung innate immunity eliciting es- brane intercalation provide an explanation for the sential immunomodulatory functions on alveolar biological activities of the mycobacterial lipopep- macrophages which constitute the majority of resi- tide. Surprisingly, we found that activation of hu- dent immune cells of the lung. We investigate the man macrophages to induce proinflammatory me- physico-chemical basis and molecular mechanisms diators (TNFα, IL-6, IL-8) in response to the of surfactant protein-A dependent regulation of the Mtb-lipopeptide is strongly enhanced in the ab- pulmonary sence of serum proteins suggesting a lung-specif- lipopolysaccharide. SP-A stabilizes IκB-α, the pri- ic adaptation of the immune recognition. This ob- mary regulator of NF-κB, in alveolar macrophages servation could be confirmed for the immune both constitutively and in the presence of LPS. Us- response of murine macrophages which showed a ing alveolar macrophages and PBMC from IκB-α strongly enhanced mediator release (TNFα) in the knockout/IκB-β knockin mice, we could show that absence of serum. Our data suggest that the SP-A fails to inhibit LPS-induced TNF-α production molecular mechanisms of immune recognition of (Fig. 17) and p65 nuclear translocation, confirming the lipopeptide derived from M. tuberculosis are a critical role for IκB-α in SP-A-mediated LPS inhi- tailored to the ambient conditions of the lung and bition. 60 immune response to bacterial Wissenschaftlicher Jahresbericht 2007-2008 Emmy-Noether Junior Research Group Immunobiophysics Research Reports *Division of Cellular Pneumology; Leitges M, The Biotechnolgy Centre of Oslo, University of Oslo. Supported in part by: This work was funded by DFG grants 609/1-3, 609/1-4, SCHR 621/2-2 and SCHR621/3-1. Fig. 17. SP-A fails to inhibit LPS-induced activation of IκB-α knockout/IκB-β knockin (AKBI) cells. Pooled PBMC from either three to four AKBI (A) or three wt mice (B) were left untreated or treated with 20-60 mg/ml SP-A (37°C, 1 h), and then exposed either to media, or to 0.1-100 ng/ml LPS. Cell-free supernatants were harvested after 4 h for the determination of TNF-α by ELISA. The data shown are mean ± SE of three independent experiments. Statistical analysis was performed using a two-way ANOVA with a Bonferroni post-test. * p < 0.05, ** p < 0.01, † p < 0.001 (versus LPS-induced TNF-a release in the absence of SP-A). We identifed atypical (a) protein kinase C ζ as a pivotal upstream regulator of SP-A mediated IκBα/NF-κB pathway modulation deduced from blocking experiments and confirmed by using alveolar macrophages from aPKC ζ deficient mice. SP-A transiently triggers aPKCThr410/403 phosphorylation, aPKC kinase activity, and translocation in primary rat alveolar macrophages. Coimmunoprecipitation experiments reveal that SP-A induces aPKC/p65 binding under constitutive conditions. Together the data indicate that anti-inflammatory macrophage activation via IκB-α by SP-A critically depends on PKCζ activity, and thus attribute a novel, stimulus-specific signaling function to PKCζ in SPA-modulated pulmonary immune response. Collaboration: Moulakakis C, Sender V, Stamme C, Wissenschaftlicher Jahresbericht 2007-2008 61 Division of Molecular Infection Biology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l Division of Molecular Infection Biology Head (ii) MyD88 is essential, but not because it transduces Prof Dr. Stefan Ehlers signals from TLRs, (iii) adaptive immunity to TB is largely TLR/MyD88-independent (Fig. 18). Principle Investigator PD Dr. Norbert Reiling Postdoctoral Fellows Dr. Kerstin Walter Dr. Evelin Grage-Griebenow (since 2/08) Dr. Sahar Aly (since 11/08) Dr. Jochen Behrends (since 4/08) Bachelor, Diploma/Master and Graduate Students Fig. 18 Schematic summary of mycobacterial proliferation in the lungs of Mtb-infected mice deficient for various TLRs, MyD88, IL-1R or IFN-γ. Dagmar Schneider (until 9/08) Some of the discrepancies may be resolved by co- Jan Neumann gent attribution of distinct immune functions to the in- Kollja Schaale dividual components of the TLR/MyD88 system. In Christine Steinhäuser mice, TLRs and MyD88 are fully dispensable in sensing Mtb infection and instructing T cell-mediated Technicians adaptive immunity, and while TLRs are also redun- Svenja Kröger dant during macrophage effector immunity, MyD88 Silvia Maass is essential for efficient killing of mycobacteria. This Stefanie Pfau distinction should help to molecularly pinpoint the Kathrin Seeger MyD88-dependent, yet TLR-independent critical Kerstin Kopp mechanisms of macrophage activation involved in in- Manfred Richter tracellular growth restriction of M. tuberculosis. Disrupted IL-1R and/or IFN-gamma signaling pathways Guests and Trainees likely play a much more prominent role in explaining Daniel Behme the exquisite susceptibility of MyD88-deficient mice to Department of Haematology/Oncology, Georg-Au- TB than the function of MyD88 as a TLR adaptor. gust-University, Göttingen Collaboration: Hölscher C, Junior Professorship Molecular Infection Biology, FZB. Research Report MyDths and un-TOLLed truths: sensor, instructive Supported in part by: DFG grant SFB415-C7. and effector immunity to tuberculosis LspA inactivation in Mycobacterium tuberculosis Reiling N, Ehlers S. results in attenuation without affecting phagoControversy exists concerning the role of Toll-like re- some maturation arrest ceptors and MyD88 in immunity to tuberculosis (TB). Walter K, Keller C, Ehlers S. Our data argue that (i) Toll-like receptors are not es- The success of Mycobacterium tuberculosis de- sential for an effective immune response against TB, pends on its ability to survive within host 62 Wissenschaftlicher Jahresbericht 2007-2008 Division of Molecular Infection Biology Research Reports macrophages. Here, M. tuberculosis avoids the Ac(2)PIM(5). Phosphatidylinositol mannoside and acidic, hydrolytically competent environment of the its related compounds lipomannan (LM) and phagolysosome by arresting phagosome matura- lipoarabinomannan (LAM) have been shown to tion. Having shown previously that a M. tuberculo- modulate the host response to an infection with M. sis mutant deficient in lipoprotein signal peptidase tuberculosis. Here, we generated a deletion mutant (LspA) is strongly attenuated in vivo in a mouse of Rv1500 in M. tuberculosis H37Rv, and analyzed model of infection, we now studied putative mech- the mutant using a biochemical approach as well anisms involved in attenuation of the lspA: : aph mu- as in vitro and in vivo infection models. Inactivation tant at a cellular level. In this work we investigated of Rv1500 did not lead to an altered expression pat- the ability of the mutant to interfere with two host de- tern of PIMs in M. tuberculosis H37Rv. We found fence mechanisms, i.e. Toll-like receptor (TLR)2-de- phosphatidylinositol pendent immune response and phagosome matu- Ac(2)PIM(2), and AcPIM(6) in both strains, but were ration. While mycobacterial lipoproteins have been unable to detect Ac(2)PIM(7) or Ac(2)PIM(5) either reported to trigger a TLR2 signalling pathway criti- in the wild type or the mutant strain. Uptake and cal for innate immune responses, we found that growth of H37Rv and Rv1500 mutant strains in growth control of the lspA : : aph mutant was inde- murine bone marrow-derived macrophages was pendent of TLR2. In addition, the lspA : : aph mutant identical, and TNFalpha and IL-12p40 production in arrested phagosome maturation to an extent simi- mouse macrophages and dendritic cells was in- lar to that of the wild-type, as measured by lysoso- duced to similar levels following infection with either mal-associated membrane protein 1 (LAMP1) co-lo- strain. Aerosol challenge of mice showed that wild calization These type and Rv1500 mutant strains had identical observations demonstrate severe attenuation even growth rates in infected organs over time. We veri- in the presence of arrested phagosome maturation, fied mRNA expression of Rv1500 in H37Rv and con- and point to a role for the early phagosome in clude that Rv1500 must serve a redundant role in vi- growth restriction of the M. tuberculosis lspA mutant. ability and virulence of M. tuberculosis. Collaboration: Rampini SK, Selchow P, Böttger EC, Collaboration: Malm S, Bange FC, Department of Sander P, Institut für Medizinische Mikrobiologie, Medical Microbiology and Hospital Epidemiology, Universität Zürich, Switzerland. Medical School Hannover, Germany; Holst O, Engel and intraphagosomal pH. (PI), PIM(2), AcPIM(2), R, Structural Biochemistry, FZB; Lindner B, ImmunoSupported in part by: Cluster of Excellence, Re- chemistry, FZB. search Area H. Supported in part by: DFG grant SFB470-C9. In vitro and in vivo characterization of a My- cobacterium tuberculosis mutant deficient in gly- Mycobacterium tuberculosis prevents inflamma- cosyltransferase Rv1500. some activation Walter K, Ehlers S. Walter K, Keller C, Ehlers S. In Mycobacterium marinum, the homologue of Mycobacterium tuberculosis (Mtb) parasitizes host Rv1500 of M. tuberculosis encodes a glycosyltrans- macrophages and subverts host innate and adap- ferase. Initially, it was suggested that this gene is in- tive immunity. Several cytokines elicited by Mtb are volved in the synthesis of phosphatidylinositol man- mediators of mycobacterial clearance or are in- nosides (PIMs), generating Ac(2)PIM(7) from volved in tuberculosis pathology. Surprisingly, inter- Wissenschaftlicher Jahresbericht 2007-2008 63 Division of Molecular Infection Biology Research Reports leukin-1beta (IL-1beta), a major proinflammatory cy- fected by the mutation, indicating a separate path- tokine, has not been implicated in host-Mtb inter- way for arginine degradation under aerobic condi- actions. IL-1beta is activated by processing upon as- tions. Following aerosol infection in mice, the sembly of the inflammasome, a specialized DeltaarcA mutant and wild-type strain of M. tuber- inflammatory caspase-activating protein complex. culosis multiplied and persisted in infected organs Here, we show that Mtb prevents inflammasome ac- in a similar fashion. Fo r s c h u n g s z e n t r u m Bo r s t e l tivation and IL-1beta processing. An Mtb gene, zmp1, which encodes a putative Zn(2+) metallo- Collaboration: Sürken M, Röhker C, Bange FC. De- protease, is required for this process. Infection of partment of Medical Microbiology and Hospital macrophages with zmp1-deleted Mtb triggered ac- Epidemiology, Medical School Hannover, Germany. tivation of the inflammasome, resulting in increased IL-1beta secretion, enhanced maturation of Mtb containing phagosomes, improved mycobacterial Location of persisting mycobacteria in a guinea clearance by macrophages, and lower bacterial pig model of tuberculosis revealed by r207910 burden in the lungs of aerosol-infected mice. Thus, Aly S, Ehlers S. we uncovered a previously masked role for IL-1beta in the control of Mtb and a mycobacterial system The lengthy chemotherapy of tuberculosis reflects that prevents inflammasome and, therefore, IL-1be- the ability of a small subpopulation of Mycobac- ta activation. terium tuberculosis bacteria to persist in infected individuals. To date, the exact location of these per- Collaboration: Master SS, Davis AS, Timmins GS, sisting bacteria is not known. Lung lesions in guinea Deretic V. Department of Molecular Genetics and pigs infected with M. tuberculosis have striking sim- Microbiology, University of New Mexico Health Sci- ilarities, such as necrosis, mineralization, and hy- ences Center, Albuquerque, USA; Rampini SK, poxia, to natural infections in humans. Guinea pigs Springer B, Sander P, Institut für Medizinische Mikro- develop necrotic primary lesions after aerosol in- biologie, Universität Zürich, Switzerland. fection that differ in their morphology compared to secondary lesions resulting from hematogenous dis- Supported in part by: the Cluster of Excellence, Re- semination. In infected guinea pigs conventional search Area H. therapy for tuberculosis during 6 weeks reduced the bacterial load by 1.7 logs in the lungs and, although this completely reversed lung inflammation associ- Anaerobic arginine metabolism of Mycobacteri- ated with secondary lesions, the primary granulo- um tuberculosis is mediated by arginine deimi- mas remained largely unaffected. Treatment of an- nase (arcA), but is not essential for chronic per- imals with the experimental drug R207910 (TMC207) sistence in an aerogenic mouse model of for 6 weeks was highly effective with almost com- infection plete eradication of the bacteria throughout both Walter K, Keller C, Ehlers S. the primary and the secondary lesions. Most importantly, the few remnants of acid-fast bacilli re- In many pathogens, degradation of arginine via the maining after R207910 treatment were to be found arginine deiminase pathway supports anaerobic extracellular, in a microenvironment of residual pri- metabolism. Here we show by deletion of Rv1001 mary lesion necrosis with incomplete dystrophic cal- (arcA) in Mycobacterium tuberculosis that this gene cification. This zone of the primary granuloma is hy- functions as an arginine deiminase. Arginine poxic and is morphologically similar to what has metabolism in the presence of oxygen was not af- been described for human lung lesions (Fig. 19). 64 Wissenschaftlicher Jahresbericht 2007-2008 Division of Molecular Infection Biology Research Reports These results show that this acellular rim may, there- IRF-1 appeared to be directly involved in the differ- fore, be a primary location of persisting bacilli with- entiation of a type 1 immune response to my- standing drug treatment. cobacterial infection. In summary, IRF-1, rather than being a mere transcription factor downstream of IFN-gamma, may be a master regulator of mycobacteria-induced immunopathology. Fig. 19. Hypoxic and necrotizing granuloma in the lung of a M. tuberculosis-infected guinea pig detected by pimonidazole immunohistochemistry. Collaboration: Lenaerts AJ, Hoff D, Andries K, Cantarero L, Orme IM, Basaraba RJ. Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, USA. Mycobacteria-induced granuloma necrosis depends on IRF-1 Aly S, Reiling N, Ehlers S. In a mouse model of mycobacteria-induced immunopathology, wildtype C57BL/6 (WT), IL-18-knockout (KO), and IFNalphabeta-receptor-KO mice developed circumscript, centrally necrotizing granulomatous lesions in response to aerosol infection with M. avium, whereas mice deficient in the IFN-gamma-receptor, STAT-1 or IRF-1 did not exhibit granuloma necrosis. Comparative, microarray- Fig. 20. Differential gene expression in the lungs of WT versus IRF1-KO mice infected with Mycobacerium avium TMC724. Graphic representation of a cluster analysis including 528 genes regulated more than 2-fold between WT and IRF-1 KO lungs infected with M. avium. Each row in the heat map represents one probe set, the columns stand for the conditions tested. A red square indicates higher expression, a green square indicates lower expression relative to a row-wise mean (black). The different groups A-F comprise genes regulated in a similar manner. based gene expression analysis in the lungs of infected WT and IRF-1-KO mice identified a set of Collaboration: Mages J, Lang R, Institute for Medi- genes whose differential regulation was closely as- cal Microbiology and Immunology, Technical Uni- sociated with granuloma necrosis, among them versity of Munich; Kalinke U, Paul-Ehrlich-Institute, cathepsin K, cystatin F and matrix metalloprotease Langen; Decker T, Institute for Biochemistry, Univer- 10 (Fig. 20). Further microarray-based comparison sity of Vienna, Austria. of gene expression in the lungs of infected WT, IFN- Supported in part by: DFG grant SFB367, C9 and gamma-KO and IRF-1-KO mice revealed four distinct BMBF grant NGFN-2. clusters of genes with variable dependence on the presence of IFN-gamma, IRF-1 or both. In particular, Wissenschaftlicher Jahresbericht 2007-2008 65 Division of Molecular Infection Biology Research Reports Mice that overexpress CC chemokine ligand 2 in Collaboration: Schreiber O, Steinwede K, Ding N, their lungs show increased protective immunity to Srivastava M, Maus R, Länger F, Prokein J, Welte T, infection with Mycobacterium bovis bacilli Cal- Gunn MD, Maus UA, Department of Pulmonary mette-Guérin Medicine, Medical School Hannover, Germany. Fo r s c h u n g s z e n t r u m Bo r s t e l Ehlers S, Behrends J. The acute phase of mycobacterial lung infection is Decreased pathology and prolonged survival of characterized by a nearly exponential outgrowth of human DC-SIGN transgenic mice during my- mycobacteria in the alveolar airspace and lung cobacterial infection parenchymal tissue, suggesting insufficient early Reiling N, Fessler C, Walter K, Ehlers S. protective immunity against mycobacterial challenge. In the current study, we tested the hypothe- Dendritic cell (DC)-specific intercellular adhesion sis that a CC chemokine ligand 2 (CCL2)-dependent molecule-3 grabbing nonintegrin (DC-SIGN: CD209) increased mononuclear phagocyte subset accumu- is a C-type lectin that binds ICAM-2,3 and various lation in distal airspaces would improve the lungs’ pathogens such as HIV, helicobacter, and my- protective immunity to infection with Mycobacterium cobacteria. It has been suggested that Mycobac- bovis bacille Calmette-Guérin (BCG). Wild-type terium tuberculosis, the causative agent of pul- mice and CCL2-overexpressing mice that exhibited monary tuberculosis, interacts with DC-SIGN to increased pools of alveolar and lung mononuclear evade the immune system. To directly analyze the phagocytes-due to the lung-specific overexpression role of human DC-SIGN during mycobacterial infec- of human CCL2 in type-II alveolar epithelial cells- tion, we generated conventional transgenic (tg) were infected intratracheally with BCG and the de- mice (termed “hSIGN”) using CD209 cDNA under veloping lung inflammatory response was ana- the control of the murine CD11c promoter. Upon my- lyzed. CCL2-overexpressing mice demonstrated cobacterial infection, DCs from hSIGN mice pro- significantly decreased mycobacterial loads in the duced significantly less IL-12p40 and no significant bronchoalveolar space, lung parenchymal tissue, differences were be observed in the secretion lev- and spleen compared with wild-type mice, when els of IL-10 relative to control DCs. both groups of mice were infected with BCG. Moreover, in BCG-infected mice, later-developing, accelerated resolution of lung granuloma formation was noted, particularly in CCL2-overexpressing mice as compared with wild-type mice. In addition, CCL2-overexpressing mice demonstrated an increased trafficking of mycobacteria-loaded dendritic cells towards lung-draining lymph nodes that was found to coincide with increased mycobacterial loads in this compartment. The data of the current study suggest that CCL2-dependent amplification of endogenous host-defense programs in the lung may improve the lungs’ protective immunity Fig. 21. Survival of hSIGN mice after infection with 2000 CFU Mtb. Ten mice per group, log-rank test ***, p < 0.001. against mycobacterial infections. Experiments are ongoing to determine the relative importance of After high dose aerosol infection with the strain M. these mechanisms in protection against airborne tuberculosis H37Rv, hSIGN mice showed massive M. tuberculosis infection. accumulation of DC-SIGN(+) cells in infected lungs, 66 Wissenschaftlicher Jahresbericht 2007-2008 Division of Molecular Infection Biology Research Reports reduced tissue damage and prolonged survival as demonstrated for IFN-alpha response to virus. (Fig. 21). Based on our in vivo data, we propose that Currently, these PDC and myeloid DC subsets are in- instead of favoring the immune evasion of my- vestigated for their immunoregulatory role in the cobacteria, human DC-SIGN may have evolved as early pathogenesis of Wegener`s granulomatosis a pathogen receptor promoting protection by limit- and experiments with human cells are extended to ing tuberculosis-induced pathology. in vivo and in vitro studies in mice. These studies are part of the project “Molecular induction mecha- Collaboration: Schaefer M, Stephani J, Taniuchi I, nisms of danger receptor PAR-2 on DC” performed Hatam F, Ruland J, Wagner H, Sparwasser T. Insti- in the Clinical Research Group on the early patho- tute for Medical Microbiology, Immunology, and Hy- genesis of Wegener`s disease. giene, Technische Universität München, Munich, Germany; Fehrenbach H, Yildirim AO, Experimental Collaboration: Löseke S, Kauth M, Gehlhar K, Bufe Pneumology, FZB. A, Experimental Pneumology, Ruhr-University Bochum; Zawatzky R, Department FO30, German Supported in part by: DFG GRK288 A6, SFB 470 C9, Cancer Research Centre, Heidelberg; Holle J, Cser- and the German National Genome Research Net- nok E, Dept. of Rheumatology, UK-SH Lübeck and work (01GS0412). Clinic for Rheumatology, Bad Bramstedt. Anti-BDCA-4 (neuropilin-1) antibody can suppress A novel immunomagnetic approach to isolate my- virus induced IFN-alpha production of plasmacy- cobacteria-containing phagosomes from primary toid dendritic cells macrophages Grage-Griebenow E. Steinhäuser C, Pott J, Ehlers S, Reiling N. Plasmacytoid dendritic cells (PDC) in human blood M. tuberculosis (Mtb) is able to persist within the are the main source of virus-induced IFN-alpha. host alveolar macrophage by arresting the matu- They exhibit a lineage-negative phenotype but all ration of its phagosome. The Mtb phagosome re- express BDCA-4, which is homologous to the neu- tains characteristics of an early endosome and ronal receptor Neuropilin-1. Specific staining with does not fuse with lysosomes. Little is known about anti-BDCA-4 antibody is used for positive isolation signalling events starting from these intracellular of PDC from blood by magnetic cells sorting. We compartments. In order to analyse these processes demonstrated that these positively selected PDC we established a new technique to isolate my- showed reduced or completely abolished IFN-alpha cobacteria containing phagosomes from primary release compared to unstained PDC which were macrophages based on the immunomagnetic la- negatively selected by magnetic depletion of lin- belling of mycobacteria. After biotinylation of the eage-positive blood mononuclear cells. In addition, mycobacterial surface bacteria were coupled to treatment of these unstained PDC with anti-BDCA-4 magnetic streptavidin nanobeads. The stability of mAb also resulted in at least 2-fold lower or com- the labelling was monitored by flow cytometry. Elec- pletely reduced virus-induced IFN-alpha production. tron microscopy (TEM) demonstrated the integrity of It is shown that the antibody does not simply affect magnetically labelled mycobacteria within phago- cell survival or block virus attachment. IFN-alpha re- somes of murine macrophages (Fig. 22). The plas- lease induced by non-viral CpG oligodeoxynu- ma membrane of the macrophages was carefully cleotides is also reduced. In conclusion, data sug- disrupted by sonification leaving phagosomes in- gest an immunoregulatory role for BDCA-4 on PDC tact as visualized by TEM. The solution containing Wissenschaftlicher Jahresbericht 2007-2008 67 Division of Molecular Infection Biology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l the disrupted cells was used for the isolation of phagosomes in a high magnetic field. The protein composition of mycobacterial phagosomes was analysed by Western blot and revealed a differential distribution of proteins between the magnetic phagosome fraction and the non-magnetic fraction. These data indicate that the new phagosome isolation assay is a sophisticated method to examine molecular events at the interface of the host cell and the mycobacterial invader. Fig. 22. Electron microscopy of a murine macrophage infected with magnetically labeled M. avium SE01. Collaboration: Vladimir Tchikov, Stefan Schütze, Institute of Immunology, University Hospital of Schleswig-Holstein, Kiel, Germany; Karl-Heinz Wiesmüller, EMC microcollections GmbH, Tübingen, Germany. Supported in part by: DFG grant Re1228/4-1 und Sch733/7-1. Theses Master of Science Kolja Schaale Wnt5a induced signaling events in the context of inflammatory processes: studies in primary murine macrophages Masterstudiengang “Molecular Life Sciences” Technisch-Naturwissenschaftliche Fakultät Universität zu Lübeck, 2008. 68 Wissenschaftlicher Jahresbericht 2007-2008 Junior Research Group Molecular Infection Biology Research Reports Junior Research Group Molecular Infection Biology Head after 12 weeks of infection and dying significantly Prof. Dr. Christoph Hölscher (Juniorprofessor) earlier than controls. The differentiation, recruitment and activation of TH1 cells as well as the induction Staff Scientists and Postdoctoral Fellows of IFN-gamma-dependent effector genes against Jochen Behrends (from 05/08) Mtb were not affected by macrophage-derived IL- Hanna Erdmann (from 10/08) 10. However, microarray analysis of pulmonary gene expression revealed patterns characteristic of Graduate Students alternative macrophage activation that were over- Lisa Heitmann (from 02/08) represented in Mtb-infected macIL-10-transgenic Manuela Heßmann (until 03/08) mice (Fig. 23a). Kristian Holz (from 09/08) Caroline Roßnagel (until 08/07) Dominik Rückerl (until 11/07) Jan Christian Sodenkamp Technicians Alexandra Hölscher Insa Lenz (until 03/07) Gabriele Röver (from 01/08) Tanja Sonntag Kerstin Traxel (from 01/08) Johanna Volz (from 02/08) Research Reports Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity Heitmann L, Hölscher C. Elevated IL-10 has been implicated in reactivation tuberculosis (TB). Since macrophages rather than T cells were reported to be the major source of IL-10 in TB, we analyzed the consequences of a macrophage-specific overexpression of IL-10 in transgenic mice (macIL-10-transgenic) after aerosol Fig. 23. After Mtb-infection, macIL-10tg mice develop alternatively activated macrophages. FVB (open symbols) and macIL-10tg (solid symbols) mice were infected with 100 CFU Mtb via the aerosol route. (a) Signs of alternative macrophage activation in the lung transcriptome of macIL-10tg mice after Mtb infection. Gene-expression analysis was performed in lung homogenates from uninfected and mice infected for 25 and 42 days. Changes in expression of selected genes associated with alternative macrophage activation during Mtb infection of FVB and macIL-10tg mice were visualized using hierarchical clustering of z-score normalized average expression values. Similarity between experimental conditions and patterns of individual genes is indicated by dendrograms. Gene symbols are given (Mrc, macrophage mannose receptor; Chi3l3, Ym1; Chi3l4, Ym2; Il4ra, IL-4 receptor-alpha; Retlna, Fizz1; Arg2, arginase-2; Arg1, arginase-1; Chi3l1, chitinase 3l1). (b, c) Increased arginase-1 activity is concomitant with reduced production of RNI. (b) Gene-expression of Arg1 was determined in lung homogenates from uninfected and mice infected for 21, 49 and 89 days by quantitative real time RT-PCR based on expression of Hprt. (c) During the course of infection, the RNI content in sera was measured by the Griess reaction. infection with Mycobacterium tuberculosis (Mtb). MacIL-10-transgenic mice were more susceptible to Importantly, arginase-1 gene expression and activ- chronic Mtb infection than non-transgenic litter- ity were strikingly enhanced in transgenic mice ac- mates, exhibiting higher bacterial loads in the lung companied by a reduced production of reactive ni- Wissenschaftlicher Jahresbericht 2007-2008 69 Division of Biophysics Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l Together, with Mtb. Aerosol infection of IL-13tg mice resulted in macrophage-derived IL-10 triggers aspects of alter- a profound induction of arginases concomitant with native macrophage activation and promotes Mtb increased bacterial loads at chronic stages of the recrudescence independent of overt effects on an- disease very much resembling reactivation TB. Importantly, in IL-13tg mice Mtb infection resulted in tis- trogen intermediates (Fig. 23b). ti-TB T cell immunity. sue pathology similar to GN in human TB. From our Collaboration: Ehlers S, Molecular infection Biology, data we conclude that IL-4Rα-dependent mecha- Research Center Borstel; Schreiber T, Robert Koch nisms are involved in the pathogenesis of post-pri- Institute, Berlin, Germany; Lang R, Molecular mary TB. Medicine, University Hospital Erlangen, Germany; Murray P, Department of Infectious Diseases and Im- Collaboration: Ehlers S, Molecular infection Biology, munology, St. Jude Children’s Research Hospital, Research Center Borstel, Thye T, Meyer CG, Memphis, TN USA. Horstmann R, Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Supported in part by: Collaborative research grant Hamburg, Germany; McKenzie ANJ, MRC Labora- (“Host defence against infections”) from the Medical tory of Molecular Biology, Cambridge, United King- University of Lübeck; BMBF, Nation-wide Collabora- dom; Brombacher F, International Centre for Ge- tive Grant “Pulmonary Tuberculosis – host and netic Engineering and Biotechnology, University of pathogen determinants of resistance and disease Cape Town, South Africa. progression”, workpackage E “Animal Models”. Supported in part by: BMBF, Nation-wide Collaborative Grant “Pulmonary Tuberculosis - host and Granuloma necrosis in tuberculosis is mediated pathogen determinants of resistance and disease by interleukin-4 receptor-alpha-dependent mech- progression”, workpackage E “Animal Models”. anisms Heitmann L, Hölscher C. IL-17 maintains protective immunity during MyReactivation and granuloma necrosis (GN) are piv- cobacterium tuberculosis infection otal events of post-primary tuberculosis (TB). To date, Rückerl D, Behrends J, Heßmann M, Hölscher C. there is no clear evidence whether interleukin (IL)-4 and IL-13 are involved in the pathogenesis of the dis- Because a variety of autoimmune disorders have ease. Therefore, we genotyped polymorphisms in IL- now been shown to depend on interleukin (IL)-17- 4, IL-13 and the IL-4 receptor alpha-chain (IL-4Rα) in producing T helper (TH)17 cells, therapeutic block- patients with pulmonary TB from Ghana. A structural ade of TH17 development may provide a novel ap- variant of the IL-4Rα, which has been shown to be as- proach to avoid adverse consequences of sociated with an increased transcription of the gene, anti-inflammatory strategies such as reactivation of was found to be significantly associated with in- latent tuberculosis (TB). To evaluate the potential creased cavity size indicating a prominent role of the risk of interfering with IL-17-dependent inflammation, IL-4Rα in human GN. In Mycobacterium tuberculosis (Mtb)-infected mice, however, IL-4 and IL-13 are only we analyzed the outcome of experimental TB in IL17-deficient (-/-) mice after infection with Mycobac- moderately induced and necrotizing granulomas are terium tuberculosis (Mtb). IL-17 was important for the not apparent. To address the question how IL-4Rα- induction of neutrophil chemokines after Mtb infec- mediated mechanisms affect the outcome of murine TB, IL-13-overexpressing (IL-13tg) mice were infected tion, but was not involved in granuloma formation 70 and protection during the first three months of Mtb Wissenschaftlicher Jahresbericht 2007-2008 Division of Biophysics Research Reports infection. Mtb-infected IL-17-/- mice efficiently gen- IL-12/23p40 production in activated macrophages, erated interferon-gamma (IFNγ)-producing T cells we hypothesise that IL-27 modulates Th17 immune re- and IFNγ-dependent effector responses. However, IL-17-/- mice were not able to control mycobacterial sponses replication during the chronic phase of experimen- pha gp130 receptor complex. To evaluate these IL-27- tal TB and died significantly earlier than corre- mediated sponding wildtype mice. This breakdown of immune protection in IL-17-/- mice was associated with a macrophages, we analyzed inflammatory immune drop in the frequency of IFNγ-producing CD4+ T cells. Our findings reveal that IL-17 is essential for maintaining CD4+ T cell-dependent protection dur- by regulating pro-inflammatory macrophage responses through its IL-27 receptor-al- suppressive effects Mtb specifically in in -/macrophage/neutrophil-specific gp130-deficient ( ) LysMcregp130flox/flox mice. In vitro, IL-6- and IL-27- responses after infection ing chronic stages of TB. Hence, interfering with IL- mediated signal transduction was affected in macrophages from LysMcregp130flox/flox mice lead- 17-dependent pathways as an anti-inflammatory ing to an uncontrolled production of IL-12/23p40 af- therapeutic approach will possibly incur the danger ter stimulation. Following infection with Mtb, LysMcregp130flox/flox mice produced elevated amounts of reactivating latent TB. of IL-6 when compared to infected LysMcre-negative Collaboration: Ehlers S, Molecular infection Biology, littermates. Accordingly, the differentiation of Th17 Research Center Borstel Müller U and Alber G, University of Leipzig, Germany; Iwakura Y, University of cells was increased in macrophage/neutrophil-specific gp130-/- mice whereas Th1 immune responses Tokyo, Japan. were not affected. In summary, our results so far revealed that after Mtb infection Th17 differentiation is Supported in part by: Cluster of Excellence “Inflam- regulated on the level of macrophages/neutrophils mation at Interfaces, IRN F “Cytokine signalling via through gp130-mediated signals. Together, our study gp 130”, project 4 “Infection driven inflammation may expand the understanding of regulatory mech- models”. anism during Th17 differentiation implying IL-27 as a negative feedback controller which limits the Th17driving production of IL-6 and IL-23 by macrophages. gp130 on macrophages/neutrophils negatively regulates TH17 development during experimental Collaboration: Ehlers S, Molecular Infection Biology, tuberculosis Research Center Borstel Förster I, Institut für umwelt- Sodenkamp JC, Hölscher C. medizinische Forschung, Heinrich Heine Universität, Düsseldorf, Germany; Müller W, University of Man- Interleukin (IL)-6- and IL-23-driven T helper cell (Th)17 chester, Manchester, England, UK. differentiation is associated with the development of autoimmune and chronic inflammatory diseases. Af- Supported in part by: Cluster of Excellence “Inflam- ter infection with Mycobacterium tuberculosis (Mtb), mation at Interfaces, IRN F “Cytokine signalling via IL-17 deficiency results in a loss of immune protection gp 130”, project 4 “Infection driven inflammation exceptionally during chronic stages of the disease. models”; DFG HO 2145/4-3 “Regulation of inflam- However, an increased Th17 immune response in the matory and protective macrophage immune re- absence of IL-27-mediated regulatory mechanisms is sponses through Stat3-dependent signaling events”; concomitant with the development of excessive in- SFB 415, project C10 “Cell-specific mechanisms me- flammation and premature death. Hence, Th17 dif- diated by IL-27/WSX-1 during inflammatory immune ferentiation after Mtb infection has to be tightly reg- responses”. ulated. Because IL-27 is able to inhibit IL-6 and Wissenschaftlicher Jahresbericht 2007-2008 71 Division of Biophysics Research Reports Adjuvanticity of a synthetic cord factor analog for Here, we demonstrate that these glycolipids acti- subunit Mycobacterium tuberculosis vaccination vate macrophages and dendritic cells (DC) via requires FcRγ-Syk-Card9-dependent innate im- Syk-Card9-Bcl10-Malt1 signaling to induce a spe- mune activation cific innate activation program distinct from the re- Hölscher C. sponse to Toll-like receptor (TLR) ligands. APC ac- Fo r s c h u n g s z e n t r u m Bo r s t e l tivation by TDB and TDM was independent of the Novel vaccination strategies against Mycobacteri- C-type lectin receptor Dectin-1, but required the um tuberculosis (Mtb) are urgently needed. The ITAM-bearing adapter protein Fc receptor gamma- use of recombinant Mtb antigens as subunit vac- chain (FcRγ). In vivo, TDB and TDM adjuvant activ- cines is a promising approach, but requires adju- ity induced robust combined TH1 and TH17 T cell vants that activate antigen presenting cells (APC) responses to a Mtb subunit vaccine and protection for elicitation of protective immunity. The my- against Mtb challenge in a Card9-dependent man- cobacterial cord factor, Trehalose-6,6-dimycolate ner (Fig. 24). These data provide a molecular ba- (TDM), and its synthetic analog Trehalose-6,6- sis for the immunostimulatory activity of TDB and dibehenate (TDB) are effective adjuvants in com- TDM, and identify the Syk-Card9 pathway as a ra- bination with Mtb subunit vaccine candidates in tional target for vaccine delelopment against tu- mice. However, it is unknown which signaling path- berculosis. ways they engage in APC and how these are coupled to the adaptive immune response. Collaboration: Ruland J, Institute of Medical Microbiology, Immunology and Hygiene, Technical University Munich, Germany; Lang R, Molecular Medicine, University Hospital Erlangen, Germany; Agger EM, Adjuvant Research, Dept. of Infectious Disease Immunology, Statens Serum Institute, Copenhagen, Denmark. Supported in part by: Cluster of Excellence “Inflammation at Interfaces, IRN F “Cytokine signalling via gp 130”, project 4 “Infection driven inflammation models”. Theses Dissertation Rückerl, Dominik Die Bedeutung IL-27- und IL-23-vermittelter MechaFig. 24. Induction of protective immunity to Mtb by TDB/TDM adjuvant requires Card9. Wildtype and Card9-/- mice were immunized with ESAT6/AG85 in DDA or DDA-TDB liposomes and infected by aerosol with 100 CFU Mtb. (a) Immunization with ESAT6/AG85 in DDA-TDB liposomes fails to reduce the number of bacterial loads in the lungs of Card9-/- mice. After 6 weeks, mice were sacrificed and the bacterial load was determined in the lung. (b) Protection after immunization with ESAT6/AG85 in DDA-TDB liposomes correlates with the Card9-dependent induction of TH17 rather than TH1 cells. Frequency of CD4 T cells producing IL-17 or IFNg from mediastinal lymph nodes 6 weeks after Mtb infection. 72 nismen für den Verlauf entzündlicher Immunreaktionen unter besonderer Berücksichtigung der Infektion mit Mycobacterium tuberculosis. Technisch-Naturwissenschaftliche Fakultät Universität zu Lübeck, 2007. Hessmann, Manuela Wissenschaftlicher Jahresbericht 2007-2008 Division of Biophysics Research Reports Die Bedeutung des Rezeptors NKG2D und seiner Adaptermoleküle DAP10 und DAP12 für die Zell-vermittelte Immunantwort nach der Infektion mit Mycobacterium tuberculosis. Technisch-Naturwissenschaftliche Fakultät Universität zu Lübeck, 2008. Wissenschaftlicher Jahresbericht 2007-2008 73 Research Group of Cellular Pneumology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l Research Group of Cellular Pneumology Head PD Dr. Cordula Stamme Postdoctoral Fellow Dr. Christina Moulakakis Scientific Staff Alexandra Lange Vicky Sender Technician Linda Lang Research Reports Surfactant protein A activation of atypical protein kinase C ζ in IκB-α-dependent anti-inflammatory immune regulation Moulakakis C, Stamme C. Fig. 25. SP-A fails to inhibit LPS-induced p65 nuclear translocation in AKBI AM. AM from wild type (a-d) or AKBI (c-h) mice were left untreated or treated with 40 µg/ml SP-A (37°C, 1 h), exposed to media, or to 100 ng/ml LPS (1 h), and then analyzed by confocal microscopy. Color code: green: NF-κB p65; red: cell nuclei were counterstained with propidium iodide. Overlays of single stainings are shown. Images are representative of three independent experiments. Pixel densitometry of nuclear NFκ-B p65 was quantified and statistically analyzed with one-way ANOVA and Newman-Keuls post-hoc test. ** p < 0.001 (versus control), #p < 0.001 (versus LPS). The pulmonary collectin surfactant protein (SP)-A has a pivotal role in anti-inflammatory modulation of lung immunity. The mechanisms underlying SP-Amediated inhibition of lipopolysaccharide (LPS)-induced NF-kB activation in vivo and in vitro are only Fig. 26. PKCζ is vital for SP-A-mediated IB-κ stabilization and inhibition of LPS-induced NF-κB activity. (A-B) Pooled AM from either four wild-type (A) or four PKCζ-deficient mice (B) were left untreated or treated with 40 µg/ml SP-A (1 h), and then exposed either to media or to 100 ng/ml LPS (1 h). Cytosolic cell fractions were immunoblotted for IκB-α (upper panel). Nuclear extracts of the partially understood. We previously demonstrated that SP-A stabilizes inhibitory κB-α (IκB-α, the primary regulator of NF-κB, in alveolar macrophages (AM) both constitutively and in the presence of LPS. Here we show that in AM and PBMC from IκB-α knockout/IκB-α knockin (AKBI) mice SPA fails to inhibit LPS-induced TNF-α production and p65 nuclear translocation, confirming a critical role for IkB-a in SPA-mediated LPS inhibition. We identify atypical (a) protein kinase C (PKC) ζ as a pivotal upstream regulator of SP-Amediated IκB-α/NF-κB pathway modulation deduced from blocking experiments and confirmed by using AM from 74 Wissenschaftlicher Jahresbericht 2007-2008 Research Group of Cellular Pneumology cells were analyzed by EMSA for NF-κB DNA binding activity (mid panel). Data shown are representative of three independent experiments. Densitometric results are expressed as arbitrary units (a.u.). Data were analyzed by one-way ANOVA with a post-hoc Newman-Keuls test. * p < 0,01, ** p < 0,001 (versus control); #p < 0.01, ##p < 0.001 (versus LPS). Research Reports of SP-A by AMφ is a prerequisite for its modulation of the IκB-α/NF-κB pathway. The inhibition of clathrincoated pit (CCP) formation and clathrin-coated vesicle (CCV) formation/budding abrogates SP-A-medi- PKCζ-/- mice. SP-A transiently triggers aPKCThr410/403 phosphorylation, aPKC kinase activity, ated IκB-α stabilization and SP-A-mediated inhibition and translocation in primary rat AM. Co-immuno- AMφ, as determined by Western analysis, fluores- precipitation experiments reveal that SP-A induces cence-activated cell sorting, confocal microscopy, aPKC/p65 binding under constitutive conditions. To- and EMSA. Actin depolymerization and inhibition of gether the data indicate that anti-inflammatory CCP formation further abolished SP-A-mediated inhi- macrophage activation via IκB-α by SP-A critically bition of LPS-induced TNF-α release, as determined depends on PKCζ activity and thus attribute a nov- by ELISA. In addition, SP-A-induced atypical PKCζ ac- el, stimulus-specific signaling function to PKCζ in SP- tivation was abolished by pretreatment of AMφ with A-modulated pulmonary immune response. CCV inhibitors as determined by in vitro immuno- of LPS-induced NF-κB activation in freshly isolated rat complex kinase assay. While CME is classically conCollaboration: Engelhardt J, Univ of Iowa, USA; Leit- sidered as a means to terminate signaling, our results ges M, Max-Planck-Institute of Experimental En- demonstrate that SP-A uptake via CME by AMφ has docrinology, Hannover; Schromm AB, Emmy- to precede the initiation of SP-A signaling. Noether-Group of Immunophysics, Seitzer U, Division of Veterinary Infection Biology and Immunology, Research Center Borstel. Supported in part by: Deutsche Forschungsgemeinschaft, grant STA 609/1-3. Role of clathrin-mediated endocytosis of surfactant protein A by alveolar macrophages in intracellular signaling Moulakakis C, Stamme C. We recently provided evidence that anti-inflammatory macrophage activation, i.e. the inhibition of constitutive and signal-induced NF-κB activity by the pulmonary collectin surfactant protein (SP)-A, critically involves a promoted stabilization of inhibitory κB (IκB)-α the predominant inhibitor of NF-κB, via posttranscriptional mechanisms comprising the activation of atypical (a) PKCζ. SP-A uptake and degradation by alveolar macrophages (AMφ) occurs in a receptormediated, clathrin-dependent manner. However, a mutual link between endocytosis of and signaling by SP-A remains elusive. In the present study we investigated whether clathrin-mediated endocytosis (CME) Fig. 27. CCV formation and budding are required for cell-association of SP-A with AMφ. Freshly isolated primary rat AMφ in suspension were incubated 2.5 mM amantadine (30 min), 2 µM phenylarsine oxide (PAO) (30 min), 50 µM chlorpromazine (CPZ) (1 h), or 10 µM CytoD (30 min) followed by the addition of 40 µg/ml FITC-SP-A (1 h). Cells were washed and cell-association of FITC-SPA was measured by flow cytometry. Data are expressed as percent of total cell-associated SP-A ± SEM. Overlay of FACS histogram is representative of three independent experiments. Data were analyzed by one-way ANOVA with a post-hoc Newman-Keuls test. * p < 0.05, ** p < 0.01 (vs. cell-association of FITC-SP-A). Wissenschaftlicher Jahresbericht 2007-2008 75 Research Group of Cellular Pneumology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l lavage, nuclear factor kappaB, (NF-kappaB)-activation in alveolar macrophages and circulating systemic mediators were monitored. Control patients underwent bronchoalveolar lavage after intubation. RESULTS: In the IPL, mediator concentrations increased with increasing end-expiratory pressure at an EIP of 10 cm H2O, but decreased at 25 cm H2O EIP. In patients, bronchoalveolar IL-6, monocyte chemoattractant protein-1, and granulocyte monocyte-colony stimulating factor were increased by ventilation regardless of the PEEP level. IL-6 and IL8 levels were moderately increased by PEEP but not Fig. 28. Uptake of FITC-labeled SP-A by alveolar macrophages (AMφ). Confocal images of (AMφ) without treatment (a), after treatment with (b) FITC-labeled SP-A (40 µg/ml), (c) amantadine (2.5 mM) prior to SP-A, and (d) CytoD (10 µM) prior to SP-A. Color code: green: FITC-SP-A; red: actin; blue: DAPI. zero end-expiratory pressure. Nuclear factor kappaB DNA binding activity in alveolar macrophages and systemic mediator levels did not change. CONCLUSIONS: On the basis of the premise that cytokine levels may indicate mechanical stress, our Supported in part by: Deutsche Forschungsgemein- findings indicate that even low tidal volume venti- schaft, grant STA 609/1-3, 1-4. lation causes some stress. PEEP is beneficial at high inspiratory pressure, but imposes moderate stress at low inspiratory pressure. Pulmonary cytokine responses during mechanical ventilation of noninjured lungs with and without Collaboration: Uhlig U, Uhlig S, Institute of Pharma- end-expiratory pressure. cology and Toxicology, University Hospital Aachen; Stamme C. Meier T, Lange A, Papenberg H, Ziemann M, Fentrop C, Schmucker P, Department of Anesthesiology, BACKGROUND: Positive end-expiratory pressure University Medical Center Schleswig-Holstein, Cam- (PEEP) during mechanical ventilation may impose pus Lübeck. different degrees of stress on healthy lungs. On the assumption that stress is reflected by cytokine production, we performed a translational study investi- Theses gating the effect of PEEP on bronchoalveolar and systemic mediator levels in isolated perfused Dissertation mouse lungs (IPL) and in patients with healthy lungs. Moulakakis, Christina METHODS: (Part I) IPL were ventilated with end-ex- Pulmonary Surfactant Protein A’s anti-inflammatory piratory pressures of 0, 3, 6, or 10 cm H2O and end- modulation of the IkB-a/NF-kB signal transduction inspiratory pressure (EIP) levels of 10 or 25 cm H2O. pathway Interleukin (IL)-6 and macrophage inflammatory Technisch-Naturwissenschaftliche Fakultät protein-2 concentrations in the venous effluate were Universität zu Lübeck, 2008. monitored. (Part II) Patients (nonsmokers) scheduled for elective otorhinolaryngology surgery (duration>90 min) were randomized to receive either ventilation with zero end-expiratory pressure or PEEP (10 cm H2O). Mediators in bronchoalveolar 76 Wissenschaftlicher Jahresbericht 2007-2008 Abteilung Immunologie und Zellbiologie Department of Immunology and Cell Biology Fo r s c h u n g s z e n t r u m Bo r s t e l 78 Wissenschaftlicher Jahresbericht 2007-2008 Abteilung Immunologie und Zellbiologie Department of Immunology and Cell Biology Abteilung Immunologie und Zellbiologie Department of Immunology and Cell Biology Wissenschaftlicher Jahresbericht 2007-2008 79 Zusammenfassung Summary Fo r s c h u n g s z e n t r u m Bo r s t e l Abteilung Immunologie und Zellbiologie Department of Immunolgy and Cell Biology Head Head Prof. Dr. Dr. Silvia Bulfone-Paus Prof. Dr. Dr. Silvia Bulfone-Paus Secretary Secretary Annette Wallisch Annette Wallisch Die Abteilung Immunologie und Zellbiologie um- The Department of Immunology and Cell Biology fasst ein multi-disziplinäres Wissenschaftlerteam, comprises a multi-disciplinary team of scientists do- das die zellulären und molekularen Grundlagen ing research on the cellular and molecular mecha- der Infektion, der Allergie und des Tumorwachs- nisms of infection, allergy and tumor growth. The tums erforscht. Das breite Spektrum der wis- broad scale of scientific interests and methodical senschaftlichen Interessen und methodischen An- approaches constitutes the precondition for the dy- sätze bildet die Voraussetzung für die Dynamik, namics, productivity and creativity of the depart- Produktivität und Kreativität der Abteilung, die ment which has committed itself not only to a deep- sich letztendlich nicht nur dem tieferen Verständ- er understanding of pathology, but also to the de- nis der Pathologie, sondern auch der Entwicklung velopment of new forms of therapy. neuer Formen der Therapie verschrieben hat. Die Abteilung hat einen übergreifenden und synergistischen Ansatz gewählt, in dem sowohl die The department has chosen a comprehensive and angeborene als auch die erworbene Immunität synergetic approach in which both innate and ac- berücksichtigt und soweit möglich, das murine mit quired immunity are taken into account and, as far dem humanen System verknüpft wird. Beide Sys- as possible, the murine system is linked to the hu- teme bestehen aus löslichen und zellulären Kom- man one. Both systems consist of soluble and cel- ponenten, die durch Rezeptor-vermittelte Mecha- lular components which are regulated via receptor- nismen reguliert werden und verschiedene Ebe- mediated mechanisms and show different levels of nen des ‚cross-talks’ und der ‚cross-regulation’ cross-talk and cross-regulation. zeigen. The division of Innate Immunity is investigating the Die Laborgruppe Angeborene Immunität (H. Hei- molecular mechanisms by which cow shed bacte- ne) erforscht die molekularen Mechanismen, die ria may decrease allergic symptoms in farmer’s dazu führen, dass Kuhstall-Bakterien bei Kindern children. It could be demonstrated that these bac- in bäuerlichen Betrieben die Symptome der Aller- teria strongly induce an allergy-protective TH1 im- gie vermindern können. Es konnte gezeigt werden, mune response via the activation of dendritic cells dass durch diese Bakterien eine ausgeprägte Al- to produce cytokines such as IL-12 and to modulate lergie-Schutz TH1 Immunantwort induziert wird. Notch ligand expression (JACI) (supported by the Dies geschieht durch die Aktivierung von dendriti- SFB/TR22). Jennifer Debarry, who worked on this schen Zellen, welche Zytokine wie IL-12 produzie- project for her doctoral thesis, was honored with 80 Wissenschaftlicher Jahresbericht 2005-2006 Zusammenfassung Summary ren und die die Notch-Liganden-Expression (JACI) the Graduation prize in 2007, sponsored by the lo- modulieren (gefördert durch den SFB/TR22). Jen- cal government of the “Kreis Segeberg”. Further- nifer Debarry, deren Promotionsarbeit sich mit die- more, in a project in collaboration with Christoph sem Thema beschäftigte, wurde hierfür in 2007 mit Lange’s group, the expression and regulation of dem Promotionspreis des Kreises Segeberg aus- antimicrobial peptides in patients with COPD has gezeichnet. been investigated. A number of antimicrobial peptides in the lung have been detected and a correlation between the expression of human beta-de- Außerdem wurde in einem weiteren Projekt, in Zu- fensin1 (hBD-1) with the severity of the disease has sammenarbeit mit der Gruppe von Christoph Lan- been found. Currently, the epigenetic mechanisms ge, die Expression und Regulation von antimikro- regulating the expression of hBD-1 are under in- biellen Peptiden bei Patienten mit COPD unter- vestigation. sucht. Einige antimikrobielle Peptide in der Lunge konnten identifiziert und eine Korrelation zwischen der Expression von humanem Beta-Defensin 1 The division of Cellular Immunology (A.J. Ulmer) is (hBD-1) und der Schwere der Erkrankung festge- engaged in elucidating the properties of bacterial stellt werden. Zurzeit wird der Frage nachgegan- cell wall components expressing pathogen associ- gen, durch welche epigenetischen Mechanismen ated die Expression von hBD-1 moduliert wird. lipopolysaccharide, lipopeptides, which are found molecular patterns (PAMP). Beside in all bacteria species including Gram-negative and Gram-positive bacteria, mycobacteria and myDie Laborgruppe Zelluläre Immunologie (A.J. Ul- coplasma are focus of signal transduction and struc- mer) erforscht die Mechanismen der immunologi- ture/activity relationship studies. It has been schen Aktivität von bakteriellen Zellwand Be- demonstrated that lipopeptides, such as Pam2C- standteilen, die Pathogen-assoziierte Strukturen SK4 and also Pam3-MALP2, which signals through (PAMP) exprimieren. Neben den Lipopolysaccha- both, TLR2/1 and TLR2/6 heteromers activate a sim- riden der Zellwand von Gram-positiven Bakterien ilar downstream signaling pathway. Furthermore, bilden die Lipopeptide den Schwerpunkt der For- the Regulator of G-Protein Signaling 2 (RGS2) and, schung, welche in allen Bakterienspezies wie to a lesser degree the RGS1 were found to be also Gram-negative Bakterien, Gram-positive Bakteri- modulated by different TLR ligands (lipopetides and en, Mykobakterien und Mykoplasmen gefunden LPS) suggesting their important role in immunity. werden. Es konnte gezeigt werden, dass Lipopeptide, wie Pam2C-SK4 und auch Pam3-MALP2, welche sowohl durch TLR2/1 als auch durch TLR2/6 The adjuvant role of lipopeptides during develop- Heterodimere, signalisieren, einen ähnlichen „Do- ment of an immune response against an air borne wnstream-Signalweg“ aktivieren. Außerdem konn- allergen was investigated in a mouse model using te gezeigt werden, dass der Regulator des G-Pro- the Timothy grass pollen major allergen Phl p 1. tein Signaling 2 (RGS2), und in einem geringeren The mycoplasma lipopeptide FSL-1 was shown to Ausmaß des RGS1, durch verschiedene TLR-Li- boost the IgG2a Phl p 1-specific immunoglobulin in- ganden (Lippeptide und LPS) moduliert werden. dicating a Th1-type shift in presence of this adju- Dies ist offenbar bei der Entwicklung der Immu- vant. Furthermore, in cooperation with Arnd Pe- nität von großer Bedeutung. Die adjuvante Rolle tersen (Div of Clinical und Molecular Allergology), der Lipopeptide bei der Entwicklung einer Immu- the activation of lung epithelial cells to produce cy- nantwort gegen „Air-borne“ Allergene wurde, un- tokines and chemokines by Phl p 1 could be Wissenschaftlicher Jahresbericht 2005-2006 81 Zusammenfassung Summary ter zu Hilfenahme des Timothy Grass Pollen Major demonstrated, indicating that the bronchial epithel Allergen Phl p 1, in einem Mausmodell untersucht. is not only a physical barrier but is actively involved Es konnte gezeigt werden, dass die Mykoplasma in initiating a protective immune response against Lipopeptide FSL-1, die Phl p 1-spezifische Immun- pathogens. Fo r s c h u n g s z e n t r u m Bo r s t e l globulin Produktion von IgG2, deutlicher boosterte als die Produktion von IgG1. Dieses deutet auf einen Shift in Richtung einer Th1-Immunantwort in The division of Immunobiology (S. Bulfone-Paus) Anwesenheit dieses Adjuvanz. In Kooperation mit could demonstrate, employing the best-established A. Petersen (Laborgruppe Klinische und Moleku- murine model of sepsis (CLP model), an unexpect- lare Allergologie) konnte die Aktivierung der Pro- ed breach in mast cell -dependent, innate immune duktion von Zytokinen und Chemokinen in Lunge- defenses against gram-negative bacteria (Nature nepithelzellen duch Phl p 1 nachgewiesen wer- Medicine). Surprisingly, survival after septic peri- den, was darauf hinweist, dass das Bronchu- tonitis was significantly enhanced in IL-15 deficient sepithel nicht nur eine physikalische Barriere, mice. We could show that this survival advantage sondern aktiv am Aufbau einer Immunantwort ge- is mast cell-driven and IL-15-dependent. Murine gen Invasoren beteiligt ist. mast cells express constitutive and LPS-inducible IL15, and store IL-15 intracellularly, where it colocalizes with TNFα and proteases in mast cell granula. Die Laborgruppe Immunbiologie (S. Bulfone- IL-15-deficient mast cells exhibit markedly elevated Paus) konnte mittels des erprobten murinen Mo- chymase activity, leading to increased bactericidal dells der Sepsis (CLP Model) eine unerwartete activity and processing of neutrophil-recruiting Bresche in der Mastzellen-abhängigen, angebo- chemokines. By showing that intracellular IL-15 op- renen Abwehr gegen Gram-negative Bakterien erates as a specific negative transcriptional regu- nachweisen (Nature Medicine). In IL-15 defizien- lator of murine mast cell chymases, we provided ten Mäusen war die Überlebensrate nach einer the first evidence that defined mast cell protease septischen Peritonitis deutlich gesteigert. Die activities are transcriptionally regulated by an in- Gruppe konnte nachweisen, dass dieser Vorteil tracellularly retained cytokine. This newly de- von Mastzellen gesteuert wird und IL-15 abhän- scribed mechanism greatly affects an individual’s gig ist. Murine Mastzellen exprimieren konstituti- innate immune responses to septic infection and ves und LPS-induzierbares IL-15, und speichern es determines the chances of survival. intrazellulär. Hier findet es sich zusammen mit TNFalpha und Proteasen in den Zell-Granula. IL-15 defiziente Mastzellen weisen eine deutlich ge- While it is well-appreciated that the receptors for steigerte Chymase Aktivität auf, welche zu einer secreted cytokines transmit ligand-induced signals, vermehrten bakteriziden Aktivität und Prozessie- little is known about additional roles for cytokine re- rung von Chemokinen führt, die Neutrophile re- ceptor components in the control of ligand-trans- krutieren. Durch den Nachweis, dass intrazellulä- port and secretion. We could demonstrate that the res IL-15 als ein spezifischer negativer transkrip- IL-15 receptor alpha chain determines the mobi- tionaler Regulator der murinen Mastzell-Chymase lization and secretion of IL-15 therefore providing a agiert, konnte erstmals der Beweis erbracht wer- first evidence for cytokine chaperoning in the se- den, dass bestimmte Aktivitäten der Mastzell-Pro- cretory pathway by cytokine complexing with its re- teasen transkriptionell durch ein intrazellulär ge- ceptor (Mol Cell Biol). Erwin Duitman who worked speichertes Zytokin reguliert werden. Dieser erst- on the characterization of the IL-15/IL-15R trafficking mals beschriebene Mechanismus hat großen Ein- pathway was honored with the German Society for 82 Wissenschaftlicher Jahresbericht 2007-2008 Zusammenfassung fluss auf die individuelle angeborene Immunant- Summary Immunology poster prize in September 2008. wort auf septische Infektionen und bestimmt somit die Überlebenschancen. Es ist bekannt, dass die Rezeptoren für sezernierte Zytokine, Ligan- The newly established division of Molecular Im- den-induzierte Signale übermitteln. Die zusätzli- munology (K. Lee) investigates molecular and cel- chen Funktionen der Komponenten der Zytokin- lular aspects of membrane trafficking in immune Rezeptoren sind allerdings bislang recht uner- function. The research focus is to understand the forscht. Die Gruppe konnte zeigen, dass die IL- roles of receptor endocytosis and the traffick- 15alpha Kette die Mobilisierung und Sekretion ing/sorting machinery in apoptotic vs. survival sig- von IL-15 verursacht. Hierdurch konnte erstmalig, naling and its functional relevance for the immune durch Bildung eines Komplexes aus dem Zytokin system employing the death receptor Fas (CD95) mit seinem Rezeptor, ein Zytokin-Chaperoning in as a model system. Furthermore, the group is in- den sekretorischen Signalwegen nachgewiesen terested in the role of membrane trafficking in the werden (MoL Cell Biol). Erwin Duitman, der die context of an allergic reaction utilizing mast cells as Charakterisierung des IL-15/IL-15R Trafficking Sig- experimental model. The aim of the study is (1) to nalwegs bearbeitete, wurde von der Deutschen elucidate the molecular mechanisms responsible Gesellschaft für Immunologie im September 2008 for the transport and fusion of mast cell granules to mit dem Posterpreis ausgezeichnet. the plasma membrane and (2) to investigate the potential role of membrane trafficking in the development of mast cell mediated immune disor- Die neu gegründete Laborgruppe Molekulare Im- ders, with specific focus on allergy/asthma models. munologie (K. Lee) untersucht die molekularen und zellulären Aspekte der transmembranösen Signaltransduktion bei immunologischen Funktio- The division of Biochemical Immunology (F. Pe- nen. Diese Gruppe geht der Frage nach, welche tersen) places the main emphasis of its research on Rolle die Rezeptor-Endozytose und die „Traf- different aspects of the regulation, signal trans- ficking/Sorting-Maschinerie“ in der Apoptose bzw. duction and physiologic function of the CXC- beim „Survival-Signaling“ spielt. Hierfür und zur chemokine platelet factor 4 (PF-4, CXCL4), which is Aufklärung der funktionellen Relevanz für das Im- released by thrombocytes. The elucidation of the munsystem wird der „Death Receptor“ FAS (CD95) different signal pathways which participate in PF4- eingesetzt. Außerdem wird anhand von Mastzel- mediated neutrophil and monocyte activation, was len die Rolle des Membran-Trafficking im Zusam- greatly advanced during the last two years. The di- menhang mit der allergischen Reaktion unter- vision was able to identify sphingosine kinase 1 sucht. Ziel der Forschung ist (1): Darstellung der (SphK1) as a central regulator of acute and de- molekularen Mechanismen, die für den Transport layed monocyte functions. SphK1, which becomes und die Fusion von Mastzell-Granulomen zur Plas- upregulated and activated upon CXCL4 stimula- mamembran verantwortlich sind, sowie (2): Un- tion, does not only regulate monocyte survival and tersuchung der potentiellen Rolle des Membran- cytokine release by controlling the activity of Erk, Trafficking bei der Entwicklung von Mastzell-ver- but, furthermore, also the generation of oxygen mittelten Immunerkrankungen, insbesondere bei radicals (ROS) (submitted). Interestingly, long-last- Allergie/Asthma Modellen. ing release of ROS by CXCL4-activated monocytes does not only reflect a mechanism of acute defense against microbial invaders but mediated also In der Laborgruppe Biochemische Immunologie apoptosis in endothelial cells (J Leukocyte Biol). Wissenschaftlicher Jahresbericht 2007-2008 83 Zusammenfassung Summary (F. Petersen) werden schwerpunktmäßig verschie- Recent progress has been made by the division in dene Aspekte der Regulation, Signaltransduktion the analysis of interactions between mast cells and und physiologischen Funktion des von Thrombo- neutrophils in allergic asthma (supported by the zyten freigesetzten CXC Chemokins Plättchenfak- SFB/TR22) which may reflect a novel axis in the tor 4 (PF-4, CXCL4) untersucht. In den letzten zwei pathology of the disease. Activated mast cells re- Jahren hat die Aufklärung der verschiedenen Sig- lease mediators leading to the attraction of neu- nalwege, die an der von PF4-vermittelten neutro- trophils while neutrophils secrete antimicrobial philen und monozytären Aktivierung beteiligt sind, peptides which are capable to activate mast cells. große Fortschritte gemacht. Beside allergic processes, this axis may play also Fo r s c h u n g s z e n t r u m Bo r s t e l a role in the induction and maintenance of autoimmune diseases of the skin. This item is in the foDie Laborgruppe konnte Sphingosin-Kinase 1 cus of a recently launched project within the clus- (SphK1) als einen zentralen Regulator der akuten ter of excellence “Inflammation at Interfaces”. und verzögerten Monozyten Reaktion identifizieren. SphK1 wird durch CXCL4 -Stimulation hoch-reguliert und beeinflusst nicht nur das Überleben As a central aspect of research the division of Bio- der Monozyten und die Zytokin-Freigabe durch logical Chemistry (E. Brandt) is interested in the in- Kontrolle der ERK-Aktivität, sondern auch die Ge- teraction between mast cells, platelets and neu- nerierung von Sauerstoff-Radikalen (ROS) (sub- trophils in allergic and non-allergic inflammation. mitted). Interessanterweise stellt eine lang anhal- More specifically, communication of these cell pop- tende Freisetzung von ROS durch CXCL4-aktivier- ulations mediated by chemokines, proteases and te Monozyten nicht nur einen Mechanismus der antimicrobial peptides are in the focus of investi- akuten Abwehr gegen mikrobiologische Invaso- gation. Supported by the Transregio 22 and in co- ren dar, sondern sie vermittelt auch die Apoptose operation with the division of Biochemical Im- in endothelialen Zellen (J Leukocyte Biol). Einen munology it was discovered that the platelet-de- weiteren Fortschritt konnte die Gruppe bei der rived chemokine CXCL4 appears to have a gener- Analyse der Interaktionen zwischen Mastzellen al role as a regulator of human mast cell-secreted und Neutrophilen beim allergischen Asthma ver- proteases, in that it does not only inhibit process- zeichnen (gefördert durch den Transregio 22). Hier ing of chemokines by chymase but also the degra- könnte sich eine neue Achse in der Pathologie die- dation of several substrates (e.g. LL37) by tryptase. ser Erkrankung abzeichnen. Aktivierte Mastzellen Notably, cleavage by tryptase of the cathelicidin setzen Mediatoren frei, die Neutrophile anlocken. LL37 (a major neutrophil product) was found to ab- Neutrophile ihrerseits sezernieren antimikrobielle rogate its ability to induce mast cell degranulation Peptide, welche in der Lage sind, Mastzellen zu as well as its antimicrobial activity (J Immunol, un- aktivieren. Außer bei den allergischen Prozessen, der revision). In a project being aimed at elucidat- ist diese Achse möglicherweise auch bei der In- ing the impact of proteases on mast cell functions duktion und Aufrechterhaltung von Autoimmuner- the division could demonstrate the surface expres- krankungen der Haut von Bedeutung. Dieses The- sion of proteinase-activated receptor (PAR) –1 and ma ist der Mittelpunkt eines kürzlich innerhalb des intracellular expression of PAR-2 in human lung Exzellenz Clusters „Entzündung an Grenzflächen“ mast cells as well as the induction of calcium sig- gestarteten Projekts. nals by synthetic and natural PAR-1 but not PAR-2 ligands. Im Mittelpunkt der Forschung der Laborgruppe 84 Wissenschaftlicher Jahresbericht 2007-2008 Zusammenfassung Summary Biologische Chemie (E. Brandt) steht die Untersu- The division of Immune Cell-Analytics (M. Ernst) chung der Interaktionen zwischen Mastzellen, studies the contribution of central memory T-lym- Plättchen und Neutrophilen bei der allergischen phocytes in antigen-specific activation in vitro. Dif- und nicht-allergischen Entzündung. Insbesondere ferentiation, proliferation and secondarily release interessiert sich diese Gruppe für die von Chemo- of interferon gamma are the read-outs used. In par- kinen, Proteasen und antimikrobiotischen Pepti- ticular, the hypothesis that sleep and especially den vermittelte Kommunikation dieser Zellpopu- sleep-associated hormones secreted within the first lationen. Gefördert durch den Transregio 22 und half of the night (such as growth hormone and pro- in Kooperation mit der Laborgruppe Biologische lactin) may reinforce the function of memory T-lym- Chemie wurde entdeckt, dass das thrombozytäre phocytes is currently under investigation (support- Chemokin CXCL4 anscheinend eine wichtige Funk- ed by the SFB 654) utilizing cells of healthy donors tion als Regulator bei von humanen Mastzellen se- and of patients suffering from obstructive sleep ap- zernierten Proteasen hat. Hierbei inhibiert es nicht nea syndrome (OSAS) before and after therapy. nur die Prozessierung von Chemokinen durch Kina- Furthermore, in cooperation with the Division of sen, sondern auch den Abbau von verschiedenen Clinical Diseases, a new assay which allows a sen- Substraten (z.B. LL37) durch Trypase. Bemerkens- sitive/specific diagnosis of pulmonary tuberculosis werterweise zeigte sich, dass dem Kathelicidin in patients with repeated negative Ziehl-Neelsen LL37 (ein wichtiges Produkt der Neutrophilen) die stain in sputum samples (Am J Respir Crit Care Fähigkeit eine Mastzellen-Gegranulation zu indu- Med) was established by employing cell cultures zieren, und auch die antimikrobielle Aktivität, from the bronchoalveolar lavage stimulated with nach Spaltung durch Trypase, verloren ging. In ei- ESAT-6 and CFP-10 (M. tuberculosis-specific anti- nem weiteren Projekt der Laborgruppe, das den gens) and subjected to the interferon-gamma-spe- Einfluss von Proteasen auf die Funktionen der cific Elispot procedure. Mastzellen untersucht, konnte die Oberflächen Expression des Proteinase-aktivierten Rezeptors (PAR)-1 und die intrazelluläre Expression von PAR- During the transition of the division of Tumor biolo- 2 in humanen Lungen-Mastzellen, so wie die In- gy (J. Gerdes) to Immunoepigenetics (P. Singh) the duktion von Calcium Signalen durch synthetischen long-standing project to elucidate the function of und natürlichen PAR-1 (jedoch nicht durch PAR-2 Li- the proliferation-associated Ki-67 protein was con- ganden), nachgewiesen werden. cluded. It was found that pKi-67 not only physically interacts with the chromatin of the rRNA genes, but is also associated with the rRNA transcription fac- Die Laborgruppe Immunzell-Analytik (M. Ernst) un- tor UBF, indicating that the pKi-67’s likely role in cel- tersucht die Funktion von Gedächtnis-T-Lympho- lular proliferation processes may be founded upon zyten bei der Antigen-spezifischen Aktivierung in a role in ribosome biosynthesis. As part of a DFG- vitro. Differenzierung, Proliferation und sekundäre funded project it was confirmed that the loss of het- Interferon-gamma-Freisetzung sind die von der erochromatin protein 1 (HP1) results in a dramatic Gruppe genutzten „Ablesesysteme“. Der Hypo- genomic instability. Specifically, it could be shown these, dass Schlaf und vor allem Schlaf-assoziier- that the HP1 te Hormone (wie z.B. Growth Hormone und Pro- ated with aberrant cerebral corticogenesis associ- laktin), die Funktion von Gedächtnis-T-Lympho- ated with genomic instability and that the proxi- zyten verstärken können, wird zurzeit nachgegan- mate cause of death is an acute respiratory failure gen (gefördert durch den SFB 654). Hierzu werden in newborn mice (JCB). Finally, the division has in- Zellen von gesunden Probanden und von Patien- vestigated the changing epigenotype of two Wissenschaftlicher Jahresbericht 2007-2008 null mutation is lethal and is associ- 85 Zusammenfassung Summary Fo r s c h u n g s z e n t r u m Bo r s t e l ten mit obstruktivem Schlafapnoe-Syndrom (OSAS) vor und nach Therapie untersucht. genes, CD14 and CD209, which are differentially regulated during differentiation of monocytes into dendritic cells. Monocyte differentiation leads to transcription and hyperacetylation of the CD209 In Zusammenarbeit mit der Laborgruppe Klinische promoter in dendritic cells with little affect on DNA Infektiologie ist es gelungen, die ESAT-6 und methylation; the CD14 epigenotype shows, to a CFP-10 (M. tuberculosis-spezifische Antigene) sti- lesser degree, the reverse where the gene is ex- mulierten Zellkulturen aus der bronchoalveolären pressed and its chromatin acetylated in monocytes Lavage im Interferon-gamma-spezifischen Elispot- and deacetylated in dendritic cells. Verfahren einzusetzen und damit eine sensitiv/spezifische Diagnose der Lungentuberkulose bei Patienten mit wiederholt negativer Ziehl-Neel- The division of Veterinary Infection Biology and Im- sen-Färbung in Sputum-Proben (Am J Respir Crit munology (J. Ahmed) places the main emphasis of Care Med) zu ermöglichen. its investigations on the genetics as well as on cellular and molecular biological aspects of an infection with the intracellular protozoan Theileria. The Während der Umgestaltung der Laborgruppe Tu- goal of these internationally recognized studies is morbiologie in die Laborgruppe Immunoepige- the analysis and characterization of the pathogen- netik (P. Singh) wurde das lang anstehende Pro- host interaction, the development of effective vac- jekt, die Funktion des Proliferations-assozierten Ki- cines as well as diagnostic procedures. The divi- 67-Protein zu klären, verwirklicht. Es konnte ge- sion achieved the successful application of two zeigt werden, dass Ki-67 nicht nur physikalisch mit projects in 2007 supported within the EU FP6 re- dem Chromation der rRNA-Gene interagiert, son- search program (ASEM-Dialog and ConFluTech), dern auch mit dem rRNA Transkriptionsfaktor UBF and in 2008 the funding of two further projects with- assoziiert ist. Dies weist darauf hin, dass die Funk- in the EU FP7 (POSTICK and Arbo-Zoonet). Further- tion des pKi-67 im zellulären Proliferationsprozess more, the division organized a total of 16 (seven in wahrscheinlich auf einer Beteiligung in der ribo- 2007; nine in 2008) international workshops and somalen Biosynthese basiert. Als Teil eines von technical workshops and published the proceed- der DFG geförderten Projekts konnte bestätigt ings of three international meetings in Parasitology werden, dass der Verlust des Heterochromatin Research, Transboundary and Emerging Diseases Protein 1 (HP1) in einer dramatischen genomi- and Vaccine. schen Instabilität resultiert. Insbesondere wurde demonstriert, dass die HP 1 null Mutation letal ist und mit einer aberranten zerebralen Cortico- Networking: The Department of Immunology and genese mit einer genomischen Instabilität assozi- Cell Biology participates in the following coopera- iert ist. Der Grund für den letztendlichen Tod ist, in tive projects: DFG-Sonderforschungsbereiche (col- neugeborenen Mäusen, ein akutes respiratori- laborative research centers) 415, 617, 654, and Tran- sches Versagen. sregio 22 and Excellence Cluster “Inflammation at Interfaces”; EU FP6 framework program (ConFluTech): Capacity building for the control of avian Außerdem hat die Laborgruppe die wechselnden influenza through technology transfer and training; Epigenotypen von zwei Genen (CD14 und CD209) (ASEM-Dialog): EU, China, and South-East Asia: Di- untersucht. Während der Differenzierung von Mo- alogue for the Development of Research Areas in nozyten zu dendritischen Zellen werden diese auf Animal Health of Mutual Interest. Marie Curie rein- 86 Wissenschaftlicher Jahresbericht 2005-2006 Division of Immunbiology Research Reports unterschiedliche Weise reguliert. Die Monozyten- tegration grants. EU FP7: CURE, INFLA-CARE, PO- Differenzierung führt zur Transkription und Hyper- STICK and Arbo-Zoonet. acetylierung des CD209-Promotors in dendritischen Zellen, mit geringem Effekt auf die DNA-Methylierung. Der CD14 Epigenotyp zeigt, in einem weniger ausgeprägten Ausmaß, das Gegenteil. Hier ist das Gen exprimiert und das Chromatin in Monozyten acethyliert und in dendritischen Zellen deacetyliert. Im Focus der Laborgruppe Veterinärmedizinische Infektiologie und Immunologie (J. Ahmed) stehen Untersuchungen zur Genetik, sowie die zellulären und molekularbiologischen Aspekte einer Infektion mit dem intrazellulären Protozoa Theileria. Das Ziel dieser international anerkannten Studien ist die Analyse und Charakterisierung der PathogenWirt- Interaktion, die Entwicklung wirkungsvoller Impfstoffe, sowie diagnostischer Verfahren. Der Laborgruppe ist es gelungen, zwei Projekte im FP6 des EU-geförderten Forschungsprogramms (ASEMDialog und ConFluTech) und in 2008 zwei weitere Projekte im FP7 (POSTICK und Arbo-Zoonet), erfolgreich zu beantragen. Darüber hinaus organisierte die Laborgruppe insgesamt 16 (sieben in 2007; neun in 2008) internationale Workshops und technische Workshops und publizierte die Sitzungsberichte von drei internationalen Meetings in den Journals: Parasitology Research, Transboundary und Emerging Diseases und Vaccines. Netzwerkbildung: Die Abteilung Immunologie und Zellbiologie ist Partner folgender Verbundprojekte: DFG-Sonderforschungsbereiche 415, 617, 654 und Transregio 22; EU-6 Rahmenprogramm: (ConFluTech), Capacity building for the control of Avian influenza through technology transfer and training; (ASEM-Dialog), EU, China und Süd-Ost-Asien: Dialog for the Development of Research Areas in Animal Health of Mutual Interest. Marie Curie Reintegrationsförderung. EU FP7: CURE, INFLA-CARE, POSTICK und Arbo-Zoonet. Wissenschaftlicher Jahresbericht 2007-2008 87 Division of Immunbiology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l Division of Immunbiology Head show that IL-15 forms functional heterocomplexes Prof. Dr. Dr. Silvia Bulfone-Paus with soluble high affinity IL-15 receptor alpha (IL15Ralpha) chain in mouse serum and cell-condi- Postdoctoral fellows tioned medium, which prevents IL-15 detection by Dr. Rajia Bahri ELISA. We also demonstrate that two soluble IL- Dr. Annalena Bollinger 15Ralpha (sIL-15Ralpha) sushi domain isoforms are Dr. Elena Bulanova generated through a novel alternative splicing Dr. Erwin Duitman mechanism within the IL-15Ralpha gene. These iso- Dr. Orietta D’Orlando forms potentiate IL-15 action by promoting the IL-15- Dr. Niko Föger mediated proliferation of the CTLL cell line and in- Dr. Farhad Mirghomizadeh terferon gamma production by murine NK cells, Dr. Zane Orinska which suggests a role in IL-15 transpresentation. Graduate and Diploma/Master students Diego Goyeneche-Patiño Andre Jenckel Rabea Langenhaun Katharina Scholz Technicians Manuel Hein Martina Hein Marie-Luise Helms Gesine Rode Katrin Streek Katrin Westphal Kathleen Wilke Guests and Trainees Marvin Bloch Romina Pritzkow Research Reports Soluble Interleukin IL-15Ralpha is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15 Bulanova E, Budagian V, Duitman E, Orinska Z, Rückert R, Bulfone-Paus S. Fig. 29. Alternatively spliced or shed sIL-15Ralpha forms heterocomplexes with IL-15. Different IL-15Ralpha isoforms may associate with IL-15 intracellularly. IL-15·IL-15Ralpha sushi domain heterocomplexes presumably follow a secretion route. Conversely, IL-15 associated with IL-15Ralpha may be elaborated to the cell membrane, where IL-15 is presented in trans by IL-15Ralpha and stimulates neighboring cells expressing intermediate affinity IL-15Rbeta/gamma. Similarly, soluble IL-15·IL-15Ralpha sushi domain complexes stimulate such cells, inducing proliferation of T cells and IFNgamma production by NK cells. Transmembrane IL-15Ralpha molecules alone or together with IL-15 are subsequently shed by TACE, releasing sIL-15Ralpha alone or IL15·sIL-15Ralpha heterocomplexes, in which IL-15 is inactive. Diverse extracellular stimuli, such as bacteria and viruses, might shift the fine tuned balance between sushi domain and full-length IL-15Ralpha molecules. Cells may favour production of distinct IL-15Ralpha isoforms via switching between them according to particular environmental changes and demands. Interleukin 15 (IL-15) is a pleiotropic cytokine that is Conversely, a full-length sIL-15Ralpha ectodomain hardly detectable in biological fluids. Here, we released by tumor necrosis factor-alpha-converting 88 Wissenschaftlicher Jahresbericht 2007-2008 Division of Immunbiology Research Reports enzyme (TACE)-dependent proteolysis inhibits IL-15 against Gram-negative bacteria by demonstrating activity. Thus, a dual mechanism of sIL-15Ralpha that MC protease activity is regulated by interleukin- generation exists in mice, giving rise to polypep- 15 (IL-15). Mouse MCs express both constitutive and tides with distinct properties, which regulate IL-15 lipopolysaccharide-inducible IL-15 and store it in- function. tracellularly. Deletion of IL-15 in mice markedly increases chymase activities, leading to greater MC Collaboration: Krause H, Department of Urology, bactericidal responses, increased processing and Charité University Medicine, Berlin; Reiling N, Divi- activation of neutrophil-recruiting chemokines, and sion of Molecular Infection Biology, Research Cen- significantly higher survival rates of mice after sep- ter Borstel, Borstel. tic peritonitis. By showing that intracellular IL-15 acts as a specific negative transcriptional regulator of a Supported in part by: Deutsche Forschungsgemein- mouse MC chymase (mast cell protease-2), we pro- schaft (SFB415). vide evidence that defined MC protease activity is transcriptionally regulated by an intracellularly retained cytokine. Our results identify an unexpected IL-15 constrains mast cell-dependent antibacteri- breach in MC-dependent innate immune defenses al defenses by suppressing chymase activities. against sepsis and suggest that inhibiting intracel- Orinska Z, Mirghomizadeh F, Bulanova E, Buda- lular IL-15 in MCs may improve survival from sepsis. gian V, Bulfone-Paus S. Collaboration: Brandt E, Nashkevich N, Schiemann F, Schulmistrat J, Department of Immunology and Cell Biology, Research Center Borstel, Borstel; GironMichel J, U542 Institut National de la Santé et de la Recherche Médical (INSERM), Hôpital Paul Brousse, Villejuif, France; Maurer M, Metz M, Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité–Universitätsmedizin Berlin, Berlin; Paus R, Department of Dermatology, University Hospital Schleswig-Holstein, University of Lübeck. Supported in part by: grants from the Deutsche Forschungsgemeinschaft (SFB/TR22 and MA Fig. 30. Role of IL-15 in the regulation of chymase-mediated antimicrobial activity. IL-15, which shows increased expression on LPS stimulation, inhibits transcription of Mcpt2. In the absence of IL-15, transcription, intracellular storage and release of chymase on stimulation are increased. The increase in intracellular chymase activity leads to enhanced microbicidal activity, for example, by the generation of larger amounts of antimicrobial peptides (AMPs) from inactive precursors (pre-AMPs). Secreted chymases may exert their bactericidal activity directly or may function indirectly by cleaving chemokine precursors and generating activated chemokines to recruit the most potent neutrophil army. 1909/4-1/2). Sepsis remains a global clinical problem. By using Interleukin (IL)-21 is a T cell-derived cytokine which the mouse cecal ligation and puncture model of uses a heterodimeric receptor, composed of the sepsis, here we identify an important aspect of mast common gamma-chain (CD132) and an IL-21Ral- cell (MC)-dependent, innate immune defenses pha-chain. IL-21 activates lymphoid T and B cells, Interleukin-21 stimulates antigen uptake, protease activity, survival and induction of CD4+ T cell proliferation by murine macrophages. Rückert R, Bulfone-Paus S, Brandt K. Wissenschaftlicher Jahresbericht 2007-2008 89 Division of Immunbiology Research Reports modulates antibody production but also suppresses components in the control of ligand-transport and se- maturation of myeloid dendritic cells; however, its cretion. Here, we show that IL-15 translocation into role in the differentiation and function of other the endoplasmatic reticulum occurs independently of myeloid cells remains less clear. In this study we the presence of IL-15Ralpha. Subsequently, however, analysed IL-21/IL-21Ralpha effects on macrophage IL-15 is transported through the Golgi apparatus on- (MPhi) differentiation and function. MPhi could be ly in association with IL-15Rα, and is then secreted. generated readily from bone marrow with MPhi- This intracellular IL-15/IL-15Ralpha complex presum- colony-stimulating factor in the presence of IL-21 (des- ably already is formed in the endoplasmatic reticu- ignated IL-21MPhi) or from IL-21Ralpha-/- mice. IL- lum and thus enables further trafficking of complexed 21Ralpha-/- mice had normal MPhi numbers, sug- IL-15 through the secretory pathway. Just transfecting gesting a non-essential role of both IL-21 and the IL- IL-15Ralpha in cells, which transcribe, but normally do 21Ralpha could not secrete IL-15 suffice to induce IL-15 secretion. Thus, demonstrate that mature MPhi express the IL-21Ral- we here provide the first evidence of how a cytokine pha and the common gamma-chain. However, short- is chaperoned through the secretory pathway by term IL-21 stimulation did not enhance MPhi prolifer- complexing with its own high affinity receptor, and ation but induced anti-apoptotic cell-cycle regulators show that IL-15/IL-15Ralpha offers an excellent mod- p21(waf1)/p27(Kip1) and expression of suppressors el system for further exploration of this novel mecha- of cytokine signalling (SOCS)2/SOCS3. Moreover, IL- nism for the control of cytokine secretion. Fo r s c h u n g s z e n t r u m Bo r s t e l for MPhi generation. We 21 enhanced phagocytosis by MPhi via IL-21Ralpha signalling and supports protease activity and matrix metalloproteinase 12 expression. Stimulating MPhi with IL-21 enhanced their capacity to induce antigen-specific CD4+ T cell proliferation in dependence from the IL-21Ralpha, which was not the case for CD8+ T cells. Taken together, IL-21 plays a previously unrecognized role in modulating innate and acquired effector mechanisms of murine MPhi by linking these different functions to support CD4+ T cell-mediated immune responses. How a cytokine is chaperoned through the secretory pathway by complexing with its own recep- Fig. 31. Receptor chaperoning model of cytokine. Proposed model for the intracellular trafficking and IL-15Rα- dependent secretion of IL-15 in the investigated cell lines. The abbreviations C, ER, GN and E represent cytoplasm (C), endoplasmatic reticulum (ER), Golgi apparatus (GA) and environment (E). tor: lessons from interleukin-15 (IL-15)/IL-15 receptor alpha. Collaboration: Paus R, Department of Dermatology, Duitman EH, Orinska Z, Bulanova E, Bulfone-Paus S. University Hospital Schleswig-Holstein, University of Lübeck. While it is well-appreciated that receptors for secreted cytokines transmit ligand-induced signals, little is Supported in part by: Deutsche Forschungsgemein- known about additional roles for cytokine receptor schaft (SFB 415). 90 Wissenschaftlicher Jahresbericht 2007-2008 Division of Immunbiology Research Reports Theses Diploma Scholz, Katharina Characterization of BTNL2, a Butyrophilin/B7-like molecule: expression and regulation. Technisch-Naturwissenschaftliche Fakultät Universität zu Lübeck, 2008. Dissertation Stelekati, Erietta The role of mast cells in CD8+ T cell-mediated immune responses. Technisch-Naturwissenschaftliche Fakultät Universität zu Lübeck, 2008. Wissenschaftlicher Jahresbericht 2007-2008 91 Division of Cellular Immunology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l Division of Cellular Immunology Head RGS2 in a similar manner. Interestingly, the TLR3 lig- Prof. Dr. Artur J. Ulmer and poly(I:C) permanently up regulated RGS1 and RGS2 expression indicating a different modulation by Staff Scientists and Postdoctoral Fellows Dr. Sabine Riekenberg the MyD88- and TRIF-signalling pathway. This suggestion was confirmed by the use of MyD88-/- and TRIF-/- BMDM. Inhibition of phosphorylation of p38 by Graduate and Diploma Students SB203580 and ERK by PD98059 as well as inhibition Katja Farhat of G -protein signalling by PTX indicates that these Kristina Röschmann signalling pathways were not involved in RGS1 and Christine Warmbold RGS2 modulation by TLR ligands. Our data lead to the conclusion that modulation of RGS1 and RGS2 by Technicians different TLR ligands plays an important role in G-pro- Carola Schneider tein signaling during inflammatory and immunologi- Suhad Al-Badri cal reactions after bacterial and viral infections. Research Reports Activation of the MyD88-signal pathway and the TRIF-signal pathway through Toll-like receptors differently modulate Regulators of G-protein Signalling (RGS) Riekenberg S, Farhat K, Ulmer AJ. Regulators of G-protein signalling (RGS) accelerate the GTPase activity of Gα subunits, thus driving G-proteins in their inactive GDP-bound form. This property defines them as GTPase activating proteins (GAPs). In our study we analyzed the effect of different Tolllike receptor (TLR) agonists on RGS1 and RGS2 expression in mouse bone marrow-derived macrophages (BMDM) and J774 cells. After stimulation with TLR2/1 or TLR2/6 specific lipopeptide lig- Fig. 32. Modulation of RGS1 and RGS2 mRNA by TLR2 and TLR4 ligands. Expression was measured after stimulation of BMDM with 100 ng/ml LPS, 100 nM FSL-1 and 100 nM Pam3C-SK4 for 0-24 h. Specific RGS1 and RGS2 mRNA expression was determined by real-time PCR. The results show representative data from three independent experiments. ands and the TLR4/MD2 ligand LPS, microarray analyses showed most strong reduction of RGS2 mR- Collaboration: Debarry J, Heine H, Div of Innate Im- NA expression and strong modulation of RGS1. Real- munity, Research Center Borstel; Jung G, Institute of time PCR confirmed these modulations. In contrast to Organic Chemistry, University of Tübingen, Tübin- RGS2, which was always down regulated, RGS1 mR- gen; Wiesmüller K-H, EMC microcollections GmbH, NA was up regulated during the first 30 min after stim- Tübingen. ulation followed by down regulation (Fig. 32). Similar results were also found in the mouse macrophages Supported in part by: Deutsche Forschungsgemein- cell line J774 and mouse dendritic cells. ODN1826, a schaft (UL68/3-2). ligand for intracellular TLR9, modulated RGS1 and 92 Wissenschaftlicher Jahresbericht 2007-2008 Division of Cellular Immunology Research Reports Ligand binding and signal transduction induced- This indicates that Pam2C-SK4 is recognized by TLR2/1 by lipopeptides as well as by TLR2/6 rather than by TLR2-homomers Farhat K, Riekenberg S, Ulmer AJ. (Fig. 33). Toll-like receptors (TLRs) are primary triggers of the in- In a further study we have compared the signal trans- nate immune system by recognizing various microor- duction pathways activated by the different TLR2 ganisms through conserved pathogen-associated mo- dimers lecular patterns (PAMPs). Among all TLRs, TLR2 is the receptor for a functional recognition of bacterial macrophages, using the synthetic LPs PamOct2C(VPGVG)4VPGKG, FSL-1 and Pam2C-SK4 to specifi- lipopeptides (LPs) and is upregulated during various cally target TLR2/TLR1 and/or TLR2/TLR6, respec- disorders like chronic obstructive pulmonary disease tively. Immunoblotting of MAP-kinases, usage of dom- (COPD) and sepsis. This receptor is unique in its abili- inant negative forms of adaptor molecules as well as ty to form heteromers with either TLR1 or TLR6 to me- microarray analyzes indicate that all dimers use the diate intracellular signaling. According to the fatty same signaling cascade to activate transcription fac- acid pattern as well as the assembling of the polypep- tors leading to an identical pattern of gene activa- tide tail LPs can signal through TLR2 in a TLR1- or TLR6- tion. In conclusion, LPs from mycoplasma, Gram-pos- dependent manner. As shown recently there are also itive and Gram-negative bacteria, although they may di- and triacylated LPs, like Pam2C-SK4 and Pam3MALP2, which stimulate cells of TLR1-/- and of TLR6-/- use different TLR2 dimers, induce the same signal in murine bone marrow derived transduction pathway during infection. mice. Inhibition of TLR1-expression with TLR1-siRNA in TLR6-/- cells and inhibition of TLR6-expression with Collaboration: Debarry J, Heine H, Div of Innate Im- TLR6-siRNA in TLR1-/- cells resulted in an marked re- munity, Research Center Borstel; Lang R, Mages J, In- duction of the response to Pam2C-SK4. stitute of Medical Microbiology, Immunology and Hygiene,Technical University Munich; Jung G, Institute of Fig. 33. Inhibition of lipopeptide-induced TNF release in mouse TLR1/- or TLR6-/- macrophages by TLR6- or TLR1-siRNA, respectively. BMDM of (A) TLR1- or (B) TLR6-deficient mice were transfected with 25 nM of non target siRNA, (A) TLR6 siRNA, or (B) TLR1 siRNA. After 48 hours these cells were stimulated with 100 nM of FSL-1, Pam2CSK4, PamOct2C-(VPGVG)4VPGKG, or 100 ng/ml LPS for additional 24 hours. The TNF-α release into the culture supernatant was determined by ELISA. The results are expressed as % of TNF-α release obtained from stimulated non target siRNA-transfected cells. Organic Chemistry, University of Tübingen; Wiesmüller K-H, EMC microcollections GmbH, Tübingen. Supported in part by: Deutsche Forschungsgemeinschaft (UL68/3-2). Wissenschaftlicher Jahresbericht 2007-2008 93 Division of Cellular Immunology Research Reports The adjuvant activity of FSL-1 during immunization We found that FSL-1 exhibits mitogenic activity on of mice with the Timothy grass polen major aller- mouse spleen B-lymphocytes and induces TNF-alpha gen Phl p 1 is TLR6-dependent release in bone-marrow derived macrophages. Farhat K, Röschmann K, Riekenberg S, Buwitt- Whereas the activity of FSL-1 is absent in TLR6-defi- Beckmann U, Ulmer AJ. cient cells, the tri-acylated derivative Pam3-FSL-1 (Pam3C-GDPKHPKSPF) is TLR6-independent but Bacterial lipopeptides (LP) are known to be strong TLR1-dependent. Furthermore, TLR2, CD14 and stimulators of the innate immune system and potent MyD88 are involved in FSL-1 induced signal trans- adjuvants of the adaptive immune system. The re- duction. Additionally, we have investigated the ad- ceptor for the recognition of LP is TLR2. TLR2 is juvant activity of FSL-1 during immunization of mice unique in its ability to form heteromers with either with the Timothy grass pollen major allergen Phl p TLR1 or TLR6 to mediate intracellular signalling. FSL- 1. Our results show that FSL-1 boosts the Phl p 1-spe- 1 (Pam2C-GDPKHPKSPF) represents a di-acylated LP of Mycoplasma salvarium, which signals through cific immunoglobulin production of both IgG1 and TLR2 in a TLR6-dependent manner as determined in Th1-immune responses (Fig. 34). Results with TLR6- transfected human HEK293 cells. However, its re- deficient mice indicate a central role of TLR6 in this ceptor requirement during immune responses of system. As a TLR6 polymorphism seems to play a mice in vitro and in vivo has not been defined so far. role in the pathogenesis of childhood asthma, this Fo r s c h u n g s z e n t r u m Bo r s t e l IgG2a indicating an enhancement of both Th2- and study might give insights into the importance of TLR concerning the development of atopic diseases. Collaboration: Seitzer U, Div. of Vet.-Infektiology u. –Immunology, Research Center Borstel; Petersen A, Div. of Clin. and Mol. Allergology, Research Center Borstel; Jung G, Institute of Organic Chemistry, University of Tübingen; Wiesmüller K-H, EMC microcollections GmbH, Tübingen. Supported in part by: Deutsche Forschungsgemeinschaft (Ul 68/3-1 and SFB/TR22, A3). Activation respiratory epithelial cells by the Timothy grass pollen major allergen Phl p 1 Röschmann K, Farhat K, Ulmer AJ. Fig. 34. Adjuvant effect of FSL-1 on the immunisation of mice with Phl p1, the major allergen of Timothy grass Phleum pratense. Groups of 5 mice were immunized intra peritonial with 10µg FSL-1 or 1µM Phl p 1 alone or in combination. Serum samples were collected and analyzed for Phl p 1 specific IgG1 and IgG2a on various days of the immunisation protocol. FSL-1 did not induce the production of Ig in any of the animals, while immunization with the allergen Phl p 1 resulted in an increase of IgG1. In contrast, in the presence of FSL-1, administration of Phl p 1 induced much higher amounts of the Th2-polarizing IgG1, indicating the adjuvant capacity of FSL-1. This effect is even more prominent concerning the IgG2a titer. Phl p 1 alone did not induce any of the Th1-related antibody, whereas co-immunisation with FSL-1 resulted in a strong IgG2a production. 94 Group 1 allergens from grass pollen (e.g. Phl p 1, the major allergen of Timothy grass Phleum pratense) cause IgE-reactivity in about 95 % of allergic subjects and exist in all grass species. The respiratory epithelium represents a first line of contact of the immune system with airborne allergens. It functions as physical barrier and is an important immunological regulation system, which is also involved in allergic Wissenschaftlicher Jahresbericht 2007-2008 Division of Cellular Immunology Research Reports reactions like asthma. The aim of this study was to an indirect mechanism through which the allergen investigate the interaction of Phl p 1 with human res- may cross the epithelial barrier and attracts im- piratory epithelium to elucidate the contribution of munocompetent cells, thereby contributing to aller- epithelial cells to the development of allergic reac- gic responses in asthmatic airways. tions. Fig. 35. Effect of Phl p 1 and Der p 1 on cilia-driven particle transport in mouse tracheae ex vivo. 15-30 min after addition of the beads to the isolated trachea a baseline of the velocity of particle transport has been come up and the allergens or control buffer was added (first arrow) [(A) ctrl: 200 µl Hepes-Ringer solution, (B) 5 µM Phl p 1, (C) 1 µM Der p 1]. At the end of each experiment 100 µM ATP was added (second arrow) to test the vitality of the ciliated epithelial cells. Representative results from at least 3 independent experiments are shown. Collaboration: Petersen A, Div. of Clin. and Mol. Allergology, Research Center Borstel; König P, Institute for Anatomy, University of Lübeck; Suck R, Allergopharma Joachim Ganzer KG, Reinbek. Supported in part by: Deutsche Forschungsgemeinschaft (SFB/TR22, A3). We found that Phl p 1 activates respiratory epithelial cells as measured by release of IL-8 and IL-6 and induction of TGF-β mRNA. Phl p 1, in contrast to Der Effects of microbial and allergic components on p 1, an allergen from the house dust mite, does not the immune system of the fruitfly Drosophila exert proteolytic activity, as investigated by micro- melanogaster scopical observation and zymograms. In an ex vivo Warmbold C, Röschmann K, Ulmer AJ. model with mouse tracheae we were able to show that Der p 1 but not Phl p 1 causes injure of ciliated The fruitfly Drosophila melanogaster has been used tracheal epithelium. In addition, Der p 1, in contrast as a powerful model to study basic aspects of the to Phl p 1, enhances the transportation velocity of innate immune system. The two independent signal particles by the tracheae, presumably by ATP re- transduction pathways Toll and IMD are con- leased from the injured epithelium (Fig. 35). We con- stituents of the fruitfly`s immune system. The Toll- clude that Phl p 1 affects tracheal epithelial cells pathway is involved in signal transduction in re- through a non-proteolytic activity. Enhancement of sponse to infection with Gram-positive bacteria, TGF-β expression induced by Phl p 1 together with whereas the IMD-pathway is stimulated during in- the increased release of IL-6 and IL-8 might provide fection with Gram-negative bacteria. We have now Wissenschaftlicher Jahresbericht 2007-2008 95 Division of Cellular Immunology Research Reports investigated whether isolated cowshed dusts as we furthermore discovered that allergic proteins of Fo r s c h u n g s z e n t r u m Bo r s t e l well as isolated bacteria and lipopeptides, which Timothy grass pollen (Phleum pratense), namely Phl have never been tested before in this system, are p 1 and of housedust mite (Der p 1, Der- able to activate the innate immune system. For our matophagoides pteronyssinus) are also able to ac- analysis we use the macrophage-like cell line SL2 tivate the Toll- and IMD-pathway in Drosophila (Fig. isolated from embryos of the D.m. strain Oregon R. 36). By using RNAi-experiments and microarray- The results of our studies are based on real-time analyses we will confirm our current data. PCR and on a luciferase reporter assays. In this assay a Firefly-luciferase is under the control of the Collaboration: A. Petersen, Petersen A, Div. of Clin. drosomycin-promotor as a read-out-system for the and Mol. Allergology, Research Center Borstel; Toll-pathway and the diptericin-promotor for the Roeder T, Div. of Zoophysiology, Christian-Albrechts IMD-pathway. The data are normalized by the con- University Kiel. stitutive Renilla-luciferase. Supported in part by: Deutsche Forschungsgemeinschaft (SFB/TR22, A3 and A7). Fig. 36. Effects of allergens on the immune system of Drosophila melanogaster. The S2 cell line of the fruitfly is responsive to the major allergen of Timothy grass pollen (Phl p1). In this experiment we were able to show that the signalling occurs via the Toll pathway and this signalling is dose-dependent. In contrast, the IMD pathway is not involved. In our experiments we found that isolated cowshed dusts and bacteria excluding L.lactis G121 can activate the fruitfly`s immune system. In the human system L.lactis G121 leads to a delayed immune response. In addition to these bacterial components 96 Wissenschaftlicher Jahresbericht 2007-2008 Division of Molecular Immunology Research Reports Division of Molecular Immunology Head of Fas signaling can activate divergent signaling Dr. Kyeong-Hee Lee pathways to direct either cellular survival or apoptotic signals. These data suggest a different para- Postdoctoral fellow digm for transmembrane signaling and emphasizes Dr. Gulnar Fattakhova the role of the endocytic pathway for both receptor degradation as well as signal propagation. Little in- Graduate students formation exists regarding the molecular elements Xuan-Hung Nguyen regulating the spatial and temporal compartmen- Beate Schurek talization in the endocytic pathway that contribute to biologic responses. We have also identified im- Technicians mune specific regulators which are involved in re- Patricia Prilla ceptor endocytosis and membrane dynamics. By studying the mechanisms by which our target molecules are regulated and how they control immune Research Reports cell signaling and function, we hope to better un- Integrating molecular and cellular aspects of derstand signaling pathways during normal im- membrane trafficking and immune function mune responses and how perturbations in these Nguyen XH, Fattakhova G, Lee KH. pathways can lead to immune deficiency or autoimmunity. We are interested in the roles of receptor endocytosis and the traffick- ing/sorting machinery in apoptotic vs. survival signaling and its functional relevance for immune function. Receptor endocytosis, in addition to serving as a degradation pathway, can also target activated receptors to the endocytic compartment to facilitate signaling. This mode of regulation can control the assembly of activated receptors with downstream signaling molecules as well as titrate signal intensity and thereby serves as Fig. 37. Model for compartmentalization of Fas signaling. a cellular mechanism to direct specific biologic responses. We are studying the function of the traf- The internalization of Fas receptor is required for ficking/sorting machinery in signal transduction and FasL-mediated death inducing signaling complex the molecular mechanisms that regulate endocytic (DISC) assembly, caspase activation and apoptosis. pathways employing the death receptor Fas (CD95) However, in cells in which Fas internalization is dis- as our model system. Our studies have demon- abled, FasL stimulation activates both Erk and NFκB strated that endosomal compartments are major signaling pathways. Hence, the subcellular local- sites for the initiation of Fas mediated death sig- ization and internalization pathways of Fas play im- naling complex formation and apoptosis. Moreover, portant roles that control activation of distinct sig- we have demonstrated that compartmentalization naling cascades to determine divergent cellular Wissenschaftlicher Jahresbericht 2007-2008 97 Division of Molecular Immunology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l fates, such as apoptosis versus cellular survival. Furthermore, we are currently generating a mouse deficient for this Rab5 regulator to elucidate the role Collaboration: Marcus E. Peter, the Ben May Insti- of this Rab5 regulator in membrane trafficking and tute for Cancer research, University of Chicago, mast cell function in an in vivo setting. USA; Stefan Schütze, Institute of Immunology, UniCollaboration: Silvia Bulfone-Paus, Research Center versity of Kiel, Germany. Borstel, Germany. Supported in part by: Fritz Thyssen Research Foundation and the German Research Foundation Supported in part by: Marie Curie International (DFG). Reintegration Grant (FP7). The role of membrane trafficking in mast cell function Schurek B, Prilla P, Lee KH. We are also interested in the role of membrane trafficking in the context of an allergic reaction utilizing mast cells as experimental objects. Mast cells provide an excellent model system to study the physiological role of membrane trafficking. Mast cells play a pivotal role in human allergic and inflammatory disease and intensively require specifically regulated vesicle transport and membrane fusion processes. Activated mast cells in response to triggering of the high affinity receptor for IgE, rapidly reorganize lysosomal vesicles and secrete inflammatory mediators by a process called degranulation. Our research focus is to elucidate the molecular mechanisms responsible for the transport and fusion of mast cell granules to the plasma membrane. We have established a lenti-viral based miRNA vector system which allows for an efficient transfection of miRNA into primary mast cells and to generate stable cell lines expressing gene specific miRNA. Employing these genetic tools, our studies have indentified a regulator for the small GTPase Rab5. The knock-down of the novel regulator in mast cells results in an increased and sustained mast cell degranulation, indicating a novel function of Rab5 for mast cell degranulation. Our on-going studies are investigating the underlying mechanism by which this molecule affects the trafficking and membrane fusion of mast cell granules utilizing various mutants. 98 Wissenschaftlicher Jahresbericht 2007-2008 Division of Immune Cell-Analytics Research Reports Division of Immune Cell-Analytics Head Activated human leukocyte antigen-DR-positive cells, Dr. Martin Ernst as well as memory CD4CD45R0-positive T-cells, were expanded among cells of the BALF. Compared Staff Scientists and Postdoctoral Fellows with a group of control patients with alternative pul- Dr. Franziska Schwartzkopff monary pathologies, there was no significant difference in lymphocyte subpopulations. However, Technicians ESAT-6- and CFP-10-specific lymphocytes were more Renate Bergmann (until December 2007) concentrated, with a median BALF:peripheral blood Franziska Daduna (since March 2008) ratio of 9.9 and 8.9, respectively, in patients with PTB. Erika Kaltenhäuser Mycobacterium tuberculosis-specific T-cells are highly selectively compartmentalised at the site of infec- Guests and Trainees tion in active pulmonary tuberculosis. Dr. José Fernando García, Barcelona, Spain (June 2007) Collaboration: Jafari C*, Strassburg A, Greinert U*, Kalsdorf B*, Lange C* (Division of Clinical Infectious Diseases and Medical Clinic Borstel), Kirsten D# Research Reports (Krankenhaus Großhansdorf). Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot Ernst M , Jafari C*, Strassburg A*, Greinert U*, Rapid diagnosis of CNS tuberculosis by a T-cell in- Kalsdorf B*, Kirsten D#, Lange C*. terferon-γγ release assay on cerebrospinal fluid Lymphocytes are crucial in the immune defence mononuclear cells Ernst M, Kösters K1, Nau R2, Bossink A3, Greiffen- against Mycobacterium tuberculosis (MTB) infection. The aim of the present study was to ascertain dorf I1, Jentsch M1, Thijsen S3, Hinks T4, Lalvani A4, Lange C5. whether or not MTB-specific lymphocytes are selectively compartmentalised in the lungs of patients with Central nervous system tuberculosis remains a clini- minimal active pulmonary tuberculosis (PTB). Patients cal diagnostic challenge. The ex vivo Mycobacteri- with smear-negative MTB-culture-confirmed PTB were um tuberculosis-specific enzyme-linked immunospot prospectively recruited. Differential cell counts, im- assay (ELISPOT) is a novel assay for the rapid de- munophenotyping with monoclonal antibodies di- tection of M. tuberculosis-specific T-lymphocytes in rected against the cell surface markers CD4, CD8, the peripheral blood. However, when performed on CD4CD45RA, CD4CD45R0, CD38, human leukocyte peripheral blood, this assay cannot distinguish bet- antigen DR, CD19, CD3, CD57 and CD16 and MTB- ween active tuberculosis or latent tuberculosis in- specific enzyme-linked immunospot assays of peri- fection. On the assumption that M. tuberculosis-spe- pheral blood mononuclear cells and bronchoalveo- cific T-lymphocytes migrate to sites of infection, we lar lavage (BAL) mononuclear cells with 6-kDa early were able to demonstrate high levels of M. tubercu- secretory antigenic target (ESAT-6) and culture filtra- losis-specific cells by ELISPOT in the cerebrospinal te protein 10 (CFP-10) were performed. Among 12 pa- fluid of a patient with tuberculous meningitis and in- tients with culture-confirmed smear-negative PTB, no tracerebral tuberculoma (Fig.38) four weeks before differences were found in the distribution of total CD4 cerebrospinal fluid culture became positive for M. tu- or CD8 T-cells in peripheral blood or BAL fluid (BALF). berculosis by culture. Wissenschaftlicher Jahresbericht 2007-2008 99 Division of Immune Cell-Analytics Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l assay (ELISPOT)) are more sensitive for the diagnosis of Mycobacterium tuberculosis (MTB) infection than the tuberculin skin test (TST), but cannot distinguish active from latent MTB infection. The present authors report a 38-yr-old female presenting with a 3-week history of malaise, dyspnoea, fevers and coughing, who had received immunosuppressive therapies over 8 months for mixed connective tissue disease. Chest radiograph and thoracic computed tomography showed ground glass opacities in both Fig. 38. MTB specific ELISPOT with ESAT-6 and CFP-10 antigen on mononuclear cells from the cerebrospinal fluid. For the MTB-specific ELISPOT (T-SPOT.TB, Oxford Immunotec, Abingdon, UK), 2.5 x 105 mononuclear cells isolated from CSF are put in microtiter plate wells in the presence of ESAT-6 and CFP-10 or PHA (positive control) or in the absence of antigen (negative control). Antigen-reactive T-cells in the wells release interferon-γ upon antigen contact. Subsequently interferon-γ is bound to an anti-interferon-γ-specific antibody at the bottom of the wells. After counterstaining with a second soluble enzyme-conjugated anti-interferon-γ-specific monoclonal antibody and a color reaction, spots are visible on the bottom of the plates at locations where single cells have produced interferon-γ following antigen contact. Test results are available within 24 h. On PBMCs the recommended cutoff for a positive response is 5 spot forming cells (sfc)/250,000 mononuclear cells. There is no accepted cutoff value for extrasanguineous fluids currently. lower lobes. The TST-induration was 0 mm and AFBs or MTB nucleic acid was not detected on sputum and bronchial secretions. However, TIGRAs performed on peripheral blood cells were reactive. A high frequency of MTB-specific T-cells compatible with the immunodiagnosis of active pTB was detected among bronchoalveolar lavage cells using ELISPOT. Antituberculous therapy was initiated 18 days before MTB was discovered on sputum cultures. Detection of Mycobacterium tuberculosis-specific Tcells in the bronchoalveolar lavage using enzymelinked immunospot assay is a promising tool for the Collaboration: 1Kösters K, Greiffendorf I, Jentsch M (Klinikum Krefeld, Krefeld, Germany), 2Nau R (Uni- diagnosis of active pulmonary tuberculosis in im- versity Hospital of Göttingen, Göttingen, Germany), 3Bossink A, Thijsen S (Diakonessenhuis Utrecht, bacilli smears. Utrecht, The Netherlands), 4Hinks T, Lalvani A (Imperial College, London, UK), 5Lange C (Division of Clin- Collaboration: Strassburg A*, Jafari C, Lotz W*, ical Infectious Diseases and Medical Clinic Borstel). and Medical Clinic Borstel). Rapid diagnosis of pulmonary TB by BAL enzyme- Effects of sleep on in vitro cytokine production af- linked immunospot assay in an immunocompro- ter polyclonal and antigen-specific stimulation mised host - a case study Schwartzkopff F, Marienfeld K, Ernst M. munocompromised patients with negative acid-fast Lange C* (Division of Clinical Infectious Diseases Ernst M, Strassburg A*, Jafari C*, Lotz W* , Lange C*. Results of recent in vitro experiments concurred with the notion that sleep supports the immunological ABSTRACT: Immunocompromised patients with synapse between APC and T-cell. Blood was taken acid-fast bacilli (AFB) smear-negative active pul- at 08:00 h after two nights of regular sleep (baseli- monary tuberculosis (pTB) often present with non- ne) and after one night of continuous wakefulness specific clinical symptoms and findings. T-cell inter- in 14 healthy subjects. PBMC were differentiated by feron-c release assays (TIGRA) performed on who- flow cytometry and stimulated with three antigen- le blood (using ELISA) or peripheral blood mo- specific stimuli (purified protein derivate/tuberculin nonuclear cells (using enzyme-linked immunospot (PPD), influenza A antigen, toxoplasma gondii anti- 100 Wissenschaftlicher Jahresbericht 2007-2008 Division of Immune Cell-Analytics Research Reports gen) and two polyclonal stimuli (phytohaemagglu- 39). Since antigen-specific IFN-γ release from T-cells tinin (PHA) and anti-CD3) to assess IFN-γ production is strictly dependent on appropriately functioning in supernatants 96 hours later. While sleep compa- APC, we assume that sleep deprivation hampers red to continuous wakefulness did not influence PB- the immunological synapse between these cells MC subsets at this time point, polyclonal stimulati- while T-cell function per se is rather enhanced. on with PHA and anti-CD3 was significantly weaker after regular sleep than after the night of continuous wakefulness. This effect, however, was not evident Fig. 39. IFN-γ production in supernatants 96 hours after polyclonal and antigen-specific stimulation of PBMC at 08:00 h after two nights of regular sleep or one night of continuous wakefulness. p-values are indicated for Wilcoxon matched pairs signed-ranks test of logarithmized data. in PPD and influenza A antigen stimulated cultures. Supported in part by: Deutsche Forschungsge- In contrast, IFN-γ production in toxoplasma gondii meinschaft (DFG), SFB 654 “Plasticity and Sleep”, positive subjects was significantly higher after reg- project C2. ular sleep than after continuous wakefulness (Fig. Wissenschaftlicher Jahresbericht 2007-2008 101 Division of Biological Chemistry Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l Division of Biological Chemistry Head granulation. Moreover, it became evident that pro- Prof. Dr. Ernst Brandt cessing dramatically affected the interaction of the cathelicidin with bacteria and their products. Staff Scientists and Postdoctoral Fellows Dr. Florian Schiemann Graduate and Diploma Students Oranos Ghulam (since 08/2006) Jan Schulmistrat (since 06/2006) Technicians Christine Engellenner Gabriele Huß Research Reports Human mast cells degrade LL37 by tryptase Schiemann F, Schulmistrat J, Brandt E. The cathelicidin LL37 represents a potent antimicrobial and a cell-stimulating agent, most abundantly Fig. 40. LL37 interacts with human lung mast cells. Mast cells were incubated alone or in the presence of increasing concentrations of LL37. After 30 min, cell-free supernatants were harvested and incubated with a chromogenic substrate for hexosaminidase. Thereafter the reaction was stopped and liberated free p-nitrophenol measured. The percentage of hexosaminidase enzymatic activity released was calculated relative to lysed cells run in parallel. Shown is the mean ±SD of three independent experiments. expressed in peripheral organs such as lung and skin during inflammation. Since mast cells (MC) overtake In contrast to the intact protein, LL37 fragements did prominent immunmodulatory roles in these organs, neither act microbicidal on gram-positive and –neg- we wondered whether there exists interaction be- ative bacteria nor did they neutralize the cell-stimu- tween MC and LL37. Here we show for the first time latory effect of LPS. Taken together our results sug- that physiological concentrations of LL37 induce de- gest that the intruiging two-step process initiated by granulation in purified human lung MC (Fig. 40). As LL37, consisting in mast cell acvtivation followed by an intriguing consequence, LL37 rapidly undergoes rapid mast cell-mediated degradation of the stimu- limited cleavage by a released protease. Indeed, lus in return, can be assigned a dead-end route, blocking of degranulation by specific signal trans- where the activating agent is finally removed and duction inhibitors impaired cleavage of LL-37, demon- no longer available for autocrine and paracrine ac- strating that the cathelicidin induces its own pro- tivation of cells. cessing. The protease responsible for processing was identified as tryptase by inhibitor studies and by Collaboration: Petersen F, Mittelstädt J, Division of comparison of the LL-37 fragments formed to those Biochemical Immunology, Lindner B, Division of Im- generated following incubation with the recombinant munochemistry, Research Center Borstel. enzyme. To get an impression of the functional consequences, we examined the resulting fragments for Supported in part by: Deutsche Forschungsgemein- typical functions exhibited by the fullsize LL37. In a schaft, SFB/TR22 „Allergische Immunantworten der first set of experiments we could clearly show that Lunge“, Projekt A11. these fragments fail to activate mast cells for de- 102 Wissenschaftlicher Jahresbericht 2007-2008 Division of Biological Chemistry Research Reports The platelet chemokine CXCL4 is an inhibitor of Collaboration: Petersen F, Division of Biochemical mast cell tryptase activity Immunology, Research Center Borstel; Sommerhoff Schiemann F, Brandt E. CP, Department of Clinical Chemistry and Clinical Biochemistry, Ludwig-Maximilians University, Mu- In a previous study we showed that the platelet-de- nich, Germany. rived chemokine CXCL4 represents a strong regulator of mast cell chymase-mediated proteolysis, Supported in part by: Deutsche Forschungsgemein- by acting as a direct inhibitor of the enzyme. In or- schaft, SFB/TR22 „Allergische Immunantworten der der to elucidate whether CXCL4 would play a more Lunge“, Projekt A11. general role in the functional regulation of mast cell specific enzymes, we investigated its impact on the second major mast cell protease, i.e. on Biology of proteinase-activated receptors on hu- tryptase-mediated proteolysis. In initial experi- man mast cells ments we observed that CXCL4, within physiologi- Ghulam O, Brandt E. cally relevant concentrations, efficiently protected the cathelicidin LL37 from degradation by tryptase Proteinase-activated receptors (PARs) are widely ex- as well as by degranulating mast cells (refer to an- pressed in many immune and tissue cells, e.g. in tecedent report above). This effect was based on platelets, leukocytes, endothelial and vascular wall the direct inhibition of tryptase catalytic activity cells and also in the cells of the gastrointestinal tract. rather than on protective protein-protein interac- PARs are seven transmenbran proteins belonging to tion of CXCL4 with the substrate LL37. This was the G protein-coupled receptor family. They comprise shown by corresponding experiments where CX- four members (PAR-1 to 4) and have various physio- CL4 likewise inhibited the cleavage of a chro- logical roles, such as in hemostasis where they me- mogenic peptide-substrate by tryptase. Raising diate platelet activation, in tissue repair by promoting questions as to the underlying mechanism(s), we angiogenesis, as well as in inflammation by enhanc- found that the efficiency of CXCL4 in counteracting ing leukocyte adherence and proinflammatory cy- the conversion of the chromogenic substrate was tokine production by cells from a variety of tissues. highly dependent on the presence of heparin as a PARs are characterized by an unique mechanism of co-factor, the inhibitory capacity of CXCL4 being activation. Proteases, especially serine proteases are negatively related to the concentration of heparin. able to cleave the receptors at a specific site, there- Against the background, that tryptase evolves its by exposing a tethered ligand domain that binds to catalytic activity only as a heparin-stabilized and activates the receptors. Alternatively, some pro- tetrameric molecular complex, these results strong- teases may disarm the receptors by cleavage at a dif- ly suggest that the inhibitory capacity of the cation- ferent site. Recent research in mice suggests that ac- ic CXCL4 is based on its high affinity to anionic gly- tivation of proteinase-activated receptors at the sur- cosaminogylcans. According to this model, com- face of mast cells (MC) may play a role during in- petition of CXCL4 for tryptase-associated heparin flammation and the immune response. There are results in the disintegration of the tetrameric mo- initial hints that also in human MC PARs could be in- lecular complex and in its concomitant inactiva- volved in cell activation. We therefore set out to in- tion. In general, our findings that CXCL4 counter- vestigate whether human MC responses can be acti- regulates two major proinflammatory mast cell vated or modulated via ligands of PARs. In first ex- specific proteases may indicate a special regula- periments we observed that PAR-activating peptides tory role for this chemokine during inflammatory (PAR-APs: short synthetic peptides, representing the processes. proteolytically released tethered ligand sequences) Wissenschaftlicher Jahresbericht 2007-2008 103 Division of Biological Chemistry Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l for PAR-1 and PAR-4 are able to induce degranulation Bacterial modification of CXCL7 of human primary skin and lung mast cells whereas Schulmistrat J, Brandt E. PAR-2-AP does not (Fig. 41). Interestingly, proteases known to activate these receptors did not induce MC The platelet-derived chemokine CXCL7 occurs in a degranulation but nevertheless elicited intracelluar Ca2+-signals, indicating the presence of these re- variety of molecular forms that are generated ceptors on human MC. Concerning human lung MC crete the longest molecules termed platelet basic we found expression of mRNA as well as protein for protein (PBP, 94 aa) and its N-terminally truncated PAR-1 and PAR-2, the former being exposed at the derivative connective tissue-activating peptide III cell membrane, the latter occuring exclusively intra- (CTAP-III, 85 aa). N-terminal truncation of these pre- cellularly (Fig. 41). At present we are investigating cursors by leukocyte and/or mast cell proteases what MC functions other than degranulation, e.g. cy- leads to the formation of the active chemokine neu- tokine and leukotriene production, might be regulat- trophil-activating peptide 2 (NAP-2, 70aa), which ed by PARs. We expect that investigating the modu- causes neutrophil recruitment and activation by in- lation of mast cell activity via PARs will contribute to teraction with receptors CXCR-1 and CXCR-2. In ad- the development of therapies for mast cell-depend- dition to their function as chemokines, certain CXCL- ent inflammatory or immune pathologies. 7-variants are also able to act as direct microbici- through limited proteolysis. Platelets contain and se- dal agents on bacteria and fungi. Due to these combined characteristics CXCL-7 plays an important role as a first-line mediator of innate immunity in tissue injury and microbial invasion. As bacteria exhibit a broad spectrum of proteases, and moreover, as recent studies have shown that these proteases principally have the capability to cleave CXC chemokines (e.g. CXCL-8), we were interested whether bacteria may also proteolytically modify CXCL7 and thereby generate cleavage products with altered functional characteristics. In our present study we therefore investigated different strains of gram-positive and gram-negative bacteria with respect to their ability to modify CXCL7. For this purpose bacteria and PBP were coincubated for increasing periods of time and cell-free supernatants were analysed by electrophoresis and Western blotting for the formation of cleavage products. As it turned out several of these bacterial strains had a high capacity to generate immuno-reactive fragments of the chemokine while others were comFig. 41. Surface expression and funcionality of PARs on human lung mast cells. Either intact or permeabilized human lung mast cells were stained with antibodies specific for PAR-1 or PAR-2 and recepor expression was evaluated by FACS analysis (A). Human lung mast cells were incubated alone or in the presence of increasing dosages of receptor-activating peptides for PAR-1 and PAR-2, and degranulation of cells was assessed by measurement of hexosaminidase release (B). 104 pletely inactive. Purification of these cleavage products by immunoaffinity-chromatography and further analysis by mass spectrometry revealed the formation of several molecular variants smaller in size than CTAP-III. Some of these exhibited drastically altered bactericidal activity. Altogether our results Wissenschaftlicher Jahresbericht 2007-2008 Division of Biological Chemistry Research Reports show that there exists a bidirectional relationship between bacteria and antimicrobial agents in that bactericidal molecules may not only impact bacteria, but the latter may also modify functions of antimicrobials by proteolytic processing. Collaboration: Lindner B, Division of Immunochemistry, Research Center Borstel. Wissenschaftlicher Jahresbericht 2007-2008 105 Division of Tumor Biology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l Division of Tumor Biology Head physiological function remains unknown. In a first at- Prof. Dr. Johannes Gerdes (until April 2007) tempt to elucidate the function of these proteins in after 20,5 years at the FZB, I took advantage of ear- vivo, we disrupted the murine Cbx1 gene, which en- ly retirement regulations on 01. 05. 2008. Thus, for codes the HP1β isotype, and show that the Cbx1 - the very last time, my legendary farewell address: null mutation leads to perinatal lethality. The new- Vielen Dank! born mice succumbed to acute respiratory failure, und ... — Tschüss! whose likely cause is the defective development of –/– neuromuscular junctions within the endplate of the Dr. Prim B. Singh (since May 2008) diaphragm. We also observe aberrant cerebral cortex development in Cbx1 –/– mutant brains, which Principle Investigators have reduced proliferation of neuronal precursors, Dr. Thomas Scholzen (until April 2008) widespread cell death, and edema. In vitro cultures Dr. Prim B. Singh (until April 2008) of neurospheres from Cbx1 –/– mutant brains reveal a dramatic genomic instability. Our results demonStaff scientists and Postdoctoral Fellows strate that HP1 proteins are not functionally redun- Dr. Jeremy P. Brown (since September 2008) dant and that they are likely to regulate lineage- Dr. Jörn Bullwinkel specific changes in heterochromatin organization. Dr. Ramtin Rahmanzadeh (until February 2007) Graduate and diploma students Mustafa Billur Hélène D. Kamdem (until March 2008) Renja Romey (until June 2007) Technicians Bettina Baron-Lühr Anja Lüdemann Guest scientists and Trainees Dr. Christian Bader (until May 2007) David Gräser (until September 2007) Kalicharan Patra (September 2008) Vladimir Shteyn (June 2007 to January 2008) Fig.42. A Giemsa-stained, mitotic chromosome spread from a HP1β -/- animal possessing diplochromosomes (eg. at 2 o’clock). Red: Telomeric probe. Research Reports β is required for development of the cerebral HP1β neocortex and neuromuscular junctions Collaboration: Aucott R (Div. of Genetics and Ge- Bullwinkel J, Billur M, Brown JP, Singh PB. nomics, Roslin Institute, University of Edinburgh, Scotland), Yu Y, Shi W, Fundele R (Dep. of Devel- HP1 proteins are thought to be modulators of chro- opment and Genetics, Uppsala University, Swe- matin organization in all mammals, yet their exact den), Menzel U, Kioussis D (Div. of Molecular Im- 106 Wissenschaftlicher Jahresbericht 2007-2008 Division of Tumor Biology Research Reports munology, National Institute of Medical Research, London, England) , Wang G (School of Biological Sciences, University of Liverpool, England), Reisert I (Dep. of Anatomy and Cell Biology, University of Ulm), Weimer J (Clinic of Obstetrics and Gynecology, Lab. of Oncology, UKSH, Kiel) Pandita RK, Sharma GG, Pandita TK (Dep. of Radiation Oncology, Washington University School of Medicine, St. Louis, USA). The epigenotype of CD14 and CD209 during differentiation of monocytes to dendritic cells Bullwinkel J, Gerdes J, Singh PB. Fig. 43. Metaphase chromosomes of mouse embryonic fibroblasts deficient for HP1α. DNA (blue), kinetochore protein cohesin (red) and centromere protein CENP (green). In the course of differentiation processes cells change their gene expression profiles drastically. Collaboration: Brümmendorf T, Braig M (Div. of Using a model system, where monocytes are treat- Telomer-/ Stem Cell-Biology, University Hospital Ep- ed with GM-CSF and IL-4 to induce differentiation to pendorf, Hamburg). dendritic cells, we have studied changes in the epigenotype of CD14. CD14 undergoes repression Supported in part by: DFG grant SI 1209/2-1. when monocytes differentiate into dendritic cells. We found that active chromatin marks (histone acetylation) are dramatically reduced upon differ- Functional analysis of the Ki-67 protein entiation whilst other epigenetic modifications, such Romey R, Kamdem H, Gerdes J, Scholzen T. as DNA methylation and repressive chromatin marks, remain unchanged mainly unchanged. Antibodies against the nuclear Ki-67 protein (pKi-67) are widely used as a prognostic tool to determine the growth fraction of tumor cells in cancer diag- β Regulation of genomic instability by HP1β nostics. Previous studies performed in our labora- Billur M, Singh PB. tory suggested a role of pKi-67 in ribosomal RNA (rRNA) synthesis. In this context we could show that We are investigating the genomic instability ob- the upstream binding factor (UBF), which is a key served in the HP1β mutant mice using a variety of regulator of rRNA synthesis, colocalized with a frac- approaches including a study of the telomeres tion of the nuclear pKi-67. To further analyze this as- (measurement of telomere length and determina- sociation we performed immunoprecipitations, tion of protein constituents), the role of cohesins clearly demonstrating an interaction of pKi-67 with (SMC proteins, Sgo1 and Scc1) and the effect of the both isoforms of UBF. Pulldown experiments with mutations on senescence-associated heterochro- bacterially expressed UBF and pKi-67 fragments fur- matin foci (SAHF). To date, we have shown that ther revealed that this interaction is direct and does HP1β is not required to maintain telomere length not depend on additional adapter proteins. With re- and constitution. Cells that are null for HP1β escape spect to pKi-67 the binding is mediated by the pro- cellular senescence and our current work focusses tein region encoded by the exons 8-10. To gain fur- on this aspect of HP1β function. ther insight into the physiological role of pKi-67, we Wissenschaftlicher Jahresbericht 2007-2008 107 Division of Tumor Biology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l utilized RNA interference to knock down protein ex- Kamdem, Hélène D. pression. Small interfering RNAs (siRNAs) directed Beitrag zum Verständnis der zellulären Funktion des against the pKi-67 mRNA led to a profound reduc- Ki-67-Proteins. tion in cellular pKi-67 content within 48 hours while Hochschule für Angewandte Wissenschaften control RNAs had no effect. Interestingly, a small Hamburg, 2008 fraction of pKi-67 appeared to be quite stable and was present even after extended times of siRNA application. This fraction was located at the fibrillar centers of the nucleoli during interphase and at the corresponding nucleolar organizing regions during mitosis. Although cells treated with siRNAs tended to accumulate in the G0 phase, a substantial fraction was nevertheless able to enter S-phase, as was evident by the incorporation of labeled deoxynucleotides. Moreover, we frequently observed cells in different mitotic phases showing a strong reduction in pKi-67 expression. These results argue against an essential role of the protein for the passage through S-phase or mitosis. Analysis of the rRNA synthesis did not show an obvious difference in transcription or processing of these ribosomal components. However, it has to be considered that the stable pKi-67 fraction resides at regions associated with rRNA synthesis and may be sufficient to sustain pKi-67 function at these sites. Theses Dissertations Rahmanzadeh, Ramtin Untersuchungen zur Inaktivierung von Zellen und Proteinen mit Hilfe optischer Adsorber. Technisch-Naturwissenschaftliche Fakultät Universität zu Lübeck, 2007 Diploma Romey, Renja Untersuchungen zur Inhibition der Ki-67 Proteinexpression mittels RNA-Interferenz. Mathematisch-Naturwissenschaftliche Fakultät Christian-Albrechts-Universität zu Kiel, 2007 108 Wissenschaftlicher Jahresbericht 2007-2008 Division of Veterinary Infectiology and Immunology Research Reports Division of Veterinary Infectiology and Immunology Head Research Reports Prof. Dr. Jabbar Ahmed Identification, molecular characterization and subcellular localization of a Theileria annulata Principle Investigators parasite protein secreted into the host cell Prof. Dr. Ulrike Seitzer Schneider I, Haller D, Kullmann B, Beyer D, Ahmed JS, Seitzer U. Graduate and Diploma Students Jassim Abdo (since 27.07.08) Awadia Ali Silke Gerber Diaeldin Hassan Zhijie Liu Heike Müller Stefanie Renneker Technicians Doreen Beyer Jessica Dobschanski Birgit Kullmann Guests and Trainees Mohammed Abdigoudarzi, Razi Vaccine and Serum Research Institute, Karaj, Tehran, Iran, 25.10.25.11.2007 Nuran Aysul, Veterinary Faculty Adnan Menderes University, Aydin, Turkey, 04.05.-31.5.2008 Mohammed A. Bakheit, National Research Center for Protozoan Diseases, Obihiro University for Agriculture and Veterinary Medicine, Japan 31.05.30.06.2008 Mehmet-Ali Türkyilmaz, Pendik Veterinary Research and Control Institute, Istanbul, Turkey (16.12.31.12.2007, 1.01.-20.06.2008) Tian Zhancheng, Lanzhou Veterinary Research Institute, Lanzhou, Gansu, China 5.3.–25.4.2008 Fig. 44. Analysis of subcellular localization of the Theileria annulata TaSE protein in infected bovine cells. a) The signal for TaSE detection (red) shows a parasite associated staining (green: parasite membrane) but also away from the parasite in small globular domains. TaSE is localized within the parasite, in the parasite membrane (yellow signals) and outside the parasite membrane in the host cell cytoplasm. b) Co-localization of TaSE with the host cell tubulin network: Overlay image of tubulin (green) and TaSE (red) detection demonstrating a close association of TaSE with the host tubulin network as well as points of co-localization (yellow signals). c) Close up and overlay image of the tubulin (green) and TaSE-specific signals (red) from a parasite-free area of a cell. A very close association TaSE to the tubulin network can be seen. Size bars: a) 10 µm b) 10 µm c) 1 µm Wissenschaftlicher Jahresbericht 2007-2008 109 Division of Veterinary Infectiology and Immunology Research Reports Intracellular leucoproliferative Theileria are unique cations, management systems and age could be as eukaryotic organisms that transform the immune held as risk factors for T. annulata infection in North- cells of their ruminant host. Theileria utilize the un- ern Sudan, while for T. parva locations and seasons controlled proliferation for rapid multiplication and could be held as risk factors in Southern Sudan. The distribution into host daughter cells. The equal dis- results of this study will assist in the development of tribution of the schizont into the daughter cells is more effective control strategies for smallholder thought to be accomplished by a tight association dairy farms in the country. Fo r s c h u n g s z e n t r u m Bo r s t e l with the host cell mitotic apparatus. In this study, we describe a highly conserved novel 37 kD Theileria Collaboration: El Hussein AM, Central Veterinary Re- annulata protein (TaSE). TaSE was found to be lo- search Laboratories, Alamarat, Khartoum, Sudan; calized inside the parasite, the parasite membrane Kyule MN, Zessin KH, Faculty of Veterinary Medi- and within the host cell cytoplasm. Moreover, it co- cine, Free University of Berlin, Königsweg 67, D- localized at distinct points with host cell micro- 14163 Berlin, Germany. tubules, which was especially apparent during mitosis, where co-localization was found with the cen- Supported in part by: International Foundation for tromere, the mitotic spindle and the midbody. As- Science, Stockholm, Sweden; Organisation of Is- sociation of TaSE with the host cell tubulin network lamic Conference Standing Committee on Scientific was corroborated by coimmunoprecipitation and and Technological Cooperation (COMSTECH), Is- transient transfection experiments. This is the first lamabad, Pakistan; Coordinated Action “Integrated description of a theilerial protein co-localizing and Consortium on Ticks and Tick-borne Diseases” potentially interacting with a host cell protein. The (ICTTD-3) Asian Component, Project number 510561. distribution of TaSE during mitosis makes it a protein to consider as playing a potential role for parasite At least two genetically distinct large Babesia distribution into daughter host cells. species infective to sheep and goats in China Schnittger L, Ahmed JS. Supported in part by: ICTTD Concerted Action Project on Integrated Control of Ticks and Tick-borne A fatal disease of sheep and goats in the northern Diseases, contract no. IC18-CT95-0009). part of China has been reported to be due to Babesia ovis. However, some characteristics of the causative agent in recent reports are not in accorDetermination of potential risk factors associated dance with the original attributes ascribed to this with Theileria annulata and Theileria parva in- parasite. Therefore, the 18S small subunit ribosomal fections of cattle in the Sudan RNA (18S rRNA) genes of a number of Babesia iso- Salih DA, Ahmed JS, Seitzer U. lates in China were sequenced and compared with that of other Babesia and Theileria species in an at- A multi-variate logistic regression analysis was per- tempt to clarify their taxonomic position. In the pres- formed on two sets of data on the prevalence of ent study, seven Babesia isolates were collected Theileria annulata in Northern Sudan and Theileria from distinct areas of northern China, and the 18S parva in Southern Sudan, to determine the potential rRNA genes were amplified and sequenced. The risk factors that might affect the distribution of the phylogenetic trees were inferred based on 18S infections in those regions. The logistic regression rRNA gene sequences of the Chinese ovine Babesia model was fit with the tested risk factors for each isolates and some of ovine Babesia and Theileria disease, separately. The results indicated that lo- species available in GenBank. In the phylogenetic 110 Wissenschaftlicher Jahresbericht 2007-2008 Division of Veterinary Infectiology and Immunology Research Reports tree, Babesia sp. isolates from Madang, Tianzhu, Theileria buffeli (0.5 %), Theileria annulata (0.2 %), Lintan, Ningxian, Hebei and Liaoning all grouped Babesia bovis (1.7 %), and Babesia bigemina (0.3 %). with B. motasi with 88.2-99.9 % identity, while Mixed infections were detected in 406 samples Babesia sp. Xinjiang grouped in a separate clade (67.7 %) accounting for 17 different combinations. between B. ovis and B. crassa with 79.7-81.2 % iden- High infection of Theileria parva was reported tity. The results indicated that there are at least two among young calves compared to older cattle. The distinct Babesia species groups-B. motasi and highest prevalence of Theileria parva was reported Babesia sp. Xinjiang, the latter was distinctly differ- in the rainy season (October). The implications of ent from other ovine Babesia isolates from China these results on the epidemiology of tick-borne dis- with less than 86.6% identity. eases are discussed with emphasis on East Coast fever. Collaboration: Liu AH, Yin H, Guan GQ, Liu ZJ, Ma ML, Dang ZS, Liu JL, Ren QY, Bai Q, Luo JX, Lanzhou Collaboration: El Hussein AM, Central Veterinary Re- Veterinary Research Institute, Lanzhou, Gansu, China. search Laboratories, Alamarat, Khartoum, Sudan. Supported in part by: National Natural Sciences Supported in part by: International Foundation for Foundation of China (No. 30571397) and the Natu- Science, Stockholm, Sweden; Organisation of Is- ral resource platform project (No. 2005DKA21104). lamic Conference Standing Committee on Scientific European Commission’s Inco-Dev Coordinated Ac- and Technological Cooperation (COMSTECH), Is- tion “Integrated Consortium on Ticks and Tick-borne lamabad, Pakistan; Coordinated Action “Integrated Diseases” (ICTTD-3) Asian Component, Project num- Consortium on Ticks and Tick-borne Diseases” ber 510561. (ICTTD-3) Asian Component, Project number 510561. Epidemiological studies on tick-borne diseases of Status of tick distribution in Bangladesh, India cattle in Central Equatoria State, Southern Sudan and Pakistan Salih DA, Seitzer U, Ahmed JS. Seitzer U, Ahmed JS. A herd-based study was carried out in Central Equa- On a global basis, ticks transmit a greater variety toria State, Southern Sudan, to study epidemiologi- of pathogenic microorganisms, protozoa, rickettsi- cal aspects of tick-borne diseases. Six herds of cat- ae, spirochaets, and viruses than any other arthro- tle situated in three different locations were select- pods and are among the most important vectors of ed and investigated every 3 months during the year diseases affecting livestock, humans, and compan- 2005. Blood smears for Giemsa staining and blood ion animals. Ticks and tick-borne diseases (TTBDs) spots on filter paper for deoxyribonucleic acid ex- affect 80% of the world cattle population and are traction were collected from 600 apparently healthy widely distributed throughout the world, particular- indigenous cattle. A total of 69 (11.5 %) samples ly in tropical and subtropical countries including In- showed the presence of piroplasms in Giemsa- dia, Pakistan, and Bangladesh. Ticks and tick-trans- stained blood smears, and polymerase chain re- mitted infections have coevolved with various wild action increased the detection limit to 297 (49.5 %). animal hosts, which constitute the reservoir hosts for Using reverse line blot, it was possible to detect and ticks and tick-borne pathogens of livestock, pets, differentiate eight different piroplasms namely, and humans. In this region, the livestock sector is Theileria parva (71.2 %), Theileria mutans (73 %), suffering from a number of disease problems Theileria velifera (45.3 %), Theileria taurotragi (2.7 %), caused by bacteria, viruses, fungi, and parasites. Wissenschaftlicher Jahresbericht 2007-2008 111 Division of Veterinary Infectiology and Immunology Research Reports Among the parasitological problems, the damage ue of 68.2% in May, declining in October and reach- caused by TTBDs is considered very high, and the ing the lowest value of 36.4% in January. The data control of TTBDs has been given priority. indicate that seroprevalence of anti-Theileria anti- Fo r s c h u n g s z e n t r u m Bo r s t e l bodies correlate to the known activities of its transCollaboration: Ghosh S, Bansal GC, Gupta SC, Ray mitting vector and also imply that chemical therapy D, Division of Parasitology, Indian Veterinary Re- of animals should be performed during May to June search Institute, Izatnagar 243122, India; Khan MQ, in these Theileriosis-epidemic regions. Irshad H, Animal Health Laboratories, Animal Sciences Institute, National Agricultural Research Cen- Collaboration: Guo S, Mu YMa D, Yang S, Ge G, tre, Islamabad, Pakistan; Shahiduzzaman M, De- Fang B, Ga D, Animal Husbandry and Veterinary partment of Parasitology, Faculty of Veterinary Sci- Medicine Institute of Gannan Tibet Autonomous Re- ence, Bangladesh Agricultural University, My- gion, Hezuo, Gansu 747000, PR China; Liu Z,Ma M, mensingh-2202, Bangladesh. Luo J, Yin H, Lanzhou Veterinary Research Institute, Lanzhou, Gansu, China. Supported in part by: Coordinated Action “Integrated Consortium on Ticks and Tick-borne Dis- Supported in part by: European Commission’s Inco- eases” (ICTTD-3) Asian Component, Project number Dev Research Program “Molecular and immuno- 510561. logical characterization of merozoite antigens and their encoding genes of a Theileria species highly pathogenic for small ruminants in China: applica- Serological investigation of ovine theileriosis by tion for the development of diagnostics and vac- ELISA in Gannan Tibet Region of Gansu Province cine.”, Project number: ICA-1999-30151; Coordinated in China Action “Integrated Consortium on Ticks and Tick- Seitzer U, Ahmed JS. borne Diseases” (ICTTD-3) Asian Component, Project number 510561. The Gannan Tibet Autonomous Region is the biggest and most important stock-raising region of Gansu Province, People’s Republic of China. Many A survey of ticks (Acari:Ixodidae) on cattle, sheep sheep and goats from this region suffer from Thei- and goats in the Dohuk Governorate, Iraq leria challenge each year, resulting in inestimable Seitzer U, Ahmed JS. economical losses. A first large-scale serological investigation by enzyme-linked immunosorbent assay A survey on hard ticks affecting cattle, sheep, and of ovine theileriosis in this region was performed by goats was done in Dohuk Governorate from March testing a total of 1,165 sera samples collected from 2005 until February 2006 in three areas (Dohuk sur- seven districts of three counties. The results showed rounding area, Barwary Balla near Turkish border, that seroprevalence of reactive antibodies varied and Eqre). The species collected from cattle were from 27.8 to 83.3%, whereby the average was 70.1% Hyalomma anatolicum anatolicum and Hyalomma in the disease-endemic areas. Another 44 sera sam- anatolicum marginatum, while the species collect- ples collected every month from July 2004 to June ed from sheep and goats were Rhipicephalus bur- 2005 from a stable flock of sheep in Biandu Town of sa, Rhipicephalus turanicus, Haemaphysalis parva, Lintan County were analysed to evaluate the sea- and Hyalomma spp. The occurrences of the ticks in sonal kinetics of anti-Theileria antibodies. The re- the three areas were different; in Dohuk surround- sults indicated that anti-Theileria antibody sero- ing area they occured at the beginning of March prevalence rose from March, reaching a peak val- and disappeared in the middle of April, while in the 112 Wissenschaftlicher Jahresbericht 2007-2008 Division of Veterinary Infectiology and Immunology Research Reports Barwary area the ticks occured at the end of March and distribution of tick differentiation protocols and and disappeared at the end of May. In Eqre, the diagnostic tools. peaks of infestation occurred after harvesting of cereals in the middle of June until end of July. Collaboration: Alp H, Aksin M, Pendik Veterinary Control and Research Institute, Pendik, Istanbul, Collaboration: Omer LT, Dohuk Research Center, Turkey. College of Veterinary Medicine, University of Dohuk, Dohuk, Iraq; Kadir MA, College of Medicine, Uni- Supported in part by: Coordinated Action “Inte- versity of Kirkuk, Iraq. grated Consortium on Ticks and Tick-borne Di Supported in part by: Coordinated Action “Integrated Consortium on Ticks and Tick-borne Dis- Development and evaluation of a loop-mediated eases” (ICTTD-3) Asian Component, Project number isothermal amplification method for diagnosis of 510561. tropical theileriosis Salih DA, Liu Z, Bakheit MA, Ali AM, Seitzer U, Ahmed JS. Current status of ticks in Asia. Ahmed JS, Seitzer U. A loop-mediated isothermal amplification (LAMP) assay was developed and evaluated for diagno- Ticks and tick-borne diseases (TTBD) pose a major sis of tropical theileriosis. A set of six primers was constraint for the development and improvement of designed based on the unique gene of Theileria the livestock industry. They cause economical loss- annulata (Theileria annulata strain Ankara hypo- es by decreasing milk production, effecting weight thetical protein (GeneDB TA04795). The protocol loss, and increasing risk for bacterial, viral, and fun- for the reaction was setup and the specificity and gal infections. It has been reported that 80% of sensitivity of the assay were established. The 1,200 million cattle are at risk for TTBDs causing a specificity experiment showed that LAMP primers global annual loss of US$7,000 million. Ticks are cur- amplified T. annulata DNA successfully, while no rently considered to be second only to mosquitoes amplification was seen for Theileria parva, Theile- as vectors of human infectious diseases in the ria mutans, Theileria sergenti, Theileria sinensis, world. There are more than 850 species recognized Babesia bovis as well as bovine genomic DNA with approximately 180 in the family Argasidae (soft and water control. When the sensitivity of LAMP as- ticks) and the others in the family Ixodidae (hard say was compared with that of conventional PCR ticks). In Asia, the economical losses due to TTBDs a 10-fold higher sensitivity was found, with a de- is great; however, the knowledge on Asian ticks is tection limit of 10 pg/microl of genomic DNA iso- scarce and needs intensive studies regarding their lated from a T. annulata-infected cell line. The geographical distribution, ecology, and diseases LAMP product was confirmed by restriction diges- transmission. To close this gap, the Asian compo- tion and staining with SYBR Green I. Furthermore, nent of the Integrated Consortium on Ticks and Tick- the LAMP assay was applied for the diagnosis of Borne Diseases (ICTTD-3) organized a meeting held T. annulata in field samples and compared with re- from 26th-28th April 2006 in Pendik, Istanbul, Turkey verse line blot (RLB), demonstrating that results of on the characterization of Asian ticks. Besides the the LAMP assay corresponded to those of RLB. knowledge dissemination, this meeting resulted in These results indicate that the LAMP assay is rap- a number of achievements such as the establish- id and simple to run, cost-effective, sensitive and ment of working groups for epidemiological studies specific and has potential usefulness for applica- Wissenschaftlicher Jahresbericht 2007-2008 113 Division of Veterinary Infectiology and Immunology Research Reports tion in epidemiological studies on T. annulata in- with a calculated sensitivity and specificity of 77.4 % fection of cattle. and 100%, respectively. Thus the test proved its suit- Fo r s c h u n g s z e n t r u m Bo r s t e l ability for the diagnosis of tropical theileriosis and Collaboration: El Hussein AM, Central Veterinary Re- has application for use in serological surveys to search Laboratories, Alamarat, Khartoum, Sudan; monitor the prevalence of the disease or identify Unger H, Viljoen G, Animal Production and Health Sec- carrier animals with high specificity. tion, Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, International Atomic Energy Agency, Vienna International Centre, Wagramer Strasse 5, P.O. Box 100, A1400 Vienna, Austria Supported in part by: International Atomic Energy Agency (IAEA) through Technical Co-operation project no. SUD/05/029 entitled “Characterization and quality assured production of an attenuated Theileria annulata vaccine”. IAEA fellowship (SUD/07020).; European Commission’s Inco-Dev Specific Support Action “ Evaluation and improvement of integrated Fig. 45. Specificity of cELISA established with rTaSP antigen and monoclonal antibody 1C7. Only the positive control and different sera from T. annulata infected animals are positive, all other tested sera from animals with different infections, including T. parva, were negative. Dotted line: established threshold value of the cELISA. livestock disease control measures through distribution of molecular diagnostic tools, evaluation of Collaboration: Bakheit MA, National Research Cen- disease situation, training and capacity building in ter for Protozoan Diseases (NRCPD), Obihiro Uni- Asia” (INCOME), Project number PL 515915. versity for Agriculture and Veterinary Medicine, Inada-cho, Obihiro, 080-8555, Hokkaido, Japan; Geysen D, Department of Animal Health, Institute of Tropical Development of a competitive ELISA for detection Medicine, Nationalestraat 155, 2000 Antwerp, Bel- of Theileria annulata infection gium; Shiels B, Tait A, Parasitology Group, Division Renneker S, Kullmann B, Gerber S, Dobschanski of Infection and Immunity, Institute of Comparative J, Ahmed JS, Seitzer U. Medicine, Glasgow University Veterinary School, Bearsden Road, Glasgow G61 1QH, UK. In previous studies, Theileria annulata surface protein (TaSP) was identified as an immunodominant Supported in part by: European Commission’s Inco- antigen and successfully used to develop and vali- Dev Specific Support Action “Evaluation and im- date a recombinant-protein-based ELISA for the de- provement of integrated livestock disease control tection of circulating antibodies in serum of T. an- measures through distribution of molecular diag- nulata-infected animals. In this study, the same anti- nostic tools, evaluation of disease situation, training gen was used to develop a competitive ELISA and capacity building in Asia“ (INCOME), Project (cELISA) using a monoclonal antibody that was number PL 515915. found to bind to TaSP. The cELISA accurately differentiated T. annulata-infected from uninfected animals and demonstrated a satisfactory performance 114 Wissenschaftlicher Jahresbericht 2007-2008 Division of Veterinary Infectiology and Immunology Research Reports Evaluation of Theileria annulata recombinant im- nostic tools, evaluation of disease situation, training munodominant proteins for the development of and capacity building in Asia“ (INCOME), Project ELISA number PL 515915. Seitzer U, Beyer D, Kullmann B, Ahmed JS. A number of Theileria annulata genes have been Improved diagnosis for nine viral diseases con- cloned, sequenced and expressed, including TaSP, sidered as notifiable by the world organization TaD, TaSE and TamtHSP70. Several recent publica- for animal health tions document the suitability of the recombinant Ahmed JS. TaSP protein for use in the diagnosis of tropical theileriosis. To investigate whether TaD, TaSE or TamtH- Nine viral diseases included in the World Organi- SP70 elicit a humoural immune response in the T. zation for Animal Health list of notifiable diseases annulata-infected host and to assess the potential (former list A) were chosen for their contagiousness of these proteins for development of diagnostics, a and high capacity of spreading to improve their di- total of 156 field sera from Sudan and 49 negative agnosis using new and emerging technologies. All sera from Germany were investigated in ELISA for the selected diseases—foot-and-mouth disease, the presence of specific antibodies against these swine vesicular disease, vesicular stomatitis, classi- recombinant proteins in comparison to TaSP. Anti- cal swine fever, African swine fever, bluetongue, bodies against TaD and TaSE were found to be African horse sickness, Newcastle disease and present, whereas no antibody response could be highly pathogenic avian influenza—are considered detected against the recombinant TamtHSP70. as transboundary diseases, which detection causes Highest titres were found to be present against the the prohibition of livestock exportation, and, thus, it TaSP protein, with antibody titres against TaD and leads to high economical losses. The applied di- TaSE being in general somewhat lower. Correlation agnostic techniques can fall into two categories: (i) analysis showed a significant correlation of TaSP nucleic-acid detection, including padlock probes, and TaSE and of TaSE and TaD antibody titres, how- real-time PCR with TaqMan, minor groove binding ever not between TaSP and TaD. In conclusion, the probes and fluorescence energy transfer reaction infected bovine host was shown to produce anti- probes, bodies against three of the four recombinant T. an- Cleavase/Invader assay or the loop-mediated am- isothermal amplification like the nulata proteins tested, all three having been de- plification technology and the development of rap- scribed or predicted to be parasite membrane pro- id kits for ‘mobile’ PCR and (ii) antigen-antibody de- teins. The outstanding performance of the TaSP pro- tection systems like simplified and more sensitive tein for detection of T. annulata infection in indirect ELISA tests. Besides, internal controls have been im- ELISA was confirmed. proved for nucleic acid-detecting methods by using an RNA plant virus—Cowpea Mosaic Virus—to en- Collaboration: Bakheit MA, National Research Cen- sure the stability of the RNA used as a positive con- ter for Protozoan Diseases (NRCPD), Obihiro Uni- trol in diagnostic real-time RT-PCR assays. The de- versity for Agriculture and Veterinary Medicine, In- velopment of these diagnosis techniques has re- ada-cho, Obihiro, 080-8555, Hokkaido, Japan. quired the joint efforts of a European consortium in which nine diagnostic laboratories and an SME who Supported in part by: European Commission’s Inco- have collaborated since 2004 within the European Dev Specific Support Action “Evaluation and im- Union-funded Lab-on-site project. provement of integrated livestock disease control measures through distribution of molecular diag- Collaboration: Rodriguez-Sanchez B, Sanchez-Viz- Wissenschaftlicher Jahresbericht 2007-2008 115 Division of Veterinary Infectiology and Immunology Research Reports caino JM, Animal Health Department, Veterinary Fac- tion was confirmed through EcoRI restriction enzyme ulty, Universidad Complutense de Madrid, Avda digestion analysis and sequencing. The assay was Puerta de Hierro s/n, 28040 Madrid, Spain; Uttenthal proven sensitive since specific amplification was ob- A, Rasmussen TB, Department of Virology, National tained from 0.1 pg DNA of T. luwenshuni or T. uilen- Veterinary Institute, Technical University of Denmark, bergi. The LAMP assay was evaluated by testing 86 Lindholm, Fo r s c h u n g s z e n t r u m Bo r s t e l Denmark; field samples in comparison to the reverse line blot Hakhverdyan M, Belak S, Department of Virology, method, showing a sensitivity and specificity of 66.0% National Veterinary Institute, Ulls väg 2B, SE-751 89 and 97.4%, respectively. These results indicate that Uppsala, Sweden; King DP, Ferris NP, Ebert K, Reid the LAMP assay is rapid and simple to run, cost ef- SM, Department of Exotic Disease Control, Ash Road, fective, sensitive, and specific and has potential use- Pirbright, Surrey, GU24 0NF, UK; Kiss I, Veterinary In- fulness for application in diagnostics of and epi- stitute of Debrecen, 2, Pf. 51, H-4002 Debrecen, Hun- demiological studies on T. luwenshuni and T. uilen- gary; Brocchi E, Cordioli P, Department of Research, bergi infection of small ruminants. DK-4771 Kalvehave, Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna, Via Bianchi 7/9, 25124 Bres- Collaboration: Bakheit MA, National Research Cen- cia, Italy; Hjerner B, McMenamy M, Department of ter for Protozoan Diseases (NRCPD), Obihiro Uni- Veterinary Science, The Queen’s University of Belfast, versity for Agriculture and Veterinary Medicine, In- Stoney Road BT4 3SD Belfast, UKMcKillen J, Veteri- adacho, Obihiro, 080-8555, Hokkaido, Japan; Luo J, nary Sciences Division, Agri–food and Biosciences In- Yin H, Hou J, Lanzhou Veterinary Research Institute, stitute, Stormont, Belfast, BT4 3SD, UK. Lanzhou, Gansu, China. Supported in part by: Lab-on-site Project of the Supported in part by: “863” Project (2006 European Commission, project number: SSPECT- AA10A207), Specific Fund for Sino-Europe Coopera- 2004-513645. tion, MOST, and EU-funded Coordinated Action “Integrated Consortium on Ticks and Tick-borne Diseases” (ICTTD-3), Project number 510561, National Development of loop-mediated isothermal am- Natural Sciences Foundation of China ( 30571397), plification (LAMP) assay for rapid diagnosis of International Cooperation Fund of NSFC, Beijing, ovine theileriosis in China China. ZL is the recipient of a DAAD scholarship. Liu Z, Salih DA, Ahmed JS, Seitzer U. Loop-mediated isothermal amplification (LAMP) is a Existence of splicing products in homologues of novel nucleic acid detection method in which the tar- Theileria lestoquardi clone-5 gene in T. annulata get deoxyribonucleic acid (DNA) can be efficiently and T. parva amplified with high specificity and sensitivity under Kullmann B, Ahmed JS, Seitzer U. isothermal conditions using a set of either four or six specific primers. In this study, we have identified a Clone 5 has been described as an immunogenic pro- conserved sequence for Theileria luwenshuni (UTR- tein and was used to establish an ELISA for malignant lu8) and for T. uilenbergi (UTRu6) suitable for de- theileriosis. Molecular characterization of the gene signing a set of six primers for the simultaneous de- product revealed alternative splicing at the single in- tection by LAMP of these pathogens causing theile- tron resulting in two mRNA transcripts, translating in- riosis in sheep and goats in China. LAMP was per- to a long and a short protein form.2 Homologues of formed at 63 degrees C, and the amplified DNA was clone 5 exist in Theileria annulata and T. parva ac- detectable within 15 min. The specificity of the reac- cording to the available annotated GenBank se- 116 Wissenschaftlicher Jahresbericht 2007-2008 Division of Veterinary Infectiology and Immunology Research Reports quences, showing however only the long protein “863” Project (2006AA10A207), Specific Fund for forms in these parasites (GenBank accession num- Sino–Europe Cooperation, MOST, and European bers CAI73679, EAN33624).The present study aimed Union-funded Coordinated Action “Integrated Con- to determinewhether two splice variants of homo- sortium on Ticks and Tickborne Diseases” (ICTTD-3), logues of clone 5 occur in T. annulata and T.parva. Project number 510561. ZL is the recipient of a DAAD scholarship. Collaboration: Bakheit MA, National Research Center for Protozoan Diseases (NRCPD), Obihiro University for Agriculture and Veterinary Medicine, In- Comparison of the molecular structure of the TaSP ada-cho, Obihiro, 080-8555. gene of Theileria annulata from Sudanese isolates Supported in part by: Coordinated Action “Inte- Ali AM, Ahmed JS, Seitzer U. grated Consortium on Ticks and Tick-borne Diseases” (ICTTD-3) Asian Component, Project number The polymorphic region of the Theileria annulata sur- 510561. face protein TaSP was cloned and sequenced from different isolates of cattle and cell lines from different areas of Sudan. Amino acid sequence alignment Small-scale expressed sequence tag analysis of revealed a high diversity showing amino acid and Theileria sp. (China) length polymorphism, both within and between par- Liu Z, Ahmed JS, Seitzer U. asite isolates. The generation of TaSP diversity may allow the evasion of host immunity by the parasite Recently, Theileria sp. (China) has been designat- since TaSP is a highly antigenic parasite protein. ed as T. luwenshuni [formerly Theileria sp. (China 1)] and T. uilenbergi [formerly Theileria sp. (China 2)]. Collaboration: D Hassan, EL Hussein ARM, Central A cDNA library of T. uilenbergi merozoites was con- Veterinary Research Laboratories, Al Amarat, Khar- structed and subjected to random sequencing. toum, Sudan; SM Hassan, Faculty of Veterinary Med- Among the obtained sequences were three highly icine, University of Khartoum, Khartoum North, Sudan; identical cDNA clones, indicating a gene family. MM Mukhtar, Institute of Endemic Diseases, Univer- Bioinformatic analyses indicated these genes con- sity of Khartoum, Khartoum, Sudan; M Bakheit, Na- tain signal peptides and encode potential im- tional Research Center for Protozoan Diseases (NR- munogenic proteins. The presence of tandemly CPD), Obihiro University for Agriculture and Veteri- arranged and additional variants of these genes nary Medicine, Inada-cho, Obihiro, 080-8555. was shown. Analysis of one recombinantly expressed clone revealed immunoreactivity for serum Supported in part by: DAAD, European Union (ICA4- from Theileria-infected animals. No cross-reaction 1999-30151), Animal Resources Bank (Sudan), IAEA with serum of T. lestoquardi-, Babesia motasi-, or NO.SUD04/027 entitled “Control of ticks and tick- Anaplasma ovis-infected animals was observed, in- borne diseases in the Sudan”. dicating a potential antigen for development of serological diagnostic tools. Immune response of Theileria sp. (China) infectCollaboration: Z Dang, J Hou, J Luo, H Yin, Lanzhou ed sheep to recombinant Theileria proteins Veterinary Research Institute, Lanzhou, Gansu, China. Seitzer U, Beyer D, Kullmann B, Miranda J, Ahmed JS. Supported in part by: Supported in part by the Sheep and goats in northwest China suffer from Wissenschaftlicher Jahresbericht 2007-2008 117 Division of Veterinary Infectiology and Immunology Research Reports theileriosis from infection with Theileria sp. (China), their encoding genes of a Theileria species highly resulting in large economic losses. To investigate pathogenic for small ruminants in China: applica- the immune response to infection with Theileria sp. tion for the development of diagnostics and vac- (China), parameters of cellular and humoral immu- cine.”, (ADDAV), Project number: ICA-1999-30151. Fo r s c h u n g s z e n t r u m Bo r s t e l nity of experimentally infected sheep against two recombinantly expressed Theileria proteins were investigated. The in vitro proliferative response of Influence of subculturing on gene expression in a blood mononuclear cells to a recombinant T. annu- Theileria lestoquardi infected cell line lata membrane protein and a recombinant Theile- Ali AM, Beyer D, Bakheit MA, Kullmann B, Salih ria sp. (China) homologue to T. annulata surface DA, Ahmed JS, Seitzer U. protein, both putative membrane proteins, was significantly elevated and significant amounts of spe- In this study potential molecularmarkers for identifi- cific immunoglobulinswere produced against both. cation of attenuation in a Theileria lestoquardi-infected cell line to be used in vaccination trials were identified. Two markers associated with attenuation in Theileria annulata vaccine strainswere analyzed (metalloproteinase activity and TNFα mRNA expression). The result showed a decreased activity ofMMP9 and decreased mRNA expression of TNFα with increasing passage number. Suppression subtractive hybridization was used to identify potential new markers of attenuation. Random screening revealed nine differentially expressed genes, one from the parasite and eight from the host. Quantitative real time-PCR confirmed mRNA expression of the parasite vacuolar H+ATPase to be downregulated at higher passages. Fig. 46. Proliferative response of experimentally infected animals 23 days p.i. to different antigens. a) Average values of four animals each per group. b) Data for four individual sheep each of tick or blood infected animals are shown. Averages are depicted with standard deviations. *p<0.05 compared to respective uninfected control animal (→). rTaD: recombinant TaD protein; rTcSP: recombinant TcSP protein; merozoite: Theileria sp. (China) merozoite crude antigen. Tick infected: animals infected by attraction of 200 Haemaphysalis qinghaiensis ticks. Blood infected: animals infected with T. sp. (China) infected blood. Collaboration: M Bakheit, National Research Center for Protozoan Diseases (NRCPD), Obihiro University for Agriculture and Veterinary Medicine, Inada-cho, Obihiro, 080-8555. Supported in part by: EU-funded AsianComponent of the Inco-Dev ICTTD-3 Coordination Action Project (Project No. 510561). AA is the recipient of a schol- Collaboration: Liu Z, Yin H, Lanzhou Veterinary Re- arship from the Sudanese Government; DAS is the search Institute, Lanzhou, Gansu, China; Miranda J, recipient of an IAEA fellowship (SUD/07020). cInstituto de Biologia Experimental e Tecnologica/ Instituto de Tecnologia Quimica e Biologica / Universidade Nova de Lisboa, Oeiras, Portugal. Supported in part by: European Commission’s IncoDev Research Program “Molecular and immunological characterization of merozoite antigens and 118 Wissenschaftlicher Jahresbericht 2007-2008 Division of Biochemical Immunology Research Reports Division of Biochemical Immunology Head However, the intracellular signaling pathways acti- PD Dr. Frank Petersen vated by CXCL4 are not well understood. Over the past decade, it has become abundantly clear that Staff Scientists and Postdoctoral Fellows sphingolipids and their metabolites are key signal- Dr. Brigitte Kasper ing molecules. Sphingolipids are ubiquitous com- Dr. Jessica Mittelstädt ponents of cell membranes and their metabolites Dr. Xinhua Yu ceramide, sphingosine, and sphingosine-1-phosphate (S1P) have important physiological functions, Graduate and Diploma Students including regulation of cell growth and survival. In Roland Gross (until 10/07) the present study we investigated the role of sphin- Lisette Leonhardt gosine kinase 1 in CXCL4-induced cytokine release Janne Wessel (until 04/08) and monocyte survival. We could show that CXCL4- Geske Woller (until 10/07) induced mRNA expression of IL-6, TNF, and MCP-1 as well as the release of the corresponding proteins Technicians is strongly reduced in the presence of pharmaco- Cindy Hass logical SphK inhibitors (SKI and DMS). Furthermore, Diana Heinrich pretreatment of the cells with SKI reverts CXCL4-mediated rescue from apoptosis. CXCL4-induced monocyte survival is accompanied by inhibition of Research Reports caspases which is controlled by SphK1 and its The role of sphingosine kinase 1 in CXCL4-in- down-stream element Erk. Taken together, these da- duced cytokine release and monocyte survival ta demonstrate the critical role of SphK1/S1P in CX- Kasper B, Petersen F. CL4 signaling in monocytes and suggest that SphK1 is a potential therapeutic target to suppress proin- CXCL4 (Platelet factor 4; PF4) belongs to the family flammatory responses induced by CXCL4. of CXC chemokines, and shares 30 % to 60 % sequence identity and typical structural properties Collaboration: Brandt E, Division of Biological with other CXC chemokines, including the neu- Chemistry, Research Center Borstel; Schütze S, De- trophil-activating peptide-2 (NAP-2; CXCL7), inter- partment of Immunology, UKSH, Campus Kiel. leukin-8 (IL-8; CXCL8), or interferon (IFN)-inducible protein 10 (IP-10; CXCL10). However, with regard to Supported in part by: DFG SFB 415 “Spezifität und its receptors, signal transduction, and biological Pathophysiologie von Signaltransduktionswegen”, functions, CXCL4’s role within the family of Teilprojekt B6. chemokines appears to be rather exceptional. Unlike other chemokines, which affect only a limited set of target cells, CXCL4 was reported to be active CXCL4-induced oxygen radical formation in hu- on a variety of different cell types including ba- man monocytes is regulated by multiple sig- sophils, T cells, NK cells, neutrophils, and mono- nalling pathways cytes. On the latter cells, CXCL4 induces a complex Kasper B, Petersen F. spectrum of activities including the expression and release of proinflammatory cytokines/chemokines Monocytes and macrophages can respond to and the protection from spontaneous apoptosis. proinflammatory stimuli by a variety of acute and Wissenschaftlicher Jahresbericht 2007-2008 119 Division of Biochemical Immunology Research Reports delayed defense mechanism such as oxygen radi- treated monocytes SphK1 mRNA becomes signifi- cal (ROS) formation, phagocytosis and killing of mi- cantly up-regulated and that CXCL4 induces SphK1 croorganisms, or the presentation of antigens. enzyme activity as well as its translocation to the Fo r s c h u n g s z e n t r u m Bo r s t e l Fig. 47. Effect of SphK inhibitor (SKI) or SphK1-specific siRNA on CXCL4-induced ROS formation. A: Freshly isolated monocytes were preincubated for 20 min at 37°C in the presence or absence of increasing concentrations SKI, or DMSO as solvent control. Subsequently, cells were stimulated with 4 µM CXCL4 and ROS formation was quantified by chemiluminescence in the presence of luminol and recorded for 60 min. Individual assay backgrounds were determined in samples of unstimulated cells in the presence or absence of inhibitors run in parallel and were subtracted. Either data (relative light units; RLU) from one representative experiment are given (inset), or data were integrated over 60 min and shown as mean ± SD of four independent experiments. Asterisk (*) indicates statistically significant differences (P < .04) between inhibitor-treated samples and untreated controls. B-D: GM-CSF generated macrophages were transfected with either SphK1-specific siRNA or non-silencing control-siRNA. (B) Cell viability (annexin V/PI staining), and transfection efficiency was tested 24 h after transfection using Cy5-labeled non-silencing control siRNA. (C) After 24 h, total RNA was isolated, transcribed into cDNA and SPHK1 expression was tested by RQ-PCR. Relative quantification was performed using RelQuant software and data were presented as normalized ratio of SPHK1 versus HPRT. D: Alternatively, 24 h after transfection ROS formation was determined in these cells following stimulation with 4 µM CXCL4 as described above. Data are shown as mean ± SD of eight independent experiments. Asterisk (*) indicates statistically significant differences (* P < .005, ** P < .0003) between SphK1-siRNA and control-siRNA treated samples. However, only limited information exists on the spe- cell membrane. Furthermore, using specific SphK in- cific signaling pathways which are involved in the hibitors (SKI) we could demonstrate that preincu- control of these biological responses. Recently, we bation of the cells with SKI resulted in a significant could show that CXCL4-induced formation of ROS is and dose-dependent reduction of CXCL4-mediated controlled by a rapid activation of PI3K and p38 respiratory burst by 47% at 0.33 µM SKI to 98 % at MAPK. Here, we report for the first time that sphin- 27 µM SKI (Fig. 47A). These data provided first evi- gosine kinase 1 (SphK1) plays a key role in CXCL4- dence that activation of SphK is involved in the gen- triggered signaling. We demonstrate that in CXCL4- eration of ROS in monocytes. To strengthen our re- 120 Wissenschaftlicher Jahresbericht 2007-2008 Division of Biochemical Immunology Research Reports sults with SphK inhibitors we next used siRNA knockdown strategy to verify these data. ROS production induced by CXCL4 has been shown in monocytes as well as in macrophages. Since for technical reasons monocytes could not be used for knockdown experiments, GM-CSF-generated macrophages were used instead. In a first approch we tested cell viability (annexin V/PI staining), and transfection efficiency 24 h after transfection using Cy5-labeled nonsilencing control siRNA (Fig. 47B). After 24 h 77 ± 14 % are viable and 57 ± 12% of the cells were positive for Cy5-labeled siRNA. More importantly, treatment of macrophages with SphK1-specific siRNA resulted in 37 % decreased SphK1 mRNA expression (Fig. 47C), and 45% reduction in CXCL4-mediated ROS production after 24 h (Fig. 47D). Finally, although monocyte responses induced by CXCL4 could be partially mimicked by the addition of high dosages of exogenous sphingosine-1-phosphate (S1P), CXCL4-signals were transduced independently from S1P receptors. Taken together, our data indicate that SphK1 is a central signalling element in CXCL4-induced monocyte activation which is involved in the regulation of short term (ROS production) as well as long term functions (cytokine production and cell survival). Collaboration: Brandt E, Division of Biological Chemistry, Research Center Borstel; Schütze S, Department of Immunology, UKSH, Campus Kiel. Supported in part by: DFG SFB 415 “Spezifität und Pathophysiologie von Signaltransduktionswegen”, Teilprojekt B6. Regulation of T cell chemotaxis by CXCL4 Woller G, Leonhardt L, Petersen F. Directed migration of cells along a chemotactic gradient is a fundamental cellular process involved e.g. in host defense, tissue development, and wound repair. Surprisingly, although a broad spectrum of different mediators is able to induce Fig. 48. Effect of CXCL4 on T cell chemotaxis. A: CXCL4 lacks chemotactic activity on T cells. PHA-generated T cell blasts (105/well) were placed in the upper compartment of a Boyden chamber system and migration was determined towards increasing concentrations of native CXCL4, recombinant CXCL4, or recombinant CXCL11. B./C: CXCL4 inhibits CXCL11 and CXCL9-induced chemotaxis. Increasing concentration of CXCL11(I-TAC; B), CXCL9 (MIG; C) or medium alone (dashed line) were placed in the lower compartments of a 48-well microchamber and the migration of T cells (105/well) was determined. In a parallel set 4 µM CXCL4 was added to the cells in the upper wells. D: CXCL4 does not modulate CXCL10-induced chemotaxis. In a parallel set of experiments migration of T cells towards CXCL10 (IP10) in the presence or absence of CXCL4 was determined. Data are given as mean + SD obtained from 4 or 5 independent experiments. Statistically significant differences between samples receiving CXCL11 alone or in combination with CXCL4 are indicated (*, P < 0.05). Wissenschaftlicher Jahresbericht 2007-2008 121 Division of Biochemical Immunology Research Reports a chemotactic response, only very few regulators allelic gene variant of CXCL4 was discovered and or inhibitors of this function are known. CXCL4 the corresponding protein, termed CXCL4L1, has (platelet factor 4; PF4), a platelet-derived CXC- been detected recently in supernatants of activat- chemokine, modulates long-term immunregulatory ed platelets. While the N-termini of CXCL4 and CX- functions in T cells but lacks the capacity to induce CL4L1 are identical, both variants differ in three chemotaxis in these cells (Fig. 48A). However, in amino acid residues within the C-terminal a-helix. the current study we are able to show for the first Since biological functions and biochemical prop- time, that CXCL4 acts as a potent inhibitor of T cell erties of CXCL4L1 are largely unknown, we ana- chemotaxis induced by CXCR3 ligands CXCL11 lyzed the capacity of the C-terminal peptides 47-70 and CXCL9, but not CXCL10 (Fig. 48B-D). CXCL4 did of CXCL4 and CXCL4L1 to regulate cellular func- neither interfere with ligand binding to CXCR3 nor tions of human monocytes, neutrophils, and T cells. with ligand-induced internalization or calcium sig- Comparable to full-size CXCL4, both partial struc- naling of CXCR3. By several lines of evidence we tures were able to promote exocytosis in neu- could rule out the participation of known CXCL4-re- trophils, to generate ROS production in monocytes ceptors, like proteoglycans or CXCR3-B, in CXCL4- as well as to inhibit chemotaxis in T cells. Interest- mediated inhibition of chemotaxis. Interestingly, CX- ingly, CXCL4L1(47-70) displayed a significant high- CL4, but not CXCL11, activates the beta2-integrin er potency in the induction of monocyte and neu- LFA-1, suggesting that reduced chemotaxis involves trophils functions as compared to CXCL4 or its cor- an enhanced adhesion of the cells. This more gen- responding C-terminal peptide. These differences eral mechanism would explain our further finding suggest that not only the partial structures but al- that CXCL4 also inhibits the chemotaxis of T cells so the native molecules differ in their capacity to and neutrophils induced by the CXCR3-independent induce cellular effects. Thus, despite to their prin- ligand CXCL12 (SDF-1a). Taken together, our results cipal similar biological functions the individual ex- identify CXCL4 as the first chemokine which acts as pression of both variants could play a role in the an inhibitor rather than an inducer of chemotaxis on fine-tuning of an inflammatory response. Fo r s c h u n g s z e n t r u m Bo r s t e l T cells and neutrophils in vitro. Supported in part by: DFG SFB 415 “Spezifität und Supported in part by: DFG SFB 415 “Spezifität und Pathophysiologie von Signaltransduktionswegen”, Pathophysiologie von Signaltransduktionswegen”, Teilprojekt B6. Teilprojekt B6. Crossregulation of immune responses by mast Activation of human phagocytes and T cells by cells and dendritic cells variants of platelet factor 4 (CXCL4) Mittelstädt J, Schiemann F, Petersen F. Wessel J, Petersen F. Mast Cells are well known for their pivotal role in The platelet-derived chemokine CXCL4 is known as allergic as well as autoimmune diseases. Howev- a potent activator of human phagocytes inducing er, today it is clear that mast cells are key players adhesion and exocytosis in neutrophils as well as in the innate immune response and participate in phagocytosis and the generation of reactive oxy- a wide range of chronic and acute inflammatory gen species (ROS) in monocytes. Furthermore, CX- diseases. It is commonly accepted that investiga- CL4 has the capacity to prevent monocyte from un- tions limited on these cells alone are not sufficient dergoing apoptosis and to promote their differen- to understand their impact and physiological func- tiation into macrophages. A few years ago, a non- tion. Within this view, we focused our investigations 122 Wissenschaftlicher Jahresbericht 2007-2008 Division of Biochemical Immunology Research Reports on the cellular interaction of mast cells and den- Cellular interactions of human mast cells and neu- dritic cells. Beside enzymes, mast cells are capa- trophil granulocytes in allergic asthma ble to release a variety of cytokines and Leonhardt L, Petersen F. chemokines, which may affect DC functions and their differentiation. Dendritic cell activation and Asthma is characterized as a chronic inflammation maturation can be mediated by LPS or cytokines of the airways which involves various cell types in- like TNF-alpha and is accompanied by expression cluding eosinophils, neutrophils and mast cells. of costimulatory molecules as well as cytokines. This inflammatory process is seen as directly Since mast cells as well as DC are in the first line causative for the asthma pathology in terms of air- of defence of the host against microbial invaders, way hyperreactivity and airway remodelling. Al- we asked whether both cell type could interact though eosinophilia of the lung is a hallmark of the which each other resulting in a cross-regulatory allergic inflammation, disappointing results from process. In a first approach, where we analysed anti-IL-5 as wells as IL-12 studies revealed that the consequences during coculture of immature DC accumulation of eosinophils alone cannot explain (iDC) with human primary lung mast cells, we nei- the pathology of asthma. Today it is clear, that oth- ther observe relevant changes in DC phenotype er cell types including neutrophils and mast cells nor the induction of cytokine release or modulation also contribute to the disease. However, the un- of T cell responses by DC. In a more indirect ap- derlying pathomechanisms as well as pathophys- proach, we investigated the effect of mast cell pro- iological role of these cells in asthma remain to be teases on the maturation of DC in presence of LPS elucidated. Following our hypothesis, activated and the cathelicidin LL37, an antimicrobial peptide mast cells are essential for neutrophil accumula- abundantly present in microbial infections. Inter- tion and activation in the allergic lung. Further- estingly, LL37 does not directly modulate DC func- more, the interaction between both cell types tions, but has the capacity to prevent LPS-induced could play a key role in the structural and func- maturation of iDC. By contrast, we could show that tional alteration of the airways. In first experiments LL37 acts as a potent activator of MC inducing the we could show that Fc-eRI-activated human lung release of mast cell proteases such as tryptase. mast cells release immediately (30 min) and de- Most intriguing, blocking of LPS-induced matura- layed (4-24h) mediators which are capable to in- tion by LL37 was completely abrogated in the pres- duce a chemotactic response in neutrophils. Cur- ence of mast cells or mast cell tryptase. We could rently, we are working on the identification of these show that tryptase released by LL37-activated mediators by HPLC-chromatography in combina- mast cells is responsible for a rapid degradation tion with nano-ESI-FT mass spectrometry. These tri- of the AMP into biological inactive fragments als will be accompanied by transcriptome analy- which leads to the reconstitution of DC activation sis of activated mast cells. In the long run we will by LPS. Our findings suggest an indirect interplay evaluate relevant mediators in sputum and lavage between mast cells and dendritic cells in a com- fluids of patients suffering from allergic and non- plex inflammatory situation. allergic asthma. We hope that our approaches do not only provide a better understanding of the Collaboration: Brandt E, Division of Biological pathological processes in asthma but will help to Chemistry, Research Center Borstel. improve diagnosis and development of new strategies for the treatment of the disease. Supported by in part by: DFG PE 967/1-1. Collaboration: Brandt E, Division of Biological Chemistry, Research Center Borstel; Lindner B, Divi- Wissenschaftlicher Jahresbericht 2007-2008 123 Division of Biochemical Immunology Research Reports sion of Immunochemistry, Research Center Borstel. mast cells are involved in the pathogenesis of ex- Fo r s c h u n g s z e n t r u m Bo r s t e l perimental EBA and if MCs-targeted treatment may Supported in part by: DFG SFB/TR 22 “Allergische serve as a potential therapeutic strategy of EBA. Fi- Immunantworten der Lunge“, Teilprojekt A11. nally, by using corresponding knock-out animals, we aim to identify cytokines playing an essential role in EBA. From our approaches we expect the develInvestigating the molecular mechanism of tissue opment of novel strategies in the diagnosis and damage in autoimmunity to type VII collagen us- treatment of autoimmune dermatoses. ing experimental models Collaboration: Zillikens D, Ludwig R, Department of Yu X, Petersen F. Dermatology, UKSH, Campus Lübeck; Bulfone-Paus S, Epidermolysis bullosa acquisita (EBA) is an autoim- Division of Immunobiology, Research Center Borstel. mune bullous disease caused by autoantibodies to type VII collagen, the main constituent of anchoring Supported in part by: Cluster of Excellence „Inflam- fibrils in dermal-epidermal junction. Recently, in vi- mation at Interfaces”; Research Area H: IRN Au- vo mouse models of EBA have been established, by toimmunity to Type VII Collagen. active immunization of type VII antigen or passive transfer of autoantibody to type VII collagen. As an autoantibody-mediated autoimmune disease with Theses well characterized autoantigen and ingenious disease modelling, EBA emerges as a unique model Diploma for investigating the pathogenesis of autoantibody- Wessel, Janne mediated autoimmune diseases. With the recently Aktivierung humaner Leukozyten durch Varianten established mouse models, investigators demon- des CXC-Chemokins Plättchenfaktor 4 strated that some biological possesses are essen- Technisch-Naturwissenschaftliche Fakultät tial in the development of the disease, including Universität zu Lübeck, 2008. generation of tissue-bound autoantibodies, activation of complement system, generation of reactive Dissertation oxygen species (ROS) by neutrophils and neutrophil Gross, Roland degranulation. Despite of those significant findings, Direkte und indirekte Effekte thrombozytärer Che- the pathogenesis of the diseases is still largely un- mokine auf humane Mastzellen. clear. Therefore, identifying biological events in- Technisch-Naturwissenschaftliche Fakultät volved in the development of EBA and further char- Universität zu Lübeck, 2007. acterizing their molecular mechanisms will help to explore the pathogenesis of the disease as well as Woller, Geske to search for novel therapeutic targets. In addition, Regulation der Chemotaxis humaner T-Zellen durch clarity of the pathogenesis of EBA will also help to das thrombozytäre Chemokin Plättchenfaktor 4. elucidate the pathogenesis of other anti-body me- Technisch-Naturwissenschaftliche Fakultät diate inflammatory diseases in general. To under- Universität zu Lübeck, 2007. stand the molecular mechanism responsible for neutrophil-mediated tissue damage we will investigate mediators, signalling pathways and receptors involved in the control of neutrophil activation. Furthermore we will address the question whether 124 Wissenschaftlicher Jahresbericht 2007-2008 Division of Innate Immunity Research Reports Division of Innate Immunity Head nificant increase only in Defensin Beta-1 (DEFB1) PD Dr. Holger Heine mRNA expression in bronchial biopsy samples of COPD patients that weakly but significantly corre- Staff Scientists and Postdoctoral Fellows lates with disease severity (Fig. 49A, B). Dr. Thomas Scholzen (since 04/2008) Dr. Jennifer Debarry (07/2007 - 02/2008) Graduate and Diploma Students Jennifer Debarry (until 06/2007) Ellen Andresen Karina Stein Technicians Ina Goroncy Katrin Sprenger Research Reports Molecular basis of increased DEFB1 gene expression in the lung of COPD patients Andresen E, Heine H. Ongoing inflammatory immune responses in the lung are characteristic for the pathophysiology of 10 healthy volunteer controls and 35 individuals Fig. 49. Study of DEFB1 gene expression in biopsy samples. Here, we tested the hypothesis that the DEFB1 mRNA is differently regulated and expressed in the peripheral lung during pathogenesis of COPD. (A) In biopsies obtained from 10 healthy controls and 32 COPD patients, the DEFB1 mRNA expression was analyzed by quantitative real-time PCR and normalized to 2-microglobulin expression. The one-tailed hypothesis was tested using unpaired ttest from log transformed data; all data is shown as mean ± SEM. DEFB1 mRNA expression is significantly increased in biopsies of COPD patients. (B) Spearman correlation between the DEFB1 mRNA expression and the percent of predicted FEV1/VC (N = 41). The DEFB1 mRNA showed a weak but significant correlation with the disease severity. with stage I-IV COPD (defined by an FEV1/VC < 70 % and FEV1 < 80 % of predicted) were recruited at The first discovered human DEFB1 has been large- the Medical Clinic of the Research Center Borstel. ly considered as a constitutively expressed de- The study was approved by the Ethical Committee fensin, but recent observations suggest some sort of of the Medical faculty of the University of Lübeck. DEFB1 gene regulation in a variety of cell types. Following written informed consent bronchoscopy However, the molecular mechanisms responsible was performed according to national guidelines for the upregulation of DEFB1 gene expression in with epithelial cell biopsies and bronchoalveolar COPD are still unknown. Alterations in gene ex- lavage (BAL) with 300 ml of normal saline. Of all de- pression can be caused by epigenetic program- fensins investigated, our data demonstrated a sig- ming leading to changes in the chromatin state (hi- Chronic Obstructive Pulmonary Disease (COPD). Defensins are components of the innate host response against bacterial infections and regulators of inflammation and immunity. In the present study, we tested the hypothesis that defensins are differently regulated and expressed in the peripheral lung tissue during pathogenesis of COPD. For this purpose, Wissenschaftlicher Jahresbericht 2007-2008 125 Division of Innate Immunity Research Reports stone modifications and DNA methylation). We (Fig. 50B). Altogether, our results support the hy- demonstrated modulation of DEFB1 gene expres- pothesis that the observed alterations in DEFB1 sion by using inhibitors of human histone deacety- gene expression in COPD are a consequence of lases (HDACi) or DNA methylation suggests an im- epigenetic changes, although definitive proof will portant role for epigenetic mechanisms in the require additional studies. The understanding of DEFB1 gene regulation (data not shown). Further- the biological function and interplay of epigenetic more, bisulfite sequencing analysis of DNA methy- mechanisms in DEFB1 gene expression might be an lation revealed that the increased DEFB1 mRNA lev- important contribution to the understanding of the el found in biopsies of COPD patients correlates pathogenesis of COPD. Fo r s c h u n g s z e n t r u m Bo r s t e l with the decreased methylation of distinct CpG sites at the DEFB1 promoter (Fig. 50A). Collaboration: Lange C, Div. Clinical Infectious Diseases, Research Center Borstel. Supported in part by: DFG, SFB617, project A23. Investigation of allergy-protective mechanisms by microarray analysis of human dendritic cells stimulated with four different bacterial strains Stein K, Debarry J, Heine H. The incidence of allergic diseases is worldwide increasing, especially in industrialized regions. A growing number of publications indicate that farming environment in early childhood reduces the occurrence of allergic reactions later in life. Recently, we showed that the cowshed isolates Lactococcus lactis G121 and Acinetobacter lwoffii F78 prevent allergic immune responses in a mouse asthma model. However, the molecular mechanisms modulating Fig. 50. Epigenetic studies in DEFB1 gene regulation. (A) Bisulfite sequencing analysis of specific promoter CpG sites among biopsies from 4 healthy controls and 4 COPD patients. Positions of individual CpG sites relative to the transcriptional start are indicated. Increased DEFB1 mRNA level found in biopsies of COPD patients correlates with the decreased methylation of distinct CpG sites at the DEFB1 promoter. (B) ChIP assays were performed with chromatin from BAL fluid cells of 11 study subjects. Spearman correlation between the DEFB1 mRNA expression and H3K4me3 showed a strong positive correlation with the establishment of the active histone modification in the vicinity of the transcriptional start site of the DEFB1. allergic reactions in humans are only poorly understood. Thus, we stimulated human dendritic cells (DC) with these bacteria and two other reference strains, Escherichia coli F1111 9-41 and Bacillus sub- tilis DSM618, and prepared microarray analysis after 3, 6 and 12 hrs of stimulation. The results showed that a total number of 3623 probe sets in L. lactis-, 4254 sets in A. lwoffii- and 4625 sets in E. coli-treated DCs were regulated at least three-fold but only 1939 probe sets in B. subtilis-treated DCs. Scatter- Moreover, histone H3K4 trimethylation (H3K4me3) was profoundly increased in the vicinity of the tran- plot analysis revealed that the induced expression scriptional start site of DEFB1 and showed a strong comparable, with already a high number of regu- positive correlation with DEFB1 gene expression lated genes after 3 hrs. In contrast, nearly no genes 126 pattern of E. coli and A. lwoffii stimulated DCs is Wissenschaftlicher Jahresbericht 2007-2008 Division of Innate Immunity Research Reports were regulated in L. lactis-treated DCs after 3 or 6 ther characterized and identified using blocking hrs and only a moderate number after stimulation experiments. with B. subtilis. However, after 12 hrs of stimulation, L. lactis-treated DCs showed an expression pattern similar to that induced by A. lwoffii and E. coli whereas DCs treated with B. subtilis differed clearly. Furthermore, cluster analysis confirmed a close relation between A. lwoffii-, E. coli- and L. lactis-treated DCs after 12 hrs whereas B. subtilis-treated DCs formed a separate cluster. Overall, the analysis of gene expression induced by cowshed bacteria patterns leads to a better understanding of the molecular mechanism preventing allergic immune responses. Collaboration: Hanuszkiewicz A, Holst O, Dept. of Immunochemistry and Biochemical Microbiology, Research Center Borstel. Supported in part by: DFG, SFB/Transregio 22, project A2. The allergy-protective properties of Acinetobac- ter lwoffii F78 are imparted by its lipopolysaccharide Debarry J, Stein K, Heine H. An increasing number of epidemiological studies Fig. 51. TLR4/lipid A antagonist compound 406 blocks the TH1polarizing effects of A. lwoffii F78. Human moDCs were stimulated with indicated stimuli in presence or absence of C406. (A) After 16 hours of stimulation the concentration of IL-12 was measured in the supernatant. (B) After 16 hours of stimulation these DCs were co-cultured with autologous naïve T cells and were restimulated after 5 days. The induced IFN-γ release was measured in the supernatant after additional 20 hours. Presented data (mean values ± SD) are representative for at least 3 independent experiments with moDCs from different healthy donors. show that exposure to farming environment during ment of allergic reactions later in life (“hygiene hy- We could show that A. lwoffii F78 induced a TH1polarizing program in human dendritic cells which pothesis”). Also, it had been shown that certain led to TH1-differentiation. In addition, a positive in- bacteria from this environment may have allergy- fluence on the TBet/GATA3 level could be detect- protective properties. In the present study we fur- ed. Preincubation with the TLR4 antagonist com- ther characterized one of these bacteria, namely pound 406 inhibited activation by A. lwoffii F78 Acinetobacter lwoffii F78, with regard to the bac- (Fig. 51) and the isolated LPS of A. lwoffii F78 pro- early childhood strongly influences the develop- teria-induced signaling and possible mechanisms moted induction of IL-12 and IFN-γ as well as the of allergy protection. The impact of A. lwoffii F78 whole bacteria (Fig. 52). In summary, we found ev- on human monocyte-derived dendritic cells espe- idence that the allergy-protecting effects of cially with respect to their THelper cell polarization A. lwoffii F78 are due to the activation of a TH1-po- capacity was investigated by ELISA and Real-time larizing program in human dendritic cells and that PCR experiments as well as confocal microscopy. the LPS of A. lwoffii F78 is responsible for these The molecule responsible for these effects was fur- beneficial effects. Wissenschaftlicher Jahresbericht 2007-2008 127 Division of Innate Immunity Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l ing environment during early childhood concomitant with increased exposure to microbial substances can lead to a decreased risc of developing allergies in later life. Recently, we showed that the Gram+ cowshed isolate Lactococcus lactis G121 prevents allergic immune responses in a mouse allergy model. However, receptors and signalling pathways involved in immune cell activation by this bacterium are mainly unknown. L. lactis-stimulated human monocyte-derived dendritic cells (DCs) showed an induction of IL-12p70, the main TH1-polarizing cytokine, which is known to inhibit the allergy-associated TH2-driven immune response. Stimulation of mouse bone marrow-derived Toll-like receptor (TLR) 2 deficient cells revealed no major role for this receptor in L. lactis-mediated activation. However, when we preincubated human DCs with inhibitors of phagocytosis (Cytochalasin D) or endosomal acidification (Bafilomycin A1, Fig. 53), L. lactis–induced secretion of IL-12 was almost completely blocked. Fig. 52. A. lwoffii F78-LPS is responsible for the TH1 polarization. Human moDCs were stimulated with indicated stimuli. (A) After 16 hours of stimulation the concentration of IL-12 was measured in the supernatant. (B) After 16 hours of stimulation these DCs were co cultured with autologous naïve T cells in a ratio of 1:10 (DC:T cell) and were restimulated with PMA and Ionomycin after 5 days. The IFN-γ release was measured in the supernatant after additional 20 hours. Data are representative for at least 3 independent experiments with moDCs from different healthy donors. Collaboration: Hanuszkiewicz A, Holst O, Dept. of Immunochemistry and Biochemical Microbiology, Research Center Borstel. Supported in part by: DFG, SFB/Transregio 22, project A2. Fig. 53. Influence of the inhibitor for phagosomal maturation Bafilomycin A1 on IL-12 cytokine secretion after stimulation with L. lactis. Human monocyte-derived dendritic cells were preincubated with Bafilomycin A1 for 30 min followed by treatment with the indicated stimuli. After 20 hrs of stimulation IL-12p70 release in the supernatant was measured by ELISA. Lipopolysaccharide (LPS) treatment and stimulation with the acidification-dependent TLR7 ligand CL097 were used as controls. This strongly indicates the importance of uptake and endosomal maturation for activation by L. lacIntracellular recognition of the cowshed bacteria tis, and, thus, the involvement of intracellular re- L. lactis G121 is required to induce an allergy pre- ceptors. However, stimulation of mouse bone mar- ventive immune response row-derived dendritic cells from TLR-KO animals with L. lactis showed no implication of the intracel- Stein K, Debarry J, Heine H. lullar TLRs 3, 7 or 9. Despite the fact that MyD88-KO, An increasing number of studies indicate that farm- 128 in contrast to Trif-KO, macrophages could not be ac- Wissenschaftlicher Jahresbericht 2007-2008 Division of Innate Immunity Research Reports tivated after stimulation with L.lactis G121. Interest- Diploma ingly, immortalized mouse bone marrow-derived Stein, Karina macrophages deficient for the intracellular receptor Einfluss von Mustererkennungsrezeptoren auf die NOD2 showed a strong decrease of cytokine in- Regulation der Immunantwort dendritischer Zellen duction upon L. lactis-treatment (Fig. 54), despite the nach Stimulation mit Kuhstallbakterien. fact that MDP, the minimal ligand for NOD2, does Mathematisch-Naturwissenschaftliche Fakultät not activate the cells by itself. Overall, identifying Christian-Albrechts-Universität zu Kiel, 2008. the molecular mechanism of the activation of immune cells by L. lactis G121 will lead to a better understanding of the molecular mechanism preventing allergic immune responses. Fig. 54. Cytokine release of Wildtype and NOD2 deficient cells after L. lactis treatment. Wildtype (WT) immortalized mouse bone marrow-derived macrophages or cells deficient for NOD2 were stimulated with L. lactis and Lipopolysaccharide (LPS) as control. After 20 hrs TNF-α release in the supernatant was measured by ELISA. Collaboration: Hanuszkiewicz A, Holst O, Dept. of Immunochemistry and Biochemical Microbiology, Research Center Borstel. Supported in part by: DFG, SFB/Transregio 22, project A2. Theses Dissertation Debarry, Jennifer Mögliche Mechanismen der Allergieprävention: dendritische Zellen als Regulatoren der durch Stallbakterien ausgelösten allergieprotektiven Immunantwort. Mathematisch-Naturwissenschaftliche Fakultät Christian-Albrechts-Universität zu Kiel, 2007. Wissenschaftlicher Jahresbericht 2007-2008 129 Abteilung Klinische Medizin Department of Clinical Medicine Fo r s c h u n g s z e n t r u m Bo r s t e l 130 Wissenschaftlicher Jahresbericht 2007-2008 Abteilung Klinische Medizin Department of Clinical Medicine Abteilung Klinische Medizin Department of Clinical Medicine Wissenschaftlicher Jahresbericht 2007-2008 131 Zusammenfassung Summary Fo r s c h u n g s z e n t r u m Bo r s t e l Abteilung Klinische Medizin Department of Clinical Medicine Leiter/Head Leiter/Head Prof. Dr. Peter Zabel Prof. Dr. Peter Zabel Sekretariat/Secretary Sekretariat/Secretary Sylvia Kempf Sylvia Kempf Insgesamt ist es der Abteilung Klinische Medizin During the last two years, the Department of Clini- auch in den vergangenen 2 Jahren gelungen, cal Medicine succeeded in further reinforcing the durch Optimierung der Patientenversorgung, Im- clinical and translational pulmonary research at the plementierung des neuen Bereiches „Experimen- Research Center Borstel through the optimisation of tellen Pneumologie“, Einwerbung zusätzlicher the patient care, the implementation of the new sec- Drittmittel, Entwicklung innovativer Methoden für tion “Experimental Pneumology”, the development Forschung und Diagnostik sowie Generierung neu- of innovative methods for research and diagnostics er Kooperationen und Verbundprojekte die Klini- as well as the creation of new cooperations and col- sche und Translationale Lungenforschung am FZB laborative projects. Most of the research projects weiter zu stärken. Dabei sind die meisten For- dedicated to the Borstel mission are correspond- schungsprojekte unserer Borsteler Mission ent- ingly structured interdisciplinarily and comprehen- sprechend interdisziplinär und abteilungsüber- sively with respect to the different departments and greifend angelegt und haben so eine einzigarti- thus resulted in a unique connection between basic ge Verbindung von Grundlagenwissenschaft und science and the clinic which is further to be culti- Klinik erreicht, die es weiter zu pflegen und aus- vated and extended. zubauen gilt. This Borstel expertise became especially apparent 49th Annual Congress for Pneumology and Ventilation Medicine 2. Deutscher Allergie-Kongress In zwei von der Abteilung organisierten großen through two big congresses organised by the de- Kongressen konnte diese Borsteler Expertise be- partment: Wolf-Meinhard Becker was the president sonders sichtbar gemacht werden: Wolf-Meinhard Becker war Kongresspräsident des „2. Gemeinsa- of the “Second Joint German Allergy Congress” in Lübeck from 26th to 29th September 2007. This suc- men Deutschen Allergie-Kongress“ vom 26. - 29. cessful congress met with an extremely positive re- September 2007 in Lübeck. Bei den über 1000 Kongressteilnehmern stieß dieser erfolgreiche Kon- sponse of the more than 1000 participants. For the first time Lübeck then hosted the 49th Annual Con- gress auf eine äußerst positive Resonanz. Vom 9. gress of the “German Society for Pneumology and bis 12. April 2008 war dann der 49. Jahreskongress der „Deutschen Gesellschaft für Pneumologie und Ventilation Medicine” presided by Peter Zabel from 9th to 12th April 2008. With nearly 3000 participants Beatmungsmedizin“ mit Peter Zabel als Kongres- the congress was not only the biggest one this city spräsident zum ersten Mal in Lübeck zu Gast. Mit had ever experienced but also one of the most vis- nahezu 3000 Teilnehmern war der Kongress in Lü- ited of the Society. It reflected the whole range of beck nicht nur der größte, den diese Stadt je er- pneumology with 13 plenary sessions, 56 symposia, lebt hat, sondern auch einer der meistbesuchten 3 hot topic sessions, 8 workshops, 28 industrial sym- unserer Gesellschaft. Mit 13 Plenarsitzungen, 56 posia, 19 post-graduate courses and more than 400 132 Wissenschaftlicher Jahresbericht 2007-2008 Zusammenfassung Kapitel Symposien, 3 Hot Topic Sitzungen, 8 Workshops, scientific abstracts. The leader of the Federal state 28 Industriesymposien, 19 PG-Kursen und über 400 of Schleswig-Holstein, Peter Harry Carstensen, wissenschaftlichen Abstracts spiegelte der Kon- opened the congress by expressing his respect for gress die ganze Breite der Pneumologie wider. the outstanding performances of the Research Cen- Der Ministerpräsident von Schleswig-Holstein, Pe- ter Borstel in the field of pulmonary research. At the ter Harry Carstensen, eröffnete den Kongress und beginning of the congress, a top-class international bekundete dabei seinen Respekt für die hervor- ERS (European Respiratory Society) symposium with ragenden Leistungen des Forschungszentrums the subject “State of the Art in Tuberculosis” carried Borstel auf dem Gebiet der Lungenforschung. Ein out in our manor house directly integrated Borstel hochkarätiges internationales ERS-Symposium into the congress events and was one of its high- zum Thema „State of the Art in Tuberculosis“ am lights. Beginn des Kongresses im unserem Herrenhaus bezog auch Borstel direkt in das Kongressgeschehen ein und war einer der Höhepunkte des Over the last two years, the Medical Clinic of Bors- Kongresses. tel has been able to further consolidate its position as a highly competent hospital specialized in pulmonary, infectious and allergic diseases and in ad- Die Medizinische Klinik Borstel hat auch in den ver- dition to optimise the patient care. This develop- gangenen zwei Jahren ihre Position als hochkom- ment is especially due to the cooperation practised petente pneumologische, infektiologische und al- on all levels with the Medical Clinic III of the Uni- lergologische Fachklinik ausbauen können und versity Clinic of Schleswig-Holstein (UK S-H), Campus die Patientenversorgung weiter optimiert. Dazu Lübeck, which is also directed by Peter Zabel and trägt besonders auch die in allen Ebenen geleb- has resulted in a complementary university con- te Kooperation mit der Medizinischen Klinik III des nection of the patient care in Borstel. UK S-H, Campus Lübeck bei, die ebenfalls von Pe- Besides the permanent exchange of assistants con- ter Zabel in Personalunion geleitet wird, und zu ei- tinuing their education between these two clinics, ner komplementären universitären Anbindung der this cooperation is also used for common scientific Krankenversorgung in Borstel geführt hat. projects, clinical studies and joint projects with oth- Neben dem ständigen Ärzte-Team Austausch von Assistenten in Weiterbildung Medical Team zwischen diesen beiden Kliniken wird diese Kooperation auch für gemeinsame wissen- schaftliche Projekte, klinische Studien und Verbundprojekte mit anderen Kliniken und Instituten der Universität Lübeck genutzt. Die gemeinsame Zertifizierung als einziges „Zentrum für Klinische Wissenschaftlicher Jahresbericht 2007-2008 133 Zusammenfassung Summary Infektiologie“ in Schleswig-Holstein von der Deut- er clinics and institutes of the University of Lübeck. schen Gesellschaft für Infektiolologie und die ge- The common certification as the only “Center for meinsame ambulante Versorgung allergologi- Clinical Infectiology” in Schleswig-Holstein by the scher Patienten durch den Ausbau der interdiszi- German Society of Infectiology and the joint ambu- plinären Allergiesprechstunde in Kooperation mit lant treatment of allergy patients by the extension der Hautklinik, der HNO-Klinik, der Pädiatrie und of the interdisciplinary allergy consulting hour in co- der Med. Klinik III am Campus Lübeck belegen die- operation with the Clinics of Dermatology, ENT, Pae- se Synergien eindrucksvoll. Im Jahr 2007 konnte an diatrics, and the Medical Clinic III at the Campus der Medizinischen Klinik Borstel nach langen Ver- Lübeck give impressive evidence of these synergies. handlungen endlich ein Medizinisches Versor- In the year 2007, a Medical Treatment Center (MVZ) Fo r s c h u n g s z e n t r u m Bo r s t e l Gründung des MVZ gungszentrum (MVZ) gegründet werden, das die could finally be founded at Borstel after long ne- Praxen für Pathologie (E. Vollmer) und Lungen- und gotiations, which organisationally unites the Prac- Bronchialheilkunde (U. Greinert) organisatorisch tices for Pathology (E. Vollmer) and Bronchopul- zusammenführt und eine Sicherung der ambulan- monary Medicine (U. Greinert) and serves as a ten Krankenversorgung in Borstel bedeutet. Diese guarantee for the ambulant patient treatment in neue Versorgungsstruktur kann zusammen mit dem Borstel. This new structure for patient care is able to seit 2005 bestehenden Klinischen Studienzentrum ensure the execution of the multiple clinical studies (Leiter: C. Lange) an der Medizinischen Klinik Bor- at the Medical Clinic in Borstel together with the stel die Durchführung der vielfältigen klinischen Clinical Study Center (head: C. Lange) existing since Studien gewährleisten. In den vergangenen zwei 2005. Within the past two years, the economic situ- Jahren ist die ökonomische Situation der Klinik ation of the clinic remained pleasantly stable de- trotz abschmelzender Budgets und weiterer großer spite further decreasing budgets and other severe Belastungen durch die Wandlungen im Gesund- financial burdens due to the modifications in the heitssystem bei gleichzeitig notwendiger Qua- health system besides mandatory quality improve- litätssteigerung und fortschreitender Leistungsver- ment and a further rise in efficiency. This is only pos- dichtung erfreulich stabil. Dies gelingt nur dank sible owing to the particular commitment and the des besonderen Einsatzes und der hohen Motiva- high motivation of the members of the clinical staff tion der Mitarbeiter der Klinik, denen an dieser who have especially to be thanked here. Stelle ganz besonders gedankt werden muss. The restructuring of the Department of Clinical Med- Appointment: Heinz Fehrenbach, Experimental Pneumology (W3), University of Lübeck Die Neustrukturierung der Abteilung Klinische Me- icine with the further reinforcement of translational dizin mit der weiteren Stärkung der translationa- pulmonary research was decisively pushed by the len Lungenforschung wurde im Jahre 2008 durch appointment of Heinz Fehrenbach for the W3 pro- die Berufung von Heinz Fehrenbach auf die im fessorship for Experimental Pneumology within the Rahmen des Exzellenz-Clusters „Inflammation at framework of the Excellence Cluster “Inflammation Interfaces“ neu geschaffene W3-Professur für Ex- at Interfaces” in the year 2008. Heinz Fehrenbach perimentelle Pneumologie entscheidend voran- had up to then headed a group of researchers in getrieben. Heinz Fehrenbach war bis dahin Leiter Marburg supported by the BMBF and brings a num- einer BMBF-geförderten Forschergruppe in Mar- ber of complex animal models for the research of burg und bringt eine Reihe komplexer Tiermodel- inflammation and regeneration processes in the le zur Erforschung der Entzündungs- und Regene- lung to Borstel. Since August 2008, the former labo- rationsvorgänge in der Lunge mit nach Borstel. Zu ratory group of “Clinical Immunopharmacology”, seinem Bereich gehört ab August 2008 auch die which was headed by P. Zabel, also belongs to his 134 Wissenschaftlicher Jahresbericht 2007-2008 Zusammenfassung Summary ehemalige von P. Zabel geleitete Laborgruppe section and is now dedicating itself to “Functional „Klinische Immunpharmakologie“, die sich jetzt Inflammation Research”, headed by Hans-Peter unter der Leitung von Hans-Peter Hauber der Hauber. Above that, the field of “Experimental Pneu- „Funktionellen Entzündungsforschung“ widmet. mology” recently comprises the research groups of Der Bereich „Experimentelle Pneumologie“ um- “Cellular Pneumology” (head: C. Stamme) and fasst darüber hinaus neu die Forschergruppen “Barrier Integrity” (head: I. Lautenschläger) so that „Zelluläre Pneumologie“ (Leiterin: C. Stamme) the tandem formation striven for of experimental und „Barriereintegrität“ (Leiter: I. Lautenschläger), and clinical pneumology has now been translated so dass jetzt die angestrebte Tandembildung aus into action. Experimenteller und Klinischer Pneumologie umgesetzt ist. During the years 2007/08, a multitude of national and international studies/cooperations were exIm NRZ (Leiterin: S. Rüsch-Gerdes) wurden in den tended in the National Reference Center (NRZ; Jahren 2007/08 eine Vielzahl nationaler und inter- head: S. Rüsch-Gerdes) in order to meet the dra- nationaler Studien/Kooperationen erweitert, um matically changed world-wide resistance develop- der dramatisch veränderten weltweiten Resisten- ment of M. tuberculosis (cooperation or study part- zentwicklung von M. tuberculosis Rechnung zu tra- ners: Robert Koch Institute (RKI), health authorities, gen (Kooperations- bzw. Studienpartner: Robert WHO, Médecins Sans Frontières (MSF), Internation- Koch Institut (RKI), Gesundheitsämter, WHO, Mé- al Committee of the Red Cross (ICRC), and The decins Sans Frontières (MSF), International Com- Foundation for Innovative New Diagnostics (FIND)). mittee of Red Cross (ICRC) und The Foundation for In addition, the cooperation with the “Global Fund” Innovative New Diagnostics (FIND)). Darüber hin- to build up laboratories and to establish networks aus wurde die Zusammenarbeit mit „Global in selected countries with high resistance rates has Fund“ zum Aufbau von Laboratorien und Etablie- been intensified. The presence and the spreading rung von Netzwerken in ausgewählten Ländern of extremely resistant tuberculosis strains (XDR-TB) mit hohen Resistenzraten intensiviert. Das Vor- put the research of the resistance origin of reserve kommen und die Verbreitung von extrem resisten- antibiotics such as Linezolid into the focus. The char- ten Tuberkulosestämmen (XDR-TB) hat die Erfor- acterization of the first Linezolid-resistant strains oc- schung der Resistenzentstehung von Reserveanti- curred phenotypically and molecular-biologically at biotika wie Linezolid in den Fokus gerückt. Die the NRZ. In order to reveal possible resistance Charakterisierung der ersten Linezolid-resistenten mechanisms, Linezolid-resistant strains were gener- Stämme erfolgte phänotypisch und molekularbio- ated and typed in vitro for the first time. Evaluations logisch im NRZ. Um mögliche Resistenzmechanis- of new diagnostic procedures also represent an im- Linezolid-resistant strains were generated and typed in vitro for the first time men aufzudecken, wurden erstmals in vitro Line- portant principal topic at the NRZ. On the one hand, XDR-TB Stämme zolid-resistente Stämme erzeugt und typisiert. Eva- a new hybridisation strip test, the MTBDRplus, for luierungen neuer diagnostischer Verfahren stellen the molecular biological determination of resist- ebenfalls einen wichtigen Schwerpunkt im NRZ ance against Rifampicin and Isoniazid of the M. tu- dar. Zum einen wurde ein neuer Hybridisierungs- berculosis complex was evaluated. On the other streifentest, der MTBDRplus, zur molekularbiolo- hand, a new procedure for the direct determination gischen Resistenzbestimmung gegenüber Rifam- of M. tuberculosis in the sputum and the simultane- picin und Isoniazid von M. tuberculosis-Komplex ous testing for Rifampicin resistance was tested in evaluiert. Zum anderen wurde in einer internatio- an international multi-center study (coordinated by nalen Multi-Center-Studie (koordiniert durch FIND) FIND) for the first time. In this course the new real- Wissenschaftlicher Jahresbericht 2007-2008 135 Zusammenfassung Summary ein neues Verfahren zum direkten Nachweis von time PCR-based procedure is tested in comparison M. tuberculosis im Sputum und der simultanen Te- with conventional and alternative molecular bio- stung auf Rifampicin-Resistenz erstmalig erprobt. logical techniques. Fo r s c h u n g s z e n t r u m Bo r s t e l Dabei wird das neue, auf real time-PCR basierende Verfahren gegen konventionelle und alternative molekularbiologische Techniken getestet. During the last two years, the division of “Molecular Mycobacteriology” (head: S. Niemann) was able to successfully implement its research concept with TB-Genomforschung mit modernen ultraschnellen Hochdurchsatz Systemen world-wide first online database for the automated identification of clinical isolates Die Molekulare Mykobakteriologie (Leiter: S. Nie- the focus on “Tuberculosis Epidemiology”, “Spread- mann) konnte in den letzten zwei Jahren ihr For- ing and Origin of Resistances”, and “Population schungskonzept mit den Schwerpunkten „Tuberku- Structure and Virulence of Clinical M. tuberculosis lose Epidemiologie“, „Verbreitung und Entstehung Complex Isolates“. Three new extramurally funded von Resistenzen“, und „Populationsstruktur und Vi- projects were granted (BMBF and EU FP7) in this ex- rulenz von klinischen M. tuberculosis Komplex Iso- tremely competitive field which allow international- laten“ erfolgreich umsetzen. So wurden in diesem ly embedded long-term research. A BMBF grant äußerst kompetitiven Feld drei neue Drittmittel- with a main emphasis on genome research with projekte eingeworben (BMBF und EU FP7), die modern ultra-fast high-throughput systems is espe- langfristige Forschungsarbeiten mit internationaler cially worth mentioning. Within the framework of this Einbettung ermöglichen. Besonders erwähnens- project the genomes of more than 10 clinical iso- wert ist hierbei eine Schwerpunktförderung des lates will be decoded in order to analyse the high- BMBF für die Genomforschung mit modernen Ul- ly interesting question of micro-evolution of clinical traschnellen Hochdurchsatz Systemen. Im Rahmen isolates for example in infection chains or in the dieses Projekts werden die Genome von mehr als case of a resistance development. The basic results 10 klinischen Isolaten entschlüsselt, um die hoch- concerning the global population structure of tu- interessante Fragestellung der Mikroevolution von berculosis pathogens were used for the establish- klinischen Isolaten z.B. in Infektketten oder bei Re- ment of the world-wide first online database for the sistenzentwicklung zu analysieren. Die grundle- automated genden Erkenntnisse zur globalen Populati- (www.MIRU-VNTRplus.org). Pioneering papers in onstruktur von Tuberkulose Erregern wurden darü- high-ranking journals on the origin of extremely re- ber hinaus zur Etablierung der weltweit ersten On- sistant tuberculoses and the therapy of MDR pa- line-Datenbank zur automatisierten Identifizierung tients represented scientific highlights. klinischer Isolate genutzt identification of clinical isolates (www.MIRU-VNTR- plus.org). Wissenschaftliche Höhepunkte waren wegweisende Arbeiten in hochrangigen Journalen The main topics of research in the division of “Clin- zur Entstehung „Extrem Resistenter Tuberkulosen“ ical Infectiology” (head: C. Lange) were the devel- unter Therapie von MDR-Patienten opment and validation of immunological methods for the quick differentiation of active and latent infections with M. tuberculosis (together with the divi- TBNET Forschungsschwerpunkte der „Klinischen Infektio- sion of “Immunocellular Analytics” at the RCB) and logie“ (Leiter: C. Lange) waren die Entwicklung the evaluation of clinical cohorts of patients with und Validierung immunologischer Methoden zur multiresistant and extensively resistant tuberculosis raschen Differenzierung aktiver und latenter In- (XDR-Tb) in Germany and Europe. The division of fektionen mit M. tuberculosis (gemeinsam mit der Clinical Infectiology is scientifically closely connect- Immunzell-Analytik am FZB) und die Evaluation ed with other European teams via the TBNET (Tu- 136 Wissenschaftlicher Jahresbericht 2007-2008 Zusammenfassung Summary stenter und extensiv-resistenter Tuberkulose (XDR- berculosis Network European Trialsgroup), an as- Tb) in Deutschland und Europa. Über das TBNET sociation with more than 160 members in 28 coun- (Tuberculosis Network European Trialsgroup), ei- tries founded in 2006. Having the overall charge in nem 2006 gegründeten Studienverbund mit mehr the TBNET and funded by the European Commis- als 160 Mitgliedern in 28 Ländern, ist die Klinische sion, the Clinical Infectiology will build up a data- Infektiologie mit anderen europäischen Arbeits- base on multiresistant tuberculosis during the next gruppen wissenschaftlich eng verbunden. Feder- years. A German-wide project on host and führend im TBNET wird die Klinische Infektiologie pathogen determinants for resistance and disease in den kommenden Jahren mit Mitteln der Eu- progression in tuberculosis, supported by the BMBF, ropäischen Kommission eine klinische Datenbank represents the division of Clinical Infectiology in zur multiresistenten Tuberkulose aufbauen. In ei- clinical and basic research. Projects on the co-in- nem Deutschland-weiten Projekt zu Wirts- und Pa- fection of M. tuberculosis and HIV, supported by the thogen-Determinanten zur Resistenz und Krank- Hector foundation in Weinheim and the DFG, and heitsprogression bei der Tuberkulose, welches on the role of antimicrobial peptides in COPD, sup- vom BMBF gefördert wird, ist die Klinische Infek- ported by the DFG, have successfully been able to tiologie in der Klinischen- und Grundlagenfor- be carried on in the current year. schung vertreten. Projekte zur Koinfektion von M. tuberculosis und HIV, die von der Hector-Stiftung in Weinheim und der DFG gefördert werden, und In the Division of “Clinical and Experimental Pathol- zur Rolle antimikrobieller Peptide bei der COPD, ogy” (head: E. Vollmer) the examinations of the ex welches von der DFG gefördert wird, konnten im vivo tissue culture model were further extended; laufenden Jahr erfolgreich fortgeführt werden. they allow functional studies in the human system. This model is unique and the result of a very fruitful continuous interdisciplinary cooperation. Mean- In der „Klinischen und Experimentellen Patholo- while procedures have been established to carry gie“ (Leiter: E. Vollmer) wurden die Untersuchun- out transcriptome analyses of tissue materials from gen am ex-vivo Gewebekulturmodell weiter aus- this model which already resulted and will further gebaut; sie erlauben funktionellen Studien im hu- result in the discovery of new molecular relation- manen System. Dieses Modell ist einzigartig und ships in the course of pulmonary diseases. The ex- Ergebnis einer sehr fruchtbaren kontinuierlichen in- pression and the regulation of the chemokine re- terdisziplinären Kooperation. Zwischenzeitlich ceptor CXCR7 in non-small-cell lung carcinomas for wurden Verfahren etabliert, um Transkriptomana- example have thus been described. In addition, the lysen an Gewebematerialien aus diesem Modell identification of a so far unknown pulmonary TGF-β durchzuführen, welche bereits zur Entdeckung neu- receptor was possible, which is up-regulated in the er molekularer Zusammenhänge im Verlauf von case of an infection and obviously connected with Lungenerkrankungen geführt haben und auch wei- pulmonary fibrosis or emphysema formation. Apart ter führen werden. Beispielsweise wurde so die Ex- from this, the establishment of proteome-wide pression und Regulation des Chemokinrezeptors analysis procedure took place which contributes to CXCR7 in nichtkleinzelligen Lungenkarzinomen be- the elucidation of disease-relevant pathomech- schrieben. Es gelang weiter die Identifizierung ei- anisms in human lung tissues as additional complex nes bislang in der Lunge unbekannten TGF-ß-Re- read-out possibilities. zeptors, welcher bei Infektion herauf reguliert wird und augenscheinlich in Zusammenhang mit pulmonaler Fibrosierung bzw. Emphysembildung In cooperation with groups from the Netherlands, Wissenschaftlicher Jahresbericht 2007-2008 137 ex-vivo Gewebekulturmodell: Transkriptomanalysen Zusammenfassung Summary steht. Darüber hinaus ist die Etablierung proteom- the USA, and England, the division of “Cellular Al- weiter Analyseverfahren erfolgt, welche als zu- lergology” (head: H. Haas) succeeded for the first sätzliche komplexe „Read Out“-Möglichkeit zur time in demonstrating that the glycoprotein Omega- Aufklärung krankheitsrelevanter Pathomechanis- 1, which is secreted by Schistosoma eggs, triggers men in humanen Lungengeweben beitragen. a T-helper type 2 response in vitro and in an animal Fo r s c h u n g s z e n t r u m Bo r s t e l model. This effect, which may be achieved both with natural and recombinant Omega-1, could also be The 3-D structure of IPSE/alpha-1 was elucidated by means of NMR and X-ray crystal structural analysis. Die Gruppe „Zelluläre Allergologie“ (Leiter: H. detected in IL-4 receptor knock-out animals and thus Haas) konnte in Zusammenarbeit mit Gruppen is not linked to the function of the IL-4 receptor. The aus den Niederlanden, USA und England erstmals ability for the induction of the Th2-response makes zeigen, dass das von Schistosomen-Eiern sezer- Omega-1 an interesting candidate molecule for nierte Glykoprotein Omega-1 in vitro und im Tier- therapeutic application in diseases accompanying modell eine T-Helfer Typ 2-Antwort auslöst. Dieser a pathological Th1-phenotype. This is why a patent Effekt, der sowohl mit natürlichem als auch re- has been applied for for Omega-1. The European kombinantem Omega-1 zu erzielen ist, war auch patent was granted for IPSE/alpha-1, an im- in IL-4-Rezeptor-knockout-Tieren nachweisbar und munomodulatory molecule, which is also secreted ist somit nicht an die Funktion des IL-4-Rezeptors by Schistosoma eggs. The granting in Japan and gekoppelt. Die Fähigkeit zur Induktion der Th2-Ant- the USA is to come shortly. The 3-D structure of wort macht Omega-1 zu einem interessanten Kan- IPSE/alpha-1 was elucidated by means of NMR and didatenmolekül für die therapeutische Anwen- X-ray crystal structural analysis. dung bei Erkrankungen, die mit einem pathologischen Th1-Phänotyp einhergehen. Für Omega-1 wurde daher ein Patentantrag eingereicht. Für IP- The application for the project “In vitro culture of SE/alpha-1, ein ebenfalls aus Schistosomen-Eiern Schistosoma mansoni – culture dish instead of mam- sezerniertes immunmodulatorisches Molekül, wur- mal final host“ was positively approved by the de das Europäische Patent erteilt, die Zuteilung in BMBF. It is the aim of the project to optimise the in Japan und den USA steht kurz bevor. Die 3-D-Struk- vitro culture of Schistosoma in such a way that the tur von IPSE/alpha-1 wurde mittels NMR und Rönt- larvae of the parasite completely develop in vitro genkristallstruktur-Analyse aufgeklärt. until the adult stage inclusive of the laying of ripe infectious eggs. The in vitro culture is a highly effective instrument for parasitological and immuno- In vitro-Kultur von Schistosoma mansoni Vom BMBF wurde der Antrag „In vitro-Kultur von logical questions allowing to test the effect of po- Schistosoma mansoni – Kulturschale statt Säuge- tential new pharmaceuticals against Schistosoma tierendwirt“ positiv begutachtet. Ziel des Vorha- using a high-throughput method and thus to note bens ist es, die in vitro-Kultur von Schistosomen so morphological modifications of the parasite after zu optimieren, dass sich die Larven des Parasiten drug addition in real-time. This project will lastingly in vitro komplett bis zum Erwachsenenstadium in- reduce the number of animal experiments for the re- klusive Ablage reifer, infektiöser Eier entwickeln. search of Schistosoma. Die in vitro-Kultur ist ein hoch-effektives Instrument für parasitologische und immunologische Fragestellungen, das es u.a. ermöglicht, den Effekt The award of the internationally announced Kanert potentieller neuer Pharmaka gegen Schistosomen prize to the research project “Detection of lipid im high-throughput-Verfahren zu testen, und dabei adducts at the panallergens of the peanut (Arachis morphologische Veränderungen des Parasiten hypogaea) Ara h 8, Ltp, and Oleosin and investi- 138 Wissenschaftlicher Jahresbericht 2007-2008 Zusammenfassung Summary nach Wirkstoffzugabe in Echtzeit zu registrieren. gation of their contribution to allergenicity” was an Dieses Vorhaben wird die Anzahl der Tierversuche important milestone for the laboratory group of zur Erforschung von Schistosomen nachhaltig re- “Molecular and Clinical Allergology” (head: W.-M. duzieren. Becker). The prize was handed over to W.-M. Becker and A. Petersen in Davos in September 2008. The topic of the prize marked the beginning of the new Ein wichtiger Meilenstein für die Laborgruppe research field of comparative examinations on the „Molekulare und Klinische Allergologie“ (Leiter: interaction and processing of allergens (aeroaller- W.-M. Becker) war die Zuerkennung des interna- gens and nutrient allergens) in the respiratory and tional ausgeschriebenen Karnert-Förderpreises gastro-intestinal tract (lung and colon) (cooperation mit dem Forschungsprojekt: Nachweis von Lipi- with I. Lautenschläger and S. Bade). The common daddukten an die Panallergene der Erdnuss (Ara- participation of the teams of “Molecular and Clini- chis hypogaea) Ara h 8, LTP und Oleosin und Untersuchung ihres Beitrags zur Allergenität. Der cal Allergology” and “Mucosa Immunology” on the 3rd Joint German Allergy Congress 2008 in Erfurt, at Preis wurde im September 2008 W.-M. Becker und which three of nine poster/seminar prizes were A. Petersen) in Davos überreicht. Die Thematik awarded to the colleagues of the Research Center des Preises markierte den Beginn des neuen For- Borstel, represented another highlight of the year schungsfeldes der vergleichenden Untersuchun- 2008. In cooperation with T. Goldmann (Clinical and gen zur Interaktion und Prozessierung von Aller- Experimental Pathology) the uptake of aeroaller- genen (Aeroallergenen und Nahrungsallergenen) gens (grass allergens) could also be detected on im Respirations- und Gastrointestinaltrakt (Lunge pulmonary biopsy material for the first time in 2008. und Darm, Kooperation mit I. Lautenschläger und By means of microarray analysis, a gene expression S. Bade). Ein weiterer Höhepunkt des Jahres 2008 cluster could subsequently be determined through war die gemeinsame Teilnahme der Arbeitsgrup- activation with the grass pollen major allergen Phl pen „Molekulare und Klinische Allergologie“ und p 1. The characterization of the relevant signal trans- „Mukosaimmunologie“ am 3. Gemeinsamen Deut- duction is the subject of current investigations. Kanert Forschungspreis schen Allergie-Kongress 2008 in Erfurt, auf dem den Mitarbeitern des Forschungszentrums Borstel drei von neun Poster-/ Vortragspreisen zuerkannt Within the period 2007/2008 covered by this report, wurden. In Zusammenarbeit mit T. Goldmann (Kli- a number of extramural grant applications were ap- nische und Experimentelle Pathologie) konnte in proved for the laboratory group of “Mucosa Im- 2008 die Aufnahme von Aeroallergenen (Grä- munology” (head: A. Frey): (i) a DFG application be- serallergenen) erstmals auch an Lungenbiopsie- longing to the program 1313 with the main empha- material nachgewiesen werden. Mittels Mikroar- sis on “Biological Responses to Nanoscale Parti- ray konnte anschließend das Genexpressionsmu- cles“ within the cooperation “PARENTRY – How ster durch die Aktivierung mit dem Gräserpollen- particles enter the body: investigating particle-bar- Majorallergen Phl p 1 bestimmt werden. Die rier interactions at the intestinal mucosa” with the Charakterisierung der relevanten Signaltransduk- University of Lübeck and the University of Hamburg, tion ist Gegenstand laufender Untersuchungen. (ii) the application made for the Division of Clinical Medicine within the framework of the pact for research and innovation “Recognition and classifica- Im Berichtszeitraum 2007/2008 wurden für die La- tion of antigens at mucosal border areas”, and (iii) borgruppe „Mukosaimmunologie“ (Leiter A. Frey) an application within the program “Imaging in dis- eine Reihe von Drittmittelanträgen bewilligt: (i) ease processes” being part of the research focus Wissenschaftlicher Jahresbericht 2007-2008 139 Patent: Division of Mucosa Immunology Zusammenfassung Summary ein DFG-Antrag im Schwerpunktprogramm 1313 “Biomedical techniques” at the University of Lübeck. „Biological Responses to Nanoscale Particles“ im The first patent applied for by the laboratory group Verbund „PARENTRY - How particles enter the bo- of “Mucosa Immunology” in 2005 was granted (“Kit dy: investigating particle-barrier interactions at for highly sensitive detection assays“ (DE 10 2005 the intestinal mucosa“ mit der Universität zu Lü- 051976)). The patent relates to the system based on beck und der Universität Hamburg, (ii) für die Ab- 2,4-dichlorophenoxy acetic acid which may be used teilung Klinische Medizin im Rahmen des Paktes for example for the labelling and highly sensitive für Forschung und Innovation gestellte Antrag „Er- detection of proteins, peptides or nucleic acids. An kennung und Klassifizierung von Antigenen an mu- efficient national protection for the technology de- kosalen Grenzflächen“ und (iii) ein Antrag im veloped at the Research Center could thus be Schwerpunktprogramm „Bildgebung bei Krank- achieved until 2025. The laboratory group of “Mu- heitsprozessen“ im Forschungsschwerpunkt „Bio- cosa Immunology” was able to establish and to medizintechnik“ der Universität zu Lübeck. Das er- strengthen numerous industrial cooperations (for ste, von der Laborgruppe Mukosaimmunologie in example with Boehringer Ingelheim Pharma Ltd. & 2005 angemeldete Patent („Kit for highly sensitive Co. KG, Karl Storz Ltd. & Co. KG, Atto-Tec Ltd., R-Bio- detection assays“ (DE 10 2005 051976)) wurde er- Pharm AG, the Society for Silica Microsystems Ltd., teilt. Das Patent betrifft das auf 2,4-Dichlorphe- Laser and Medicine Technology Ltd. Berlin). Fur- noxyessigsäure basierende System, welches bei- thermore, the preparations for first translational spielsweise zur Markierung und zum hochsensiti- projects on the subjects of “allergy origin” and ven Nachweis von Proteinen, Peptiden oder Nu- “chronic inflammatory respiratory diseases” could kleinsäuren eingesetzt werden kann. Damit be concluded. Fo r s c h u n g s z e n t r u m Bo r s t e l konnte wirksamer nationaler Schutz für die am Forschungszentrum entwickelte Technologie bis 2025 Rat model: isolated perfused small intestine erlangt werden. Die Laborgruppe Mukosaimmun- The research group of “Barrier Integrity” (head: I. ologie konnte zahlreiche Industriekooperationen Lautenschläger) succeeded in completely establish- etablieren und festigen (z.B. mit Boehringer In- ing the isolated perfused small intestine of the rat, a gelheim Pharma GmbH & Co. KG, Karl Storz new method for the examination of barrier functions GmbH & Co. KG, Atto-Tec GmbH, R-BioPharm AG, of this important surface organ. The intestine model Gesellschaft für Silizium-Mikrosysteme mbH, Laser- allows to analyse the barrier, transport, and immuno- und Medizin-Technologie GmbH Berlin). Des Wei- functions in the isolated organ in detail via the on-line teren wurden die Vorbereitungen für erste trans- access on the decisive compartments (vascular bed, lationale Projekte zu den Themen „Allergieent- lumen, lymph, and intestinal tissue). Most recent se- stehung“ und „chronisch-entzündliche Atemwegs- ries of experiments show that the intestine in this erkrankungen“ abgeschlossen. model now remains stable for at least 4 hours. The previously available period of time for the observation of different physiological and pathophysiologi- In der Forschergruppe „Barriereintigrität“ (Leiter: cal mechanisms thus nearly doubles and may be ex- I. Lautenschläger) gelang die vollständige Eta- tended onto the level of gene regulation and gene blierung des isoliert perfundierten Dünndarms der products (protein level). By means of this model, the Ratte, einer neuen Methode zur Untersuchung von project “Recognition and classification of antigens at Barrierefunktionen dieses wichtigen Oberflächen- mucosal border areas” (see above), which is sup- organs. Das Darmmodell ermöglicht über den On- ported by the pact for research and innovation in co- line-Zugriff auf die entscheidenden Kompartimen- operation with the Clinic of Anaesthesiology of the te (Gefäßbett, Lumen, Lymphe und Darmgewebe) UK S-H, Campus Kiel, will decisively be promoted. 140 Wissenschaftlicher Jahresbericht 2007-2008 Zusammenfassung Summary detailliert die Barriere-, Transport- und Immun- The research group of “Cellular Pneumology“ funktionen im isolierten Organ zu analysieren. (head: C. Stamme) was especially successful in ex- Neueste Versuchsreihen zeigen, dass der Darm in tramural fund-raising during the reporting period. diesem Modell nun über mindestens 4 Stunden Two DFG applications (1. “Pulmonary C-type lectin stabil bleibt. Dadurch verdoppelt sich annähernd regulation of the immune balance to bacterial das bislang realisierte Zeitfenster zur Beobach- lipopolysaccharide“, 2. “Endosomal signalling in in- tung unterschiedlicher physiologischer und pa- nate immunity“) with a total volume of 600,000 Euro thophysiologischer Mechanismen, die nun auch were approved. In addition, further support was auf die Ebene der Genregulation und der Gen- granted by the University of Lübeck within the main produkte (Proteinebene) erweitert werden kann. research focus of Biomedical Techniques, “Respira- Mit Hilfe dieses Modells wird das durch den Pakt tion and Ventilation”. Also the members of the für Forschung und Innovation geförderte Projekt group received special personal awards: C. „Erkennung und Klassifizierung von Antigenen an Moulakakis concluded her doctoral thesis on the mukosalen Grenzflächen“ (s.o.) in Kooperation mit subject of “Pulmonary Surfactant Protein A’s anti-in- der Klinik für Anästhesiologie des UK S-H, Campus flammatory modulation of the IkB-a/NF-kB signal Kiel entscheidend befördert. transduction pathway” with the overall mark 1.2 and for this was awarded the PhD prize of the district of Bad Segeberg and C. Stamme was “Invited Die Forschergruppe „Zelluläre Pneumologie“ (Lei- Chair” at the American Thoracic Society (ATS) Con- terin: C. Stamme) war im Berichtszeitraum im Be- gress in Toronto, Canada, in May 2008. reich der Drittmitteleinwerbung besonders erfolgreich. So wurden 2 DFG-Anträge (1. “Pulmonary C-type lectin regulation of immune balance to The laboratory group of “Functional Inflammation bacterial lipopolysaccharide”, 2. “Endosomal sig- Research” (head: H.-P. Hauber) puts its main em- nalling in innate immunity”) mit einem Gesamtvo- phasis on the pathomechanisms of mucus hyper- lumen von 600 TEuro bewilligt. Zusätzlich erfolgte secretion in chronic inflammatory respiratory dis- eine Weiterförderung durch die Universität zu Lü- eases (COPD, cystic fibrosis, bronchial asthma) and beck im Rahmen des Schwerpunktes Biomedizin- the possibility of therapeutic influences on them as technik ‚Atmung und Beatmung’. Auch die Mit- well as on the pathomechanisms of ventilation-in- glieder der Gruppe erhielten ganz persönliche duced lung damage. These questions are of great Anerkennungen: C. Moulakakis schloss ihre Pro- clinical relevance and reflect important problems of motion zum Thema „Pulmonary Surfactant Protein the patients treated in the Medical Clinic (Weaning κB-α α/NFA’s anti-inflammatory modulation of the Iκ Center) so that the findings revealed though inno- κB signal transduction pathway“ mit der Gesamt- vative models may be translationally verified and note 1,2 ab und erhielt dafür 2008 den Promo- further developed in the clinical situation. The mod- tionspreis des Kreises Segeberg zuerkannt und C. el of the explanted human mucosa (explant model) Stamme war „Invited Chair“ beim Amercian Thor- from the upper respiratory tract could further be de- acic Society (ATS) Congress in Toronto, Canada, veloped. After the mucosa had been stimulated im Mai 2008. with bacterial components such as LPS or PAM3 as well as cytokines (interleukin-4 and interleukin-13 among others) during the past years, it is now pos- Die Laborgruppe „Funktionelle Entzündungsfor- sible for the first time to carry out a stimulation with schung“ (Leiter: H.-P. Hauber) befasst sich schwer- living bacteria (Chlamydiae and Pseudomonas punktmäßig mit den Pathomechanismen der Mu- aeruginosa). By means of this stimulation the ex- Wissenschaftlicher Jahresbericht 2007-2008 141 Promotionspreis des Kreises Segeberg: Christina Moulakakis Zusammenfassung Summary kushypersekretion bei chronisch entzündlichen plant model may now be used for examinations of Atemwegserkrankungen (COPD, Cystische Fibro- the early interaction between pathogen and host in se, Asthma bronchiale) und ihrer therapeutischen the upper respiratory tract and complements the Beeinflussbarkeit sowie den Pathomechanismen model of infection of the lower respiratory tract in des beatmungsinduzierten Lungenschadens. Die- human lungs (D. Drömann, J. Rupp). The ventilation se Fragestellungen sind von großer klinischer Re- model of the mouse was also further developed so levanz und reflektieren wichtige Probleme der in that intratracheal provocation with bacterial com- der Medizinischen Klinik behandelten Patienten ponents became possible. In this way, the early (Weaning Zentrum), so dass die in innovativen phase of ventilation-associated pneumonia could Modellen gewonnen Erkenntnisse translational in be simulated in an animal model for the first time. der klinischen Situation überprüft und weiterent- The expansion of this ventilation mouse model on- wickelt werden können. to pre-damaged lungs (by infection, emphysema or Fo r s c h u n g s z e n t r u m Bo r s t e l Model of infection of the lower respiratory tract in human lungs fibrosis) will convey important insights in the understanding of the clinically relevant ventilation situaDas Modell der explantierten humanen Mukosa tions. (Explant model) aus den oberen Atemwegen konnte weiterentwickelt werden: Nachdem in den vergangenen Jahren die Mukosa mit bakteriellen Bestandteilen wie LPS oder PAM3 sowie Zytokinen (u. a. Interleukin-4 und Interleukin-13) stimuliert wurde, es ist jetzt erstmals möglich eine Stimulation mit lebenden Bakterien (Chlamydien und Pseu- domonas aeruginosa) durchzuführen. Durch die Stimulation mit lebenden Bakterienstämmen kann das „Explant model“ nun zu Untersuchungen der frühen Interaktionen zwischen Erreger und Wirt im oberen Respirationstrakt verwendet werden und ergänzt das Modell der Infektion des unteren Respirationstraktes an humanen Lungen (D. Drömann, J. Rupp). Das Beatmungsmodell der Maus wurde ebenfalls weiter entwickelt, so dass die intratracheale Provokation mit bakteriellen Bestandteilen möglich wurde. Auf diese Weise konnte erstmals im Tiermodell die Frühphase einer beatmungs-assoziierten Pneumonie simuliert werden. Die Ausweitung dieses Beatmungsmodells in der Maus auf vorgeschädigte Lungen (durch Infektion, Emphysem oder Fibrose) wird wichtige Erkenntnisse zum Verständnis der klinisch relevanten Beatmungssituationen vermitteln. 142 Wissenschaftlicher Jahresbericht 2007-2008 Division of Clinical Immunopharmacology Research Reports Division of Clinical Immunopharmacology Head model of explanted human mucosal tissue from the Prof. Dr. Peter Zabel (until 08/08) upper airways. Calu-3 cells and explanted mucosa PD Dr. Hans-Peter Hauber (since 08/08) were stimulated with different concentrations of CP. Mucus protein expression and mucin gene tran- Principle Investigator scription (MUC5AC) were quantified using PAS stain- PD Dr. Karoline I. Gaede ing and real time PCR. CP significantly increased mucus protein and MUC5AC mRNA expression in Staff scientists and postdoctoral fellows Calu-3 cells and in the explant model (P < .05). In Dr. Daniel Droemann further experiments dexamethasone (DEX) was Dr. Markus Blaukovitsch added at different concentrations to CP-stimulated Dr. Stefanie Heinemann Calu-3 cells and explanted tissue. DEX significantly reduced CP-induced mucus protein and MUC5AC Technicians mRNA expression in a dose dependent manner Jessica Hofmeister (P < .05). DEX-mediated suppression of CP-induced Simone Ross mucus expression could be partly antagonized by Carmen Schöne addition of the glucocorticoid receptor antagonist RU 486. Our data suggest that CP can directly in- Trainees duce mucus expression in epithelial cells. This effect Franziska Ganzert can at least in part attenuated by glucocorticos- Özke Köz teroids. Further studies will have to define the exact Melanie Röpcke intracellular pathway (eg. MAP kinase). Romina Pritzkow Frederike Sührk Svenja Schulz Meriam Winterhoff Research Reports Chlamydia pneumoniae induces mucus expression that can be attenuated by glucocorticos- Fig. 55. Epithelial mucus protein expression (red cells) in explanted mucosal tissue from upper airways after 24 h without (A) and in the presence of Chlamydia pneumoniae (15 cfu/well). PAS staining. Original magnification x 200. teroids Collaboration: Goldmann T, Vollmer E, Division of Hauber HP, Zabel P. Clinical and Experimental Pathology, Research Center Borstel; Wollenberg B, ENT-Department, Univer- Chlamydia pneumoniae (CP) can lead to acute and sity Hospital Schleswig-Holstein, Campus Lübeck; chronic infection of the lung. Mucus hypersecretion Rupp J, Department of Microbiology, University Hos- can often be found in chronic inflammatory lung dis- pital Schleswig-Holstein, Campus Lübeck. ease. Although CP induces inflammatory changes in the airway mucosa it is unclear whether CP can directly stimulate mucus expression. To address this question the effect of CP on mucus expression was investigated using in vitro cell culture techniques (Calu-3, a mucoepidemoid cell line) and an ex vivo Wissenschaftlicher Jahresbericht 2007-2008 143 Division of Clinical Immunopharmacology Research Reports Inhibition of cyclooxygenase-2 reduces bacterial cause lung injury (ventilator-induced lung injury, and allergic induced mucus expression in human VILI). Moroever, ventilated patients are at high risk airway mucosa of developing infections of the lower airways (ven- Heinemann S, Zabel P, Hauber HP. tilator-associated pneumonia, VAP). We used a Fo r s c h u n g s z e n t r u m Bo r s t e l model of mechanically ventilated mice (C57/Bl6) to Mucus hypersecretion is frequently observed in investigate the effect of inhaled lipooplysaccharide chronic inflammatory lung disease. Excessive mucus (LPS) and lipopetide (PAM3) on ventilated lungs. production leads to airway obstruction and supports We hypothesized to simulate an early phase of VAP. bacterial infection and colonization of the lung. At In addition we wanted to compare the effects of LPS present no specific mucus regulating drug is avail- and PAM3 since PAM3 has not been investigated able. Cyclooxygenase(COX)-2 is an important for very well until yet. Mice were mechanically ventilat- the generation of prostaglandins (PGs). PGs play an ed for 120 min. After 30 min intratracheal challenge important role as mediators in bacterial and aller- was carried out with sterile saline solution (sham), gic inflammation. Explanted mucosal tissue from up- LPS or PAM3. Lung function parameters as well as per airway mucosa was stimulated with Th2 type cy- neutropil influx and proinflammatory cytokine ex- tokines interleukin(IL)-4, IL-9, and IL-13 as well as with pression (TNFα and MIP-2) were measured. Me- lipopolysaccharide (LPS) and lipopetide (PAM3). Ep- chanical ventilation alone significantly increased ithelial mucus expression was using PAS staining. resistance and significantly decreased compliance Th2 type cytokines, LPS and PAM3 significantly in- over time (P < .05). This effect was augmented by duced mucus expression (P < .05). By adding the sham challenge. PAM3 but not LPS significantly in- COX-2 specific inhibitor rofecoxib bacterial and al- creased resistance compared to sham (P < .05). Me- lergic induced mucus expression could be signifi- chanical ventilation alone significantly increased cantly decreased (P < .05). Our data suggest that in- TNFα and MIP-2 mRNA expression compared to hibition of COX-2 may offer a therapeutic option to spontaneously breathing animals (P < .05). Both LPS reduce mucus hypersecretion. Ongoing studies will and PAM3 significantly increased the numbers of have to define which PGs are most important for and neutrophils as well as TNFα and MIP-2 mRNA ex- which PG receptors are mainly involved in inducing pression in the lungs compared to sham (P < .05). LPS mucus expression. Moreover, the effects of blocking had a stronger effect compared to PAM3 (P < .05). COX-1 and COX-2 will be compared. Our data show that LPS as well as lipopetide (PAM3) augment inflammation in ventilated lungs. Collaboration: Goldmann T, Vollmer E, Division of PAM3 but not LPS increases resistance. The under- Clinical and Experimental Pathology, Research Cen- lying mechanisms are under current investigation. ter Borstel; Wollenberg B, ENT-Department, University Hospital Schleswig-Holstein, Campus Lübeck; Rupp J, Department of Microbiology, University Hospital Schleswig-Holstein, Campus Lübeck Comparison of the effect of LPS and PAM3 on ventilated lungs Hauber HP, Zabel P. Invasive mechanical ventilation is a life saving technique. However, mechanical ventilation itself can 144 Fig. 56. Histology sections of ventilated mouse lungs without (A) and with intratracheal application of sterile saline (B), LPS (C) and PAM3(D). Note the increase in neutrophil numbers after challenge with either LPS or PAM3. HE staining. Original magnification x200. Wissenschaftlicher Jahresbericht 2007-2008 Division of Clinical Immunopharmacology Research Reports the cytospins. Neutrophils dominated the inflammatory cells in both OSA patients and healthy control subjects. The numbers of lymphocytes were significantly increased in OSA patients compared to controls (P < .05). In addition the numbers of lymphocytes increased with severity of OSA. Our data show that PHAL can be used to investigate local inflammatory cell profiles in upper airways. Further studies are warranted to compare the inflammatory cell counts in the PHAL of OSA patients before and after therapy with continous positive airway Fig. 57. MIP-2 and TNFα mRNA expression in spontaneously breathing animals (w/o) and in ventilated mice without (control) and after challenge with sterile saline (sham), LPS or PAM3. Bars indicate mean values+SEM. *: P < .05 vs w/o. **: P < .05 vs control. +: P < .05 vs sham. §: P < .05 vs +PAM3. pressure (CPAP). Moreover, differential cell counts in the PHAL of OSA patients will have to be compared to heavy snorers without OSA. Collaboration: Karp D, Division of Inflammation and Collaboration: Rüller S, Müller E, Sleep Disorder Regeneration, Research Center Borstel. Unit, Medical Clinic, Research Center Borstel. Pharnygeal lavage as a new tool to evaluate lo- New aspects in obstructive sleep apnea: Coher- cal inflammation in patients with obstructive ences with iron metabolism sleep apnea Eberhardt F, Zabel P. Hauber HP, Zabel P. Study Objectives: Hepcidin and ferritin are both Obstructive sleep apnea (OSA) is characterized by known to be influenced by hypoxia, a key feature of recurrent episodes of apnea and snoring. Previous the obstructive sleep apnea syndrome (OSAS). Nev- studies have demonstrated that apnea and hypox- ertheless, potential effects of therapeutic improve- ic stress are associated with systemic inflammation. ments in oxygenation levels on iron metabolism have Limited data from the literature also indicate that lo- not been examined in OSAS so far. We assumed the cal inflammation is present in the upper airways of main parameters of iron regulation to be sensitive to patients with OSA. However, sampling of biopsies improvements in oxygenation levels by continuous from the upper airways is uncomfortable for pa- positive airway pressure (CPAP) therapy. Design: Fol- tients. Therefore we evaluated a new technique, the low-up study over three months of CPAP therapy. pharyngeal lavage (PHAL). Patients gargled with Setting: The sleep laboratory of the Pulmonary Re- sterile saline solution, cytospins were made and dif- search Center Borstel, Germany ferential cell counts were prepared. Squamous ep- Patients: A group of 56 patients with newly diag- ithelial cells were the most prominent cell group in nosed OSAS. Wissenschaftlicher Jahresbericht 2007-2008 145 Division of Clinical Immunopharmacology Research Reports Interventions: Indices of cardiorespiratory polygra- come a valuable technique to assess airway in- phy and plasma concentrations of prohepcidin, fer- flammation and severity of disease in asthmatic ritin, IL-8 as inflammation marker, and further pa- subjects and to adjust anti-inflammatory treatment. rameters of iron regulation were assessed before However, other detection of exhaled in NO in other and after three months of scheduled CPAP-therapy. inflammatory airway disease (eg. pneumonia) has Results: Cardiorespiratory parameters improved in- not been studied very well yet. dicating a successful therapy (p<0.001 for all). Pro- Patients with community acquired pneumonia (CAP) hepcidin concentrations increased during CPAP-ther- were recruited and fractionated exhaled NO apy (p<0.001) and were correlated with improve- (FENO) of the alveolar compartment was detected ments in mean oxygen saturation (MOS, R=0.349, using the chemiluminescence Analysator CLD 88 sp p=0.01) and decreases in IL-8 concentrations (R=- (Eco medics). Detection of neutrophil activation 0.503, p<0.001). Ferritin concentrations decreased markers CD11b and CD66b was done by FACS during therapy (p<0.001) with this drop being asso- analysis in induced sputum. FENO-levels in hospi- ciated with rises in MOS (R=-0.315, p=0.023) and talized patients with CAP on admission day com- decrements in IL-8 (R=0.507, p<0.001). Moreover, pared to healthy individuals were significantly high- CPAP-therapy decreased concentrations of iron, er (P < 05) as well as on admission day compared transferrin receptor, and lactoferrin (p<0.02 for all) to a follow up examination five days later (P < .05). and increased concentrations of UIBC (p=0.01). In addition we found a significant correlation be- Conclusions: Three months of successful CPAP-thera- tween FENO and CD11b and CD66b expression on py affected most parameters of iron regulation with neutrophils in induced sputum (P < .05). Further- prohepcidin and ferritin being correlated to im- more lower FENO-levels were demonstrated in pa- provements in mean oxygen saturation and inflam- tients who received an additional glucocorticoide mation. Our data indicate a so far neglected clini- therapy. We conclude that FENO is an adequate cally relevant relationship between iron metabolism technique to assess the severity of airway inflam- and oxygenation levels. mation and to monitor the response to antibiotic Fo r s c h u n g s z e n t r u m Bo r s t e l treatment in non-severe CAP. Collaboration: J. Klement, A. Peters (Departments of Internal Medicine I), M. Voss (Psychiatry and Psy- Collaboration: Jungnitz C, Dalhoff K, Schaaf B, Med- chotherapy) and C. Benedict, J. Born, K.M. Oltmanns ical Clinic III, University Hospital Schleswig-Holstein (Neuroendocrinology) University of Luebeck; A.J. Ghio Campus Lübeck (United States Environmental Protection Agency, North Carolina, USA); B. Schultes (Interdisciplinary Obesity Center, Kantonsspital St. Gallen, Switzerland) Nontypeable Haemophilus influenzae infection of human lung tissue induces proinflammatory cy- Supported in part by: Deutsche Forschungsgemein- tokine response via Toll-like receptor 2 and EGF- schaft (SFB 654, C2) receptor Drömann D, Zabel P. Exhaled nitric oxide detection for monitoring of Pulmonary presence of the facultative intracellular airway inflammation in community acquired pathogen nontypeable Haemophilus influenzae pneumonia (NTHI) is associated with acute infection and has Drömann D, Zabel P. been implicated as an infectious trigger in chronic obstructive pulmonary disease. In addition NTHI Measurement of exhaled nitric oxide (NO) has be- 146 represents a predominant cause of bacterial pneu- Wissenschaftlicher Jahresbericht 2007-2008 Division of Clinical Immunopharmacology Research Reports monia and is able to activate EGFR signaling by fect phenocopy of sarcoidosis, it might be misdiag- NTHI-derived EGF-like factor. Vital lung specimens were infected with a suspension of 106 colony form- nosed as sarcoidosis. In the current it was hypothe- ing units (cfu) x ml-1 over a periode of 24h. Presence tients. In a prospective case study, sarcoidosis pa- of NTHI DNA was detected using in situ hybridiza- tients were evaluated for potential beryllium expo- tion (ISH) in in vitro infected lung tissue. CXCL-8 and sure. In those patients in whom beryllium exposure TNF expression was determined by ELISA. Toll-like was confirmed and beryllium hypersensitivity receptor- (TLR) 2 mRNA was analyzed by realtime- demonstrated, the diagnosis of sarcoidosis was re- PCR. Expression of the MAP-kinases p38 and jected and corrected to CBD. In 84 patients seen for p42/44 was determined by western blot. re-evaluation or making a diagnosis of sarcoidosis, NTHI DNA was found to be located in 60-75% of beryllium exposure was recognised and a diagno- alveolar macrophages (AM) and 15-25 % of epithe- sis of CBD was made in 34 out of 84 patients. The lial cells (AEC) in in vitro infected lung tissues. NTHI time lag between clinical diagnosis of sarcoidosis infection increased TLR2 mRNA expression and in- and the final diagnosis of CBD ranged 0-18 yrs (me- duced a strong release of CXCL-8 (NTHI 325±170 vs dian 3 yrs) and the mean (range) age at time of di- control 55±43 µg/ml) and TNF (NTHI 304±190 vs agnosis of CBD was 43.9(25-80) yrs. Beryllium-con- control 39±28 pg/ml) in in vitro infected lung speci- taminated workplaces causing disease encom- mens (P < .01). In addition increased expression of passed a wide spectrum of industries and technical the MAP-kinases p38 and p42/44 was observed af- trades in which beryllium-exposure is generally not ter infection. Blockade of TLR2 and EGFR by mono- perceived as a health hazard. In conclusion, chron- clonal antibody as well as specific inhibition of the ic beryllium disease still belongs to the spectrum of MAP-kinases by SB203580 and UO126 significantly differential diagnoses of granulomatous disorders. sised that CBD exists in cohorts of sarcoidosis pa- decreased the proinflammatory cytokine response. In conclusion AM and AEC serve as host cells for pri- Collaboration: Müller-Quernheim J., Prasse A. and mary NTHI infection. The strong proinflammatory cy- Zissel G. Dept. of Pneumology, Medical University tokine expression in human lung tissue is by medi- Hospital Freiburg, Freiburg, Germany; Fireman E. ated by TLR2 and EGFR via the p38 and p42/44 Dept. of Pulmonary and Allergic Diseases, Tel Aviv MAP-kinase pathway. Sourasky Medical Center, Tel Aviv, Israel. Collaboration: Rupp J, Department of Microbiology, Supported in part by: Deutsche Forschungsgemein- University Hospital Schleswig-Holstein Campus schaft, grant MU 692/7-1. Lübeck; Goldmann T, Division of Clinical and Experimental Pathology, Research Center Borstel; Xu F, Limmer S, Dalhoff K, Medical Clinic III, University CC chemokine ligand-2 (CCL2) gene polymor- Hospital Schleswig-Holstein Campus Lübeck. phism and protein expression in sarcoidosis Gaede KI. Diagnoses of chronic beryllium disease within co- CC chemokine ligand-2 (CCL2), also known as horts of sarcoidosis patients monocyte chemoattractant protein (MCP)-1 is ex- Gaede KI. pressed by monocytes and human alveolar epithelial cells type-2 and many others. CCL2 exhibits An increase in chronic beryllium disease (CBD) has chemotactic activity towards macrophages/ mono- been suggested due to higher industrial use of cytes as well as lymphocytes and induces the pro- beryllium alloys. Since occupational CBD is a per- duction of inflammatory cytokines affecting granu- Wissenschaftlicher Jahresbericht 2007-2008 147 Division of Clinical Immunopharmacology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l loma formation. Its role in the pathogenesis of sar- Theses coidosis is under discussion. A biallelic A/ G polymorphism in the distal regulatory region of the CCL2 Habilitation gene at position –2518 is known to affect the level Dr. med. Hauber, Hans-Peter of CCL2 expression in response to inflammatory Für das Fach ‚Innere Medizin’ stimuli. This study investigated the influence of the Medizinische Fakultät CCL2 (-2518) gene polymorphism on alveolar and Universität Lübeck, 2007. systemic protein expression, susceptibility to sarcoidosis and its clinical phenotypes. The study population consisted of 123 patients with sarcoidosis (radiograph type I: n = 20; II: n = 60; III: n = 35; IV: n = 8) and 119 age matched healthy controls. The CCL2 polymorphism was genotyped by a PCR-restriction fragment length polymorphism method. CCL2 protein expression in serum, bronchoalveolar lavage fluid and supernatants of LPS stimulated and unstimulated cells of the bronchoalveolar lavage and the blood was determined by ELISA. The genotype distribution and the allele frequency of patients with sarcoidosis showed no significant differences as compared with controls. Basically, sarcoidosis patients produced higher levels of CCL2 than controls. The LPS induced CCL2 production by blood cells correlated significantly with the number of G alleles in patients with active sarcoidosis (p < 0.001) and in patients with type II sarcoidosis (p < 0.05) Interestingly, disease activity evaluated by increased serum levels of angiotensin converting enzyme (sACE) correlated significantly with the number of G alleles patients with type I sarcoidosis (p<0.05). Increased CCL2 production by blood cells observed in G positive patients with active sarcoidosis is in line with G allele associated sACE concentrations. In summary, our study gives good evidence for a role of the CCL2 G allele as a disease modifier influencing inflammatory responses and radiographic type. Collaboration: Müller-Quernheim J. and Zissel G. Dept. of Pneumology, Medical University Hospital Freiburg, Freiburg, Germany. Supported in part by: Deutsche Forschungsgemeinschaft, grant MU 692/7. 148 Wissenschaftlicher Jahresbericht 2007-2008 Division of Clinical and Experimental Pathology Research Reports Division of Clinical and Experimental Pathology Head Research Reports Prof. Dr. Dr. Ekkehard Vollmer What’s going on in human lung tissues? A human ex vivo model system for pulmonary re- Principle Investigator search PD Dr. Torsten Goldmann Goldmann T, Schultz H, Lang DS, Kähler D, Stellmacher F, Vollmer E. Staff Scientists Dr. Holger Schultz On the path to enlighten at least some of the com- Dr. Florian Stellmacher plex events taking place within pathologic changes Dr. Jürgen Galle during pulmonary disorders, we have developed a Dr. Dagmar S. Lang novel model system which facilitates to gain insights into the underlying molecular background. Here we Graduate and Diploma Students want to present some current results employing this Andreas Zyzik model, which is the result of a continuous fruitful co- Dipl. Ing. Daniel Kähler operation of the disciplines biology, pathology, pul- Mahdi Abdullah monary medicine, microbiology, allergology, and Uwe Mertens surgery. Sebastian Marwitz Janine Radtke Technicians Angela Kelp Heike Kühl Maria Lammers Waltraud Martens Heidi Scheibel Jasmin Tiebach Rolf Warneke Tanja Zietz Secretary Fig. 58. Schematic overview. Gabriele Cornehls Iris Jonas Methodologically based on the HOPE-technique Monika Wolgast which has been brought to applicability in the Clin. & Exp. Pathology in Borstel, this model uses fresh human lung tissues which are subjected to a short term tissue culture. During cultivation, these tissues undergo a whole variety of different stimulations before being fixed by the HOPE-technique. After paraffin-embedding these paraffin embedded speci- Wissenschaftlicher Jahresbericht 2007-2008 149 Division of Clinical and Experimental Pathology Research Reports mens are ready to be analyzed by a complete pan- Small Cell Lung Cancer (NSCLC), with the astonish- el of molecular and histologic techniques. We have ing finding of TLR9 to be functionally active ex- shown that the tissues respond to the stimulations pressed here, we faced our interest in equal meas- with remarkable changes in the expression of RNA ure towards pulmonary infections. An elementary and proteins as well. series of experiments dated back to 2003 showed Fo r s c h u n g s z e n t r u m Bo r s t e l that mycobacteria (BCG) are capable of infecting human lung tissues within the model, that they infect only certain alveolar macrophages (Fig. 59A, B), and that this infection seems to have an influence onto the expression of TLR2 by human alveolar macrophages (Fig. 59C, D). This prompted us for further research using different pathologically relevant infectious agents as, for exFig. 59. Ziehl-Neelsen staining of ex vivo infected human alveolar macrophages using the STST model and BCG. B: PCR control of the ex vivo infected lung tissues (1, 4: non infected lungs; 2, 3: infected lungs; Ex and -: controls). C, D: Detection of TLR2 in ex vivo infected or non infected human lung tissues (C: non infected, D: infected with BCG). ample Chlamydia pneumoniae in the course of COPD (Fig. 60). As a relatively new field we have now entered allergy, where the effects of different allergens are being studied in human lung tissues. As an example we show the uptake of Phlp1 in the human alveolar compartment (Fig. 61). Fig. 60. Immunohistochemical staining of Toll-like receptor (TLR)-2 (A) and TLR4 (B) in chronic obstructive pulmonary disease (COPD) lung tissue (original magnification, x400). (C) TLR2 mRNA expression in controls, Chlamydia pneumoniae (Cpn)+ and Cpn– COPD (Cpn+, n = 4; Cpn–, n = 4), and in vitro–infected COPD lung tissue (n = 4). *p < 0.05 compared with controls, Cpn+, and Cpn– COPD lung tissue. (D) IL-8 secretion in lung tissue after Cpn infection over 24 hours ± blocking of TLR2 and TLR4 by monoclonal antibody. *p < 0.05 compared with Cpn infection, Cpn infection + isotype antibody and Cpn + anti–TLR4 antibody. Fig. 61. Immunohistochemical detection of the ex vivo uptake of Phlp1 in the alveolar compartment of human lung tissues using a monoclonal antibody and polymer detection with visualization by HRP and AEC (400x). By successful application of transcriptome and proteome analyses using archived tissues from this Currently, this unique system is broadly applied, model, we are now capable to complexly describe and demanded to be used, to address problems of the underlying molecular events during stimulation, different scientific sectors such as infection, allergy which also delivers information about novel relevant and tumor-immunology. After successful initiation of target-genes in human pulmonary disorders (for ex- the model, which was designated STST (Short Term ample the discovery of CXCR7 in NSCLC). Stimulation of Tissues), mainly for studying immuno- Taken together, we are assured that this unique in- logical events during ex vivo stimulation of Non terdisciplinary model system will continue to take 150 Wissenschaftlicher Jahresbericht 2007-2008 Division of Clinical and Experimental Pathology Research Reports substantial part within the illumination of molecular key regulator of apoptosis, cleaved caspase-3 was events in the course of lung diseases by providing evaluated immunohistologically and by reverse tran- both functional insights and diagnostic information scriptase – polymerase chain reaction (RT-PCR); the as well. TUNEL labeling assay was additionally performed.In Collaboration: Drömann D, Dalhoff K, Zabel P, Med. chemo-sensible CPC-N cells (SCLC) Ki-67 expression Clinic Borstel, Research Center Borstel and Med. Clin- was consistently reduced by more than 50 % follow- ic III, UK-SH Campus Lübeck; Rupp J, Med. Microbiol- ing chemotherapy, whereas caspase-3 expression ogy, UK-SH Campus Lübeck; Petersen A, Molecular & was consistently induced up to 30 % in response to Clin. Allergology, Research Center Borstel; Branscheid each anticancer agent. In contrast, in the chemo-re- D, Hospital Großhansdorf, Center for Lung Diseases sistant A549 cell line (AC) the Ki-67-index of 90 % re- and Thoracic Surgery; Ullmer A, Röschmann K, Cellu- mained nearly unaffected and both caspase-3 pro- lar Immunology, Research Center Borstel. tein levels and gene expression were unaltered by the different chemotherapeutic agents. In addition, one vital specimen of a patient with chemo-sensitive SCLC STST (Short term stimulation of tissues): analysis of and four different samples of human breast cancer tis- molecular events during lung cancer chemotherapy sues consistently revealed reduced proliferation and Lang DS, Schultz H, Vollmer E, Goldmann T. clearly increased protein levels as well as enhanced gene expression (in SCLC) of cleaved caspase-3 in re- To date, no effective chemotherapeutic treatment for sponse to the individual cytotoxic drugs. Under the non-small cell lung cancer (NSCLC) exists. Therefore, chosen culture conditions characteristic differences re- this type of tumor is characterized by a poor progno- lated to the histological type of tumor became evident sis. With regard to the high cellular heterogeneity of in NSCLC specimens without considerable effects on NSCLC, experimental data are necessary to elucidate viability or functionality of the tumor cells: untreated the molecular mechanisms underlying tumor behav- adenocarcinomas (AC) exhibited lower proliferation ior in detail, thus providing the base for development rates than squamous cell carcinomas (SCC) and af- of individual and more efficient anticancer treatment ter cultivation, only SCC showed a statistically signifi- regimens. Therefore, we used an ex vivo tissue culture cant enhancement of expression of caspase-3. model (STST: Short-Term Stimulation of Tissues) in combination with the novel HOPEtechnique (Hepes - Glutamic acid buffer mediated Organic solvent Protection Effect). To analyze the effects of conventional chemotherapy in STST we applied carboplatin, vinorelbine and gemcitabine. A series of cell culture experiments using A549 (NSCLC), CPC-N (SCLC, small-cell lung cancer), HeLa, and HEK cell lines was performed for means of comparison. Two different chemo-susceptible types of cancer (breast cancer and SCLC) were also included. We studied possible chemotherapy-induced alterations of multiple known relevant biomarkers in 41 samples of NSCLC. Expression of Ki-67 and BrdU-uptake were assessed by immunohistochemistry. As a Fig. 62. Individual distribution patterns of Ki 67 protein in human NSCLC specimens of both adenocarcinoma type (upper panel AC) and of squamous cell carcinoma type (lower panel D-F) in the absence (RPMI) or presence of 3 different cytotoxic drugs following 16h culture period. Wissenschaftlicher Jahresbericht 2007-2008 151 Division of Clinical and Experimental Pathology Research Reports In response to the individual anticancer drugs, prolif- ed by this investigation. In NSCLC, the observed erative activity was always effectively abrogated in all drug-induced effects upon a number of multiple bio- tumor samples. Despite a high variability in the Ki-67 markers are in good agreement with existing data response patterns among the individual NSCLC tissue from both experimental and clinical studies. How- specimens, differences in Ki-67 labeling index, which ever, the consistent differences in the responsive- were characteristic for the histological type of NSCLC ness of the human NSCLC samples in STST that remained evident under chemotherapy with SCC ex- were closely related to the histological type of tis- hibiting much less responsiveness to the same drugs sue have not yet been reported in detail. The (Fig. 62). chemo-sensitivity of SCLC and breast cancer that Fo r s c h u n g s z e n t r u m Bo r s t e l was consistently evident following short-term cultiIn addition, AC exhibited higher expression of vation was in marked contrast to the effects seen in cleaved caspase-3 levels when compared to SCC in the more chemo-resistant NSCLC specimens, thus re- response to chemotherapeutical treatment condi- vealing the close correlation of our experimental tions that were not statistically significant (Fig. 63). data to the situation in vivo. This experimental ap- Likewise, transcription of caspase-3 in four different proach should also be applicable for other types of NSCLC samples (SCC n = 3, AC n = 1) did not exhibit cancer and it should also be possible to elucidate a significant upregulation in response to any of the molecular mechanisms within tumor-free tissues, cytotoxic drugs, which is in marked contrast to the e.g. the events taking place upon corticosteroid highly responsive SCLC. treatment within the human lung. Collaboration: Zabel P, Drömann D, Med. Clinic Borstel, Research Center Borstel and Med. Clinic III, UK-SH Campus Lübeck; Branscheid D, Hospital Großhansdorf, Center for Lung Diseases and Thoracic Surgery; Ressmeyer A, Martin C, Pulmonary Pharmacology, Re- search Center Borstel; Zeiser T, Dept. of Gynecology, Asklepios Hospital, Bad Oldesloe. Fig. 63. Individual distribution patterns of activated caspase-3 protein in human NSCLC specimens of both adenocarcinoma type (upper panel A-C) and of squamous cell carcinoma type (lower panel D-F) in the absence (RPMI) or presence of 3 different cytotoxic drugs following 16h culture period. The chemokine receptor CXCR7 is consistently expressed in human Non Small Cell Lung Cancer The major focus of this study was to examine the re- and tumor-free lung tissues with possible regula- liability of a novel ex vivo tissue model (STST) and tion upon chemotherapy to evaluate multiple aspects of human lung tumor Goldmann T, Radtke J, Marwitz S, Lang DS, behavior in response to conventional chemothera- Schultz H, Vollmer E. py. With such an experimental approach, not only the complexity within the tissue is maintained but al- Various chemokine receptors are expressed by ma- so the heterogeneity among individual patients can lignant tumors and have been associated with tu- be studied directly, which was clearly demonstrat- mor progression and metastasis. A recent study 152 Wissenschaftlicher Jahresbericht 2007-2008 Division of Clinical and Experimental Pathology Research Reports demonstrated the promotion of tumor growth in Lower panel: RT-PCR targeting CXCR7 and GAPDH mRNA in human NSCLC after STST: a: medium controls; b: stimulation with carboplat and gemcitabine. M=pBr322 Msp1; upper signals: A 257 bp fragment of GAPDH; lower signals: CXCR7. B, C, D) In situ hybridization targeting mRNA of CXCR7 in human lung tissues using a digoxigenin-labeled DNA-probe and new-fuchsine as a chromogen: B) Adenocarcinoma of the lung (400x) C) Alveolar macrophages (400x) D) Alveolar epithelial cell type II, see arrow (1000x). breast and lung cancer by CXCR7, formerly known as orphan receptor CMKOR1/RDC1 utilizing cell lines and animal models. CXCR7-expression in human breast and lung cancer specimens, as well as in the tumor vasculature was shown on the proteinlevel by immunohistochemistry. Here we employed human lung tissues treated with the novel HOPEtechnique to analyze the overall expression of CR- Stimulation of tumor tissues with physiological con- CX7 on the mRNA-level in Non Small Cell Lung Can- centrations of carboplat and gemcitabine (N=30) cer (NSCLC) and tumor-free lung tissues. Addition- was performed within the human model system des- ally, the effect of chemotherapy upon the transcrip- ignated STST (Short Term Stimulation of Tissues) in tion of CRXR7 was addressed, employing a comparison to corresponding tissues, which re- currently established human model system. Apply- ceived cultivation without stimulation. Here we ing RT-PCR with a specific primer set spanning an found an up-regulation of CXCR7-transcription upon amplicon of 156bp (5’–TGCTGGACATCTTCTCCATC- chemotherapy in 13.4% of the cases, down-regula- 3’ forward, 5’-CTTCATCAGCTCCTACCT-3’ reverse), tion in 33.3%, and no regulation in 53.3%, as deter- we found transcription of CXCR7 in all of the 30 mined by semiquantitative RT-PCR in relation to NSCLC samples analyzed. A set of 10 examples is GAPDH (exemplified in the lower panel of figure 1a; shown in Fig. 64A. Specificity of the RT-PCR was ver- note up-regulation of CXCR7 in sample 4 upon ified by sequencing of the PCR-products. The results chemotherapy).Taken together, our study verifies of RT-PCR were then validated by in situ hybridiza- the recently reported results on the mRNA-level in a tion (N=21) using a double stranded DNA-probe la- comparably large amount of specimens. However, beled with digoxigenin, which revealed transcripts although some signals were occasionally observ- of CXCR7 within the tumor cells of 17 samples (Fig. able, we did not detect strong expression within the 64B) with only some occasional signals in the tumor- tumor-associated vasculature on the RNA-level. The associated vasculature. Moreover, 20 specimens of effects of chemotherapy onto CXCR7 are heteroge- tumor–free human lungs were also subjected to in neous. Nevertheless, the same holds true for the situ hybridization and all revealed transcripts local- overall characteristics of the tumors themselves and ized mainly in alveolar macrophages (Fig. 64C), their behavior upon chemotherapeutic interventions and in cells, which reflect the morphology of alveo- within the patients. Therefore, the effects of lar epithelial cells type II (Fig. 64D). chemotherapy onto CXCR7 might be valuable hints towards an understanding of the broad chemotherapy-resistance found in NSCLC. We have additionally shown a consistent transcription of CXCR7 within tumor free lung tissues suggesting a possible new function of this receptor in non-malignant processes within the human lung. Collaboration: Drömann D, Med. Clinic III, UK-SH Campus Lübeck; Branscheid D, Hospital GroßhansFig. 64. A) Upper panel: RT-PCR targeting CXCR7 and GAPDH mRNA in human NSCLC: M=pBr322 Msp1; upper signals: A 257 bp fragment of GAPDH; lower signals: CXCR7. dorf, Center for Lung Diseases and Thoracic Surgery. Wissenschaftlicher Jahresbericht 2007-2008 153 Division of Clinical and Experimental Pathology Research Reports On the role of Transketolase-like enzyme 1 (TKTL1) cubated for 30 min. in a 1:100 dilution. We used an human lung tissues and Non Small Cell Lung Cancer enzyme-polymersystem (ZytochemPlus HRP Polymer Schultz H, Kähler D, Vollmer E, Goldmann T. Kit, Zytomed Systems) for sensitive detection with Fo r s c h u n g s z e n t r u m Bo r s t e l permanent AEC (Zytomed Systems) as chromogen. It has recently been shown that TKTL1 particularly Tissue arrays were counterstained by incubation in influences total transketolase activity and cell pro- Mayer’s haemalum for 5 minutes. Negative-controls liferation by providing the ability of tumors to de- were included in each staining series under omis- grade glucose through the anaerobic transketolase- sion of primary antibody. The immunohistochemical dependant pentose phosphate pathway. TKTL1 mR- stainings showed elevated expression of TKTL1 in NA silencing (via small interfering anti-TKTL1-mRNA human lung cancer: 40.9% expressed TKTL1 weakly constructs) leads to inhibition of cell proliferation in (score 1), 38.6% moderately (score 2), 17.1% strong- colorectal cancer; protein overexpression and a sig- ly (score 3), and 3.4% of the tumors were TKTL1-neg- nificant correlation to Her2 overexpression was ative (score 0). Breast cancer specimen stainings found in breast cancer cells where 89 % expressed were scored 0: none; scored 1: 32%; scored 2: 36%; TKTL1 and 45% showed strong expression. Gastric scored 3: 32%. In general, adenocarcinomas were tumors and granulosa cell tumors of the ovary were more often strongly positive (score 3) than the squa- also found to express high amounts of TKTL1 (36.9 %; mous cell carcinomas (22.1 % for adenocarcinomas 81 %). Further, with renal cancer another carcinoma and 12.2% for squamous cell carcinomas). Staining displayed intensively elevated transketolase activi- of the HOPE-fixed specimens showed comparable ty due to TKTL1-upregulation. Proliferation-influenc- results; these results verify findings in the five cases ing activities of TKTL1 might play a role in a variety of adenocarcinomas of the lung previously de- of cancers. Hence we investigated a capacious col- scribed. Signals were recognized in the cytoplasm lective of 88 formalin-fixed non-small cell lung can- and occasionally in nuclei of tumor cells. cer (NSCLC)-tissues (39 adenocarcinomas; 49 squamous cell carcinomas) by immunohistochemistry to describe TKTL1 protein expression in human lung carcinomas. A collective of 24 breast cancer specimens was also included in the study (21 invasiveductal; 1 tubular; 1 lobular; 1 mucinous carcinoma). Further, we challenged a potential correlation of TKTL1 to age, sex, TNM-classification and grading as well as TTF1 and SPA expression. Tissues were fixed with formalin and paraffin embedded. Additionally we investigated 40 HOPE (Hepes Glutamic Acid Buffer Mediated Organic Solvent Protection Effect)fixed NSCLC-tissue probes. For increased inter specimen comparability and even staining quality we utilized Tissue Microarrays (TMAs) using an MTA1 Fig. 65. Examples of TKTL1-stained A) adenocarcinomas; B) squamous cell carcinomas; C) breast cancer specimens; D) TKTL1-positive macrophages in the neighbourhood of an adenocarcinoma and E) TKTL1-positive AEC II cells in the neighbourhood of an adenocarcinoma (arrows). (Manual Tissue Arrayer 1) device (Alphametrix). For There was a conspicuous amount of signal-contain- homogeneous high-throughput staining conditions ing alveolar macrophages and alveolar epithelial the tissues were stained automatically (Autostainer cells type II (AEC II cells), observed in the close 480, Medac, Germany). TMAs were deparaffinized neighborhood of the NSCLC (Fig. 65 D, E) as well as and rehydrated; primary antibody (anti-TKTL1; in completely healthy parts of lung tissue (not clone: JFC12T10; Zytomed Systems, Berlin) was in- shown). Examples of stained tumor types, alveolar 154 Wissenschaftlicher Jahresbericht 2007-2008 Division of Clinical and Experimental Pathology Research Reports macrophages and AEC II cells are shown in figure sic sciences continuously contributes to direct scien- 8 A-E. No staining was found in negative controls. tific output. This requires intensive collaborations with Comparison of TKTL1-expression to several clinical other hospitals and provides indispensable sources parameters revealed that there is no significant cor- of material for various research activities. relation between TKTL1-appearance and age, sex, We thank these colleagues of the different hospitals TNM-classification parameters or tumor grading. we cooperate with in routine diagnostic services for Further, no correlation could be defined concerning their confidence in our work. In cooperation with the SPA and TTF1 expression. National Reference Center for Mycobacteria we have analyzed different tissues infected with NTB My- A high variability of TKTL1-expression has been de- cobacteria and found curious strains by sequencing, scribed in several tumor types. There is proven evi- like M. tilburgii, M. neoaurum or other acid fast germs dence that TKTL1-associated or -inducing, abnormal like Rhodococcus equi. As a molecular technique cru- glucose degradation is increased in tumors. But TK- cial for the decision regarding targeted therapy of TL1 is also a key enzyme in the healthy organism colorectal carcinomas with an Anti-EGF-R regimen, whose activation-status influences the balance of we have established the analysis of K-ras mutations anaerobic glucose- or oxygen-focussed bioenergy- out of formalin-fixed, paraffin-embedded tissues obtainment. Natural appearance is proven through again in close cooperation with the National Refer- positive detected macrophages and AEC II cells (Fig. ence Center for Mycobacteria Molecular techniques 65 D, E) as well as signals in healthy lung tissues. are increasingly becoming important in routine di- Therefore tests on cancer cells or cancer tissues agnostics, the application of which - due to the use alone are not capable to gain insights into the com- of formalin as a fixative - is restricted to a large de- plex situation in patients subjected to diets or other gree. In cooperation with our clinical partners we treatments. We have shown that a large portion of have now continued to implement the HOPE-tech- NSCLC overexpresses TKTL1; moreover there was a nique into routine pathology as a base for improved significant expression in non malignant cells of the diagnostics and therapeutics, especially within the di- lungs. Although it is tempting to speculate of a po- agnostics necessary to apply targeted therapies, to tential therapeutic benefit by modulation of TKTL1-ac- the welfare of patients.Also embodied in clinico- tivity in the future, further studies are necessary to in- pathological interactions where the diagnostic ex- vestigate the real amount of effects during TKTL1-tar- pertise of tissue analyzes is indispensable, we are geted diets or therapies within the human organism. engaged in several scientific multicenter studies concerning NSCLC and are an active member of the Eu- Collaboration: Zabel P, Med. Clinic Borstel, re- ropean Study Group on Rare Lung Diseases. We search Center Borstel and Med. Clinic III, UK-SH have continued the work as a reference center for the Campus Lübeck; Branscheid D, Hospital Großhans- quality control in molecular pathology detecting my- dorf, Center for Lung Diseases and Thoracic Sur- cobacteria by the Professional as well as the Scien- gery; Zeiser T, Dept. of Gynecology, Asklepios Hos- tific Society of German Pathologists. pital, Bad Oldesloe. Theses Scientific observations in diagnostic pathology Vollmer E, Goldmann T, Schultz H, Galle J, Stell- Diploma macher F. Kähler, Daniel Hochdurchsatzanalysen molekularer Biomarker an Routine pathology as a link between clinical and ba- humanen Lungenkarzinomgeweben. Wissenschaftlicher Jahresbericht 2007-2008 155 Division of Clinical and Experimental Pathology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l Technisch-Naturwissenschaftliche Fakultät Universität Lübeck, 2008. Bachelor of Science Marwitz, Sebastian Molekularbiologische Analyse von Entzündungsmediatoren in humaner Lunge. Studiengang Molecular Life Sciences Universität zu Lübeck, 2008. Radke, Janine Molekularbiologische Gewebeuntersuchungen von Genregulationen an humanen Nichtkleinzelligen Lungenkarzinomen. Studiengang Molecular Life Sciences Universität zu Lübeck, 2008. 156 Wissenschaftlicher Jahresbericht 2007-2008 Division of Mycobacteriology and National Reference Center for Mycobacteria Research Reports Division of Mycobacteriology and National Reference Center for Mycobacteria Head Dr. Sabine Rüsch-Gerdes Research Reports Worldwide emergence of extensively drug-resist- Deputy ant tuberculosis PD Dr. Elvira Richter Rüsch-Gerdes S. Principle Investigator Multidrug-resistant tuberculosis (MDR TB) has been Dr. Doris Hillemann documented in nearly 90 countries and regions worldwide. Treatment for MDR TB patients requires Secretary use of second-line drugs for >24 months. To facilitate Birgit Voß treatment of MDR TB in resource-limited countries, where most TB cases occur, the World Health Or- Graduate and Diploma Students ganization (WHO) and its partners developed the Janina Kolb Green Light Committee, which helps ensure proper use of second-line drugs, to prevent further drug re- Technicians sistance. Nonetheless, the Green Light Committee Kristine Beuck encountered numerous anecdotal reports of MDR Manuela Dorn TB cases with resistance to most second-line drugs. Gudrun Heinonen Once a strain has developed resistance to second- Silvia Höllger line drugs, these new TB strains are even more dif- Margrit Kernbach ficult to treat with existing drugs. Mycobacterium tu- Anne-Kathrin Landgraf berculosis strains that are resistant to an increasing Kirsten Ott number of second-line drugs used to treat MDR TB Ilse Radzio are becoming a threat to public health worldwide Frauke Schaefer (Fig. 66). Birte Schlüter Daniela Stephan Tanja Struwe-Sonnenschein Ann-Kathrin Witt Research Reports Guests and Trainees approx. 110 national and international guests attended the NRC for advanced training in 2007 and 2008 Fig. 66. XDR-TB cases world-wide, www./WHO/HTM/TB/2008.394, Anti-tuberculosis drug resistance in the world, Fourth global report. In this study the Network of Supranational Reference Wissenschaftlicher Jahresbericht 2007-2008 157 Division of Mycobacteriology and National Reference Center for Mycobacteria Research Reports Laboratories was surveyed for M. tuberculosis iso- multidrug-resistant and extensively drug-resistant tu- lates that were resistant to second-line anti-TB drugs berculosis, resistance to the injectable drug capre- during 2000–2004. Extensively drug-resistant TB (XDR omycin was an independent predictor for therapy TB) was defined as MDR TB with further resistance to failure in this cohort. As Mycobacterium tuberculo- >3 of the 6 classes of second-line drugs. Of 23 eligi- sis drug resistance is increasing worldwide, there is ble laboratories, 14 (61 %) contributed data on 17,690 an urgent need for novel interventions in the fight isolates, which reflected drug susceptibility results against tuberculosis. Fo r s c h u n g s z e n t r u m Bo r s t e l from 48 countries. Of 3,520 (19.9 %) MDR TB isolates, 347 (9.9 %) met criteria for XDR TB. Further investiga- Collaboration: WHO Collaborating Centre for TB tion of population-based trends and expanded ef- and Lung Diseases, Fondazione S. Maugeri, Care forts to prevent drug resistance and effectively treat and Research Institute, via Roncaccio 16, 21049, patients with MDR TB are crucial for protection of Tradate, Italy. giovannibattista.migliori@fsm.it public health and control of TB. Collaboration: various members of the Suprana- Multidrug-resistant tuberculosis treatment out- tional Reference Laboratories Network. comes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures Rüsch-Gerdes S. Resistance to second-line injectables and treatment outcomes in multidrug-resistant and exten- A pilot programme to treat multidrug-resistant TB sively drug-resistant tuberculosis cases (MDR-TB) was implemented in Karakalpakstan, Rüsch-Gerdes S. Uzbekistan in 2003. This region has particularly high levels of MDR-TB, with 13% and 40% among new and No information is currently available on the influ- previously treated cases, respectively. The study de- ence of injectable second-line drugs on treatment scribes the treatment process and outcomes for the outcomes of multidrug-resistant (MDR) and exten- first cohort of patients enrolled in the programme, sively drug-resistant (XDR) tuberculosis (TB) patients. between October 2003 and January 2005. Con- To investigate this issue, a large series of MDR- and firmed MDR-TB cases were treated with an individ- XDR-TB cases diagnosed in Estonia, Germany, Italy ualised, second-line drug regimen based on drug and the Russian Federation (Archangels Oblast) be- susceptibility test results, while suspected MDR-TB tween 1999 and 2006 were analysed. All study sites cases were treated with a standardised regimen performed drug susceptibility testing for first- and pending susceptibility results. Of 108 MDR-TB pa- second-line anti-TB drugs, laboratory quality assur- tients, 87 were started on treatment during the study ance and treatment delivery according to World period. Of these, 33 (38%) were infected with strains Health Organization recommendations. Out of resistant to at least one second-line drug at base- 4,583 culture-confirmed cases, 240 MDR- and 48 line, but none had initial ofloxacin resistance. Treat- XDR-TB cases had a definitive outcome recorded ment was successful for 54 (62%) patients, with 13 (treatment success, death, failure). Among MDR- (15%) dying during treatment, 12 (14%) defaulting and XDR-TB cases, capreomycin resistance yielded and 8 (8%) failing treatment. Poor clinical condition a higher proportion of failure and death than capre- and baseline second-line resistance contributed to omycin-susceptible cases. Resistance to capre- treatment failure or death. Treatment regimens omycin was independently associated with un- were changed in 71 (82%) patients due to severe ad- favourable outcome (logistic regression analysis: verse events or drug resistance. Adverse events odds ratio 3.51). In the treatment of patients with were most commonly attributed to cycloserine, 158 Wissenschaftlicher Jahresbericht 2007-2008 Division of Mycobacteriology and National Reference Center for Mycobacteria Research Reports ethionamide and p-aminosalicylic acid. Extensively to generate and subsequently characterize linezol- drug resistant TB (XDR-TB) was found among 4 of id resistant M. tuberculosis strains by determination the 6 patients who failed treatment and were still of MIC-values, analysis of growth characteristics, alive in November 2006. While acceptable treat- and mutations in the putative target gene. Ten in vit- ment success was achieved, the complexity of treat- ro-selected linezolid-resistant Mycobacterium tu- ment and the development of XDR-TB among treat- berculosis mutants were isolated and character- ment failures are important issues to be addressed ized. Strains with mutations in the 23S rDNA gene when considering scaling up MDR-TB treatment. (G2576T and G2061T) showed decelerated growth and higher levels of MIC (minimal inhibitory con- Collaboration: Cox H, Macfarlane Burnet Institute centration)-values (16 and 32µg/ml) compared to for Medical Research and Public Health, Mel- those without mutations in the 23S rDNA (MIC-values bourne, Australia; Kalon S, Allamuratova S, 4 and 8µg/ml). Médecins Sans Frontières, Tashkent, Uzbekistan; Sizaire V, Médecins Sans Frontières, London, United Kingdom; Tigay ZN,4 Karimovich HA, Ministry of Evaluation of the GenoType® MTBDRplus Assay Health, Karakalpakstan, Uzbekistan; Kebede Y, for rifampicin and isoniazid susceptibility testing Mills C, Médecins Sans Frontières, Amsterdam, The of Mycobacterium tuberculosis strains and in clin- Netherlands. ical specimens Hillemann D, Richter E, Rüsch-Gerdes S. In vitro selected linezolid-resistant Mycobacteri- The worldwide increase of multidrug-resistant tu- um tuberculosis mutants berculosis points out how the importance of timely Richter E, Hillemann D, Rüsch-Gerdes S. identification of resistant Mycobacterium tuberculo- sis (MTBC) strains to achieve effective disease manLinezolid has been a valid alternative drug in the agement and prevention of its spreading. Recently, management of multidrug resistant tuberculosis. It nonradiometric fully automated systems for resist- belongs to an entirely new class of antibiotics, the ance screening were introduced with technical and oxazolidinones, and has a spectrum of activity safety advantages. However, the time for resistance against virtually all important gram-positive testing still is around 7 to 10 days beginning from pathogens. Linezolid interacts with the domain V of the positive culture. The most rapid results could be the 23S rRNA, which is part of the peptidyltrans- achieved by direct testing of patient specimens with ferase center of the ribosome although not inhibiting the peptidyltransferase activity. So far, the first fast molecular methods. DNA strip assays targeting rpoB plus katG (GenoType® MTBDR; Hain Life- in vitro generated linezolid-resistant mycobacteria science, Nehren, Germany) were developed and were M. smegmatis clones. Within these, two class- evaluated for MTB cultures and spear-positive spec- es of mutants were found. Mutants of the first class imens. DNA strip assays are based on a multiplex had alterations in the domain V of 23S rRNA PCR in combination with a reverse hybridization. In (G2447T, according to Escherichia coli numbering order to enlarge the detection capacity of drug re- system), high MIC-values of ≥64 µg/ml, and a de- sistance, a new GenoType® MTBDRplus assay was creased growth rate in culture. The other mutants developed including a broader variety of rpoB showed wild-type growth characteristics in cultures, gene mutations and inhA gene mutations. Covering lower MIC-values of 4-8 µg/ml, and no mutation in mutations in the regulatory region of inhA, it can be the 23S rRNA, pointing to a non-ribosomal mecha- expected that additional INH-resistant strains can nism of resistance. In the present study, we aimed be detected. The aim of the present study was to Wissenschaftlicher Jahresbericht 2007-2008 159 Division of Mycobacteriology and National Reference Center for Mycobacteria Research Reports determine the sensitivity and accuracy of the new The MDR isolate 2 showed RMP resistance in both MTBDRplus assay in comparison to the MTBDRas- assays (MTBDR: omission of rpoB WT5 and positive say for the detection of the presence of INH and for rpoB MUT3; MTBDRplus: omission of rpoB WT8 RMP resistance-associated mutations in rpoB, katG, and positive for rpoB MUT3). Concerning INH re- and inhA from culture specimens and directly from sistance isolate 2 had to be interpreted as INH sus- smear-positive clinical specimens. Compared to the old MTBDR assay the new GenoType® MTBDRplus whereas the MTBDRplus indicated INH resistance assay enhanced the detection of isoniazid resist- (omission of the inhA WT1 probe, positive for the in- ance from 102 (87.8%) to 106 (90.2%) of 116 INH resistant strains. Thus, the new GenoType® MTBDR- hA MUT1 probe). plus assay represents a reliable and upgraded tool Collaboration: Allerheiligen V, Hain Lifescience for the detection of INH and RMP resistance in GmbH, Germany. Fo r s c h u n g s z e n t r u m Bo r s t e l ceptible (katG WT probe) by the MTBDR assay, strains or directly from smear-positive specimens. Mycobacterium bohemicum and cervical lymphadenitis in children Richter E. Members of the genus Mycobacterium are well-established causes of granulomatous lymphadenitis in children. M. bohemicum was first described in 1998 in a patient with Down syndrome. The organism is characterized by a unique 16S rRNA gene sequence and has been isolated from humans, animals, and the environment. We report on 4 cases of cervical lymphadenitis caused by M. bohemicum that occurred in 4 children (2 boys, 2 girls) from Austria during 2002–2006. From all patients, parts of the exFig. 67. Representative patterns of a pansusceptible (lanes 1) and an MDR strain (lanes 2), which had an inhA C15T mutation in the regulatory region of inhA obtained with the new MTBDRplus assay (B) but not the MTBDR (A). The positions of the oligonucleotides and the marker lines are given. The targeted genes and specificity are shown from left to right as follows. The MTBDR assay (A): conjugate control; amplification control; M. tuberculosis complexspecific control; rpoB amplification control; rpoB wild-type probes located in the hotspot region WT1-5; rpoB mutant probes (Mut1, 2A, 2B, and 3) with mutations in codons rpoB D516V, H526Y, H526D, S531L; katG amplification control; katG codon 315 wild-type probe; katG codon 315 mutation probes (MUT1 and MUT2) with AGC-toACC (S315T1) and AGC-to-ACA (S315T2) exchanges. The MTBDR plus assay (A) has additional three rpoB WT probes (resulting in WT 1-8) and targets the regulatory region of the inhA gene with the inhA amplification control; inhA gene wild-type probes WT1 spanning region -9 to -22 and WT from -1 to -12; inhA mutant probes MUT1, 2, 3A and 3B with mutations -15C/T, -16A/G, -8T/C and -8T/A. cised lymph nodes were directly used for culture and M. bohemicum was identified by DNA sequencing of part of the 16S rRNA gene. Nontuberculous mycobacterial cervical lymphadenitis is most frequently caused by M. avium (80%), M. mal- moense, M. kansasii, M. lentiflavum, M. haemophilum, and M. scrofulaceum. Because the phenotypic characteristics of M. bohemicum closely resemble those of M. scrofulaceum, these species can easily be misidentified by analysis of biochemical and cultural features only. M. bohemicum infection has only been reported in 5 patients worldwide. The high rate of 4 cases of M. bohemicum occurring in The pansusceptible isolate 1 was positive with the Austria as a relatively small country (8 million in- wild-type rpoB and katG probes of the MTBDR, and habitants) could be an indication, that infections additionally inhA wild-type probes of MTBDRplus. with M. bohemicum may be more common than 160 Wissenschaftlicher Jahresbericht 2007-2008 Division of Mycobacteriology and National Reference Center for Mycobacteria Research Reports previously thought. More such cases may be dis- the Escherichia coli numbering system) and pheno- covered as a result of improved microbiologic di- typic characteristics group the species among the agnostic techniques. We believe that M. bo- slowly growing mycobacteria.It was proposed to hemicum should be listed among the species that name the new species Mycobacterium alsiense, induce nontuberculous mycobacterial infections. pertaining to the Isle of Als (Denmark), the location Collaboration: Huber J, Eberl, R, Zenz,W, Medical of the hospital to which the first patient was admit- University of Graz, Graz, Austria; Binder L Elisa- ted. bethinen Hospital, Linz, Austria, Maaß, M, UniversiCollaboration: Engel R, Research Center Borstel, ty Hospital Salzburg, Salzburg, Austria. Structural Biochemistry; Tortoli E, Regional Reference Center for Mycobacteria, Careggi Hospital, Mycobacterium alsiense, a novel, slowly growing 50134 Florence, Italy; Kristiansen JE, Hendricks, O, species isolated from two patients with pul- Department of Research and Department of Clini- monary disease cal Microbiology, Sygehus Sønderjutland/ Sønder- Richter E, Hillemann D. borg, University of Southern Denmark, 6400 Sønderborg, Denmark; Fischer A, Schubert, S, Institute A previously undescribed, slowly growing My- for Medical Microbiology and Virology, University cobacterium species was isolated from pulmonary Hospital Schleswig-Holstein, 24105 Kiel. specimens of two patients, one from Denmark and one from Italy. The phenotypic characteristics of the new strain were poorly distinctive. The strain grew Occurrence and clinical relevance of Mycobac- at 25°C to 37°C, but not at 45°C, with a weak yel- terium chimaera sp. nov., Germany low pigment under both light and dark conditions Richter E. on Löwenstein-Jensen and Stonebrink medium. It remained unpigmented on solid Middlebrook 7H10 Bacteria of the Mycobacterium avium complex medium. Mycolic acid methyl esters were analyzed (MAC) play an important role among infections by thin-layer chromatography and revealed the caused by nontuberculous mycobacteria. MAC con- presence of - and keto-mycolic acids, with methoxy- sists of the 2 well-established species, M. avium mycolic acids being present in minor quantities, a (which has 4 subspecies) and M. intracellulare, as common pattern among mycobacterial species. well as several other closely related mycobacteria. Fatty acid methyl esters were identified by Recently, a new species derived from the group of gas/liquid spectrome- unnamed members of the MAC has been defined. try.High-performance liquid chromatography re- It combines features characteristic of different MAC vealed an identical profile characterized by a sin- members and has been named M. chimaera sp. gle, late cluster of peaks grossly resembling My- nov.. Molecular genetic standard tools in clinical mi- cobacterium palustre and Mycobacterium lacus. crobiologic laboratories do not differentiate MAC However, phenotypic characteristics alone do not members. These tools merely provide a rough clas- chromatography-mass allow a clear identification of a new strain. The iso- sification in M. intracellulare and M. avium and/or lates showed unique 16S rRNA internal transcribed the MAC group as a whole. Currently, a detailed spacers and hsp65 sequences: the 16S rRNA was genotyping of MAC is restricted to research labo- most closely related to Mycobacterium szulgai and ratories. Nevertheless, several studies have shown Mycobacterium malmoense. Both genotypic char- that certain serotypes or genotypes were associat- acteristics including the presence of a long helix 18 ed with different clinical manifestations of MAC in- at positions 451 to 482 of 16S rRNA (according to fection concerning the patient groups affected, the Wissenschaftlicher Jahresbericht 2007-2008 161 Division of Mycobacteriology and National Reference Center for Mycobacteria Research Reports localization and course of disease, and the antimi- Krautwald-Junghanns ME, Clinic for Birds and Rep- crobial drug resistance patterns. Retrospective mo- tiles, Faculty of Veterinary Medicine, University of lecular genetic analysis of 166 Mycobacterium in- Leipzig, Leipzig, Germany Fo r s c h u n g s z e n t r u m Bo r s t e l tracellulare isolates showed that 143 (86%) strains could be assigned to Mycobacterium chimaera sp. nov. Of 97 patients from whom M. chimaera sp. nov. NRL activities was isolated, only 3.3% exhibited mycobacterial Rüsch-Gerdes S, Richter, E, Hillemann D, Niemann S. lung disease, whereas all M. intracellulare isolates caused severe pulmonary infections. In recent years the global situation concerning drug resistance has changed dramatically. In order to Collaboration: Schweickert B, Petrich A, Göbel UB, combat this, the NRL has begun as cooperation Buchholz P, Moter A, Charité-Universitätsmedizin, partner/study site to enlarge the activities for the en- Berlin, Germany; Goldenberg O, Transgenomic Ltd., hancement of better diagnostic tools for the rapid Glasgow, Scotland, UK. detection of drug-resistant TB. Especially in collaboration with FIND (The Foundation for Innovative New Diagnostics, Geneva) the improvement, evalu- Transmission of tuberculosis between men and ation and implementation of new diagnostic meth- pet birds: a case report ods was forced in the last years. The NRL is one of Richter E. the international multi-center-study sites (coordinated by FIND) to evaluate new assays for the detec- This case report describes an infection of My- tion and identification of M. tuberculosis as well as cobacterium tuberculosis in an African Grey parrot for resistance testing. Concerning the improvement (Psittacus erithacus erithacus) kept as a pet bird. Di- of TB-Surveillance in Germany the NRL focussed agnosis was confirmed by microbiologic and patho- mainly on the investigation of the epidemiology of logic results, and indicated a human-avian trans- TB. By combining classical and modern molecular mission. Clinical signs included sublingual nodules epidemiological tools the longitudinal studies in resulting in anorexia and signs of osteolysis in the Hamburg, Schleswig-Holstein, and most recently in long bones. Proliferation consisted of several nod- Baden-Württemberg were continued. These studies ules with small greenish-caseous foci in cross-sec- were performed in close cooperation with the pub- tion and revealed a severe granulomatous inflam- lic health offices in the respective regions. Several mation without intralesional acid-fast rods. M. tu- aspects of TB epidemiology were addressed, e.g. berculosis was cultured from a pooled sample of trends in resistance rates, outbreaks, and emer- sublingual and liver nodules, and was confirmed via gence of particular M. tuberculosis strains. Further- polymerase chain reaction. Transmission between more, the molecular strain typing results will be con- men and parrot was proved by spoligotyping pat- nected with the epidemiological data of the RKI. tern analysis. The absence of facial skin lesions and Quality control gets more and more importance in acid-fast rods within the tubercles is contrary to pre- laboratory diagnostic. Therfore, the NRL was asked vious publications of tuberculosis in birds. This dis- to take the lead in the so called “Ringversuch” from ease in a common pet bird species is of zoonotic INSTAND e.V. in Düsseldorf. Since beginning of 2008 importance, and those parrots with close contact to the NRL is responsible for the preparation of spec- owners suffering from tuberculosis may serve as a imens and samples for microscopy, primary detec- potential reservoir for human infection. tion, identification of mycobacteria, and susceptibility testing. After successful establishment of the Collaboration: Schmidt V, Schneider S, Schlomer J, 162 first series now twice a year all samples for app. Wissenschaftlicher Jahresbericht 2007-2008 Division of Mycobacteriology and National Reference Center for Mycobacteria Research Reports 250 national and international laboratories were produced, the results assessed, laboratories certificated and consulted concerning quality improvement. Furthermore, in its function as a Supranational Reference Laboratory for DST, the NRL has broadened its activities concerning inter-laboratory proficiency testing. Meanwhile the NRL performs quality assurance for more than 10 National Reference Laboratories of other countries (e.g. Austria, Kazakhstan, Serbia, and Uganda). One further focus is the support of laboratories implementing new methods by training and attending. In this connection the availability of the proficiency testing samples provided by the NRL aided laboratories in new method performance and implementation. Theses Habilitation Dr. rer. nat. Richter, Elvira für das Fach ‚Mikrobiologie’ Medizinische Fakultät Universität zu Lübeck, 2008. Wissenschaftlicher Jahresbericht 2007-2008 163 Division of Molecular Mycobacteriology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l Division of Molecular Mycobacteriology Head Main Results: For the TST, 40.4% (243/601) of contacts PD Dr. Stefan Niemann were positive at a 5-mm cutoff, whereas only 66 (11%) were QFT positive. QFT positivity, but not TST, was as- Staff Scientists and Postdoctoral Fellows sociated with exposure time (P < 0.0001). Six contacts Dr. Silke Feuerriegel progressed to TB disease within the 2-year follow-up. All were QFT positive and had declined preventive Graduate and Diploma Students treatment, equating to a progression rate of 14.6% Claudia Plinke (6/41) among those who were QFT positive. The pro- Susanne Homolka gression rate for untreated TST-positive subjects was Caterina Sibilia significantly lower (P < 0.003), at 2.3% (5 of 219), and Stefanie Schweinhuber one subject who progressed was TST negative. Conclusions: Results suggest that QFT is a more accurate Technicians indicator of the presence of LTBI than the TST and pro- Lisa Dost vides at least the same sensitivity for detecting those Tanja Ubben who will progress to active TB. The high rate of pro- Petra Vock gression to active TB of those who are QFT positive (14.6%), which is far greater than the 2.3% found for Guests and Trainees those who are TST positive, has health and econom- Claudio Köser, University of Cambridge ic implications for enhanced TB control, particularly if this higher progression rate is seen in studies of other at-risk populations. Research Reports Predictive value of a whole blood IFN-gamma Collaboration: Roland Diel, School of Public Health, assay for the development of active tuberculosis University of Düsseldorf, Düsseldorf, Germany; Robert disease after recent infection with Mycobacteri- Loddenkemper, German Central Committee against um tuberculosis Tuberculosis, Lungenklinik Heckeshorn, HELIOS, Niemann S. Klinikum Emil von Behring, Berlin, Germany; Karen Meywald-Walter, Public Health Department Hamburg- Rationale: Numerous studies have been published on Mitte, Hamburg, Germany; Albert Nienhaus, Institution the new Mycobacterium tuberculosis (MTB)–specific for Statutory Accident Insurance and Prevention in the IFN-gamma release assays. However, their prognos- Health and Welfare Services, Hamburg, Germany. tic value for progression from latent tuberculosis infection (LTBI) to active TB has yet to be established. Objectives: To compare the QuantiFERON-TB Gold In- Molecular evidence of a microepidemy among Tube assay (QFT) with the tuberculin skin test (TST) in Hungarian homeless patients with tuberculosis in recently exposed close contacts of active TB cases Budapest due to a newly identified local My- with respect to their development of TB disease with- cobacterium tuberculosis lineage in 2 years. Methods: Close contacts (n = 601) of MTB- Niemann S. positive source cases underwent both TST and QFT testing and were subsequently observed for 103 In a retrospective study that included 66 homeless (±13.5) weeks. Risk factors for MTB infection were eval- tuberculosis patients representing 47.1% of all home- uated by multivariate analysis. Measurements and less cases notified in Budapest in 2002 in a subset 164 Wissenschaftlicher Jahresbericht 2007-2008 Division of Molecular Mycobacteriology Research Reports of 12 (18.1 %) patients a locally emerged lineage demiological link, were perfectly matched by MIRU- which led to a microepidemy was identified and de- VNTR typing with the 24 loci. Two IS6110 clusters were fined by IS6110 fingerprinting, spoligotyping and split by differences into 6 to 12 MIRU-VNTR loci, clear- mycobacterial interspred repetitive unit typing. ly supporting the absence of a link, as judged by con- These data may serve as a reference to better mon- tact tracing data. In contrast, only one MIRU-VNTR clus- itor and understand the patterns and transmission ter, grouping what were probably epidemiologically dynamics of tuberculosis in this at risk population in unlinked isolates, was split by IS6110 RFLP. However, Hungary. The findings also indicate that tuberculo- these isolates were also distinguished by spoligotyp- sis control and prevention steps among the home- ing. Both the optimized 24-locus and 15-locus sets thus less need to be strengthened. showed a comparable to slightly better predictive value, especially when combined with spoligotyping, Collaboration: Csaba Ködmön, National Public Heal- than the current gold standard IS6110 RFLP for the th and Medical Officers Service, Miskolc, Hungary; study of tuberculosis transmission in Hamburg. Be- Cristina M. Gutierrez, Centre National de Reference cause the epidemiological characteristics of this set- des Mycobacteries, Institute Pasteur, Paris, France; ting are similar to those of many developed countries, Cristophe Sola, Unité de la Tuberculose et des Myco- these results support the wide applicability of this re- bactéries, Institut Pasteur de Guadeloupe, Pointe-á- al-time genotyping approach for population-based Pitre, Guadeloupe; Judit Lukács, Ákos Somoskövi; De- studies of M. tuberculosis transmission partment of Respiratory Medicine, School of Medicine, Semmelweis University, Budapest, Hungary. Collaboration: Sabine Rüsch-Gerdes, National Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany; Mara Cardoso Oele- Assessment of an optimized mycobacterial inter- mann, Philip Supply, Vincent Vatin, Camille Locht, In- spersed repetitive-unit-variable-number tandem- stitut Pasteur de Lille, Lille, France; Roland Diel, repeat typing system combined with spoligoty- School of Public Health, University of Düsseldorf, ping for population-based molecular epidemio- Düsseldorf, Germany; Walter Haas, Department for logy studies of tuberculosis Infectious Disease Epidemiology, Robert Koch-Insti- Niemann S. tut, Berlin, Germany. An optimized set of 24 mycobacterial interspersed Supported in part by: Germany Ministry of Health, repetitive-unit-variable-number tandem-repeat (MIRU- Berlin, Germany; the Robert Koch Institute, Berlin, VNTR) loci, including a discriminatory subset of 15 loci, Germany; INSERM and Institut Pasteur de Lille, has recently been defined for the typing of Mycobac- France; and the European Community (grant QLK2- terium tuberculosis. Here, we evaluated the perform- CT-2000-00630). ances of this MIRU-VNTR typing system in combination with spoligotyping for the detection of transmission chains in a population-based study comprising 91% of Evaluation and strategy for use of MIRU-VNTRplus, culture-confirmed tuberculosis patients reported in a multifunctional database for online analysis of ge- 2003 in Hamburg, Germany. Of the 154 isolates in- notyping data and phylogenetic identification of vestigated, more than 90% had high IS6110 copy num- Mycobacterium tuberculosis complex isolates bers (6). IS6110 restriction fragment length polymor- Niemann S. phism (RFLP) typing resulted in 13 clusters, 5 of which had a confirmed epidemiological link. All five, as well Because of its portable data, discriminatory power, as six of the eight IS6110 clusters with no identified epi- and recently proposed standardization, mycobac- Wissenschaftlicher Jahresbericht 2007-2008 165 Division of Molecular Mycobacteriology Research Reports terial interspersed repetitive-unit-variable-number The results can easily be exported. In the present tandem-repeat (MIRU-VNTR) typing has become a study, we evaluated the database consistency and major method for the epidemiological tracking of My- various analysis parameters both by testing the ref- cobacterium tuberculosis complex (MTBC) clones. erence collection against itself and by using an ex- However, no public MIRU-VNTR database based on ternal population-based data set comprising 629 dif- well-characterized reference strains has been avail- ferent strains. Under the optimal conditions found, lin- able hitherto for easy strain identification. Therefore, eage predictions based on typing by 24-locus MIRU- a collection of 186 reference strains representing the VNTR primary MTBC lineages was used to build a data- spoligotyping were verified in >99% of the cases. On base, which is freely accessible at http://www.MIRU- the basis of this evaluation, a user strategy was de- VNTRplus.org. The geographical origin and the drug fined, which consisted of best-match analysis fol- susceptibility profile of each strain were stored to- lowed, if necessary, by tree-based analysis. The gether with comprehensive genetic lineage informa- MIRU-VNTRplus database is a powerful tool for high- tion, including the 24-locus MIRU-VNTR profile, the resolution clonal identification and has little equiva- spoligotyping pattern, the single-nucleotide- and lent in terms of functionalities among the bacterial large-sequence-polymorphism profiles, and the genotyping databases available so far. Fo r s c h u n g s z e n t r u m Bo r s t e l analysis optionally combined with IS6110 restriction fragment length polymorphism fingerprint. Thanks to flexible import functions, a single Collaboration: Caroline Allix-Béguec, Genoscreen, 1, or multiple user strains can be analyzed, e.g., for lin- rue du Professeur Calmette, Lille 59019 Cedex, eage identification with or without the use of refer- France; Dag Harmsen, Thomas Weniger, Department ence strains, by best-match or tree-based analyses of Periodontology, University Hospital Münster, with single or combined marker data sets. Waldeyerstrasse 30, Münster, Germany; Philip Supply, Institut Pasteur de Lille, 1, rue du Professeur Calmette, Lille 59019 Cedex, France. Supported in part by: INSERM, the Institut Pasteur de Lille, Lille, France, the Germany Ministry of Health and the German Federal Ministry for Education and Research (BMBF) within the PathoGenomikPlus Network. Fig. 68. Phylogenetic composition of the Mycobacterium tuberculosis complex. A radial tree was constructed by using the 24-locus MIRUVNTR typing data for the reference strains in the MIRU-VNTRplus database and 187 genotypes with unassigned or T spoligotypes from the Brussels population-based collection by using the neighbour-joining algorithm and categorical distance coefficient. The positions of Brussels genotypes with unassigned or T spoligotypes are indicated by yellow circles. Lineages containing exclusively T-spoligotype strains or lineages corresponding to well-characterized, classical clades of the Euro-American superlineage (such as the Haarlem lineage) comprising T-spoligotype strains are denoted T-specific and T-aspecific, respectively. EAI, East African-Indian; West Afri 2, West African 2 (M. africanum 2); West Afri 1, West African 1 (M. africanum 1); Tur, Turkish; BJ, Beijing; CAS, Central Asian; LAM, Latin American-Mediterranean. The data were analyzed by using the MIRU-VNTRPlus Webseite (www.miru-vntrplus.org). Originally published in JCM 2008 46:2692-2699. 166 Wissenschaftlicher Jahresbericht 2007-2008 Division of Molecular Mycobacteriology Research Reports Emergence and transmission of second line drug Risk of acquired drug resistance during short- resistant Mycobacterium tuberculosis complex course directly observed treatment of tuberculo- strains in Germany sis in an area with high levels of drug resistance Niemann S, Rüsch-Gerdes S. Niemann S, Rüsch-Gerdes S. Background. Drug resistant tuberculosis (TB) has be- Background. Data on the performance of stan- come a serious challenge for global TB control. dardized short-course directly observed treatment High rates of resistant and multidrug resistant (MDR, (DOTS) of tuberculosis (TB) in areas with high levels resistance to at least isoniazid and rifampin) M. tu- of drug resistance and on the potential impact of berculosis complex (MTBC) strains have been doc- DOTS on amplification of resistance are limited. umented in several “hot spot” areas around the Therefore, we analyzed treatment results from a world. Additionally, increasing rates of second line cross-sectional sample of patients with TB enrolled drug resistance have been reported and an out- in a DOTS program in an area with high levels of break of an extensively resistant (XDR, defined as drug resistance in Uzbekistan and Turkmenistan in MDR plus resistance to any fluoroquinolone and in- Central Asia. jectable drugs) strain in South Africa has attracted Methods. Sputum samples for testing for suscepti- world wide attention. Therefore, representative da- bility to 5 first-line drugs and for molecular typing ta on the prevalence and spread of second line were obtained from patients starting treatment in 8 drug resistant TB are urgently needed to develop districts. Patients with sputum smear results positive more effective TB control strategies. for TB at the end of the intensive phase of treatment Methods. Second line drug resistance testing and and/or at 2 months into the continuation phase molecular typing (IS6110 DNA fingerprinting and were tested again. spoligotyping) will be performed for MDR strains. Results. Among 382 patients with diagnoses of TB, Results. In the study period, more than 700 MDR 62 did not respond well to treatment and were strains were notified at the NRC. So far, a significant found to be infected with an identical Mycobacteri- number of second line drug resistant strains could um tuberculosis strain when tested again; 19 of be determined. In year 2005, 40% of the MDR strains these patients had strains that developed new or showed additional resistance to prothionamide, additional drug resistance. Amplification occurred 10% were additionally resistant to amikacin, and in only 1.2% of patients with initially susceptible or 12% showed additional resistance to capreomycin. monoresistant TB strains, but it occurred in 17% of DNA fingerprinting revealed that an increasing those with polyresistant strains (but not multidrug-re- number of strains belonged to the Beijing genotype. sistant strains, defined as strains with resistance to Transmission of second line resistant strains could at least isoniazid and rifampicin) and in 7% of those be documented. Further analyses are in progress. with multidrug-resistant strains at diagnosis. Overall, Conclusions. Our preliminary data already docu- 3.5% of the patients not initially infected with mul- mented a significant number of second line drug re- tidrug-resistant TB strains developed such strains sistance among MDR strains investigated. The Bei- during treatment. Amplification of resistance, how- jing genotype, which has been shown to be a ma- ever, was found only in polyresistant Beijing geno- jor cause of resistant TB in several high incidence type strains. settings, is also frequent among MDR strains from Conclusions. High levels of amplification of drug re- Germany. sistance demonstrated under well-established DOTS program conditions reinforce the need for implementation of DOTS-Plus for multidrug-resistant TB in areas with high levels of drug resistance. The Wissenschaftlicher Jahresbericht 2007-2008 167 Division of Molecular Mycobacteriology Research Reports strong association of Beijing genotype and amplifi- ofloxacin resistance amplification, while strains cation in situations of preexisting resistance is strik- from 4 patients displayed different DNA fingerprints ing and may underlie the strong association be- during treatment, 3 of which matched those of co- tween this genotype and drug resistance. hospitalised patients. A final patient with ofloxacin Fo r s c h u n g s z e n t r u m Bo r s t e l resistance was found to have a mixed infection durCollaboration: Helen S. Cox, Australian Internatio- ing treatment, also potentially indicating reinfection. nal Health Institute, University of Melbourne, Aus- Pre-existing second line resistance and severe clin- tralia; Gabit Ismailov, Juan Daniel Orozco, Daribay ical condition were associated with amplification of Doshetov, Médecins Sans Frontières and Ministry of ofloxacin resistance, while poor treatment adher- Health, Nukus, Karakalpakstan; Lucie Blok, Méde- ence was not found to be a significant contributor. cins Sans Frontières, Amsterdam. Conclusions: Ofloxacin resistance and XDR-TB emerging during treatment for MDR-TB was caused Supported in part by: Robert-Koch-Institute (Berlin, by both amplification and exogenous nosocomial Germany), the European Union Concerted Action reinfection. The emergence of XDR-TB during sec- project (QLK2-CT-2000-00630), and the World Health ond line MDR-TB treatment is alarming and has im- Organization. plications for the scale up of such treatment. Development of ofloxacin and XDR tuberculosis during MDR-TB treatment is caused by resistance amplification and exogenous reinfection Sibilia K, Schmidt S, Rüsch-Gerdes S, Niemann S. Background: While there is an urgent need to scale up the provision of treatment for multidrug resistant tuberculosis (MDR-TB) internationally, limited data exists on the emergence of extensively drug resistant TB (XDR-TB) during currently recommended second line treatment. Method: The development of ofloxacin resistance and XDR-TB during MDR-TB treatment with a regimen containing at least 5 drugs to which the strain was presumed to be susceptible was assessed in a cohort of 87 patients treated in Karakalpakstan, Uzbekistan. Isolates from patients at baseline and Fig. 69. IS6110 DNA fingerprint patterns of the 4 isolates displaying ofloxacin resistance amplification during therapy (A, patient 9) and those from patient 14 potentially reinfected with a second strain from patient 10 during his stay in the hospital in Karakalpakstan (Uzbekistan) (B). Resistance is displayed by a black box. Abbreviations: H=Isoniazid, R=Rifampicin, E=Ethambutol, P=Pyrazinamide, S=Streptomycin, Ofx=Ofloxacin, Cm=Capreomycin, Eto=Ethionamide, Cs=Cycloserine, PAS=p-aminosalicylic acid, Am=Amikacin. Originally published in N Engl J Med. 2008 359(22):2398-400. during treatment underwent drug susceptibility test- Collaboration: Helen S. Cox, Burnet Institute for ing and DNA fingerprinting. Medical Research and Public Health, Melbourne, Results: While none of the 87 patients displayed Australia; Stobdan Kalon, Jonny Polonsky, Médecins ofloxacin resistance at baseline, isolates from 18 Sans Frontières, Karakalpakstan, Nukus, Uzbekistan; patients (21%) developed ofloxacin resistance dur- Zinaida N. Tigay, Hamraev A. Karimovich, Ministry ing treatment, with 10 (11%) defined as XDR-TB. On- of Health, Nukus, Karakalpakstan, Uzbekistan; Clair ly 5 (28%) of these patients were successfully treat- Mills, Médecins Sans Frontières, Amsterdam, The ed. Isolates from 13 patients had identical DNA fin- Netherlands. gerprints 168 throughout treatment representing Wissenschaftlicher Jahresbericht 2007-2008 Division of Molecular Mycobacteriology Research Reports Supported in part by: German Ministry of Health. Health and the Robert-Koch-Institute, Berlin, Germany. Tuberculosis ethambutol resistance: Concor- Analyses of mutations conferring resistance to dance between phenotypic and genotypic test re- second-line drugs in Mycobacterium tuberculosis sults strains from a high incidence region Plinke C, Rüsch-Gerdes S, Niemann S. Feuerriegel S., Rüsch-Gerdes S, Niemann S. Mutations in the embB306 codon of Mycobacterium Background. Resistance to second-line drugs (fluoro- tuberculosis are potential markers for detecting re- quinolones and injectable aminoglycosides) has be- sistance to ethambutol. However, more recently, em- come a serious problem for the treatment of My- bB306 mutations have been found in ethambutol cobacterium tuberculosis infections. Resulting XDR-tu- susceptible isolates and an association with broad berculosis implies an enormous threat for tuberculosis drug resistance rather than ethambutol resistance control worldwide. It is therefore of great importance has been reported. To further investigate this ques- to analyze the genetic basis of clinical resistance. tion, we analyzed the association between em- Methods. M. tuberculosis strains from a high-inci- bB306 mutations and phenotypic ethambutol re- dence region in Uzbekistan (Karakalpakstan) which sistance among isolates from a cross-sectional drug displayed resistance to ofloxacin (n = 56) and to resistance survey carried out in Karakalpakstan, capreomycin and/or amikacin (n = 111), respective- Uzbekistan. Among 197 strains analyzed, 40 (20%) ly, were sequenced concerning the resistance de- had an embB306 mutation, out of which 32 were termining regions (gyrA, gyrB, rrs, tlyA). 25 of the EMB resistant also. Among the eight strains with dis- strains showed resistance to both second-line drugs crepant results, one was found to have an embB306 and were therefore XDR-TB. wild type sequence and seven were tested EMB re- Results. The most common mutation seen among sistant after re-analysis. All of these had an in- ofloxacin resistant strains is the substitution of as- creased ethambutol MIC, however, for three strains partic acid to glycine at codon 94 (32.1 %) followed it was below the critical concentration of 2 µg/ml. by the substitution of alanine to valine at codon 90 Furthermore, in four strains we confirmed the pres- (30.4 %) in the gyrA region. 17.9 % of the ofloxacin re- ence of heteroresistant mixed populations which sistant strains display substitutions of aspartic acid might also influence conventional ethambutol test- other than glycine at codon 94 and changes of ser- ing.Our results confirm that embB306 mutations are ine for proline at codon 91 in gyrA, respectively. Two useful markers for predicting ethambutol resistance. ofloxacin resistant strains show SNPs in gyrB at Discrepancies between molecular and phenotypic codon ethambutol resistance test results are most likely 543 (GCG ACG), respectively, that have not been re- caused by problems with conventional susceptibili- ported previously. Concerning resistance to amikacin ty testing mainly due to the small increase of the and capreomycin the most common mutation seen is MIC observed in some ethambutol resistant strains. the substitution of nucleotide adenine to guanine at 485 (CGT TGT) and at codon position 1401 (67.6 %) in rrs followed by a change of Collaboration: Helen S. Cox, Macfarlane Burnet Insti- cytosine to thymine at position 1402 (2.7 %). tute for Medical Research and Public Health, Aus- Conclusion. This is the first study analyzing tralia; Stobdan Kalon, Médecins Sans Frontières, M. tuberculosis strains from a high-incidence region Uzbekistan; Daribay Doshetov, Ministry of Health, for fluoroquinolone and aminoglycoside resistance Karakalpakstan, Uzbekistan. Funding: Parts of this determining mutations. In addition to the previous- work were supported by the Germany Ministry of ly described mutations, new SNPs in gyrB and tlyA Wissenschaftlicher Jahresbericht 2007-2008 169 Division of Molecular Mycobacteriology Research Reports were detected, whose impact needs to be further population structure of MTBC strains shows an in- elucidated. Sequence analysis in general is of great triguing diversity. M. africanum is still a significant importance for the rapid detection of XDR strains. cause of TB in the study region; however, the ma- Fo r s c h u n g s z e n t r u m Bo r s t e l jority of strains belong to the M. tuberculosis Euro Collaboration: Helen Cox, Macfarlane Burnet Insti- American lineage further divided in six sublineages. tute for Medical Research and Public Health, Australia; Stobdan Kalon, 3Médecins Sans Frontières, Karakalpakstan, Uzbekistan; Zinaida Tigay, Ministry of Health, Tashkent, Uzbekistan; Clair Mills, Médecins Sans Frontières, Amsterdam, The Netherlands. High genetic diversity among Mycobacterium tuberculosis complex strains from Sierra Leone Homolka S, Rüsch-Gerdes S, Niemann S. Pathogens of the Mycobacterium tuberculosis complex (MTBC) remain one of the leading infectious killers worldwide. Among tuberculosis (TB) high incidence regions, Sub Saharan Africa is particularly affected with approx. 1.6 million new cases every year. Besides this dramatic situation, data on the diversity of MTBC strains causing this epidemic in this area are only sparsely available. Here we analyzed Fig. 70. Population structure of clinical M. tuberculosis complex isolates from Sierra Leone. Minimum spanning tree based on the diversity of MIRU-VNTR data. Circles show the different clonal complexes identified (maximum neighbour distance: 4 changes; minimum size: 2 MIRU-VNTR types) by the set of 24 loci among the 97 MTBC strains analyzed. The size of each circle is proportional with the number of MIRU-VNTR types belonging to a particular complex. Colours indicate strain previous classification (Table 2). EAI, M. tuberculosis East African Indian; LAM, M. tuberculosis Latin American Mediterranean. Originally published in BMC Microbiology 2008, 8:103. the population structure of MTBC strains from Sierra Leone with a special focus on the prevalence of Collaboration: Erik Post, Barbara Oberhauser, Ger- M. africanum. A total of 97 strains isolated from man Leprosy and TB Relief Association, Würzburg, smear positive cases registered for re-treatment in Germany; Abu Garawani George, Lars Westman, the Western Area and Kenema districts in years National Leprosy/TB Reference Laboratory, Free- 2003/2004 were investigated by susceptibility test- town, Sierra Leone; Foday Dafae, National Program ing (first line drugs) and molecular typing (IS6110 Manager for Tuberculosis and Leprosy, Freetown, DNA fingerprinting, spoligotyping, and MIRU-VNTR Sierra Leone. typing). Among the strains analyzed, 32 were re- Funding: Parts of this work were supported by the sistant to isoniazid, and 11 were multidrug resistant Germany Ministry of Health and the German Fed- (at least resistant to isoniazid and rifampin). The eral Ministry for Education and Research (BMBF) most prominent genotype found, was M. africanum within the PathoGenomikPlus Network. West African-2 (n=17), followed by M. tuberculosis Haarlem (n=14), LAM (n=11), M. africanum West African-1 (n= 6), M. tuberculosis EAI (n=4), Beijing Pulmonary tuberculosis: Virulence of Mycobacteri- (n=4), S (n=4) and Cameroon genotype (n=4). Fur- um africanum and relevance in HIV co-infection thermore, two new genotypes Sierra Leone-1 and - Kubica T, Rüsch-Gerdes S, Niemann S. 2 were found, that represent 7 % and 10 % of all isolates, respectively. In conclusion, resistance rates in Although Mycobacterium africanum is being isola- Sierra Leone have reached an alarming level. The ted in a significant proportion of cases of pul- 170 Wissenschaftlicher Jahresbericht 2007-2008 Division of Molecular Mycobacteriology Research Reports monary tuberculosis in West Africa, its pathogenic versity of Science and Technology, Kumasi, Ghana; potential remains a matter of discussion. Recent re- Margaret Amanua Chinbuah, John Gyapong, Ivy ports leave the question of whether M. africanum Osei, Health Research Unit, Ghana Health Service, causes more severe pathology than M. tuberculosis Accra, Ghana. or resembles opportunistic pathogens and might gain importance in the course of the HIV pandem- Supported in part by: German Federal Ministry of ic. Patients with pulmonary tuberculosis associated Education with M. africanum (n = 556) and M. tuberculosis Genome Research Network (NGFN1; Project (n = 1350) were studied in Ghana, West Africa, and 01GS0162). and Research, German National compared regarding self-reported signs and symptoms, chest radiography, HIV status, mycobacterial drug resistance and mycobacterial clustering as de- Origin, spread and demography of the My- termined by spoligotyping and IS6110 fingerprints. cobacterium tuberculosis complex The rate of M. africanum infections was similar in Wölbeling F, Kubica T, Niemann S. HIV-positive (27 %) and HIV-negative (30 %) patients. M. africanum clustered less than M. tuberculosis (21 % vs 79 %; OR, 0.38; 95% CI, 0.3–0.5; p < 0.001) corresponding to its lower prevalence (29 % vs 70 %). Clinically and radiographically, no significant differences were found except that M. africanum caused lower-lobe disease less frequently than M. tuber- culosis (OR, 0.39; 95% CI, 0.2–0.7; pc = 0.01), whereby this association applied to HIV-negative patients only. No difference in virulence, as assessed by the severity of radiological presentation, was found when the two M. africanum subtypes West African 1 and West African 2 were compared. In the population studied, M. africanum closely resembled M. tuberculosis in pathology and cannot be considered an opportunistic pathogen. Collaboration: Christian G. Meyer, Thorsten Thye, Rolf D. Horstmann, Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Genevieve Scarisbrick, De- Fig. 71. Mycobacterium tuberculosis complex (MTBC) evolutionary scenario (out of Mesopotamia). The main migration events are numbered and correspond to: 1, M. prototuberculosis, the ancestor of the MTBC, this bacterium reached the Fertile Crescent some 40,000 years ago by sea or land; 2 and 3, two distinct basal lineages arose, EAI and LAM and spread out of Mesopotamia some 10, 000 years ago; 4, 5 and 6, later on (8–5000 years ago) derived populations from clade 1 followed main human migration patterns to Africa, Asia and Europe, giving rise to locally adapted tubercle strains and further diversifications. Note that the depicted borders are “artificial” and are used for the demonstration. Global movements and intercontinental exchanges tend to blur this phylogenetic signal though strong enough to be detected nowadays. Originally published in Plos Pathog 2008 4(9): e1000160. partment of Radiology, Komfo Anokye Teaching Hospital, Kumasi, Ghana; Edmund N.L. Browne, El- The evolutionary timing and spread of the My- lis Owusu-Dabo, Department of Community Health, cobacterium tuberculosis complex (MTBC), one of School of Medical Sciences, Kwame Nkrumah Uni- the most successful groups of bacterial pathogens, Wissenschaftlicher Jahresbericht 2007-2008 171 Division of Molecular Mycobacteriology Research Reports remains largely unknown. Here, using mycobacter- High functional diversity in Mycobacterium tuber- Fo r s c h u n g s z e n t r u m Bo r s t e l ial tandem repeat sequences as genetic markers, culosis driven by genetic drift and human de- we show that the MTBC consists of two independ- mography ent clades, one composed exclusively of M. tuber- Homolka S, Niemann S. culosis lineages from humans and the other composed of both animal and human isolates. The lat- Mycobacterium tuberculosis infects one third of ter also likely derived from a human pathogenic lin- the human world population and kills someone eage, supporting the hypothesis of an original every 15 seconds. For more than a century, scien- human host. Using Bayesian statistics and experi- tists and clinicians have been distinguishing be- mental data on the variability of the mycobacterial tween the human- and animal-adapted members markers in infected patients, we estimated the age of the M. tuberculosis complex (MTBC). However, of the MTBC at 40,000 years, coinciding with the ex- all human-adapted strains of MTBC have tradi- pansion of “modern” human populations out of tionally been considered to be essentially identi- Africa. Furthermore, coalescence analysis revealed cal. We surveyed sequence diversity within a glob- a strong and recent demographic expansion in al- al collection of strains belonging to MTBC using most all M. tuberculosis lineages, which coincides seven megabase pairs of DNA sequence data. We with the human population explosion over the last show that the members of MTBC affecting humans two centuries. These findings thus unveil the dy- are more genetically diverse than generally as- namic dimension of the association between hu- sumed, and that this diversity can be linked to hu- man host and pathogen populations. man demographic and migratory events. We further demonstrate that these organisms are under Collaboration: Sabine Rüsch-Gerdes, National Ref- extremely reduced purifying selection and that, as erence Center for Mycobacteria, Research Center a result of increased genetic drift, much of this ge- Borstel, Borstel, Germany; Thierry Wirth, Falk Hilde- netic diversity is likely to have functional conse- brand, Ecole Pratique des Hautes Etudes, Muséum quences. Our findings suggest that the current in- National d’Histoire Naturelle, UMR-CNRS 5202, Dé- creases in human population, urbanization, and partement Systématique et Evolution, Paris, France ; global travel, combined with the population ge- Caroline Allix-Béguec, Institut Pasteur de Bruxelles, netic characteristics of M. tuberculosis described Laboratoire Tuberculose et Mycobactéries, Brussels, here, could contribute to the emergence and Belgium; Kristin Kremer, Dick van Soolingen, Na- spread of drug-resistant tuberculosis. tional Institut of Public Health and Environment, Bilthoven, The Netherlands; , Camille Locht, Philip Collaboration: Ruth Hershberg, Mikhail Lipatov, Supply, Institut Pasteur de Lille, Lille, France; Sylvain Hadar Sheffer, Dmitri A. Petrov, Marcus W. Feldman, Brisse, Institut Pasteur, Genotyping of Pathogens Department of Biology, Stanford University, Stan- and Public Health, Paris, France; Axel Meyer, ford, California, United States of America; Peter M. Lehrstuhl für Zoologie und Evolutionsbiologie, De- Small, Institute for Systems Biology, Seattle, Wash- partment of Biology, University of Konstanz, Kon- ington, United States of America; Jared C. Roach, stanz, Germany. Seattle Children’s Hospital Research Institute, Seattle, Washington, United States of America; Kristin Supported in part by: Germany Ministry of Health and Kremer, Mycobacteria Reference Unit (CIb-LIS), Na- the German Federal Ministry for Education and Re- tional Institute of Public Health and the Environment, search (BMBF) within the PathoGenomikPlus Network. Bilthoven, The Netherlands; Sebastien Gagneux, MRC National Institute for Medical Research, London, United Kingdom. 172 Wissenschaftlicher Jahresbericht 2007-2008 Division of Molecular Mycobacteriology Research Reports Supported in part by: Wellcome Trust and by Na- will be further explored. tional Institutes of Health (NIH grant AI34238), by Conclusions. The genetic diversity among MTBC NIH grant GM28016, by the German Ministry of strains appears to be higher than previously antici- Health and Ministry for Education and Research pated and might have functional consequence as (BMBF) within the PathoGenomikPlus Network, already indicated by differences in virulence model by NIH grant 5K08AI056092, by the Medical systems. Research Council, UK and by NIH grant HHSN266200700022C. Collaboration: Sabine Rüsch-Gerdes, National Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany; Norbert Reiling, Kerstin Genetic and biological diversity of clinical Walter, Stefan Ehlers, Molecular Infection Biology, Mycobacterium tuberculosis complex strains Research Center Borstel, Borstel, Germany; Corde- Homolka S, Niemann S. lia Arndt-Sullivan, Klaus-Peter Pleissner, Stefan Kaufmann, 3Max Planck Institute for Infection Biology, Background. Pathogens of the Mycobacterium tu- Berlin, Germany. berculosis complex (MTBC; causative agents of tu- Supported in part by: German Ministry of Health berculosis [TB]) remain one of the leading infectious and Ministry for Education and Research (BMBF) killers worldwide. Only recently, fine molecular typ- within the PathoGenomikPlus Network. ing has indicated that the genetic heterogeneity among MTBC isolates, albeit relatively low, influences the transmissibility and virulence of clinical ALOX5 variants associated with susceptibility to isolates as well as the induced immune response. human pulmonary tuberculosis However, only limited information about the under- Niemann S. lying pathogenomic mechanisms is available. In this work we have used a combination of different The 5-lipoxygenase (ALOX5)-derived lipid media- experimental approaches to further investigate the tors leukotrienes and lipoxins have regulatory func- genetic and biological diversity of clinical MTBC iso- tions in inflammation by modulating activities of im- lates. Results. Based on the analysis of a collection of 176 mune cells and cytokine production. Recently, it was shown in ALOX5–/– mice that host control of My- strains we were able to define main phylogenetic cobacterium tuberculosis is regulated by 5-lipoxy- lineages that show a geographic sub-structuring genase (5-LO). ALOX5 polymorphisms were geno- with distinct African, Asian and an African-European typed in 1916 sputum-positive patients with pul- branching. The genetic diversity was further ex- monary tuberculosis (TB) from Ghana and in 2269 plored by multi locus sequence typing that revealed exposed, apparently healthy controls. Polymor- lineage specific SNPs with potential functional im- phisms of a variable number of tandem repeats plications. To investigate pathogenetic properties of (VNTR) of the ALOX5 promoter and of the exonic strains of different lineages, a standardized culti- non-synonymous variant g.760G>A were analysed vation system was established that allows a com- by fragment length determination and fluorescence parative transcriptome and proteome analysis as resonance energy transfer, respectively, and DNA well as investigations in virulence model systems. sequencing. Mycobacterial lineages of >1400 iso- First experiments e.g. with murine macrophages lates were differentiated biochemically and genet- and in a low dose aerosol infection mouse model ically. Carriers of one variant (n repeats 5) and one already revealed pathogenomic differences in in- wild-type VNTR allele (n = 5) or of the exonic allele dividual clinical strains of particular genotypes that g.760A had a higher risk of TB [Pcorrected = 0.026, Wissenschaftlicher Jahresbericht 2007-2008 173 Division of Molecular Mycobacteriology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l odds ratio (OR) 1.19 (95 % CI 1.04–1.37) and Pcorrected = 0.026, OR 1.21 (95 % CI 1.04–1.41), respectively]. The association of the exonic variant was stronger in infections caused by the mycobacterial lineage M. africanum West-African 2 [Pcorrected = 0.024, OR 1.70; (95 % CI 1.2–2.6)]. Determination of haplotypes revealed the strongest associaton with TB for the ‘non-5/760A’ haplotype compared with the ‘non-5/760G’ haplotype (P = 0.003, OR 1.50). Our observation of an association of ALOX5 variants with susceptibility to TB contributes evidence of the importance of 5-LO products to the regulation of immune responses to M. tu- berculosis. Collaboration: Sabine Rüsch-Gerdes, National Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany; Florian Herb, Thorsten Thye, Rolf D. Horstmann, Christian G. Meyer, Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Edmund N.L. Browne, Ellis Owusu-Dabo, Margaret A. Chinbuah, Department of Community Health, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; John Gyapong, Ivy Osei, Health Research Unit, Ghana Health Service, Accra, Ghana; Oliver Werz, Department of Pharmaceutical Analytics, Institute of Pharmacy, Eberhard Karls University, Tuebingen, Germany. Supported in part by: German Federal Ministry of Education and Research, German National Genome Research Network (NGFN1; Project 01GS0162; NGFN2, NIE-S17. Theses Bachelor of Science Schweinhuber, Stefanie Genomische Diversität klinischer Mycobacterium tuberculosis Komplex Isolate Studiengang Molecular Life Science Universität zu Lübeck, 2007. 174 Wissenschaftlicher Jahresbericht 2007-2008 Division of Molecular and Clinical Allergology Research Reports Division of Molecular and Clinical Allergology Head Research Reports Dr. Wolf-Meinhard Becker Degradation, processing and transmission of the major grass pollen allergen Phl p 1 at the respi- Associated Physician ratory interphase Dr. Gabriele Berger (Clinical and Paediatric Aller- Petersen A, Becker W-M. gology) The respiratory epithelium forms the first line of conPrinciple Investigators tact and interaction between airborne particles, Prof. Dr. A. Petersen e.g. pollen, their released proteins and the innate Dr. F. Schocker (since 01.09.2008) immune system. At this level the induction of immune responses is initiated. We focused on the fate Graduate and Diploma Students of timothy grass pollen allergen Phl p 1 and its mo- Susanne Krause (née Riecken) (until 10/2008) lecular modifications after contact with the respira- Sandara Rennert tory interface. To investigate the influence of mucosal secretion, immunoblotting and zymography Technicians was performed. The allergen uptake and transmis- Marisa Böttcher sion by epithelial cells were studied by FACS analy- Stefanie Fox (until 05/2008) sis, confocal microscopy and determinations of cy- Maren Hohn (since 9/2008) tokine release and immunohistology. Mucosal se- Daniela Warneke cretions, e.g. nasal secretions of patients suffering from bronchial inflammations or allergy to aeroal- Guest and Trainees lergens, revealed proteolytic activity. Also super- Florian Wölbeling, Master student, Life sciences at natants from mast cells or neutrophils, a situation the University of Lübeck, Master practical course similar to acute inflammation, cause a partial cleav- (6 weeks, 11/06 – 2/07): Untersuchungen zum Nach- age of the Phl p 1. To analyze the allergen uptake weis von Erdnussallergen-Fragmenten in der Mut- by epithelial cells, two cell lines were used that rep- termilch. resent different regions of the lung: A549 (derived Anika Gallinger, Master student, Life sciences at the from alveolar pneumocytes) and Calu-3 (from the University of Lübeck, Master practical course upper respiratory epithelium). Both cell lines were (6 weeks, 11/07 – 2/08): Strukturelle Untersuchung activated by Phl p 1 as demonstrated by the release proteolytischer Fragmente des Gräserpollenaller- of IL-8 and IL-6. A549 cells take up the allergen into gens Phl p 1. vesicles, which are not associated to lysosomes Jana Schlenk, Diploma student, Biology at the Uni- (macropinocytosis). Afterwards the allergen is re- versity of Kiel, Practical course (6 weeks, 8/07 – leased into the culture medium in a time-dependent 10/07): Untersuchung der RNase-Aktivität des Erd- manner. In contrast, Calu-3 cells revealed colocal- nussallergens Ara h 8. ization of Phl p 1 and lysosomes as demonstrated Dr. Marija Gavrovic-Jankulovic, Faculty of Chemistry, by using confocal microscopy (probably accessory Dept. Biochemistry, University of Belgrade, Serbia antigen presenting cells). Additionally, Calu-3 cells (11/08) express MHCII molecules on the cell surface, which is a prerequisite for antigen processing and presentation. Wissenschaftlicher Jahresbericht 2007-2008 175 Division of Molecular and Clinical Allergology Research Reports To examine the allergen uptake under more physio- ized concerning their structure, immunogenicity and logical conditions, biopsies were taken from different function. For estimation of the molecular mass, ex- regions of the human lung, incubated with Phl p 1 tract and Phl p 1 samples were analysed by gelfil- and immunostained. Only low amounts of antigen tration. We determined complexes of up to 500 kDa, were taken up in the alveolar regions, while the al- but about 50% of the proteins still revealed molecu- lergen uptake of the epithelial cells in the bronchial lar masses of 60 - 10 kDa. The immunogenicity was sections was stronger. However, macrophages in the determined by Western blotting using patients’ sera alveolar space showed a considerable antigen up- and monoclonal antibodies. The binding patterns of take. The secretions of the respiratory tract cause an the HCHO treated samples were quite similar to incomplete fragmentation of allergens which may fa- those of the untreated controls, but the intensity was cilitate the allergen uptake by epithelial cells. Our re- diminished. Performing the CD203c basophil acti- sults reveal differences in the uptake and transmis- vation test, again no significant differences were ob- sion of the allergen in the two cell lines. While the ep- served compared to the untreated samples. After ithelial cells of the upper airways probably degrade KCNO treatment the binding patterns were dra- and process the allergens, cells of the lower airways matically changed and showed a severe decrease seem to transmit the unprocessed allergens. Addi- in intensity. Reactivity was only detectable with mon- tionally, we are in progress to perform comparative oclonal antibodies harbouring linear epitopes. No studies on primary alveolar epithelial cells (AEC-II) binding was observed with patients’ sera. The isolated from human lung. CD203c assay resulted in a 100fold less activation, Fo r s c h u n g s z e n t r u m Bo r s t e l when the allergoids were used instead of the unCollaboration: Röschmann K, Ulmer AJ, Division of treated controls. After HCHO or KCNO treatment Cellular Immunology, Goldmann T, Division of Clin- about 50% of the protein content was polymerised ical and Experimental Pathology, Research Center to allergoid complexes of molecular masses up to Borstel; Blume C, ZAUM-Center of Allergy and Envi- 500 kDa. By use of KCNO the allergens were much ronment, Division of Environmental Dermatology more modified than by use of HCHO and differed and Allergy, Munich. individually among the different allergens. Our studies establish the molecular basis to investigate Supported in part by: DFG-SFB TR 22, project A3. the uptake of allergoids by antigen presenting cells. Collaboration: Ernst M, Immune Cell Analytics, ReStructural, immunological and functional charac- search Center Borstel, Borstel; Bellinghausen I, terization of grass pollen allergoids König B, Saloga J, Dermatology Department, Uni- Petersen A, Becker, W-M. versity of Mainz, Mainz. Allergoids are often used for specific immunother- Supported in part by: DFG (Pe 491/8). apy instead of allergen extracts. They are structurally modified by chemical treatment to reduce allergenicity but retain immunogenicity. In order to de- Recombinantly produced banana lectin isoform: termine the influence of allergoids on the uptake by a valuable tool for glycoproteomics and a potent antigen presenting cells and the further processing, modulator of the proliferation response in CD3+, we have produced allergoids of timothy grass CD4+ and CD8+ populations in human PBMCs pollen and the major allergen Phl p 1 by treatment Petersen A. with fomaldehyde (HCHO) or potassium cyanate (KCNO). Afterwards, the allergoids were character- 176 Lectins as carbohydrate binding proteins have Wissenschaftlicher Jahresbericht 2007-2008 Division of Molecular and Clinical Allergology Research Reports been employed in various biological assays for de- Ara h 8 – analysis of natural and recombinant tection and characterization of glycan structures on preparations glycoproteins, including clinical biomarkers in dis- Riecken S, Petersen A, Becker W-M. ease states. A mannose specific banana lectin (BanLec) is unique in its specificity for internal Peanuts belong to the classical or true food aller- α1,3 linkages as well as β1,3 linkages at the re- gens which can directly sensitize patients and elic- ducing termini. The immunomodulatory potential of it mild to severe allergic reactions. A subgroup of natural BanLec was recognized by a strong im- grass and birch pollen allergic patients reacts to munoglobulin G4 antibody response and T cell mi- peanuts with an OAS. This may be caused by a togen activity in humans. To explore its applicabili- cross-reactivity between the peanut profilin Ara h 5 ty in glycoproteomics and its modulatory potential, and Ara h 8, which is a Bet v 1 homologous protein. the gene of banana lectin was cloned, sequenced Both allergens were found by DNA-technology. The and a recombinant protein was produced in E. coli. aim of our study is to identify natural Ara h 8 in Protein sequencing as well as mass spectrometry of peanut extract, to develop a strategy to purify it the recombinant BanLec (rBan Lec) and its tryptic from peanut extract and to characterize it by N-ter- in-gel digest were performed. The specificity in gly- minal sequencing. A three step purification protocol can structure detection was examined with five pro- was developed for the isolation of Ara h 8 from tein extracts rich in glycoprotein content, as well as roasted peanuts. In a first step, size exclusion chro- horseradish peroxidase glycoprotein. The im- matography from peanut extract was performed. munomodulatory potential was assessed by an in- The Ara h 8 containing fractions were analyzed by hibitory assay and a human T cell proliferation as- SDS-PAGE and immunoblotting. Afterwards, a re- say. The obtained cDNA revealed a novel banana duction and alkylation was carried out, followed by lectin isoform with an open reading frame of 426 nu- ion exchange chromatography. The amino terminus cleotides, encoding a cytoplasmatic protein of 141 was determined by microsequencing. Besides, amino acids. The molecular mass of rBanLec de- Ara h 8 was analyzed on the level of gDNA and cDNA. termined by EST FT-MS and N-terminal sequencing The recombinant protein was expressed as an His- confirmed the cDNA at the protein level. The novel tagged fusion protein in E. coli and afterwards pu- rBanLec isoform induced a strong proliferation re- rified using metal chelating chromatography. The sponse in CD3+, CD4+ and CD8+ populations in hu- natural and recombinant proteins were compared man PBMCs. The recombinant BanLec is a useful by immunoblotting with patients’ sera. The combi- reagent for glycoproteomics and lectin microarrays nation of several purification methods led to ho- with a potential for modulation of the immune re- mogenous natural Ara h 8. Using size exclusion sponse. chromatography Ara h 8 was successfully isolated from other peanut proteins. Only a cross contami- Collaboration: Gavrovic-Jankulovic M, Bobic S, Fac- nation with Ara h 6 was observed. Due to the fact ulty of Chemistry, University of Belgrade, Belgrade, that Ara h 6 contains several cysteine residues Serbia; Paulsen K, Institute of Medical Microbiology which form disulfide bonds, the subsequent reduc- and Immunology, University of Aarhus, Aarhus, Den- tion, alkylation and ion exchange chromatography mark; Brckalo T, Molecular Immunopathology Unit, led to pure Ara h 8. In comparison to the purified Universitat Pompeu Fabra (DCEXS), Barcelona, Ara h 8 the recombinant protein showed the same Spain; Lindner B, Division of Immunochemistry, Re- reactivity with patients’ sera in immunoblotting. We search Center Borstel, Borstel, Germany. developed a method for the purification of natural Ara h 8 from peanut extract. The N-termini determined by protein sequencing and deduced from the Wissenschaftlicher Jahresbericht 2007-2008 177 Division of Molecular and Clinical Allergology Research Reports cDNA sequence are absolutely identical. However, but peanut LTP as sensitizing allergen cannot be ex- the sequences differed by two amino acids from the cluded. The clinical relevance of peanut LTP re- published Ara h 8 isoform (ACC: AY328088). This in- mains an open question until peanut-allergic pa- dicates that we found a new isoform of Ara h 8. On tients are challenged with the full panel of peanut the molecular level, we confirmed the already pub- allergens. Fo r s c h u n g s z e n t r u m Bo r s t e l lished isoform as well, but the new isoform seems to be the most dominant isoform in peanut extracts. Collaboration: Mari A, Quaratino D, Zennaro D, Center for Clinical and Experimental Allergology, Collaboration: Jappe U, Paul-Ehrlich-Institut, Division IDI-IRCCS, Rome, Italy; Reese G, Vieths S, Division of of Allergology. Allergology, Paul-Ehrlich-Institut, Langen, Germany. Supported in part by: Freundeskreis ForschungsIdentification of a Lipid Transfer Protein (LTP) zentrum Borstel und Sparkassenstiftung Südholstein. in peanut extract and cloning of two LTP isoallergens Riecken S, Petersen A, Becker W-M. Detection of peanut antigens/allergens in breast milk The presence of a LTP in peanut has been hypoth- Schocker F, Petersen A, Becker W-M. esized but has never been confirmed. The aim was to identify LTP in peanut extract and characterize its Peanut allergy is one of the most severe food aller- physicochemical and immunological properties. gies because the risk for life-threatening reactions We tried to identify peanut LTP by use of cross-re- and also because it is rarely outgrown. According acting rabbit anti-Cor a 8 antiserum, sera from to the literature, allergic reactions to peanut can oc- peach and peanut-allergic patients and by N-ter- cur during first known exposure which means that minal sequencing Peanut LTP was identified in an earlier peanut exposure must have taken place. acidic extract of peanut meal at 8 kDa by im- There is some evidence suggesting that peanut ex- munoblotting and by N-terminal sequencing. The posure during lactation can trigger sensitization as IgE reactivity of two cloned and expressed isoaller- peanut protein was found in breast milk following gens was demonstrated with sera from peach and maternal dietary ingestion (Vadas et al., JAMA peanut-allergic patients by immunoblotting. The im- 2001; 285:1746-1748). Other research groups claim munoblot analysis with patients’ sera showed IgE- that there is no link beween maternal peanut avoid- reactivity to natural LTP in 68% (n=25) of patients al- ance and the development of peanut allergy in the lergic to peanut and peach (Pru p 3 positive) and breast fed baby, and that consuming peanuts 24% (n=17) of peach-allergic patients (Pru p 3 posi- would increase the development of tolerance. tive), which are asymtomatic to peanut. Only a weak Since 1998, advice in the UK has been that pregnant LTP reactivity was detectable in 29% (n=24) of pa- and lactating women should avoid eating peanuts tients with peanut allergy (Pru p 3 negative).For the if the familiy is at risk of an atopic disease. How- first time peanut LTP is described as a novel aller- ever, just recently, the House of Lords has demand- gen with immunological and molecular biological ed to withdraw the existing UK advice because the methods. The N-terminal sequence data allowed prevalence of peanut allergy has continued to rise cloning and production of recombinant LTP from despite the avoidance recommendations. What- peanut. Based on clinical data we suggest that the ever the reason for these findings could be, it re- main sensitization of peanut allergic patients to mains clear that investigations are needed to elu- peanut LTP is caused by cross reactivity to Pru p 3, cidate whether or not avoidance of peanuts while 178 Wissenschaftlicher Jahresbericht 2007-2008 Division of Molecular and Clinical Allergology Research Reports breast feeding is necessary. In the light of these con- Stipends tradicting views our project is very challenging. We Riecken, Susanne aim to identify peanut antigens/allergens in breast Freundeskreis Forschungszentrum Borstel und Spar- milk after peanut consumption and hope to learn kassenstiftung Südholstein more about how peanut allergens are processed during their passage through the gastrointestinal tract. Likewise we intend to get more information about possible protecting sIgA and IgG antibodies in breast milk and serum samples of our recruited lactating mothers. In the first step, we spiked milk samples of mothers, who avoided peanuts during lactation with extract of commercially available peanuts and analysed the samples by using SDSPAGE and immunoblot techniques. By this means we were able to detect up to 2,5 µg peanut protein in 15 µg breast milk using a rabbit antibody directed against one of the major allergens, the Ara h 2. Using the 2D electrophoresis techniques we could even detect amounts of 200 ng peanut protein in 150 µg breast milk which offers further investigations of peanut allergens for subsequent MALDI analysis. Thus, we established qualitative and quantitaive tools to detect peanut proteins in breast milk to validate these results in samples after peanut consumption. Collaboration: Ahrens F, Childrens’ Hospital Altona, Pediatric Pneumology and Allergology, Hamburg. Supported in part by: DFG (SCHO-828/2-1). Theses Dissertation Riecken, Susanne Untersuchungen zum Allergenrepertoire der Erdnuss: Molekulare Charakterisierung von Ara h 7, Ara h 8, Oleosin und LTP Technisch-Naturwissenschaftliche Fakultät Universität Lübeck, 2008. Wissenschaftlicher Jahresbericht 2007-2008 179 Division of Cellular Allergology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l Division of Cellular Allergology Head co-evolution between worm and host characterized PD Dr. Helmut Haas by the endeavour of the worm to dampen the defence of the host without harming him, and the en- Principal Investigators deavour of the host, to get rid of the undesired guest PD Dr. Jürgen van der Bosch (until 02/08) without causing “collateral damage”. Due to their Dr. Gabriele Schramm immunomodulatory properties, parasitic worms are attractive candidates for further elucidating the me- Postdocs chanism of Th2 induction and for identify- Dr. Lina Meyer (since 09/08) ing/characterizing anti-inflammatory effector molecules for designing novel strategies to fight allergy Graduate Students and autoimmune disorders. The Division of Cellular Astrid Mewes (until 12/07) Allergology focuses on Schistosoma mansoni, a parasitic fluke with high immunomodulatory capacity. Diploma and Bachelor students We have sequenced and/or further characterised Rabea Langenhaun three major immunogens from S. mansoni eggs: Katrin Marszalek omega-1, IPSE/alpha-1 and kappa-5. While omega1 and IPSE/alpha-1 are important immunomodula- Technicians tory molecules, the biological role of kappa-5 has Daniela Barths still to be elucidated. With the elaboration of an ef- Achim Gronow fective in vitro culture protocol, we got, moreover, an Heike Rohweder (since 02/08) important tool for schistosome research in our Maria Pfohl (since 09/08) hands. Birte Hanisch (since 10/08) Guests and Trainees Omega-1, a glycoprotein secreted by Schistoso- Anna Gilicze (Semmelweis University, Budapest) ma mansoni eggs, drives Th2 responses Dr. Franco Falcone (University of Nottingham) Schramm G, van der Bosch J, Haas H. Ahmed Fawzy Abou Karima (University of Southampton) The outcome of immune responses (i.e. health or di- Stefanie Neubert sease) in the course of infectious or autoimmune disorders is critically dependent on the differentiation of polarized T helper (Th) cell response. It is, there- Research Reports fore, of prime importance to understand the mecha- In contrast to allergens, parasitic worms are obli- nisms governing Th subset differentiation. While gate and potent inducers of a T helper type 2 (Th2) many microbial molecules that induce the differen- and IgE response. On the other hand, namely in the tiation of Th1 cells (e.g. LPS, CpG) are well-characte- course of chronic worm infections, Th2 (and also rized, very little is known about the molecules that re- Th1) responses are down-regulated by worm-deri- sult in the development of Th2 responses. Helminth ved highly active anti-inflammatory molecules. Thus, parasites belong to the most potent natural stimuli for parasitic worms – despite being inducers of a Th2 the induction of Th2-polarized immune responses. response – possess an anti-allergic/anti-inflamma- Among those, Schistosoma mansoni eggs and so- tory effect. This seeming paradox results from the luble extracts derived thereof (SmEA) are well known 180 Wissenschaftlicher Jahresbericht 2007-2008 Division of Cellular Allergology Research Reports and widely studied stimuli for Th2 polarization in vitro mansoni lead to the induction of a Th2 response and in vivo. In this process dendritic cells (DCs) have and later on during chronic infection to a general been shown to play an important role. However, the downregulation of inflammatory responses inclu- specific Th2-inducing components have remained ding Th2. We have previously isolated and recom- elusive. In a collaborative approach, we could de- binantly expressed a molecule from S. mansoni monstrate that omega-1, a glycoprotein secreted eggs that triggers the release of IL-4 and IL-13 from from S. mansoni eggs and present in SmEA, modu- human and murine basophils. This molecule was lates human monocyte-derived DCs to drive Th2 po- called IL-4-inducing principle from Schistosoma larization with similar characteristics as whole SmEA. mansoni eggs (IPSE/alpha-1). The fact that IL-4 as Furthermore, using IL-4 dual reporter mice we could well as IL-13 are key cytokines for the development show that both natural and recombinant omega-1 of a Th2 response and are, moreover, involved in alone are sufficient to generate Th2 responses in vi- regulatory/anti-inflammatory mechanisms, e.g. via vo even in the absence of IL-4R signaling. Thus ome- alternative activation of macrophages, suggests ga-1, a single component of SmEA, conditions DCs for that IPSE/alpha-1 plays a role in this respect. To ob- the efficient, IL-4R-independent priming of Th2 res- tain additional information on the function and the ponses. Having a single molecule with a strong Th2 mechanism of action of IPSE/alpha-1, the three-di- inducing activity will help to unravel the specific pa- mensional structure of this molecule was addres- thways governing the instruction of Th2 responses. sed. Since similarity searches revealed no sequen- Considering the translational relevance, the identifi- ces with significant homology, the three-dimensio- cation of omega-1 as a potent Th2-inducing adjuvant nal structure of IPSE/alpha-1 was analysed by NMR provides novel opportunities for the development of and X-ray crystallography in a collaborative ap- therapeutic interventions of Th1-mediated diseases proach. This analysis required IPSE/alpha-1 at high (patent application has been filed). amounts/concentrations which could be realised neither with the natural molecule due to its low Cooperation: Bart Everts, Hermelijn H. Smits, Cor- availability nor with the recombinant E. coli-ex- nelis H. Hokke, Alwin J. van der Ham, Maria Yaz- pressed material because of its tendency to self-ag- danbakhsh, Department of Parasitology, Leiden gregate. However, upon deletion of the positively University Medical Centre, 2333 ZA Leiden, The charged C-terminus (containing a nuclear localisa- Netherlands; Markus Mohrs, Georgia Perona- tion sequence and a cysteine residue responsible Wright, Katja Mohrs, Trudeau Institute, Saranac for the dimerisation of this molecule), we were ab- Lake, New York 12983, United States; Colin M. le to express and refold a highly soluble and sta- Fitzsimmons, Department of Pathology, University of ble IPSE/alpha-1 monomer. Following C13-/N15-la- Cambridge, Cambridge CB2 1QP, UK; Michael J. beling, the 3D structure of this molecule could be Doenhoff, School of Biology, University of Notting- determined by solution NMR spectroscopy. Fur- ham, Nottingham NG7 2RD, UK. thermore it was crystallized and a native X-ray data set was recorded to 1.66Å. Analysis revealed Supported in part by: DFG SFB/Transregio 22 / A12. that IPSE/alpha-1 has two Greek key motifs (each containing four anti-parallel -sheets) and belongs to the family of the extremely staDetermination of the three-dimensional structure ble / crystallins, present for example in high con- of IPSE/alpha-1 centrations in the eye lens (Fig. 72). We expect from Schramm G, Barths D, Haas H. targeted mutations based on the structural informations valuable help for elucidating the mecha- Infections with the parasitic helminth Schistosoma nism of action of this molecule. Wissenschaftlicher Jahresbericht 2007-2008 181 Division of Cellular Allergology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l ted. Interestingly, in Western blots sera from S. mansoni-infected Africans were reactive against kappa5 with IgE and IgG isotype antibodies, but against IPSE/alpha-1 and omega-1 only with IgG antibodies. The further characterisation of kappa-5 as one of the three major egg antigens should help to better understand the immunology and immunopathology of schistosomiasis. Fig. 72. Structure of an IPSE/alpha-1-Monomer containing two Greek key motifs (Ribbon Model). Cooperation: J.V. Hamilton, Institute of Biological Environmental and Rural Sciences, Aberystwyth Uni- Collaboration: Michael Sattler, Helge Meyer, Kostas versity, Ceredigion, SY23 3DA, UK; C.I.A Balog, M. Tripsianes Technical University Munich; Jochen Wuhrer, A.M. Deelder, C.H. Hokke, Department of Müller-Dieckmann, Hubert Mayerhofer, Georgios N. Parasitology, Center of Infectious Diseases, Leiden Hatzopoulos EMBL, Hamburg; Christoph Müller- University Medical Center, 2300 RC Leiden, The Dieckmann, ESRF, Grenoble, France. Netherlands, V. Wippersteg, Institute for Genetics, Heinrich-Heine-University, D-40225 Duesseldorf, Ger- Supported in part by: DFG SFB/Transregio 22 / A12. many, S. Beckmann, C.G. Grevelding, Institute of Parasitology, University of Giessen, D-35392 Giessen, Germany, E. Weber, GALMED GmbH , D- Molecular characterisation of kappa-5, a major 06097 Halle, Germany, N.W. Brattig, Bernhard antigenic glycoprotein from Schistosoma manso- Nocht Institute for Tropical Medicine, University of ni eggs Hamburg, D-20359 Hamburg, Germany, D.W. Schramm G, Gronow A, Goldmann T, Haas H. Dunne, Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK, M.J. Doenhoff, The major immunopathological consequences of School of Biology, University of Nottingham, Not- infection with Schistosoma mansoni, a T helper type tingham NG7 2RD UK. 2 response and granuloma formation leading to fibrotic tissue damage, are caused by the egg stage Supported in part by: DFG SFB/Transregio 22 / A12. of the parasite. Three antigens of S. mansoni eggs, termed IPSE/alpha-1, omega-1 and kappa-5, have been found to be the primary targets of the egg-di- In vitro culture of Schistosoma mansoni – culture rected antibody response of the host. Here, we re- dish instead of mammalian host port on the isolation, cloning and characterisation Herrmann K, Falcone FH, Barths D, Haas H. of kappa-5. Apart from an uncharacterised mRNA sequence in S. japonicum, no significant similarities Approx. 200 million people worldwide are suffering of kappa-5 to known sequences from other species from Schistosomiasis partly with life-threatening con- were found. In contrast to IPSE/alpha-1 and omega- sequences and still far more are endangered from 1, which have been found only in eggs, kappa-5 was it. The affected countries, among them potent new- present in miracidia as well as in eggs at the mR- ly industrialising economies such as China, South-Af- NA and protein levels. In eggs, isoforms of kappa- rica and Brazil, have a genuine interest in an effec- 5 were observed with both three and four fully oc- tive treatment and prevention of this disease. The cupied N-glycosylation sites, while in miracidia on- development and optimisation of the in vitro cultu- ly one isoform with four N-glycans could be detec- re of schistosomes shall pro-actively and lastingly 182 Wissenschaftlicher Jahresbericht 2007-2008 Division of Cellular Allergology Research Reports reduce/prevent the foreseeable flood in animal ex- With the in vitro culture a highly effective tool for pa- periments for studying these parasites. We have es- rasitological and immunological studies is availa- tablished in our lab an in vitro method for maturing ble which among others allows testing potential larvae (schistosomula) of Schistosoma mansoni up new drugs and vaccines against schistosomes by to the adult stage including pairing and deposition high-throughput procedures. In contrast to animal of immature eggs (Fig. 73). Using our culture proto- experiments, the in vitro culture allows continuous col, we were furthermore able to keep adult schi- monitoring of the parasite including access to each stosome pairs in vitro for more than 18 months at developmental stage as well as real time recording unimpaired motility. Based on these results and sup- of morphological changes following e.g. addition of ported by a grant (BMBF 0315277; one post-doc, drugs. one technician), we aim now at further optimising the culture conditions to obtain full egg maturation Collaboration: Cornelis H. Hokke, Department of in vitro and, thus, to completely replace experi- Parasitology, Leiden University Medical Center, mental mammalian final hosts (e.g. mice, golden 2300 RC Leiden, The Netherlands; Christoph G. hamsters) by the culture dish. In parallel, the tech- Grevelding, Institute for Parasitology, Justus Liebig nique of cryoconservation (i.e. gentle freezing) of li- University Giessen, D-35392 Giessen, Germany. ve schistosomes will be optimised along with establishment of a schistosome bank. This will allow the Supported in part by: BMBF 0315277. need-based access to infectious stages of the parasite and makes the permanent maintenance of the parasite life cycle in laboratory animals redun- Theses dant. Diploma Marszalek, Katrin Partielle Deglykosylierung von HEK-IPSE/alpha-1 für die Kristallisation Julius-Maximilians-Universität, Würzburg, 2007. Langenhaun, Rabea Etablierung einer cDNA-Expressionsbank aus basophilen Granulozyten Freie Universität Berlin, 2007. Dissertation Mewes, Astrid Untersuchung eines neuartigen Mechanismus der Fig. 73. Schistosomula were cultured in vitro to adult parasites including pairing after 6 weeks and deposition of immature eggs (resembling a string of pearls) after 8 weeks. At the upper right mature eggs isolated from infected murine liver are shown. Our aim is “closing the loop” (symbolized by the red arrow) by optimising our culture protocol to obtain full egg maturation in vitro including complete development of miracidia (life cycle stage that hatches from eggs and infects water snails as intermediate hosts). Aktivierung basophiler Granulozyten durch das sekretorische Schistosomen-Ei-Produkt, IPSE/alpha-1 Technisch-Naturwissenschaftliche Fakultät Universität zu Lübeck, 2007. Wissenschaftlicher Jahresbericht 2007-2008 183 Division of Mucosaimmunology Research Reports Fo r s c h u n g s z e n t r u m Bo r s t e l Division of Mucosaimmunology Head The stabilities of three murine B cell epitopes from the PD Dr. Andreas Frey model antigen hen egg ovalbumin in murine intestinal fluid (IntFl) were determined. While all three oval- Staff Scientists bumin-epitopes were degraded with half-lifes in the Dr. Steffen Bade range of milliseconds when present as free peptides, Dr. Barbara Frey their conjugation to cholera toxin B subunit (CTB) as Dr. Niels Röckendorf carrier protein prolonged their half-lifes up to 12 minutes. The corresponding RI peptides were not deg- Graduate Students raded by murine IntFl. Balb/c-mice were immunized Naho Fujimoto intraperitoneally or intragastrically with either a na- Fabian Reuter tural or an RI peptide conjugated to CTB. While i.p. Katrin Wehry application of natural and RI peptide-conjugates resulted in similar IgG- and IgA-titers for each peptide, Technicians by i.g. immunization RI peptides induced higher an- Alheidis Ehmke ti-peptide IgG-titers or IgA-titers than their natural Hanne Krüger counterparts (Fig. 74). Only one natural peptide, Imke Wysokinski which also showed the highest in vitro-stability in IntFl, could induce a weak IgA-response at all. However, antibodies induced by RI peptides failed to rec- Research Reports ognize the native protein ovalbumin. Influence of antigen stability on mucosal immune responses Reuter F, Bade S, Frey A. The induction of a protective secretory IgA response at the intestinal mucosa requires the delivery of an antigen to this very site. For immunization purposes this means that a vaccine should be administered orally or intragastrically and that it must to reach the inductive sites of the mucosal lymphoid tissue in the gut in uncompromised form. Hence, the digestive stability of vaccines is of utmost importance for successful immunizations. Yet, especially vaccines based on peptidic antigens may suffer considerable degradation in the proteolytic environment of the gut. It may be possible to stabilize such peptidic antigens by converting them into their retro-inverse (RI) configuration. Such RI peptides, which are composed solely Fig. 74. Immune response at mucosal surfaces after intragastrical immunization. Immunoglobulin A titers (mean ± SEM; N=6-7) in fecal extracts of mice immunized with either CTB-conjugated natural (nat) Ova-peptides or CTB-conjugated retro-inverse (RI) Ova-peptides were determined against the peptides used for immunization. Statistical analysis of the results (one-way ANOVA and Bonferroni post hoc test) revealed significant differences between the groups immunized with the respective conjugates of natural and RI peptides (***: p<0.001; **: p<0.01); n.b., not detectable. of D-amino acids, are not prone to proteolytic degradation, but their capability to induce a protective We conclude that stabilization of antigens against immune response at the intestinal mucosa needs to proteolytic degradation is a prerequisite for suc- be investigated. cessful oral vaccinations, yet maintaining the natu- 184 Wissenschaftlicher Jahresbericht 2007-2008 Division of Mucosaimmunology Research Reports ral antigen conformation is just as critical for indu- and protein-enriched simIF over 3h but (iii) are par- cing protective immunity by peptide-based vacci- tially destroyed in simIF that lacks additional pro- nes. While digestion-resistant RI peptides were ab- tease substrate. We assume that the proteins of na- le to induce high antibody-titers against themselves, tIF are preferred substrates for the intestinal pro- they did not sufficiently mimic the structure of the teases and thus can protect vaccine-targeting li- epitopes that is displayed in the context of the na- gands from destruction. tural protein. Collaboration: Hirst TR, John Curtin School of MedCollaboration: Hirst TR, John Curtin School of Med- ical Research, The Australian National University, ical Research, The Australian National University, Canberra, Australia. Canberra, Australia. Supported in part by: Deutsche ForschungsgemeinSupported in part by: Deutsche Forschungsgemein- schaft (DFG), grant Fr 958/2-4 and Bundesministeri- schaft (DFG), grant Fr 958/2-4, and Bundesministe- um für Bildung und Forschung (BMBF), grant 01 KO rium für Bildung und Forschung (BMBF), grant 01 KO 0113. 0113. Degradation of food allergens by digestive proProtection of potential vaccine targeting ligands teases against intestinal proteolysis Bade S, Reuter F, Frey A. Reuter F, Bade S, Frey A. Food allergies manifest as immunoglobulin E-mediEndowing mucosal vaccines with ligands that target ated defense reactions against certain food pro- antigen to mucosal lymphoid tissues may improve teins and may be caused by a lack of mucosal im- immunization efficacy provided that the ligands mune tolerance against the antigen in question. A withstand the proteolytic environment of the gas- faulty tolerance induction could be due to prema- trointestinal tract until they reach their destination. ture destruction or incomplete formation of tolero- We have investigated whether and how three re- genic T cell epitopes in the gut lumen. nowned ligands - Ulex europaeus agglutinin I and To determine the luminal stability of potential aller- the B-subunits of cholera toxin and E. coli heat-labi- gen-derived T cell epitopes in the murine intestinal le enterotoxin - master this challenge. We assessed fluid we used our novel protease susceptibility as- the digestive power of natural murine intestinal fluid say for peptides and standardized murine intestinal (natIF) using assays for trypsin, chymotrypsin and fluid. Major allergens from food classified by the Eu- pancreatic elastase along with a test for nonspeci- ropean Union Allergen Hitlist (crustaceans, eggs, fic proteolysis. The natIF was compared with simu- fish, peanut, soybean, milk/-products, tree nuts, se- lated murine intestinal fluid (simIF) that resembled same, mustard, celery, wheat) were synthesized in the trypsin, chymotrypsin and elastase activities of form of nested 10mer and 16mer peptides covering its natural counterpart but lacked or contained al- the entire amino acid sequences of the respective bumins as additional protease substrates. The li- allergens. The mean peptide half-lifes determined gands were exposed to the digestive fluids and de- in this set-up ranged from 52 µs to about 10 min for gradation was determined. The studies revealed the 10mers and from 55 µs to 42 s for the 16mers. that (i) the three pancreatic endoproteases consti- Although most peptides were degraded within mil- tute only one third of the total protease activity of liseconds, several peptides withstood proteolysis natIF and (ii) the ligands resist proteolysis in natIF long enough to theoretically survive at least parti- Wissenschaftlicher Jahresbericht 2007-2008 185 Division of Mucosaimmunology Research Reports ally the murine small intestinal passage. It remains many experimental set-ups, and facilitates multiple- to be elucidated if these comparably stable aller- labeling of biomolecules. Fo r s c h u n g s z e n t r u m Bo r s t e l gen-derived fragments constitute potential tolerogenic murine T cell epitopes. Collaboration: Franek M, Department of Biotechnology, Veterinary Research Institute, Brno, Czech Re- Collaboration: Becker WM, Division of Molecular public. and Clinical Allergology, Research Center Borstel, Germany; Franek M, Department of Biotechnology, Supported in part by: Bundesministerium für Bildung Veterinary Research Institute, Brno, Czech Republic. und Forschung (BMBF), grants 01 KO 0113 and 13 N 8473. Supported in part by: Bundesministerium für Bildung und Forschung (BMBF), grant 01 KO 0113; Deutsche Forschungsgemeinschaft (DFG), Schwerpunktpro- Nanoparticles at mucosal interfaces gramm 1089 „Novel vaccination strategies“, grant Bade S, Röckendorf N, Frey A. Fr 958/4-1; Deutsche Forschungsgemeinschaft (DFG) grant Fr 958/2-4. With the advent of nanotechnology, nanoscale particles (nanoparticles, NPs) have come into widespread use in basic research as well as in everyday Biolabeling with 2,4-dichlorophenoxyacetic acid applications, ranging from advanced functional ma- (2,4-D)-derivatives terials for high-tech applications in mechanical en- Bade S, Röckendorf N, Frey A. gineering, electronics and catalysis over functional coatings to suntan lotions and new drugs. This om- Current analytic and diagnostic methodologies re- nipresence carries a high risk of unvoluntary expo- quire highly-sensitive, versatile and robust tags for sure to nanoparticulate materials and requires a single- or multiple-labeling of biomolecules. We ha- thorough investigation of the physiological events ve developed a new labeling and detection system and consequences connected with the potential based on derivatives of 2,4-dichlorophenoxyacetic uptake and incorporation of engineered nanopar- acid (2,4-D) and monoclonal anti-2,4-D antibodies ticles. As the digestive tract is one of the key sites that meets these requirements.. It can be used for at which the body comes into contact with foreign a large variety of biomolecules such as (gly- matter we investigate the interactions of NPs with co)proteins, peptides and nucleic acids. When its the different layers and cells of the small intestinal sensitivity of detection is compared with that of the mucosa, identify pathways along which NPs enter established systems digoxigenin (DIG)/anti-DIG the mucosa, and quantify the exit routes of NPs to and biotin/streptavidin, the performance of 2,4-D is distant tissues. To investigate the interaction of syn- at least comparable to if not better than that of its thetic NPs with digestive juice and the pre-epitheli- competitors. Equipment of 2,4-D-derivatives with ali- al mucus layer of the intestinal barrier, we employ phatic spacers considerably increases their affinity colloidal nanocrystals composed of fluorescent co- towards the anti-2,4-D antibodies and raises the res and stabilized by a layer of surfactants/ligands sensitivity of detection up to 1,600fold compared attached to their surface. Different synthetic, water- with their respective non-spacered 2,4-D-derivati- soluble core/shell (CdSe/CdS or CdSe/ZnS) and ves. Hence, the detection of about 100 amoles spa- core/shell-alloy/shell (CdSe/CdZnS/ZnS) nanopar- cered 2,4-D-tag is possible. The 2,4-D-based labe- ticles were incubated with murine intestinal fluid in ling system augments the field of indirect labeling order to check if interaction with intestinal constitu- systems, outperforms commonly used systems in ents from the digestive juice may change the 186 Wissenschaftlicher Jahresbericht 2007-2008 Division of Mucosaimmunology Research Reports nanoparticles’ optical characteristics. Indeed, fluo- rescent dye at the sphingosine moiety of the mole- rescence of most core/shell particles was consid- cule was prepared by a convenient one pot syn- erably impaired in the presence of murine intestin- thesis. The labeled GM1 permitted the detection of al fluid (Fig. 75). However, our investigations also re- the natural ganglioside GM1 ligand Escherichia co- vealed that by choosing appropriate particle-ligand li heat-labile enterotoxin subunit B (EtxB) in pmole combinations the fluorescent properties of the na- quantities on a solid support. When an epitope- noparticles could be retained regardless of their in- mapping of several ganglioside binding proteins cubation in mucosal secretions. Further studies now and protein fragments was performed by screening focus on the identification of optimal ligand-nano- a cellulose membrane-bound synthetic library of 64 particle combinations that are useful for bio-ima- 16mer peptides with the new probe, several pepti- ging applications at mucosal interfaces. des displaying ganglioside GM1 affinity could be identified. The labeled glycolipid represents a versatile tool for various biochemical investigations. Collaboration: Hirst TR, John Curtin School of Medical Research, The Australian National University, Canberra, Australia. Supported in part by: Bundesministerium für Bildung und Forschung (BMBF), grants 13 N 8473 and 01 KO 0113. Fig. 75. Mean emission spectra of core-shell (CdS/ZnSe) nanoparticles after different treatments. Nanoparticles were incubated in water (red), physiological buffer (green) or murine intestinal fluid (mIntFl, blue) for 90 min at room temperature and fluorescence spectra were recorded. Peptide based optical contrast agents for targeting of intestinal malignancies Collaboration: Weller H, Institute of Physical Chem- Röckendorf N, Wehry K, Fujimoto N, Frey A. istry, University Hamburg, Germany; Gebert A, Institute of Anatomy, University Lübeck, Germany; Intestinal tumors exhibit cell surface properties that Hüttmann G, Institute of Biomedical Optics, Univer- differ from neighboring healthy epithelia and thus sity Lübeck, Germany; Bings N, Institute of Anor- allow tumor cell-specific molecular targeting. The ganic and Analytical Chemistry, University Mainz, accessibility of cell surface receptors such as gang- Germany. lioside GM1 is such a discriminatory characteristic. Although ganglioside GM1 is expressed in the api- Supported in part by: Deutsche Forschungsgemein- cal membrane of all intestinal epithelial cells it can schaft (DFG), grant Fr 958/5-1. be reached by particle-conjugated ligands on tumor cells only. In order to exploit this phenomenon we want to develop a nanoparticulate optical con- Identification of GM1 binding sequence motifs by trast agent equipped with a peptidic GM1 binding screening a synthetic peptide library with a new- ligand. For identification of ligand peptides a novel ly developed fluorescent ganglioside GM1 deriv- screening platform was devised where potential ative ganglioside GM1-binding peptides are generated Röckendorf N, Bade S, Frey A. on glass capillary plates using microfluidic noncontact arraying techniques and screened in situ for A ganglioside GM1 probe bearing a dark-red fluo- binding of fluorophore-labeled GM1. These three-di- Wissenschaftlicher Jahresbericht 2007-2008 187 Division of Mucosaimmunology Research Reports mensional supports are easy to handle and show “molecular evolution” of peptides with defined pro- better sensitivity than either flat glass or membrane perties. A population of peptides is prepared by supports because of their large inner surface and techniques which allow the automated synthesis of low interference with readout systems. A custom flu- up to 2,400 peptides simultaneously on cellulose orescence reader was designed to comply with the membranes or resin supports. Fo r s c h u n g s z e n t r u m Bo r s t e l specific optical behaviour of peptide arrays synthesized on microcapillary plates. This reader uses a small numerical aperture for excitation and a large numerical aperture for detection in epifluorescence-mode. Background noise from fluorescence and Raman scattering is reduced by time-gated photon counting. Peptides showing affinity to ganglioside GM1 will be conjugated to a nanoparticulate carrier bearing a fluorescent dye. The resulting optical contrast agent shall be used for fluorescence endoscopic intestinal tumor screening. Collaboration: Bürger M, Gesellschaft für Silizium Mikrosysteme mbh, Dresden, Germany; Helfmann J, Laser- und Medizin-Technologie GmbH, Berlin, Germany. Supported in part by: Bundesministerium für Bildung und Forschung (BMBF), grant 13 N 8473. Identification of peptide sequences with desired properties by using genetic algorithms Röckendorf N, Frey A. The use of small synthetic peptides as specific ligands is a versatile approach in many areas of the life sciences. Due to their small size and robust nature peptidic ligands offer several advantages over proteinacious ligands such as monoclonal antibodies. They diffuse more rapidly, are less antigenic, can be rendered protease resistant and experience less steric hindrance upon target binding. Yet, Fig. 76. Affinity improvement of peptides optimized by a molecular evolution process. The 25 best sequences taken from generation 10 show an up to 150fold higher affinity towards a fluorescently labelled ganglioside GM1 derivative than the 25 best lead peptides. Left: optimization of L-peptides (red), right: optimization of Dpeptides (green). the identification of short peptide sequences with high specific affinity to molecular targets is a chal- The peptides are then screened for binding to the lenging task since the tremendous diversity of pept- molecular target of interest, ranked according to ide sequences renders the usual high throughput their performance and are crossed and mutated in techniques quite inappropriate. We therefore devi- silico using a specially designed genetic algorithm. sed an approach for a directed, quality-driven With this cooperative in silico / in vitro optimization 188 Wissenschaftlicher Jahresbericht 2007-2008 Division of Mucosaimmunology Research Reports methodology a stepwise refinement of the peptides cer and ranks second in cancer induced deaths in is attained so that in the end a ligand is obtained Germany. However, colorectal cancer is curable in that should perfectly meet the requirements for the about 90 % of all cases if recognized early. application of interest. Various peptides exhibiting The basic screening tests for the diagnosis of colo- different specific properties, for example a high bin- rectal cancer are the fetal occult blood test (FOBT) ding affinity towards ganglioside GM1 or specific and colonoscopy. Whereas the FOBT is readily ac- binding to a defined locus on the surface of the bac- cepted, patients are often reluctant to undergo co- terial lectin FimH, were designed this way. Lead lonoscopy. Therefore it is desirable to develop al- peptides for targeting of an intracellular tumormar- ternative means for the reliable detection of early ker were identified. We could show that an evoluti- pathological changes of the intestinal wall such as on of peptide sequences assembled from L- as well the presence of small polyps. To visualize such ear- as from D-amino acid building blocks is possible. ly pathological changes a biological marker is ur- The performance of the optimization process was gently required. We observed in the course of a stu- driven to an up to 1.8 fold increase in relative pep- dy on intestinal antigen uptake that an intestinal tu- tide suitability or “fitness” per generation, an expo- mor cell line lacked a mature glycocalyx, a dense nential growth in peptide fitness was observed (Fig. network of highly glycosylated proteins and lipids 76). Starting from lead peptides with diverse se- that are anchored in the epithelial cell membrane. quences, a consensus sequence was approached Hence, we set out to investigate whether the ab- after several rounds of breeding, and the genetic sence of a glycocalyx can serve as a general mar- algorithm used converged after 10 generations to ker for intestinal neoplasia. local fitness optima. Collaboration: Schubert P, R-Biopharm AG, Darmstadt, Germany; Lindhorst TK, Christiana Albertina University of Kiel, Germany; Bürger M, Gesellschaft für Silizium Mikrosysteme mbh, Dresden, Germany; Helfmann J, Laser- und Medizin-Technologie GmbH, Berlin, Germany. Supported in part by: Bundesministerium für Bildung und Forschung (BMBF), grant 13 N 8473. The intestinal glycocalyx: a biological marker for the early detection of cancer Wehry K, Bade S, Röckendorf N, Frey A. Fig. 77. Comparison of the glycocalyx of healthy and cancerous epithelium from human colon. Apical cell surfaces were examined by TEM after treatment of the tissue for glycocalyx visualisation. A: healthy intestinal epithelium with regular, closely packed microvilli (MV) covered with a thick, continuous glycocalyx (G); B-D: (pre)cancerous intestinal epithelium (B: adenocarcinoma, C: polyp, D: carcinoma in situ) without a glycocalyx and few to no microvilli; bar: 1 µm. Tissue samples from patients diagnosed with colorectal cancer and patients diagnosed with diverti- According to the German cancer register (GEKID; culitis were analysed for the presence and archi- Gesellschaft der epidemiologischen Krebsregister tecture of the glycocalyx using a special tissue stai- in Deutschland e.V.) 73,250 people in Germany de- ning procedure and transmission electron micros- veloped colorectal cancer in 2004 (16.8 % of all can- copy (TEM). In healthy tissue areas most epithelial cer incidences) and 27,782 people died of this dis- cells had microvilli, which were covered with a thick, ease (13.3 % of all cancer induced deaths). Thus, co- continuous glycocalyx (Fig. 77A). By contrast, all lorectal cancer is the second most diagnosed can- cancerous regions of the tissues (adenocarcinoma, Wissenschaftlicher Jahresbericht 2007-2008 189 Division of Mucosaimmunology Research Reports polyps and carcinoma in situ) showed dedifferenti- blocking reagent which is intended to prevent non- ated cells without a glycocalyx and few to no mi- specific binding of sample components to solid crovilli (Fig. 77, B-D). Only in some cases thin glyco- phase immunoassay supports. Fo r s c h u n g s z e n t r u m Bo r s t e l calyx fragments were visible, but never a thick, continuous surface coat. Statistical evaluation of the da- Supported in part by: Bundesministerium für Bildung ta revealed that the thickness of the glycocalyx can und Forschung (BMBF), grant 13 N 8473. be used to discriminate early pathological changes (polyps), carcinoma in situ and adenocarcinoma from healthy tissue with high reliability. Theses Collaboration: Vollmer E, Division of Clinical and Ex- Dissertation perimental Pathology, Research Center Borstel, Reuter, Fabian Germany; Fröschle G, Division of General, Visceral, Verdauungsstabilität von Antigenen im Dünndarm - Accident and Vascular Surgery, Asklepios Clinic Bad Bedeutung für orale Immunisierungen Oldesloe, Germany. Mathematisch-Naturwissenschaftliche Fakultät Christian-Albrechts-Universität zu Kiel, 2008. Supported in part by: Bundesministerium für Bildung und Forschung (BMBF), grant 13 N 8473. Rasschaert, K. Identification of a novel F4 receptor involved in endocytosis and transcytosis. Faculty of Verterinary Novel tools for the analysis of mucus components Medicine and glycoproteins Ghent University, Belgium, 2008. Wehry K, Fujimoto, N, Frey A. Albers, E. Diagnostic as well as therapeutic approaches to- Entwicklung verdauungsresistenter Peptidantigene wards disorders of the gastrointestinal or respira- für orale Impfstoffe. Medizinische Fakultät tory tracts by necessity involve dealing with the mu- Westfälische Wilhelms-Universität Münster, 2007. cus layer and other carbohydrate-rich structures at the respective surfaces. The analysis of those glycomolecules requires special assays and reagents Stipends which we are in the progress of establishing. Spe- Fujimoto, Naho cifically, monoclonal antibodies directed against „NESACS-GDCh Exchange Program”, Boston, USA, the peptide backbone of one main component of 2007. intestinal and airway mucus, the highly glycosylated mucin protein MUC5AC, have been generated. The Patents antibodies recognize human MUC5AC in a variety Bade S, Röckendorf N, Franek M, Gorris H-H, Frey A of solid phase assay set-ups and crossreact with the (2008). Kit for highly sensitive detection assays. respective mucins of other species, thus represen- Granted German Patent; DE 10 2005 051946 C1. ting valuable tools for the analysis of human mucous samples and for investigations in animal mo- Frey A, Helfmann, J, Schmidt, MA, Müller, G (2008). del systems. Since the usually employed blocking Method and device for investigating substance li- reagents on protein- or detergent-basis may be of braries. Granted United States Patent 10/239,986. little efficiency in the analytics of carbohydrate-rich components, we have also developed a new 190 Wissenschaftlicher Jahresbericht 2007-2008 Division of Clinical Infectious Diseases and Clinical Studies Research Reports Division of Clinical Infectious Diseases and Clinical Studies Head linked-immunospot in response to purified protein PD Dr. Christoph Lange derivate (PPD) and mycobacterial specific antigens early-secretory-target (ESAT)-6 and culture-filtrate- Staff scientists and postdoctoral fellows protein (CFP)-10 by peripheral blood mononuclear Barbara Eker cells (PBMC) and bronchoalveolar-lavage mo- Dr. Ulf Greinert nonuclear cells (BALMC) of patients with pulmonary Dr. Gunar Guenter sarcoidosis, smear-negative tuberculosis and con- Dr. Claudia Jafari trols. Release of IFN-γ in response to ex vivo contact Dr. Barbara Kalsdorf with PPD, ESAT-6 or CFP-10 by BALMC and PBMC were comparable among patients with sarcoidosis Graduate and Diploma students and controls (PBMC p=0.2326; BALMC p=0.1767) Ellen Andresen and were less frequently observed in both groups Tim Grüber compared to patients with tuberculosis (BALMC Robert Hörster p<0,05; PBMC p<0.0001). Within PBMC the immun- Benjamin Krummel ophenotype of sarcoidosis-patients differed from Leonhard Leidl patients with tuberculosis, as well as from controls, Heike Sarrazin while within BALMC it resembled the one of patients Janine Wolske with tuberculosis. In contrast to patients with tuberculosis, the frequency of mycobacteria-specific local Technicians, Study nurses and systemic immuneresponses is not elevated in Francisca Danuda patients with sarcoidosis when compared to con- Andrea Glaewe trols. The immunophenotype represents the local re- Lenka Krabbe semblance of the granulomatous reaction underly- Waltraud Wappler ing tuberculosis and sarcoidosis, while showing systemical difference. These observations do not support a role of an infection with Mycobacterium Research Reports tuberculosis in the pathogenesis of sarcoidosis. Antimycobacterial immune responses in patients with pulmonary sarcoidosis Hoerster R, Jafari C, Strassburg A, Greinert U, Kalsdorf B, Lange C. Sarcoidosis is a multisystem granulomatous disease of unknown origin. Pathogenetic involvement of Mycobacterium tuberculosis has frequently been discussed in the etiology of sarcoidosis, however, studies still remain contradictory. We addressed the question of mycobacterial involvement in the pathogenesis of sarcoidosis by analysing cellular im- Fig. 78. Tuberculosis and sarcoidosis can rapidly be distinguished by assaying M. tuberculosis specific immune responses in bronchoalveolar-lavage mononuclear cells. mune responses to mycobacterial antigens. We examined the interferon (IFN)-γ production by enzyme- Collaboration: Gaede KI, Div. of Clin. Immunophar- Wissenschaftlicher Jahresbericht 2007-2008 191 Division of Clinical Infectious Diseases and Clinical Studies Research Reports macology, Research Center Borstel; Ernst M, Div. of counts, immunophenotyping with monoclonal anti- Immune Cell-Analytics, Research Center Borstel; bodies against cell surface markers CD4, CD8, Kirsten D, Hospital Großhansdorf. CD4CD45RA, CD4CD45R0, CD38, HLADR, CD19, Fo r s c h u n g s z e n t r u m Bo r s t e l CD3, CD57, CD16 and MTB-specific enzyme linked immunospot assays (ELISPOT) with early-secretoryLocal immunodiagnosis of pulmonary tuberculo- antigenic-target-6 (ESAT-6) and culture-filtrate-pro- sis by enzyme-linked immunospot tein-10 (CFP-10) of peripheral blood mononuclear Jafari C, Strassburg A, Greinert U, Kalsdorf B, cells (PBMCs) and broncho-alveolar lavage mo- Lange C. nonuclear cells (BALMCs) were performed. Lymphocytes are crucial in the immune defense Among 12 patients with culture-confirmed smear-ne- against Mycobacterium tuberculosis (MTB) infec- gative pTB, no differences were found in the distri- tion. We ascertained whether MTB-specific lym- bution of total CD4 or CD8 T cells in peripheral phocytes are selectively compartmentalised in the blood or BAL. Activated HLA DR+ cells as well as lungs of patients with minimal active pulmonary tu- memory CD4CD45R0+ T cells were expanded berculosis (pTB). among cells of the BAL. Compared with a group of control patients with alternative pulmonary pathologies, there was no significant difference in lymphocyte subpopulations. However, ESAT-6 and CFP-10 specific lymphocytes were concentrated with a median of 9.9 and 8.9 times more in BAL compared to peripheral blood in patients with pTB. MTBspecific T cells are highly selectively compartmentalised at the site of infection in active pTB. Collaboration: Ernst M, Ernst M, Div. of Immune Cell-Analytics, Research Center Borstel; Kirsten D, Hospital Großhansdorf. Rapid diagnosis of pulmonary tuberculosis by BAL-ELISPOT in an immunocompromised host Strassburg A, Jafari C, Lange C. Fig. 79. A novel test for the rapid diagnosis of acid-fast bacilli smear negative pulmonary tuberculosis, M. tuberculosis specific Tlymphocytes which are recruited to the lungs in active pulmonary tuberculosis can rapidly be detected by enzyme-linked immunospot on mononuclear cells from the bronchoalveolar-lavage. a) ELISPOT on blod mononuclear cells; b) ELISPOT on BAL mononuclear cells. Immunocompromised patients with acid-fast bacilli (AFB) smear-negative active pulmonary tuberculosis (pTB) often present with nonspecific clinical symptoms and findings. T-cell interferon-c release assays (TIGRA) performed on whole blood (using ELI- We prospectively recruited patients with smear-ne- SA) or peripheral blood mononuclear cells (using gative, MTB culture-confirmed pTB. Differential cell enzyme-linked immunospot assay (ELISPOT)) are 192 Wissenschaftlicher Jahresbericht 2007-2008 Division of Clinical Infectious Diseases and Clinical Studies Research Reports more sensitive for the diagnosis of Mycobacterium Rapid diagnosis of tuberculous meningitis by enu- tuberculosis (MTB) infection than the tuberculin skin meration of cerebrospinal fluid antigen-specific test (TST), but cannot distinguish active from latent cells MTB infection. The present authors report a 38-yr-old Lange C. female presenting with a 3-week history of malaise, dyspnoea, fevers and coughing, who had received Hospital in-patients with suspected tuberculous immunosuppressive therapies over 8 months for meningitis (TBM), predominantly in India. mixed connective tissue disease. Chest radiograph We determined whether interferon-gamma (IFN-γ) and thoracic computed tomography showed gro- secreting Mycobacterium tuberculosis antigenspe- und glass opacities in both lower lobes. The TST-in- cific T-cells are present in the cerebrospinal fluid duration was 0 mm and AFBs or MTB nucleic acid (CSF) of patients with TBM and to evaluate the fea- was not detected on sputum and bronchial secreti- sibility of CSF enzyme-linked immunospot (ELISpot) ons. However, TIGRAs performed on peripheral for the diagnosis of active TBM. This was a pros- blood cells were reactive. A high frequency of MTB- pective blinded hospital-based study. The overnight specific T-cells compatible with the immunodiagno- ELISpot assay detected M. tuberculosis antigen-spe- sis of active pTB was detected among bronchoal- cific IFN-gamma secreting T-cells in CSF from nine veolar lavage cells using ELISPOT. Antituberculous of 10 prospectively recruited patients with TBM, and therapy was initiated 18 days before MTB was dis- zero of seven control patients with meningitis of covered on sputum cultures. Detection of Mycobac- other aetiology. This corresponds to a diagnostic terium tuberculosis-specific T-cells in the bronchoal- sensitivity of 90% (95%CI 56–100) and specificity of veolar lavage using enzyme-linked immunospot as- 100% (95%CI 59–100). This pilot study demonstrates say is a promising tool for the diagnosis of active proof-ofprinciple for a new T-cell-based diagnostic pulmonary tuberculosis in immunocompromised test for TBM which is rapid, sensitive and specific. patients with negative acid-fast bacilli smears. Collaboration: Ernst M, Div. of Immune Cell-Analytics, Research Center Borstel; Nau R, Dept. of Neurology, University Hospital Göttingen; Lalvani A, Thomas MM, Imperial College, London, UK. Use of a T-cell interferon-γγ release assay for the diagnosis of tuberculous pleurisy Jafari C, Greinert U, Lange C. The diagnosis of pleural tuberculosis (plTB) by the Fig. 80. Computed tomography image of the chest of a patient with AFB-smear negative tuberculosis and non specific intersti- tial pneumonitis. analysis of pleural effusions (PEs) with standard diagnostic tools is difficult. In routine clinical practice, the present authors evaluated the performance of Collaboration: Ernst M, Div. of Immune Cell-Analyt- a commercially available Mycobacterium tubercu- ics, Research Center Borstel; Lotz W. losis (MTB)-specific enzyme-linked immunospot assay on peripheral blood mononuclear cells (PBMCs) and pleural effusion mononuclear cells (PEMCs) in patients with suspect plTB. The T-SPOT.TB test (Oxford Immunotec Ltd, Abingdon, UK) was per- Wissenschaftlicher Jahresbericht 2007-2008 193 Division of Clinical Infectious Diseases and Clinical Studies Research Reports formed on PBMCs and PEMCs in 20 patients with a aimed to ascertain in routine clinical practice the ac- clinical and radiological suspect of plTB and in 21 curacy of a novel assay using selected peptides en- control subjects with a diagnosis of PE of nontuber- coded in the mycobacterial genomic region of dif- culous origin at four centres participating in the Eu- ference (RD) 1 for the diagnosis of active tuberculo- ropean Tuberculosis Network. In total, 18 (90%) out of sis in comparison with tuberculin skin test (TST), Quan- 20 patients with plTB tested T-SPOT.TB-positive on PB- tiFERON-TB GOLD In-Tube (Cellestis Ltd., Carnegie, MCs and 19 (95%) out of 20 on PEMCs. Among con- Australia) and T-SPOT.TB (Oxfordimmunotec, Abing- trols, T-SPOT.TB was positive in seven out of 21 (33%) don, UK). 425 individuals from 6 different European patients when performed on PBMCs (these patients centres were prospectively enrolled. We found that were assumed to be latently infected with MTB) and sensitivity of the novel test, TST, QuantiFERON-TB five (23%) out of 21 when performed on PEMCs. Sen- GOLD In-Tube and T-SPOT.TB was respectively 73.1%, sitivity and specificity of T-SPOT.TB for the diagnosis 85.3%, 78.1%, and 85.2%; specificity was respectively of active plTB when performed on PEMCs were 95 70.6%, 48.0%, 61.9% and 44.3%; positive likelihood ra- and 76%, respectively. Enumerating Mycobacterium tios were respectively 2.48, 1.64, 2.05, and 1.53; ne- tuberculosis-specific T-cells in pleural effusion mo- gative likelihood ratios were respectively 0.38, 0.31, nonuclear cells by ELISPOT is feasible in routine cli- 0.35, 0.33. Sensitivity of TST combined with the novel nical practice and may be useful for a rapid and ac- test, QuantiFERON-TB GOLD In-Tube and T-SPOT.TB in- curate diagnosis of pleural tuberculosis. creased up to 92.4%, 97.7% and 97.1%, respectively. Fo r s c h u n g s z e n t r u m Bo r s t e l The likelihood ratios of combined negative results of TST with, respectively, the novel test, QuantiFERON-TB GOLD In-Tube and T-SPOT.TB were 0.19, 0.07 and 0.10. The assay based on RD1 selected peptides has similar accuracy for active tuberculosis compared with TST and commercial IGRAs. Then, independently of the spectrum of antigens used in the assays to elicit mycobacterial specific immune responses, the novel test, IGRAs, and the TST do not allow an accurate Fig. 81. Top view of a single well from a 96 well microtiter plate. Spots represent single cells among 250 000 mononuclear cells that have produced interferon-gamma in response to contact with peptides of the „early-secretory-antigenic-target-6, which is incoded in the RD-1 region of M. tuberculosis. identification of active tuberculosis in clinical practice. However, the combined use of the novel assay or commercial IGRAs with TST may allow exclusion of tuberculosis. Collaboration: Ernst M, Div. of Immune Cell-Analytics, Research Center Borstel; Losi M, Modena Italy, Collaboration: Ernst M, Div. of Immune Cell-Analyt- and members of the TBNET. ics, Research Center Borstel; Goletti D, National Institute for Infectious Diseases, Rome, Italy, and members of the TBNET. Accuracy of immunodiagnostic tests or active tuberculosis. Results from a multicenter TBNET-study Lange C. Relationship between tuberculin skin test reactivity, memory CD4 subset and circulating FoxP3 ex- The clinical application of IFN-γ release assays pressing cells in HIV-infected persons (IGRAs) has recently improved the diagnosis of latent Sarrazin H, Lange C. tuberculosis infection. In a multicenter study of the Tuberculosis Network European Trialsgroup (TBNET) we 194 Lack of reactivity to the tuberculin skin test (TST) is Wissenschaftlicher Jahresbericht 2007-2008 Division of Clinical Infectious Diseases and Clinical Studies widely observed in advanced HIV-1 infection. The Research Reports Supported in part by: HW & J Hector Foundation. TST reaction site and PPD uninfiltrated skin were biopsied in 15 HIV-1 infected and 23 uninfected persons without active tuberculosis from a community Distinct, specific IL-17- and IL-22-producing CD4+ with a very high tuberculosis incidence. 8µm histo- T cell subsets contribute to the human anti-my- logical sections were immunohistochemically cobacterial immune response stained for CD4, CD8, CD28, CD45RA, CD45RO, Kalsdorf B. CD62L, CD1a, HLA-DR, granulyzin, IFN-γ and FoxP3 and analysed by single cell in situ digital imaging. We investigated whether the proinflammatory T cell cy- Peripheral blood mononuclear cells were analysed tokines IL-17 and IL-22 are induced by human my- by FACS. In TST reactive skin test biopsies, HIV-1 in- cobacterial infection. Remarkably, >20% of specific fected persons showed less CD4+ T cells at the TST cytokine-producing CD4(+) T cells in peripheral blood site (p=0.036), but more HLA-DR+ T cells (p=0.037) of healthy, mycobacteria-exposed adults expressed IL- compared to HIV-1 uninfected. In the HIV-1 infected 17 or IL-22. Specific IL-17- and IL-22-producing CD4(+) T group, the total number of cells (p=0.008) and num- cells were distinct from each other and from Th1 cyto- bers of CD45RO+ memory T cells (p=0.003) were kine-producing cells. These cells had phenotypic cha- significantly higher in TST-reactive persons than in racteristics of long-lived central memory cells. In pati- TST-unreactive. In HIV-1 infected persons, the TST in- ents with tuberculosis disease, peripheral blood fre- duration inversely correlated with numbers of Fo- quencies of these cells were reduced, whereas bron- xP3+ T cells in the blood (p = 0.026) but was unre- choalveolar lavage fluid contained higher levels of lated to the circulating CD4+ T cell number. In HIV- IL-22 protein compared with healthy controls. IL-17 was 1 infection, the TST depends upon memory T cells not detected in this fluid, which may be due to sup- and relates better to numbers of circulating FoxP3+ pression by Th1 cytokines, as PBMC IL-17 production CD4+ T cells than total CD4+ T cells. was inhibited by IFN-gamma in vitro. However, Th1 cytokines had no effect on IL-22 production in vitro. Our results imply that the magnitude and complexity of the anti-mycobacterial immune response have historically been underestimated. IL-17- and IL-22-producing CD4(+) T cells may play important roles in the human immune response to mycobacteria. Collaboration: Scriba T, Hankom W and colleagues, South African Tuberculosis vaccine Initiative, Wilkinson RJ, Institute of Infectious Diseases and Molecular Medicine, Cape Town, Rep. South Africa. Fig. 82. Example of a microscopic view of a skin sample of tuberculin skin test reactive skin, obtained from an HIV-1 infected person and immunohistochemically stained with monoclonal antibodies against CD45 RO (original magnification 220x). LTBI: latent tuberculosis infection or lasting immune response to Mycobacterium tuberculosis. A Collaboration: Wilkinson KA, Rangaka MX, , van TBNET consensus statement Veen K, Wilkinson RJ, Institut of Infectious Diseases Lange C. and Molecular Medicine, Cape Town, Rep. South Africa; Andersson J, Radler L, Center for Infectious Tuberculosis control relies on the identification and Medicine, Karolinska Instutute, Stockholm, Sweden. preventive treatment of individuals who are latent- Wissenschaftlicher Jahresbericht 2007-2008 195 Division of Clinical Infectious Diseases and Clinical Studies Research Reports ly infected with Mycobacterium tuberculosis. Howe- tries of the World Health Organization European re- ver, direct identification of latent tuberculosis infec- gion using a standard questionnaire. Contacts are tion is not possible. The diagnostic tests used to iden- universally screened for active tuberculosis and la- tify individuals latently infected with M. tuberculosis, tent tuberculosis infection (LTBI). Most countries the in vivo tuberculin skin test and the ex vivo inter- (.70%) screen those with HIV infection, prisoners and feron-gamma release assays (IGRA), are designed in-patient contacts. Screening of immigrants is rela- to identify an adaptive immune response against, but ted to their contribution to national rates of tuber- not necessarily a latent infection with M. tuberculosis. culosis. Only 25 (50%) out of 50 advise a request for The proportion of individuals who truly remain infec- symptoms in their guidelines. A total of 36 (72%) out ted with M. tuberculosis after tuberculin skin test or of 50 countries recommend sputum examination for IGRA conversion is unknown. It is also uncertain how those with a persistent cough; 13 countries do not, long adaptive immune responses towards mycob- even if the chest radiograph suggests tuberculosis. acterial antigens persist in the absence of live my- Nearly all countries (49 out of 50) use tuberculin skin cobacteria. Clinical management and public health testing (TST); 27 (54%) out of 50 countries also per- care policies for preventive chemotherapy against tu- form chest radiography irrespective of the TST result. berculosis could be improved, if we were to gain a Interpretation of the TST varies widely. All countries better understanding on M. tuberculosis latency and use 6–9 months of isoniazid for treatment of LTBI, reactivation. This statement by the TBNET summarizes with an estimated median (range) uptake of 55% knowledge and limitations of the currently available (5–92.5%). Symptoms and sputum examination tests used in adults and children for the diagnosis of could be used more widely when screening for ac- latent tuberculosis infection. We conclude that the tive tuberculosis. Treatment of latent tuberculosis in- main issue about testing is to restrict it to those who fection might be better focused by targeted use of are known to be at higher risk of developing tuber- interferon-gamma release assays. Fo r s c h u n g s z e n t r u m Bo r s t e l culosis and who are willing to accept preventive chemotherapy. Collaboration: Bothamley G ,London, UK; Ditiu L, WHO, Copenhagen, Denmark, Migliori GB, Tradate, Collaboration: Ehlers S, Div. of Molecular Infection Italy, members of the TBNET. Biology, Hölscher C, Junior Research Group, Molecular Infection Biology, Research Center Borstel; Mack U, Oslo, Norway and members of the TBNET. Epidemiology and clinical management of XDRTB: A systematic review by TBNET Lange C. Active case finding of tuberculosis in Europe. A TBNET (Tuberculosis Network European Trialsgroup) Extensively drug-resistant tuberculosis (XDR-TB) is survey present in all regions and poses serious challenges Lange C. for public health and clinical management. Laboratory diagnosis is difficult and little evidence exists Tuberculosis control depends on successful case fin- to guide clinicians in treating people with XDR-TB ef- ding and treatment of individuals infected with My- fectively. To summarize the available data on dia- cobacterium tuberculosis. Passive case finding is wi- gnosis and treatment, we performed a systematic dely practised. The present study aims to ascertain review on 13 recent studies of the epidemiology the consensus and possible improvements in active and clinical management of XDR-TB. Studies that case finding across Europe. Recommendations from met inclusion criteria were reviewed to assess me- national guidelines were collected from 50 coun- thodology, treatment regimens, and reatment out- 196 Wissenschaftlicher Jahresbericht 2007-2008 Division of Clinical Infectious Diseases and Clinical Studies Research Reports comes. Meta-analysis of currently available data is sed, 361 (7.9%) were MDR and 64 (1.4%) were XDR. not possible because of inconsistent definitions and XDR-TB cases had a relative risk (RR) of 1.58 to have methodologies. Data show that XDR-TB can be suc- an unfavourable outcome compared with MDR-TB cessfully treated in up to 65% of patients, particularly cases resistant to all first-line drugs (isoniazid, ri- those who are not co-infected with HIV. However, fampicin ethambutol, streptomycin and, when test- treatment duration is longer and outcomes are in ed, pyrazinamide), and an RR of 2.61 compared general poorer than for non-XDR-TB patients. To with ‘‘other’’ MDR-TB cases (those susceptible to at strengthen the evidence for XDR-TB diagnosis, tre- least one first-line anti-TB drug among ethambutol, atment and prevention, future studies should: i) be pyrazinamide and streptomycin, regardless of re- prospective in design, ii) adopt standardized, in- sistance to the second-line drugs not defining XDR- ternationally accepted definitions, iii) use quality-as- TB). The emergence of extensively drug-resistant tu- sured laboratory testing for all first-and second-line berculosis confirms that problems in tuberculosis drugs, and iv) collect data on an agreed-upon set management are still present in Europe. While wait- of standard variables allowing for comparisons ing for new tools which will facilitate management across studies. Early diagnosis and aggressive ma- of extensively drug-resistant tuberculosis, accessibi- nagement of XDR-TB provide the best chance of po- lity to quality diagnostic and treatment services sitive outcome, but prevention is still paramount. should be urgently ensured and adequate public health policies should be rapidly implemented to Collaboration: Ruesch-Gerdes S, National Refer- prevent further development of drug resistance. ence Center for Mycobacteria, Research Center Borstel; Sotgiu G, Sassari (Italy), Migliori GB Tradate Collaboration: Migliori GB, Tradate, Italy, and mem- (Italy) and members of the TBNET. bers of the TBNET. Clinical and operational value of the XDR-TB def- Multi-drug resistant and extensively drug resistant inition tuberculosis, Germany Lange C. Eker B, Lange C. Currently, no information is available on the effect We evaluated risk factors and treatment outcomes of resistance/susceptibility to first-line drugs diffe- associated with multidrug-resistant (MDR)- and ex- rent from isoniazid and rifampicin in determining tensively drug-resistant (XDR)-tuberculosis (TB) in the outcome of extensively drug-resistant tuberculo- Germany in 2004-2006. In 184/4,557 (4%) of culture- sis (XDR-TB) patients, and whether being XDR-TB is positive TB cases, M. tuberculosis isolates were a more accurate indicator of poor clinical outcome MDR. 148/184 (80%) patients with MDR-TB were than being resistant to all first-line anti-tuberculosis born in countries of the former Soviet Union. 7/184 (TB) drugs. To investigate this issue, a large series (4%) met XDR-TB criteria. In patients with XDR-TB hos- of multidrug-resistant TB (MDR-TB) and XDR-TB cases pitalization was longer (mean±SD 202±130 vs. diagnosed in Estonia, Germany, Italy and the Rus- 123±81 days; p=0.015) and resistance to all first li- sian Federation during the period 1999–2006 were ne drugs was more frequent (36% vs. 86%; p=0.013) analysed. Drug-susceptibility testing for first- and se- than in patients with MDR-TB. 74/184 (40%) patients cond-line anti-TB drugs, quality assurance and tre- received treatment with linezolid. Treatment suc- atment delivery was performed according to World cess rates ranged from 59.2% for the entire cohort Health Organization recommendations in all study (59.3% for MDR-TB and 57.1 % for XDR-TB) to 87.2% sites. Out of 4,583 culture-positive TB cases analy- for those with a definitive outcome (n=125; 87.5% for Wissenschaftlicher Jahresbericht 2007-2008 197 Division of Clinical Infectious Diseases and Clinical Studies Research Reports MDR-TB and 80% for XDR-TB). Extensive antibiotic To investigate this issue, a large series of MDR- and susceptibility testing and availability of second- and XDR-TB cases diagnosed in Estonia, Germany, Italy third-line drugs under inpatient management con- and the Russian Federation (Archangels Oblast) ditions allow achieving relatively high treatment suc- between 1999 and 2006 were analysed. All study cess rates in MDR- and XDR-TB. sites performed drug susceptibility testing for first- Fo r s c h u n g s z e n t r u m Bo r s t e l and second-line anti-TB drugs, laboratory quality assurance and treatment delivery according to World Health Organization recommendations. Out of 4,583 culture-confirmed cases, 240 MDR- and 48 XDR-TB cases had a definitive outcome recorded (treatment success, death, failure). Among MDRand XDR-TB cases, capreomycin resistance yielded a higher proportion of failure and death than capreomycin-susceptible cases. Resistance to capreomycin was independently associated with unfavourable outcome (logistic regression analysis: odds ratio 3.51). In the treatment of patients with multidrug-resistant and extensively drug-resistant tuberculosis, resistance to the injectable drug capreomycin was an independent predictor for therapy failure in this cohort. As Mycobacterium tuberculosis drug resistance is increasing worldwide, there is an urgent need for novel interventions in the fight against tuberculosis. Collaboration: Migliori GB, Tradate, Italy, and memFig. 83a-c. Contact screening with a new blood test to investigate a tuberculosis outbreak in a school. bers of the TBNET. Collaboration: Ruesch-Gerdes S, National Refer- Fluoroquinolones: are they essential to treat ence Center for Mycobacteria, Research Center MDR-TB? Borstel; Lange C. 27 collaborating hospitals in Ger- many,members of the TBNET. Several publications have already demonstrated that resistance to fluoroquinolones (FQ) is indeResistance to second-line injectables and treat- pendently associated with poor outcome and/or ment outcomes in multidrug-resistant and exten- that the possibility of including FQ in regimens im- sively drug-resistant tuberculosis cases proves treatment outcomes of multidrug-resistant Lange C. (MDR)-TB cases. This happened before the (recent) description of XDR-TB. We do not know how many No information is currently available on the influ- of the patients with MDR-TB strains were, in fact, in- ence of injectable second-line drugs on treatment fected with XDR Mycobacterium tuberculosis. We outcomes of multidrug-resistant (MDR) and exten- wanted to establish the role of the different XDR-de- sively drug-resistant (XDR) tuberculosis (TB) patients. fining components (e.g. isoniazid and rifampicin, 198 Wissenschaftlicher Jahresbericht 2007-2008 Division of Clinical Infectious Diseases and Clinical Studies Research Reports FQ and injectable second-line drugs) in determining 1.14–4.89; p,0.02). The findings of our analysis sug- poor treatment outcomes. Our group has shown for gest that FQ contribute to increase the risk of death the first time that XDR-TB cases in Italy and Germany and failure, being a key XDR-defining variable. In have a five-fold increase in the risk of death (relati- conclusion, apart from linezolid, fluoroquinolones ve risk (RR) 5.45; 95% confidence interval (CI) 1.95– represent the only ‘‘new’’ class of active drugs cur- 15.27; p,0.01), require longer hospitalisation than rently available to treat drug-resistant tuberculosis. MDR-TB cases (241.2¡177.0 versus 99.1¡85.9 days; They are effective and relatively well tolerated. Fur- p,0.001), have a longer treatment duration thermore, fluoroquinolones have the potential to al- (30.3¡29.4 versus 15.0¡23.8 months; p,0.05) and, for low a reduction in the (still long) short-course che- the few cases who converted, need a longer time motherapy regimens. Unfortunately, rapid selection to smear/culture conversion (p,0.01). The findings of of drug resistance mutants to fluoroquinolones is a a second study, which included additional cases well-known phenomenon. Prevention of develop- from Estonia and the Russian Federation, demon- ment of further drug resistance is imperative until strated that XDR-TB cases had an RR of 1.58 to new drugs become available in the treatment achieve death or failure compared with MDR-TB ca- arena. ses resistant to all first-line drugs (95% CI 1.14–2.20; p,0.05) and an RR of 2.61 (95% CI 1.45–4.69; p,0.001) Collaboration: Migliori GB, Tradate, Italy, and mem- compared with MDR-TB cases in which susceptibili- bers of the TBNET. ty to at least one first-line drug still existed. These data support the observation that the loss of first-line drugs different from rifampicin and isoniazid has Clinical presentation and diagnosis of tubercu- a role in worsening prognosis of MDR-TB cases. In losis order to better understand the role of FQ in deter- Kalsdorf B, Strassburg A, Greinert U, Lange C. mining poor treatment outcomes in MDR-TB cases, we re-analysed data from the four-country study to Recently, major advances have been accomplished assess whether there is any difference in death or in the diagnosis of active tuberculosis. mortality in MDR-TB cases resistant or susceptible to FQ. The overall sample included 425 MDR-TB cases (361 MDR, 64 XDR). A total of 87 (20%) were resistant to FQ, 23 (26%) being MDR and 64 (74%) XDR. Although the proportion of MDR-TB cases resistant to FQ was similar in the three countries reporting FQ resistance (i.e. 18, 24 and 24% in Italy, Germany and Estonia, respectively), the proportion of XDR-TB cases among FQ-resistant cases was largely different (50, 27 and 88% in Italy, Germany and Estonia, respectively). FQ-resistant MDR-TB cases yielded a higFig. 84. Examining the induration in the tuberculin skin test. her proportion of deaths than non-FQ-resistant cases (20 versus 12%; p50.020), as well as a higher A comprehensive diagnostic approach of a patient proportion of treatment failures (19 versus 9%; with possible tuberculosis includes a detailed me- p50.038). At the multiple regression analysis, the dical history and clinical examination as well as the presence of XDR-TB is the only independent risk fac- results of radiological, microbiological, immunolo- tor for both death (odds ratio (OR) 2.07; 95% CI gical, molecular-biological and histological me- 1.05–4.05; p,0.034) and failure (OR 2.37; 95% CI thods. In concert, these results enable the clinician Wissenschaftlicher Jahresbericht 2007-2008 199 Division of Clinical Infectious Diseases and Clinical Studies Research Reports to develop rapidly a decision with a high probabi- Among the important novel developments ranks the lity of a diagnosis or exclusion of active tuberculo- analysis of serum procalcitonin for a better identifi- sis. Therapeutic decisions can thus be made early, cation and treatment monitoring of bacterial pneu- even though corrections in these decisions need to monias compared to conventional tests and a sim- be considered depending on the results of Mycob- ple scoring system, like the CRB-65/CURB score, for acterium tuberculosis -cultures and sensitivity a rapid risk stratification. A rational diagnostic ap- testing. proach is necessary to identify causative microor- Fo r s c h u n g s z e n t r u m Bo r s t e l ganisms of pulmonary infectious diseases depenCollaboration: Lotz J, Medical University Hannover. ding on the severity of the illness, the exposition and predisposition of the patient. In addition to the classical microbiological methods, rapid test systems Diagnosis of respiratory infectious diseases for the identification of microorganisms are beco- Strassburg A, Lange C. ming increasingly important. Lower respiratory tract infections rank among the Collaboration: Zabel P, Div. of Clin. Immunophar- most important illnesses in medicine. However, the macology, Research Center Borstel; Magnussen H, identification of a causative microbiological agent Hospital Großhansdorf, University of Lübeck, Rupp is often difficult. J, University of Lübeck, Herth, FJF, Thorax Clinic Heidelberg, University of Heidelberg. Theses Dissertation Döscher, Gabriele Evaluation eines neuen Testverfahrens zur Diagnose einer Infektion mit Mycobacterium tuberculosis. Medizinische Fakultät Universität zu Lübeck, 2007. Fig. 85. Examination of sputum in patients with pneumonia: a) suameous epithelial cells representing an insufficient specimen from the upper respiratory tract, b) polymorphonuclear granulocytes and Gram-positive diplococci in a patient with pneumococal pneumonia. Pulmonary infections must be differentiated from non-infectious causes of pulmonary diseases with similar symptoms and infiltrates on chest imaging. 200 Wissenschaftlicher Jahresbericht 2007-2008 Publikationen Publications Fo r s c h u n g s z e n t r u m Bo r s t e l Wissenschaftlicher Jahresbericht 2007-2008 202 Publikationen Publications Publikationen Publications Wissenschaftlicher Jahresbericht 2007-2008 203 Publications Peer reviewed papers 2007 Fo r s c h u n g s z e n t r u m Bo r s t e l Peer reviewed papers 2007 A B Ahmed J, Yin H, Alp H, Ghosh S, Khan MQ, Kara- Bade S, Frey A. Potential of active and passive im- genc T, Shayan P, Seitzer U. The Asian and Euro- munizations for the prevention and therapy of trans- pean collaborative network: the Asian component missible spongiform encephalopathies. Expert Rev of the integrated consortium on ticks and tick-borne Vaccines 2007; 6:153-68. diseases. Parasitol Res 2007; 101(S2):S157-S158. Bakheit MA, Seitzer U, Mbati PA, Ahmed JS. Sero- Ahmed JS, Alp H, Aksin M, Seitzer U. Ticks and Tick- logical Diagnostic Tools for the Major Tick-Borne Borne Diseases in Asia. Parasitol Res 2007; Protozoan Diseases of Livestock. Parassitologia 101(S2):S159-S162. 2007; 49(S1):53-62. Aly S, Laskay T, Mages J, Malzan A, Lang R, Ehlers Bansal GC, Gupta SC, Ghosh S, Ray DD, Khan S. Interferon-gamma-dependent mechanisms of my- MN, Shahiduzzaman M, Seitzer U, Ahmed JS. Sta- cobacteria-induced pulmonary immunopathology: tus of Tick Distribution in Bangladesh, India and Pak- the role of angiostasis and CXCR3-targeted istan. Parasitol Res 2007; 101(S2):S207-S216. chemokines for granuloma necrosis. J Pathol. 2007; Bekeredjian-Ding I, Inamura S, Giese T, Moll H, En- 212(3):295-305. dres S, Sing A, Zähringer U, Hartmann G. Staphy- Andrä J, Howe J, Garidel P, Rossle M, Richter W, lococcus aureus triggers T cell-independent B cell Leiva-Leon J, Moriyon I, Bartels R, Gutsmann T, proliferation through the engagement of the B cell Brandenburg K. Mechanism of interaction of opti- receptor and Toll-like receptor 2. J Immunol 2007; mized Limulus-derived cyclic peptides with endo- 178: 2803 – 2812. toxins. Thermodynamical, biophysical, and microbi- Bitter W, von Boxtel R, Goeneweg M, Sánchez ological analysis. Biochem J 2007; 406(2):297-307. Carballo P, Zähringer U, Tommassen J, Koster M. Andrä J, Jakovkin I, Grötzinger J, Hecht O, Kras- Role of C-terminal homology domain in the species- nosdembskaya AD, Goldmann T, Gutsmann T, specific funtioning of Pseudomonas secretins. J Bac- Leippe M. Structure and mode of action of the an- teriol 2007; 189:2967-2975. timicrobial peptide arenicin. Biochem J 2007 Oct 15; Bongiorni S, Pasqualini B, Taranta M, Singh PB, [Epub ahead of print]. Prantera G. Epigenetic regulation of facultative het- Andrä J, Monreal D, Martinez de Tejada G, Olak erochromatinisation via the Me(3)K9H3/HP1/ C, Brezesinski G, Sanchez Gomez S, Goldmann T, Me(3)K20H4 pathway. J Cell Sci 2007; 120(Pt Bartels R, Brandenburg K, Moriyon I. Rationale for 6):1072-80. the design of shortened derivatives of the NK-lysin Brandt K, Singh PB, Bulfone-Paus S, Rückert R. In- derived antimicrobial peptide NK-2 with improved terleukin-21: A new modulator of immunity, infection activity against Gram-negative pathogens. J Biol and cancer. Cytokine Growth Factor Rev 2007; Chem 2007; 282:14719-14728. 18:223-232. Anisimov AP, Shaikhutdinova RZ, Pan’kina LN, Brennecke S, Becker WM, Lepp U, Jappe U. Ana- Feodorova VA, Savostina EP, Bystrova OV et al. Ef- phylactic reaction to lupine flour. J Dtsch Dermatol fect of deletion of the lpxM gene on virulence and Ges 2007; 5:774-6. vaccine potential of Yersinia pestis in mice. J Med Brocks CP, Pries R, Frenzel H, Ernst M, Schlenke P, Microbiol 2007; 56:443-453. Wollenberg B. Functional alteration of myeloid dendritic cells through head and neck cancer. Anticancer Res 2007; Mar-Apr, 27(2):817-24. Brooks C, Muller-Loennies S, Brade L, Kosma P, Wissenschaftlicher Jahresbericht 2007-2008 204 Publications Peer reviewed papers 2007 Brade H, Evans SV. Exploration of specificity in the Lactococcus lactis strains isolated from farm cow- recognition of natural and synthetic bacterial epi- sheds possess strong allergy-protective properties. topes in a germline monoclonal antibody. J Mol Bi- J Allergy Clin Immunol 2007; 119(6):1514-1521. ol. In press. Dennison SR, Harris F, Brandenburg K, Phoenix Bulanova E, Budagian V, Duitman E, Orinska Z, DA. Characterization of the N-terminal segment Krause H, Rückert R, Reiling N, Bulfone-Paus S. Sol- used by the barley yellow dwarf virus movement uble IL-15R is generated by alternative splicing or protein to promote interaction with the nuclear proteolytic cleavage and forms functional com- membrane of host plant cells. Peptides 2007; 28: plexes with IL-15. J Biol Chem 2007; 282:13167-13179. 2091-2097. Chen X, Howe J, Andrä J, Rössle M, Richter W, Dentovskaya SV, Bakhteeva IV, Titareva GM, Galvão da Silva AP, Krensky AM, Clayberger C, Shaikhutdinova RZ, Kondakova AN, Bystrova OV, Brandenburg K. Biophysical analysis of the mech- Lindner B, Knirel YA, and Anisimov AP. Structural anisms of interaction of granulysin-derived peptides diversity and endotoxic activity of the lipopolysac- with enterobacterial endotoxins. Biochim Biophys charide of Yersinia pestis. Biochemistry (Moscow). Acta 2007; 1768:2421-2431. In press. Dialynas D, Terung S, Brown JP, Aucott R, Baron-Lühr C B, Singh PB, Georgatos SD. Plasticity of HP1 proteins in mammalian cells. J Cell Sci 2007; 120(Pt 19):3415-24. Cowell IG, Sunter NJ, Singh PB, Austin CA, Tilby Dombrowsky H, Uhlig S. Steroids and histone MJ. DNA double-strand breaks induce gH2AX foci deacetylase in ventilation-induced gene transcrip- formation preferentially in euchromatin. PLoS ONE tion. Eur Respir J 2007; 30; 5: 865-77. 2007; Oct 24;2(10):e1057. Drobniewski F, Rüsch-Gerdes S, Hoffner S. Antimi- Cox HS, Kalon S, Allamuratova S, Sizaire V, Tigay crobial susceptibility testing of Mycobacterium tu- ZN, Rüsch-Gerdes S, Karimovich HA, Kebede Y, berculosis (EUCAST document E.DEF 8.1) – Report of Mills C. Multidrug-Resistant Tuberculosis Treatment the Subcommittee on Antimicrobial Susceptibility Outcomes in Karakalpakstan, Uzbekistan: Treat- Testing of Mycobacterium tuberculosis of the Euro- ment Complexity and XDR-TB among Treatment Fail- pean Committee for Antimicrobial Susceptibility ures. PLoS ONE 2007; 7(11):e1126. Testing (EUCAST) of the European Society of Clinical Cox HS, Niemann S, Ismailov G, Doshetov D, Oroz- Microbiology and Infectious Diseases (ESCMID). co JD, Blok L, Rüsch-Gerdes S, Kebede Y. Risk of Clin Microbiol Infect 2007; 13:1144-56. acquired drug resistance during short-course di- Droemann D, Rupp J, Goldmann T, Uhlig U, Bran- rectly observed treatment of tuberculosis in an area scheid D, Vollmer E, Kujath P, Zabel P, Dalhoff K. with high levels of drug resistance. Clin Infect Dis Disparate Innate Immune Responses to Persistent 2007; Jun 1, 44(11):1421-7. and Acute Chlamydia pneumoniae Infection in Crouch, E, Head J, Kosma P, Brade H, Müller- COPD. Am J Respir Crit Care Med 2007 175(8):791-7. Loennies S, Sheikh S et al. Recognition of Heptoses Duitman E, Wyczawski D, Boven LG, Venema G, and the Inner Core of Bacterial Lipopolysaccha- Kuipers OP, Hamoen LW. Novel methods for ge- rides by Surfactant Protein D. Biochemistry In press. netic transformation of natural Bacillus subtilis isolates used to study the regulation of the mycosub- D tilin and surfactin synthetases. Appl Environ Microbiol 2007; 3:3490-6. Debarry J, Garn H, Hanuszkiewicz A, Dickgreber N, Blumer N, von Mutius E, Bufe A, Gatermann S, Renz H, Holst O, Heine H. Acinetobacter lwoffii and Wissenschaftlicher Jahresbericht 2007-2008 205 Publications Peer reviewed papers 2007 Fo r s c h u n g s z e n t r u m Bo r s t e l Biochem Cell Biol 2007, 25661-13. E Gorczynski RM, Alexander C, Bessler W, Bran- Esendagli G, Bruderek K, Goldmann T, Busche A, denburg K, Fournier K, Mach JP, Mueller S, Ri- Branscheid D, Vollmer E, Brandau S. Malignant etschel ET, Ulmer AJ, Waelli T, Zahringer U, Khatri and non-malignant lung tissue areas are differen- I. An alteration in the levels of populations of CD4+ tially populated by natural killer cells and regula- Treg is in part responsible for altered cytokine pro- tory T cells in non-small cell lung cancer. Lung Can- duction by cells of aged mice which follows injec- cer 2007. In press. tion with a fetal liver extract. Immunol Lett 2007; 109:101-112. Gorczynski RM, Alexander C, Bessler W, Bran- F denburg K, Fournier K, Hoffmann P, Mach JP, Farhat K, Riekenberg S, Heine H, Debarry J, Lang Mueller S, Rietschel ET, Terzioglu E, Ulmer AJ, R, Mages J, Buwitt-Beckmann U, Roschmann K, Waelli T, Zahringer U, Khatri I. Role of MIF and glu- Jung G, Wiesmuller KH, Ulmer AJ. Heterodimer- tathione, in association with fetal ovine globin chain ization of TLR2 with TLR1 or TLR6 expands the lig- (Hbgamma) and LPS, in induction of TNFalpha from and spectrum but does not lead to differential sig- cells of young and aged mice, and PBL from healthy naling. J Leukoc Biol 2007, [Epub ahead of print]. human populations. Immunol Lett 2007; 105:140-149. Fedtke I, Mader D, Kohler T, Moll H, Nicholson G, Greinert U, Hillemann D, Lange C, Richter E. Anti- Biswas R, Henseler K, Götz F, Zähringer U, Peschel biotika-resistente Tuberkulose. Med Klin 2007; 102, A. A Staphylococcus aureus ypfP mutant with strong- 957-66 ly reduced lipoteichoic acid (LTA) content: LTA gov- Greinert U, Jafari C, Zabel, P, Lange C. Therapie erns bacterial surface properties and autolysin ac- der Tuberkulose. Der Pneumologe 2007; 4(3):175-86. tivity. Mol Microbiol 2007; 65:1078-1091. Greinert U, Lange C. Pulmonale Erkrankungen Feodorova VA, Pan’kina LN, Savostina EP, Saya- durch Nicht-tuberkulöse Mykobakterien. Der Pneu- pina LV, Motin VL, Dentovskaya SV et al. A Yersinia mologe 2007 [epublished ahead of print]. pestis lpxM-mutant live vaccine induces enhanced Guo S, Mu Y, Ma D, Yang S, Ge G, Fang B, Ga D, immunity against bubonic plague in mice and Liu Z, Ma M, Luo J, Yin H, Seitzer U, Ahmed J. Sero- guinea pigs. Vaccine 2007; 25:7620-7628. logical Investigation of Ovine Theileriosis by ELISA Fritz M, Lokstein H, Hackenberg D, Welti R, Roth in Gannan Tibet Region of Gansu Province in Chi- M, Zähringer U, Fulda M, Hellmeyer W, Ott C, na. Parasitol Res 2007; 101(S2):S197-S200. Wolter FP, Heinz E. Channeling of eukaryotic diacylglycerol into the biosynthesis of plastidial hosphatidylglycerol. J Biol Chem2007; 282: 4613-4625. H Hansen LK, Perlovich GL, Schaper K-J, Bauer-Brandl A. Pyridine-3-carbaldehyde 2-pyridylhydrazone. G Acta Cryst 2007; E63:3042-3042. Gaede KI, Müller-Quernheim J. Chronic Beryllium Hauber HP, Goldmann T, Vollmer E, Wollenberg Disease – Risk Faktors. ErgoMed 2007; 4:117-25. B, Hung HL, Levitt RC, Zabel P. LPS-induced mucin Gavrovic-Jankulovic M, Poulsen K, Brckalo T, Bo- expression in human sinus mucosa can be attenu- bic S, Lindner B, Petersen A. A novel recombi- ated by hCLA inhibitors. J Endotoxin Res 2007; nantly produced banana lectin isoform is a valu- 13:109-116. able tool for glycoproteomics and a potent modu- Hauber HP, Goldmann T, Vollmer E, Wollenberg lator of the proliferation response in CD3(+), CD4(+), B, Zabel P. Effect of dexamethasone and ACC on and CD8(+) populations of human PBMCs. Int J bacterial induced mucin expression in human air- Wissenschaftlicher Jahresbericht 2007-2008 206 Publications Peer reviewed papers 2007 way mucosa. Am J Respir Cell Mol Biol. 2007 Nov; mer AJ, Zähringer U, Rietschel ETh, Brandenburg 37(5):606-16. K. Biophysical characterization of the interaction of Heine H, Gronow S, Zamyatina A, Kosma P, Brade endotoxins with hemoglobins. Med Chem 2007; H. Investigation on the agonistic and antagonistic 3:13-20. biological activities of synthetic Chlamydia lipid A Howe J, Hammer M, Brandenburg K. Calorimetric and its use in in vitro enzymatic assays. J Endotoxin investigations of the effect of polymyxin B on differ- Res 2007; 13(2):126-132. ent Gram-negative bacteria. Thermochim Acta Hillemann D, Rüsch-Gerdes S, Richter E. Evaluation 2007; 458: 34-37. of the GenoType MTBDRplus assay for rifampin and Howe J, von Minden M, Gutsmann T, Koch MH, isoniazid susceptibility testing of Mycobacterium tu- Wulf M, Gerber S, Milkereit G, Vill V, Brandenburg berculosis strains and clinical specimens. J Clin Mi- K. Structural preferences of dioleoyl glycolipids with crobiol 2007; 45(8):2635-40. mono- and disaccharide head groups. Chem Phys Hillemann D, Rüsch-Gerdes S, Richter E. In Vitro se- Lipids 2007; 149(1-2):52-58. lected Linezolid-Resistant Mycobacterium tubercu- losis Mutants. Antimicrob Agents Chemother. 2007, J 10; [Epub ahead of print]. Hoffmann C, Ernst M, Meyer P, Wolf E, Rosenkranz Jafari C, Ernst M, Strassburg A, Greinert U, Kals- T, Plettenberg A, Stoehr A, Horst HA, Marienfeld dorf B, Kirsten D and Lange C. Local immunodi- K, Lange C. Evolving characteristics of toxoplasmo- agnosis of pulmonary tuberculosis by enzyme-linked sis in HIV-1-infected patients: Clinical course and immunospot. Eur Resp J. In press. Toxoplasma gondii-specific immune responses. Clin Japelj B, Zorko M, Majerle A, Pristovsek P, Microbiol Infect 2007; 13(5):510-5. Sanchez-Gomez S, Martinez de Tejada G, Moriy- Hölscher C, Reiling N, Schaible UE, Hölscher A, on I, Blondelle SE, Brandenburg K, Andrä J, Lohn- Bathmann C, Korbel D, Lenz I, Sonntag T, Kröger er K, Jerala R. Acyl group as the central element of S, Akira S, Mossmann H, Kirschning CJ, Wagner H, the structural organization of antimicrobial lipopep- Freudenberg M, Ehlers S. Containment of aero- tide. J Am Chem Soc 2007; 129:1022-1023. genic Mycobacterium tuberculosis infection does not require MyD88 adaptor function for TLR 2, 4 and K 9. Eur J Immunol. In press. Howe J, Andrä J, Conde R, Iriarte M, Garidel P, Kaczynski Z, Braun S, Lindner B, Niehaus K, Holst Koch MH, Gutsmann T, Moriyon I, Brandenburg K. O. Investigation of the chemical structure and bio- Thermodynamic analysis of the lipopolysaccharide- logical activity of oligosaccharides isolated from dependent resistance of Gram-negative bacteria rough-type Xanthomonas campestris pv. campestris against polymyxin B. Biophys J 2007; 92(8):2796- B100 lipopolysaccharide. J Endotoxin Res 2007; 2805. 13(2):101-108. Howe J, Garidel P , Roessle M , Richter W, Alexa- Kasper B, Brandt E, Brandau S, Petersen F. Platelet nder C, Fournier K, Mach JP, Waelli T, Gorczynski factor 4 (CXC chemokine ligand 4) differentially reg- RM, Ulmer AJ, Zähringer U, Hartmann A, Riet- ulates respiratory burst, survival, and cytokine ex- schel ET, Brandenburg K. Structural investigations pression of human monocytes by using distinct sig- into the interaction of hemoglobin and part structu- naling pathways. J Immunol 2007; 179:2584-2591. res with bacterial endotoxins. J Endotox Res. In Khattab AA, Rother C, Toelg R, Schwarz B, Mier press. K, Geist V, Drömann D et al. Sirolimus-eluting stent Howe J, Hammer M, Alexander C, Rössle M, treatment as buffer for inflamed lesions identified Fournier K, Mach JP, Waelli T, Gorczynski RM, Ul- by serum marker estimation. The STABILISE pilot Wissenschaftlicher Jahresbericht 2007-2008 207 Publications Peer reviewed papers 2007 Fo r s c h u n g s z e n t r u m Bo r s t e l study. Int J Cardiol 2007; 122(2):173-175. microarrays with human basophils. Clin Exp Allergy Knirel YA, Dentovskaya SV, Bystrova OV, Kocharo- 2007; 37:1854-1862. va NA, Senchenkova SN, Shaikhutdinova RZ, Lin Z, Thomas NJ, Bibikova M, Seifart C, Wang Y, Bakhteeva IV, Lindner B, Pier GB, Anisimov AP. Re- Guo X, Wang G, Vollmer E, Goldmann T, Garcia lationship of the lipopolysaccharide structure of EW, Zhou L, Fan JB, Floros J. DNA methylation Yersinia pestis to resistance to antimicrobial factors. markers of surfactant proteins in lung cancer. Int J Adv Exp Med Biol 2007; 603:88-96. Oncol 2007 Jul; 31(1):181-91. Ködmön C, Niemann S, Gutierrez MC, Sola C, Ras- Liu AH, Yin H, Guan GQ, Schnittger L, Liu ZJ, Ma togi N, Lukács J, Somoskövi A. Molecular clues of ML, Dang ZS, Liu JL, Ren QY, Bai Q, Ahmed JS, Luo a microepidemy among homeless tuberculosis pa- JX. At least two genetically distinct large Babesia tients in Budapest due to a new and local My- species infective to sheep and goats in China. Vet cobacterium tuberculosis clade. Infect Genet Evol Parasitol 2007; 147:246-251. 2007; 7:632-5. Losi M, Bossink A, Codecasa L, Jafari C, Ernst M, König B, Petersen A, Bellinghausen I, Böttcher I, Thijsen S, Cirillo D, Ferrarese M, Greinert U, Fab- Becker WM, Knop J, Saloga J. Human dendritic bri LM, Richeldi L, Lange C for the European tu- cells transfected with allergen-DNA stimulate spe- berculosis network TBNET. Use of a T-cell interfer- cific immunoglobulin G4 but not specific im- on-g release assay for the diagnosis of tuberculous munoglobulin E production of autologous B cells pleurisy, Eur Resp J 2007; 30:1173-79. from atopic individuals in vitro. Immunology 2007; 122:239-46. M Mamat U, Meredith TC, Aggarwai P, Kühl A, Kir- L choff P, Lindner B, Hanuszkiewicz A, Sun J, Holst Lang DS, Droemann D, Schultz H, Branscheid D, O, Woodard RW. Single amino acid substitutions in Martin C, Ressmeyer AR, Zabel P, Vollmer E, Gold- either YhjD or MsbA confer viability to 3-deoxy-D- mann T. A novel human ex vivo model for the analy- manno-oct-2-ulosonic acid-depleted Escherichia sis of molecular events during lung cancer coli, Mol Microbiol 2007. In press. chemotherapy. Respir Res 2007; 8:43. Meredith TC, Mamat U, Kaczynski Z, Lindner B, Lange C, Grobusch M, Wagner D. XDR-Tuberkulo- Holst O, Woodard RW. Modification of lipopolysac- se. Dtsch Med Wochenschr. In press. charide with colanic acid (M-antigen) repeats in Es- Lange C, Hellmich B, Ernst M, Ehlers S. Rapid im- cherichia coli. J Biol Chem 2007; 282(11):7790-7798. munodiagnosis of tuberculosis in a woman under- Meyer B, Loeschke S, Schulze A, Weigel T, Sand- going anti-TNF therapy. Nat Clin Pract Rheumatol ham M, Goldmann T, Vollmer E, Bullerdiek J. HM- 2007; 3(9):528-34. GA2 overexpression in Non Small Cell Lung Cancer. Lange C, Jafari C, Lalvani A. Reply to Breen et al. Mol Carcinog 2007 Jul; 46(7):503-11. AJRCCM 2007; 176: 317. Migliori GB, Besozzi G, Girardi E, Kliiman K, Lenaerts AJ, Hoff D, Aly S, Ehlers S, Andries K, Lange C, Toungoussova OS, Ferrara GS, Daniela Cantarero L, Orme IM, Basaraba RJ. Location of CM, Gori A, Matteelli A, Spanevello A, Codecasa persisting mycobacteria in a Guinea pig model of LR, Mario C, Raviglione MC, SMIRA/TBNET Study tuberculosis revealed by r207910. Antimicrob Group. Clinical and operational value of the XDR- Agents Chemother 2007; Sep, 51(9):3338-45. TB definition. Eur Resp J 2007. 30(4):623-6. Lin J, Renault N, Haas H, Schramm G, Vieths S, Vo- Migliori GB, Lange C, Girardi E, Centis E, Besozzi G, gel L, Falcone FH, Alcocer M. A novel tool for the Kliiman K, Codecasa L. Spanevello A, Cirillo DM detection of allergic sensitization combining protein and SMIRA/TBNET Study Group. Fluoroquinolones: Wissenschaftlicher Jahresbericht 2007-2008 208 Publications Peer reviewed papers 2007 are they essential to treat MDR-TB? Eur Resp J. In E, Metz M, Nashkevich N, Schiemann F, Schulmis- press. trat J, Budagian V, Giron-Michel J, Brandt E, Paus Migliori GB, Lange C, Girardi E, Centis E, Besozzi R, Bulfone-Paus S. IL-15 constrains mast cell-de- G, Kliiman K, Spanevello A, Cirillo DM, SMI- pendent anti-bacterial defenses by suppressing chy- RA/TBNET Study Group. XDR-TB is worse than MDR- mase activities. Nat Med 2007; 13:927-934. TB: different methodology and settings, same results. Clin Infect Dis. In press. P Migliori GB, Ortmann J, Girardi E, Besozzi G, Lange C, Cirillo D, Ferrarese M, De Iaco G, Gori Perlovich GL, Strakhova NN, Kazachenko VP, G, Raviglione MC, SMIRA/TBNET Study Group. Volkova TV, Tkachev VV, Schaper K-J, Raevsky OA. Risk of mortality of extensively drug-resistant tuber- Studying thermodynamic aspects of sublimation, culosis (XDR-TB) in Italy and Germany. Emerg Infect solubility and solvation processes and crystal struc- Dis. 2007; 13(5): 780-82. ture analysis of some sulfonamides. Int J Pharm Moulakakis C, Adam S, Seitzer U, Schromm AB, 2007; 334:115-124. Leitges M, Stamme C. Surfactant Protein A activation Petersen A, Bals R. Epithelzellen des Respirati- of atypical protein kinase C {zeta} in I{kappa}B-{al- onstraktes regulieren die allergische Immunantwort. pha}-dependent anti-inflammatory immune regula- Allergojournal. In press. tion. J Immunol 2007; 179(7):4480-4491. Pieretti G, Corsaro MM, Lanzetta R, Parrilli M, Müller-Quernheim JM, Vollmer E, Galle J. Secondary Nicolaus B, Gambacorta A, Lindner B, Holst O. bronchial botryomycosis due to foreign body aspira- Structural characterization of the core region of the tion. Monaldi Arch Chest Dis 2007; Jun, 67(2):119-21. lipopolysaccharide from the haloalkaliphilic Halomonas pantelleriensis: Identification of the bi- N ological O-Antigen Repeating Unit (p NA). Eur J Org Chem 2007. In press. Nigg AP, Zahn S, Rückerl D, Hölscher C, Yoshimo- Pletz MW, Dickgreber N, Hagen L, Golpon H, to T, Ehrchen JM, Wölbing F, Udey MC, von Stebut Zabel P, Bauer TT, Welte T, Groneberg DA. Immu- E. Dendritic cell-derived IL-12p40 homodimer con- nisation strategies for the management of severe tributes to susceptibility in cutaneous leishmaniasis acute respiratory syndrome (SARS). Pneumologie in BALB/c mice. J Immunol 2007; 178:7251-7258. 2007; 61(10):663-7. O Q Oelemann MC, Diel R, Vatin V, Haas W, Rüsch- Qu J, Mayer C, Behrens S, Holst O, Kleinschmidt Gerdes S, Locht C, Niemann S, Supply P. Assess- JH. The periplasmic chaperone Skp of E. coli forms ment of an optimized mycobacterial interspersed 1:1 complexes with outer membrane proteins via hy- repetitive- unit-variable-number tandem-repeat typ- drophobic and electrostatic interactions. J Mol Biol ´ 2007; 374:91-105. ing system combined with spoligotyping for population-based molecular epidemiology studies of tuberculosis.J Clin Microbiol. 2007; 45:691-7. R Omer LT, Abdul-Aziz Kadir M, Seitzer U, Ahmed JS. A survey of ticks (Acari:Ixodidae) on cattle, sheep Radwanska M, Cutler A, Hoving C, Magez S, and goats in the Dohuk Governorate Iraq. Parasitol Hölscher C, Bohms A, Arendse B, Kirsch R, Alexan- Res 2007; 101(S2):S179-S181. der J, Kaye P, Brombacher F. Efficient deletion of Orinska Z, Maurer M, Mirgomizadeh F, Bulanova the IL-4Ralpha on CD4 T cells renders BALB/c mice Wissenschaftlicher Jahresbericht 2007-2008 209 Publications Peer reviewed papers 2007 resistant to Leishmania major infection. PLOS Path 2007; 3:e68. for GM1 binding sequence motifs. Bioconjugate Chem 2007; 18:573-578. Raevsky OA, Perlovich GL, Schaper K-J. Physico- Rückert R, Bulfone-Paus S, Brandt K. Interleukin-21 chemical properties/descriptors governing the sol- stimulates antigen uptake, protease activity, survival ubility and partitioning of chemicals in water-sol- and induction of CD4+ T-cell proliferation by murine vent-gas systems. Part 2. Solubility in 1-octanol. SAR macrophages. Clin Exp Immunol. In press. Fo r s c h u n g s z e n t r u m Bo r s t e l & QSAR Environ Res 2007; 18:543-578. Raevsky OA, Raevskaja OE, Schaper K-J. Physico- S chemical properties/descriptors governing the solubility and partitioning of chemicals in water-sol- Salih DA, El Hussein AM, Kyule MN, Zessin KH, vent-gas systems. Vapor pressure and concentration Ahmed JS, Seitzer U. Determination of potential risk of chemicals above saturated aqueous solutions. factors associated with Theileria annulata and Thei- QSAR Comb Sci 2007; 26:1060-1064. leria parva infections of cattle in the Sudan. Para- Rahmanzadeh R, Hüttmann G, Gerdes J, Scholzen sitol Res 2007; 101:1285-1288. T. Chromophore-assisted light inactivation of pKi-67 Salih DA, El Hussein AM, Seitzer U, Ahmed JS. Epi- leads to inhibition of ribosomal RNA synthesis. Cell demiological studies on tick-borne diseases of cat- Prolif 2007; 40(3):422-30. tle in Central Equatoria State, Southern Sudan. Par- Reiling N, Schneider D, Ehlers S. Mycobacterium tu- asitol Res 2007; 101:1035-1044. berculosis-induced cell death of primary human Sausbier M, Zhou XB, Beier C, Sausbier U, Wolpers monocytes and macrophages is not significantly D, Maget S, Martin C, Dietrich A, Ressmeyer AR, modulated by tumor necrosis factor-targeted bio- Renz H, Schlossmann J, Hofmann F, Neuhuber W, logicals. J Investig Dermatol Symp Proc 2007; May, Gudermann T, Uhlig S, Korth M, Ruth P. Reduced 12(1):26-33. rather than enhanced cholinergic airway constriction Rennemeier C, Hammerschmidt S, Niemann S, In- in mice with ablation of the large conductance Ca2+- amura S, Zähringer U, Kehrel BE. Throm- activated K+ channel. FASEB J 2007; 21; 3: 812-22. bospondin–1 promotes cellular adherence of Schaaf B, Kruse J, Rupp J, Reinert RR, Droemann Gram-positive pathogens via recognition of pepti- D, Zabel P, Ewig S, Dalhoff K. Sepsis severity pre- doglycan. FASEB J 2007; 21:3118-32. dicts outcome in community-acquired pneumococ- Renz H, Becker W-M, Bufe A, Jappe, U, Kleine-Teb- cal pneumonia. Eur Respir J 2007; 30(3):517-24. be J, Petersen A, Raulf-Heimsoth M, Saloga J, Schneider I, Haller D, Kullmann B, Beyer D, Werfel T, Worm M. Positionspapier der DGAI zur in- Ahmed JS, Seitzer U. Identification, molecular char- vitro Allergiediagnostik. Allergojournal. In press. acterization and subcellular localization of a Thei- Richter E, Rüsch-Gerdes S, Hillemann D. First line- leria annulata parasite protein secreted into the zolid-resistant clinical isolates of Mycobacterium tu- host cell cytoplasm. Parasitol Res 2007; 101:1471- berculosis. Antimicrob Agents Chemother 2007; 1482. 51:1534-6. Schramm G, Mohrs K, Wodrich M, Doenhoff MJ, Richter E, Tortoli E, Fischer A, Hendricks O, Engel Pearce EJ, Haas H, Mohrs M. Cutting edge: R, Hillemann D, Schubert S, Kristiansen JE. My- IPSE/alpha-1, a glycoprotein from Schistosoma man- cobacterium alsiense, a novel, slowly growing soni eggs, induces IgE-dependent, antigen-inde- species isolated from two patients with pulmonary pendent IL-4 production by murine basophils in vi- disease. J Clin Microbiol 2007; 45:3837-9. vo. J Immunol 2007; 178:6023-6027. Röckendorf N, Bade S, Hirst TR, Gorris H-H, Frey Schromm AB, Howe J, Ulmer AJ, Wiesmuller KH, A. Synthesis of a fluorescent ganglioside GM1 derivative and screening of a synthetic peptide library Seyberth T, Jung G, Rössle M, Koch MH, Gutsmann T, Brandenburg K. Physicochemical and Wissenschaftlicher Jahresbericht 2007-2008 210 Publications Peer reviewed papers 2007 biological analysis of synthetic bacterial lipopeptides: Validity of the concept of ‘endotoxic confor- T mation’. J Biol Chem 2007; 282(15):11030-11037. Seitzer U, Bakheit MA, Salih DA, Ali A, Haller D, Takada Y, Kyoichi I, Shinga J, Turner JAM, Kita- Yin H, Schnittger L, Ahmed JS. From molecule to di- mura H, Ohara O, Watanabe G, Singh PB, Kami- agnostic tool: Theileria annulata Surface protein jo T, Jenuwein T, Burgoyne PS, Koseki H. Mam- TaSP. Parasitol Res 2007; 101(S2):S217-S223. malian Polycomb Scmh1 mediates exclusion of Poly- Shah NS, Wright A, Bai GH, Barrera L, Boulahbal comb complexes from the XY body in the pachytene F, Martín-Casabona N, Drobniewski F, Gilpin C, spermatocytes. Development 2007; 134: 579-590. Havelková M, Lepe R, Lumb R, Metchock B, Por- Trujillo-Vargas CM, Werner-Klein M, Wohlleben G, taels F, Rodrigues MF, Rüsch-Gerdes S, Van Deun Polte T, Hansen G, Ehlers S, Erb KJ. Helminth-de- A, Vincent V, Laserson K, Wells C, Cegielski JP. rived products inhibit the development of allergic Worldwide emergence of extensively drug-resistant responses in mice. Am J Respir Crit Care Med 2007; tuberculosis. Emerg Infect Dis 2007;13:380-7. Feb 15,175(4):336-44. Spiller S, Dreher S, Meng G, Grabiec A, Thomas W, Hartung T et al. Cellular recognition of trimyris- V toylated peptide or enterobacterial lipopolysaccharide via both TLR2 and TLR4. J Biol Chem 2007; von Bulow V, Dubben S, Engelhardt G, Hebel S, 282(18):13190-13198. Plumakers B, Heine H, Rink L, Haase H. Zinc-de- Srivastava M, Meinders A, Steinwede K, Maus R, pendent suppression of TNF-{alpha} production is Lucke N, Bühling F, Ehlers S, Welte T, Maus UA. Me- mediated by protein kinase A-induced inhibition of diator responses of alveolar macrophages and ki- Raf-1, I{kappa}B Kinase beta, and NF-{kappa}B. J netics of mononuclear phagocyte subset recruit- Immunol 2007; 179(6):4180-4186. ment during acute primary and secondary my- Voss S, Ulmer AJ, Jung G, Wiesmüller KH, Brock R. cobacterial infections in the lungs of mice. Cell Mi- The activity of lipopeptide TLR2 agonists critically crobiol 2007; Mar, 9(3):738-52. depends on the presence of solubilizers. Eur J Im- Steffen A, Jafari C, Merz H, Galle J, Berger G. Sub- munol 2007; 37:3489-3498. glottic MALT lymphoma of the larynx – more attention to the glottis. In vivo 21. In press. W Strassburg A, Jafari C, Greinert U, Lange C. Klinische Diagnostik der pulmonalen Tuberkulose. Med Wagner D, Hörster R. Lange B, Lange C. Stellen- Klin 2007; 665-75. wert der Interferon-gamma Sekretionstest in der Tu- Strassburg A. Jafari C, Ernst M, Lange C. Rapid di- berkulosediagnostik. Dtsch Med Wochenschr. In agnosis of pulmonary tuberculosis by BAL-ELISPOT press. in an immunocompromised host. Eur Resp J. In Walter S, Letiembre M, Liu Y, Heine H, Penke B, press. Hao W, Bode B, Manietta N, Walter J, Schulz- Sürken M, Keller C, Röhker C, Ehlers S, Bange FC. Schuffer W, Fassbender K. Role of the toll-like re- Anaerobic arginine metabolism of Mycobacterium ceptor 4 in neuroinflammation in Alzheimer’s di- tuberculosis is mediated by arginine deiminase (ar- sease. Cell Physiol Biochem 2007; 20(6):947-956. cA), but is not essential for chronic persistence in an Watz H, Engels K, Loeschke S, Amthor M, Kirsten aerogenic mouse model of infection. Int J Med Mi- D, Magnussen H. Lymphangioleiomyomatosis— crobiol 2007; Nov 19; [Epub ahead of print]. presence of receptor tyrosine kinases and the angiogenesis factor VEGF-A as potential therapeutic targets. Thorax 2007; Jun, 62(6):559. Wissenschaftlicher Jahresbericht 2007-2008 211 Publications Peer reviewed papers 2007 Fo r s c h u n g s z e n t r u m Bo r s t e l Welker L, Akkan R, Holz O, Schultz H, Magnussen H. Diagnostic outcome of two different CT-guided fine needle biopsy procedures. Diagn Pathol. 2007 Aug 23; 2(1):31. Welker L, Müller M, Holz O, Vollmer E, Magnussen H, Jörres RA (2007). Cytological diagnosis of malignant mesothelioma—improvement by additional analysis of hyaluronic acid in pleural effusions. Virchows Arch. 2007 Apr; 450(4):455-61. Wittkowski M, Mittelstädt J, Brandau S, Reiling N, Lindner B, Torelles J et al. Capsular arabinomannans from Mycobacterium avium morphotypes SmO and SmT possess morphotype-specific structural differences but identical biological activity. J Biol Chem 2007; 282:19103-19112. Woller G, Brandt E, Mittelstädt J, Rybakowski C, Petersen F. Platelet factor 4/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals. J Leukoc Biol. In press. Y Yin H, Schnittger L, Luo J, Seitzer U, Ahmed JS. Ovine theileriosis in China: A new look at an old story. Parasitol Res 2007; 101(S2):S191-S195. Z Ziegler E, Oberbarnscheidt M, Bulfone-Paus S, Förster R, Kunzendorf U, Krautwald S. CCL19 inhibits T cell proliferation. J Immunol 2007; 179:64856493. Zughaier SM, Lindner B, Howe J, Garidel P, Koch MHJ, Brandenburg K, Stephens DS. Physicochemical characterization and biological activity of lipooligosaccharides and lipid A from Neisseria meningitides. INI. In press. Wissenschaftlicher Jahresbericht 2007-2008 212 Publications Peer reviewed papers 2008 Peer reviewed papers 2008 pathies: an urgent need? Hum Vaccin 2008; 4(1):79-81. A Aucott R, Bullwinkel J, Yang Y, Shi W, Billur M, Ahmed JS, Glass EJ, Salih DA, Seitzer U. Innate im- Brown JP, Menzel U, Kioussis D, Wang G, Reisert munity to tropical theileriosis. Innate Immun 2008; I, Weimer J, Pandita RK, Sharma GG, Pandita TK, 14:5-12. Fundele R, Singh PB. HP1β is required for devel- Ahmed JS, Oliva AG, Seitzer U. Animal Health: Har- opment of the cerebral neocortex and neuromus- monisation and Distribution of Pathogen Detection cular junctions. J Cell Biol 2008; 183(4):597-606. and Differentiation Tools. Transbound Emerg Dis 2008; 55:187-189. B Ali AM, Hassan D, Bakheit M, Hassan SM, Mukhtar MM, Ahmed JS, Seitzer U. Comparison of Bakheit MA, Kullmann B, Ahmed JS, Seitzer U. Ex- the molecular structure of the TaSP gene of Theile- istence of Splicing Products in Homologues of Thei- ria annulata from Sudanese isolates. Ann NY Acad leria lestoquardi Clone-5 Gene in T. annulata and T. Sci USA 2008; 1149:218–220. parva. Ann NY Acad Sci USA 2008; 1149:212–213. Ali, AM, Beyer D, Bakheit MA, Kullmann B, Salih Blume C, Foerster S, Gilles S, Becker WM, Ring J, DA, Ahmed JS, Seitzer U. Influence of subculturing Behrendt H, Petersen A, Traidl-Hoffmann C. Hu- on gene expression in a Theileria lestoquardi in- man epithelial cells of the respiratory tract and the fected cell line. Vaccine 2008; 26S6:G17-G23. skin differentially internalise grass pollen allergens. Allix-Beguec C, Harmsen D, Weniger T, Supply P, J Invest Dermatology. In press. Niemann S. Evaluation and strategy for use of Bollinger T, Bollinger A, Skrum L, Dimitrov S, MIRU-VNTRplus, a multifunctional database for on- Lange T, Solbach W. Sleep-dependent acitvity of T line analysis of genotyping data and phylogenetic cells and regulatory T cells. Clin Exp Immunol 2008. identification of Mycobacterium tuberculosis com- In press. plex isolates. J Clin Microbiol 2008; 46(8):2692-2699. Borowski S, Michalik D, Reinke H, Vogel C, Aly S, Mages J, Reiling N, Kalinke U, Decker T, Hanuszkiewicz A, Duda KA, Holst O. Synthesis of Lang R, Ehlers S. Mycobacteria-induced granuloma methyl 2-acetamido-2-deoxy-α- and β-D-xylo-hex- necrosis depends on IRF-1. J Cell Mol Med. 2008; opyranosid-4-ulose, a keto sugar present in bacter- Aug 14. [Epub ahead of print]. ial lipopolysaccharides. Carbohydr Res 2008; Andrä J, Böhling A, Gronewold TMA, Schlecht U, 343:1004-1011. Perpeet M, Gutsmann T. Surface acoustic wave Bothamley G, Ditiu L, Migliori GB, Lange C, TBNET biosensor as a tool to study the interaction of an- contributors. Active case finding of tuberculosis in timicrobial peptides with phospholipid and Europe. A TBNET (Tuberculosis Network European lipopolysaccharide model membranes. Langmuir Trialsgroup) survey. Eur Resp J 2008; 32:1023-30. 2008; 24:9148-53. Brandenburg S, Takahashi T, de la Rosa M, Janke Andrä J, Jakovkin I, Grötzinger J, Hecht O, Kras- M, Karsten G, Muzzulini T, Orinska Z, Bulfone-Paus nosdembskaya AD, Goldmann T, Gutsmann T, Leippe M. Structure and mode of action of the an- S, Scheffold A. IL-2 induces in vivo suppression by CD4+D25+Foxp3+Treg. Eur J. Immunol 2008; timicrobial 38:1643-1653. peptide arenicin. Biochem J 2008;410:113-22. Brooks CL, Blackler RJ, Gerstenbruch S, Kosma P, Aoufouchi S, Faili A, Zober C, D’Orlando O, Weller Muller-Loennies S, Brade H et al. Pseudo-symme- S, Weill JC, Reynaud CA, Bade S, Frey A. Vaccines try and twinning in crystals of homologous antibody against transmissible spongiform encephalo- Fv fragments. Acta Crystallogr D Biol Crystallogr Wissenschaftlicher Jahresbericht 2007-2008 213 Publications Peer reviewed papers 2008 Fo r s c h u n g s z e n t r u m Bo r s t e l 2008; 64(Pt 12):1250-1258. of Yersinia pestis. Biochemistry (Mosc) 2008;73:192- Brooks CL, Muller-Loennies S, Brade L, Kosma P, 199. Hirama T, MacKenzie CR et al. Exploration of Diel R, Loddenkemper R, Meywald-Walter K, Nie- specificity in germline monoclonal antibody recog- mann S, Nienhaus A. Predictive value of a whole nition of a range of natural and synthetic epitopes. blood IFN-gamma assay for the development of ac- J Mol Biol 2008; 377(2):450-468. tive tuberculosis disease after recent infection with Bulfone-Paus S, Paus R. Osteopontin as a new play- Mycobacterium tuberculosis. Am J Respir Crit Care er in mast cell biology. Eur J Immunol 2008; 38:338- Med 2008; 177(10):1164-1170. 341. Duitman E, Orinska Z, Bulanova E, Paus R, BulfonePaus S. How a cytokine is chaperoned through the secretory pathway by complexing with its own re- C ceptor: lessons from IL-15/IL-15Rα. Mol Cell Biol Chapman MD, Ferreira F, Villalba M, Cromwell O, 2008; 28:4851-4861. Bryan D, Becker WM, Fernández-Rivas M, Durham S, Vieths S, van Ree R. CREATE consortium. The European Union CREATE project: a model for interna- E tional standardization of allergy diagnostics and Ehlers S, Bange FC. In vitro and in vivo characteri- vaccines. J Allergy Clin Immunol. 2008;122:882-889. zation of a Mycobacterium tuberculosis mutant de- Cimmino A, Marchi G, Surico G, Hanuszkiewicz A, ficient in glycosyltransferase Rv1500. Int J Med Mi- Evidente A, Holst O. The structure of the O-specific crobiol. 2008 Oct;298(7-8):645-55. polysaccharide of the lipopolysaccharide from Pan- Ehlers S, Schreiber T, Dunzendorfer A, Lowe JB, toea agglomerans strain FL1. Carbohydr Res 2008; Hölscher C. Fucosyltransferase IV and VII - directed 343:392-396. selectin ligand function determines long-term sur- Corsaro MM, Pieretti G, Lindner B, Lanzetta R, Pa- vival in experimental tuberculosis. Immunobiology. rrilli E, Tutino ML, Parrilli M. Highly phosphorylated In press. core oligosaccharide structures from cold-adapted Eker B, Ortmann J, Migliori GB, Sotgiu G, Muet- Psychromonas arctica Chemistry 2008;14:9368-9376. terlein R, Centis R, Hoffmann H, Kirsten D, Scha- Cox HS, Sibilia K, Feuerriegel S, Kalon S, Polonsky berg T, Ruesch-Gerdes S, Lange C for the TBNET. J, Khamraev AK et al. Emergence of extensive drug Multidrug- and extensively drug-resistant tuberculo- resistance during treatment for multidrug-resistant sis, Germany. Emerg Infect Dis. 2008;14:1700-6. tuberculosis. N Engl J Med 2008; 359(22):2398-2400. Esendagli G, Bruderek K, Goldmann T, Busche A, Cramer JP, Lepenies B, Kamena F, Hölscher C, Branscheid D, Vollmer E, Brandau, Esposito N, Freudenberg MA, Burchard GD, Wagner H, Ovchinnikova OG, Barone A, Zoina A, Holst O, Ev- Kirschning CJ, Seeberger PH, Jacobs T. MyD88/IL- idente A. Host and non-host plant response to the 18-dependent pathways rather than TLRs control lipopolysaccaride early parasitaemia in non-lethal Plasmodium yoelii solanacearum, a causal agent of a devastating dis- infection. Microb Infect 2008; 10:1259-1265. ease of potato. Chem Biodiv 2008; 5:2662-2675. D isolated from Ralstonia F Dentovskaya SV, Bakhteeva IV, Titareva GM, Farhat K, Riekenberg S, Heine H, Debarry J, Lang Shaikhutdinova RZ, Kondakova AN, Bystrova OV, R, Mages J, Buwitt-Beckmann U, Roschmann K, Lindner B, Knirel YA, Anisimov AP. Structural diver- Jung G, Wiesmuller KH, Ulmer AJ. Heterodimer- sity and endotoxic activity of the lipopolysaccharide ization of TLR2 with TLR1 or TLR6 expands the lig- Wissenschaftlicher Jahresbericht 2007-2008 214 Publications Peer reviewed papers 2008 and spectrum but does not lead to differential sig- nantly produced banana lectin isoform is a valu- naling. J Leukoc Biol 2008; 83(3):692-701. able tool for glycoproteomics and a potent modu- Farhat K, Sauter KS, Brcic M, Frey J, Ulmer AJ, Jun- lator of the proliferation response in CD3(+), CD4(+), gi TW. The response of HEK293 cells transfected and CD8(+) populations of human PBMCs. Int J with bovine TLR2 to established pathogen-associ- Biochem Cell Biol 2008;40:929-941. ated molecular patterns and to bacteria causing Gavrovic-Jankulovic M, Spasic M, Cirkovic Velick- mastitis in cattle. Vet Immunol Immunopathol. ovic T, Stojanovic M, Inic-Kanada A, Dimitrijevic L, 2008;125:326-36. Lindner B, Petersen A, Becker WM, Jankov RM. Fehrenbach H, Voswinckel R, Michl V et al. Quantification of the thaumatin-like kiwi allergen by Neoalveolarisation contributes to compensatory a monoclonal antibody-based ELISA. Mol Nutr Food lung growth following pneumonectomy in mice. Eur Res 2008;52:701-707. Respir J 2008; 31(3):515-522. Gelhaus C, Jacobs T, Andrä J, Leippe M. The an- Frommhold D, Ludwig A, Bixel MG, Zarbock A, timicrobial NK-2 peptide, the core region of mam- Babushkina I, Weissinger M, Cauwenberghs S, El- malian NK-lysin, kills intraerythrocytic Plasmodium lies LG, Marth JD, Beck-Sickinger AG, Sixt M, falciparum. Lange-Sperandio B, Zernecke A, Brandt E, Weber 2008;52:1713-20. C, Vestweber D, Ley K, Sperandio M. Sialyltrans- Giuliani M, Giron-Michel J, Negrini S, Vacca P, Du- ferase ST3Gal-IV controls CXCR2-mediated firm rali D, Caignard A, Le Bousse-Kerdiles C, Chouaib leukocyte arrest during inflammation. J Exp Med S, Devocelle A, Bahri R, Durrbach A, Taoufik Y, Fer- 2008; 205:1435-1446. rini S, Croce M, Mingari MC, Moretta L, Azzarone Fukuoka S, Howe J, Andrä J, Gutsmann T, Rössle B. TRAF2 and p38 are involved in B cells CD40-me- M, Brandenburg K. Physico-chemical and biophys- diated APE/Ref-1 nuclear translocation: a novel ical study of the interaction of hexa- and heptaacyl pathway in B cell activation. PLoS ONE 2008; May lipid A from Erwinia carotovera with magainin 2-de- 21;3(5). rived antimicrobial peptides. Biochim Biophys Acta Goldmann T, Drömann D, Radtke J, Marwitz S, 2008;1778:2051-7. Lang DS, Schultz H, Vollmer E. CXCR7 transcription Antimicrob Agents Chemother in human non-small cell lung cancer and tumor-free G lung tissues; possible regulation upon chemotherapy. Virchows Arch. 2008 Jan 24 [Epub ahead of Gabriel G, Garn H, Wegmann M et al. The poten- print]. tial of a protease activation mutant of a highly path- Goletti D, Stefania C, Butera O, Amicosante M, ogenic avian influenza virus for a pandemic live vac- Ernst M, Sauzullo I, Vullo V, Cirillo D, Borroni E, cine. Vaccine 2008; 26(7):956-965. Markova R, Drenska R, Dominguez J, Latorre I, An- Garidel P, Howe J, Brandenburg K. Thermody- geletti C, Navarra A, Petrosillo N, Lauria FN, Ip- namic analysis of the interaction of lipopolysac- polito G, Migliori GB, Lange C, Girardi E. Accura- charides with cationic compounds. Eng. Life cy of immunodiagnostic tests for active tuberculosis Sci.2008; 8: 1-8. using single and combined results: a multicenter TB- Garidel, P, Howe J, Milkereit G, Rössle M, Linser NET-Study. PLoS ONE 2008;3(10):e3417. Epub 2008 S, Sven Gerber , Willumeit R, Gutsmann T, Vill V, Oct 15. Brandenburg K. Structural polymorphism of hydra- Gorelik L, Kauth M, Gelhar K, Bufe A, Holst O, Pe- ted ether-linked dimyristyl maltoside and melibiosi- ters M. Modulation of dendritic cell function by cow- de. Chem Phys Lipids 2008; 151:18-29. shed dust extract. Innate Immun 2008; 14:345-355. Gavrovic-Jankulovic M, Poulsen K, Brckalo T, Bo- Gorris HH, Bade S, Röckendorf N, Albers E, bic S, Lindner B, Petersen A. A novel recombi- Schmidt MA, Franek M, Frey A. Rapid profiling of Wissenschaftlicher Jahresbericht 2007-2008 215 Publications Peer reviewed papers 2008 peptide stability in proteolytic environments. Anal H. Investigation on the agonistic and antagonistic Chem. In press. biological activities of synthetic Chlamydia lipid A Fo r s c h u n g s z e n t r u m Bo r s t e l and its use in in vitro enzymatic assays. J Endotoxin Res 2007; 13(2):126-132. H Heinemann S, Zabel P, Hauber HP. Paraneoplas- Haase H, Ober-Blobaum JL, Engelhardt G, Hebel tic syndromes in lung cancer. Cancer Therapy 2008; S, Heit A, Heine H, Rink L. Zinc signals are essen- 6: 687-698 tial for lipopolysaccharide-induced signal transduc- Herb F, Thye T, Niemann S, Browne EN, Chinbuah tion in monocytes. J Immunol 2008; 181(9):6491- MA, Gyapong J et al. ALOX5 variants associated 6502. with susceptibility to human pulmonary tuberculosis. Hanuszkiewicz A, Hübner G, Vinogradov EV, Lind- Hum Mol Genet 2008; 17(7):1052-1060. ner B, Brade H, Brade L, Debarry J, Heine H, Holst Hershberg R, Lipatov M, Small PM, Sheffer H, Nie- O. Structural and immunochemical analysis of the mann S, Homolka S et al. High functional diversity lipopolysaccharide from Acinetobacter lwoffii F78 in Mycobacterium tuberculosis driven by genetic located outside Chlamydiaceae with a Chlamydia- drift and human demography. PLoS Biol 2008; specific lipopolysaccharide epitope. Chem Eur J 6(12):e311. 2008; 14:10251-10258. Hillemann D, Rüsch-Gerdes S, Richter E. In vitro-se- Hanuszkiewicz A, Kaczy ski Z, Lindner B, Gold- lected linezolid-resistant Mycobacterium tuberculo- mann T, Vollmer E, Debarry J, Heine H, Holst O. sis Structural analysis of the capsular polysaccharide 2008;52:800-1. from Acinetobacter lwoffii F78. Eur J Org Chem Hoerster R, Kirsten D, Gaede KI, Jafari C, Stras- 2008; 6183-6188. sburg A, Greinert U, Kalsdorf B, Ernst M, Lange C. Harrington JM, Chou HT, Gutsmann T, Gelhaus C, Antimycobacterial immune responses in patients Stahlberg H, Leippe M, Armstrong PB. Membrane with pulmonary sarcoidosis. Clin Resp J. In press. pore formation by pentraxin proteins from Limulus, Hofmann S, Franke A, Fischer A, Jacobs G, Noth- the American horseshoe crab. Biochem J. 2008 Jul nagel M, Gaede KI, Schürmann M, Müller-Quern- 15;413(2):305-13. heim J, Krawczak M, Rosenstiel P, Schreiber S. Hauber HP, Schulz M, Pforte A, Mack D, Zabel P, Genome-wide association study identifies ANXA 11 Schumacher U. Inhalation with fucose and galac- as a new susceptibility locus for sarcoidosis. Nat tose for treatment of pseudomonas aeruginosa in Med 2008; Aug 10 (Epub ahead of print). cystic fibrosis patients. Int J Med Sci 2008; 5: 371-376. Hölscher C, Reiling N, Schaible UE, Hölscher A, Hauber HP, Steffen A, Goldmann T, Vollmer E, Bathmann C, Korbel D, Lenz I, Sonntag T, Kröger Hung HL, Wollenberg B, Zabel P. Effect of steroids, S, Akira S, Mossmann H, Kirschning CJ, Wagner H, acetly-cysteine and calcium-activated chloride Freudenberg M, Ehlers S. Containment of aero- channel inhibitors on allergic mucin expression in si- genic Mycobacterium tuberculosis infection does nus mucosa. Laryngoscope 2008; 118: 1528-1533. not require MyD88 adaptor function for TLR 2, 4 and Hauber HP, Zabel P. Emerging mucus regulating 9. Eur J Immunol 2008; 38: 680-694. drugs in inflammatory and allergic lung disease. In- Homolka S, Köser C, Archer J, Rüsch-Gerdes S, flamm Allergy Drug Targets 2008; 7: 30-34. Niemann S. Single nucleotide polymorphisms in Hauer B, Diel R, Priwitzer M, Rüsch-Gerdes S, Sch- Rv2629 are specific for Mycobacterium tuberculosis aberg T, Loddenkemper R. [The new tuberculosis genotypes Beijing and Ghana but not associated rapid assay from DiaVita – no improvement of di- with rifampin resistance. J Clin Microbiol. 2008 [pub- agnostic]. Pneumologie. 2008;62:480-1. lished online ahead Nov 19]. Heine H, Gronow S, Zamyatina A, Kosma P, Brade Homolka S, Post E, Oberhauser B, George AG, mutants. Antimicrob Agents Chemother. Wissenschaftlicher Jahresbericht 2007-2008 216 Publications Peer reviewed papers 2008 Westman L, Dafae F et al. High genetic diversity K among Mycobacterium tuberculosis complex strains from Sierra Leone. BMC Microbiol 2008; 8:103. Kayser K, Gortler J, Goldmann T, Vollmer E, Huf- Howe J, Garidel P, Roessle M , Richter W, Alexan- nagl P, Kayser G. Image standards in Tissue-Based der C, Fournier C, Mach JP, Waelli T, Gorczynski Diagnosis (Diagnostic Surgical Pathology). Diagn RM, Ulmer AJ, Zähringer U., Hartmann A, Ri- Pathol. 2008 Apr 18;3(1):17 [Epub ahead of print]. etschel ETh, Brandenburg K. Structural investiga- Kayser K, Konradin Metze K, Radziszowski D, tions into the interaction of hemoglobin and part Amir-Hoshang S, Goldmann T, Kosjerina Z, structures with bacterial endotoxins. Innate Immuni- Mireskandari M, Kayser G. Texture and object re- ty 2008;14:39–49. lated automated information analysis in histological Howe J, Garidel P, Wulf M, Gerber S, Milkereit G, still images of various organs. ANAL QUANT CYTOL. Vill V, Roessle M, and Brandenburg K. Structural In press. polymorphism of hydrated monoacylated maltose Khatri I, Alexander C, Brandenburg K, Fournier K, glycolipids. Chem. Phys. Lipids 2008; 155: 31-37. Lee L, Mach JP, Rietschel ET, Ulmer AJ, Waelli T, Howe J. Richter W. Hawkins L. Rössle M. Alexan- Gorczynski RM. A role for altered TLR gene ex- der C. Fournier K. Mach JP. Waelli T. Gorczynski pression in association with increased expression of RM, Ulmer AJ, Brade H, Zamyatina A, Kosma P, CD200R in the induction of mucosal tissue CD4(+) Rietschel E Th, Brandenburg K. Hemoglobin en- Treg in aged mice following gavage with a liver ex- hances the biological activity of synthetic and nat- tract along with intramuscular monophosphoryl ural bacterial (endotoxic) virulence factors: a gen- lipid A (MPLA) injection. Exp. Gerontol. 2008, 43: eral principle. Med Chem 2008;4:520-525. 771-781. Huber J, Richter E, Binder L, Maass M, Eberl R, Kocharova NA, Kondakova AN, Vinogradov E, Zenz W. Mycobacterium bohemicum and cervical Ovchinnikova OG, Lindner B, Shashkov AS, Rozal- lymphadenitis in children. Emerg Infect Dis. ski A, Knirel YA. Full structure of the carbohydrate 2008;14:1158-9. chain of the lipopolysaccharide of Providencia rusti- gianii O34. Chemistry 2008;14:6184-6191. J Jabs S, Quitsch A, Kakela R, Koch B, Tyynela J, Ködmön C, Niemann S, Gutierrez MC, et al. Molecular clues of a microepidemy among homeless tuberculosis patients in Budapest due to a new and Brade H et al. Accumulation of bis(monoacyl- local Mycobacterium tuberculosis clade. Infect glycero)phosphate and gangliosides in mouse Genet Evol. 2007; 7:632-5. models of neuronal ceroid lipofuscinosis. J Neu- Kösters K, Nau R, Bossink A, Greiffendorf I, rochem 2008; 106(3):1415-1425. Jentsch M, Ernst M, Thijsen S, Hinks T, Lalvani A, Jafari C, Ernst M, Strassburg A, Greinert U, Kalsdorf Lange C. Rapid Diagnosis of CNS Tuberculosis by B, Kirsten D, Lange C. Local immunodiagnosis of pul- a T-Cell Interferon-gamma Release Assay on Cere- monary tuberculosis by enzyme-linked immunospot. brospinal Fluid Mononuclear Cells. Infection 2008 Eur Respir J 2008 Feb;31(2):261-5. Epub 2007 Nov 7. Dec;36(6):597-600. Epub 2008 Jan 12. Jimenez N, Canals R, Lacasta A, Kondakova AN, Kondakova AN, Ho N, Bystrova OV, Shashkov AS, Lindner B, Knirel YA, Merino S, Regué M, Tomás Lindner B, Creuzenet C, Knirel YA. Structural stud- JM. Molecular analysis of three Aeromonas hy- ies of the O-antigens of Yersinia pseudotuberculo- drophila AH-3 (serotype O34) lipopolysaccharide sis O:2a and mutants thereof with impaired 6-deoxy- core biosynthesis gene clusters. J Bacteriol D-manno-heptose biosynthesis pathway. Carbohydr 2008;190:3176-3184. Res 2008;343:1383-1389. Wissenschaftlicher Jahresbericht 2007-2008 217 Publications Peer reviewed papers 2008 Fo r s c h u n g s z e n t r u m Bo r s t e l Duarte R, Cirillo DM, Lange C for the TBNET. LTBI: L latent tuberculosis infection or lasting immune re- Lang DS, Zeiser T, Schultz H, Stellmacher F, sponses to M. tuberculosis? Europ Resp J. In press. Vollmer E, Zabel P, Goldmann T. LED-FISH: Fluo- Malm S, Engel R, Walter K, Maass S, Pfau S, Hüb- rescence microscopy based on light emitting ner G, Lindner B, Holst O, Ehlers S, Bange F-C. In diodes for the molecular analysis of Her-2/neu vitro and in vivo characterization of a Mycobacteri- oncogene amplification. Diagn Pathol. In press. um tuberculosis mutant deficient in glycosyltrans- Leone S, Lanzetta R, Scognamiglio R, Alfieri F, Iz- ferase Rv1500. Int J Med Microbiol 2008; 298:645-655. zo V, Di Donato A, Parrilli M, Holst O, Molinaro A. Mamat U, Meredith TC, Aggarwal P, Kühl A, Kirch- The structure of the O-specific polysaccharide from hoff P, Lindner B, Hanuszkiewicz A, Holst O, the lipopolysaccharide of Pseudomonas sp. OX1 Woodard RW. Single amino acid substitutions in ei- cultivated in the presence of the azo dye Orange II. ther YhjD or MsbA confer viability to 3-deoxy-D-man- Carbohydr Res 2008; 343:674-684. no-oct-2-ulosonic-depleted Escherichia coli. Mol Mi- Libani IV, Guy EC, Melchiori L, Schiro R, Ramos P, crobiol 2008; 67:633-648. Breda L, Scholzen T, Chadburn A, Liu Y, Kernbach Master SS, Rampini SK, Davis AS, Keller C, Ehlers M, Baron-Lühr B, Porotto M, de Sousa M, Rach- S, Springer B, Timmins GS,Sander P, Deretic V. My- milewitz EA, Hood JD, Cappellini MD, Giardina cobacterium tuberculosis prevents inflammasome ac- PJ, Grady RW, Gerdes J, Rivella S. Decreased dif- tivation. Cell Host Microbe. 2008 Apr 17;3(4):224-32. ferentiation of erythroid cells exacerbates ineffec- Meier T, Lange A, Papenberg H, Ziemann M, Fen- tive erythropoiesis in beta-thalassemia. Blood 2008; trop C, Uhlig U, Schmucker P, Uhlig S, Stamme C. Pul- 112(3): 875-85. monary cytokine responses during mechanical venti- Lichtenbergova L, Kolbekova P, Kourilova P, Kas- lation of noninjured lungs with and without end-expi- ny M, Mikes L, Haas H, Schramm G, Horak P, Ko- ratory pressure. Anesth Analg 2008; 107:1265-1275. larova L, Mountford AP. Antibody responses in- Merluzzi S, D’Orlando O, Leonardi A, Vitale G, Pucil- duced by Trichobilharzia regenti antigens in murine lo C. TRAF2 and p38 are involved in B cells CD40-me- and human hosts exhibiting cercarial dermatitis. diated APE/Ref-1 nuclear translocation: a novel path- Parasite Immunol 2008;30:585-95 way in B cell activation. Mol Immunol 2008; 45:76-86. Liu Z, Dang Z, Hou J, Luo J, Yin H, Ahmed JS, Meyer CG, Scarisbrick G, Niemann S, Browne EN, Seitzer U. Small-scale Expressed Sequence Tag Chinbuah MA, Gyapong J et al. Pulmonary tuber- Analysis of Theileria sp. (China). Ann NY Acad Sci culosis: virulence of Mycobacterium africanum and USA 2008; 1149:214–217. relevance in HIV co-infection. Tuberculosis (Edinb ) Liu Z, Hou J, Bakheit MA, Salih DA, Luo J, Yin H, 2008; 88(5):482-489. Ahmed JS, Seitzer U. Development of Loop-medi- Migliori GB, Lange C, Centis R, Sotgiu G, Mutter- ated Isothermal Amplification (LAMP) Assay for lein R, Hoffmann H, Kliiman K, De Iaco G, Lauria Rapid Diagnosis of Ovine Theileriosis in China. Par- FN, Richardson MD, Spanevello A, Cirillo DM; TB- asitol Res 2008; 103:1407-1412. NET Study Group. Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis M cases Pneumologia 2008; 57(3):169-70. Mack U, Migliori GB, Sester M, Rieder HL, Ehlers Migliori GB, Lange C, Centis R, Sotgiu G, Mütter- S, Goletti D, Bossink A, MagdorfK, Hölscher C, lein R, Hoffmann H, Kliimann K, De Iaco G, Lauria Kampmann B, Lalvani A, Arend SM, Detjen A, F, Richardson D, Spanevello A, Cirillo D and the Bothamley G, Zellweger JP, Milburn H, Diel R, TBNET Study Group. Does resistance to 2nd line in- Ravn P, Cobelens F, Cardona PJ, Kan B, Solovic I, jectables lead to worse treatment outcomes for Wissenschaftlicher Jahresbericht 2007-2008 218 Publications Peer reviewed papers 2008 MDR/XDR TB? Eur Resp J 2008; 31:1155-59. P Migliori GB, Lange C, Girardi E, Centis E, Besozzi G, Kliiman K, Codecasa L. Spanevello A, Cirillo Pali-Scholl I, Yildirim AO, Ackermann U et al. An- DM and SMIRA/TBNET Study Group. Fluoro- ti-acids lead to immunological and morphological quinolones: are they essential to treat MDR-TB? Eur changes in the intestine of BALB/c mice similar to Resp J 2008; 31:904-5. human food allergy. Exp Toxicol Pathol 2008; 60(4- Migliori GB, Lange C, Girardi E, Centis E, Besozzi 5):337-345. G, Kliiman K, Spanevello A, Cirillo DM and SMI- Paragh G, Schling P, Ugocsai P et al. Novel sphin- RA/TBNET Study Group. XDR-TB is worse than MDR- golipid derivatives promote keratinocyte differenti- TB: different methodology and settings, same re- ation. Exp Dermatol 2008; 17(12):1004-1016. sults. Clin Infect Dis 2008; 46(6):958-9. Parcina M, Wendt C, Götz F, Zawatzky R, Mignot G, Ullrich E, Bonmort M, Ménard C, Apetoh Zähringer U, Heeg K, Bekeredjian-Ding I. Staphy- L, Taieb J, Bosisio D, Sozzani S, Ferrantini M, lococcus aureus-induced plasmacytoid dendritic Schmitz J, Mack M, Ryffel B, Bulfone-Paus S, Zitvo- cell activation is based on an IgG-mediated mem- gel L, Chaput N. The critical role of IL-15 in the anti- ory response. J Immunol 2008,181:3823-3833. tumor effects mediated by the combination therapy Perlovich GL, Strakhova NN, Kazachenko VP, Imatinib and IL-2. J Immunol 2008; 180:6477-6483. Volkova TV, Tkachev VV, Schaper K-J, Raevsky OA. Müller-Quernheim J, Schürmann M, Hofmann S, Sulfonamides as a subject to study molecular inter- Gaede KI, Fischer A, Prasse A, Zissel G, Schreiber actions in crystals and solutions: Sublimation, solu- S. Genetics of sarcoidosis. Clin Chest Med 2008; 29: bility, solvation, distribution and crystal structure. Int 391-414. J Pharm. 2008; 349:300-313. Miyagi E, Schwartzkopff F, Plishka R, Buckler- Petersen A, Bals R. Epithelzellen des Respirati- White A, Clouse KA, Strebel K. APOBEC3G-inde- onstraktes regulieren die allergische Immunantwort. pendent reduction in virion infectivity during long- Allergojournal 2008; 17: 165–7. term HIV-1 replication in terminally differentiated Pieretti G, Corsaro MM, Lanzetta R, Parrilli M, macrophages. Virology. 2008 Sep 30;379(2):266-74. Nicolaus B, Gambacorta A, Lindner B, Holst O. Epub 2008 Aug 3. Structural characterization of the core region of the Muyal JP, Singh SK, Fehrenbach H. DNA-Microar- lipopolysaccharide ray Technology: Comparison of methodological fac- Halomonas pantelleriensis: Identification of the bi- tors of recent technique towards gene expression ological O-antigen repeating unit. Eur J Org Chem profiling. Crit Rev Biotechnol 2008; 28(4):239-251. 2008; 721-728. from the haloalkaliphilic Piotrowska-Seget Z, Engel R, Nowak E, Kozdroj J. O Successive soild treatment with captan or oxytetracycline affects non-target microorganisms. World J Oelemann MC, Diel R, Vatin V, et al. Assessment Biotechnol 2008; 24:2843-2848. of an optimized mycobacterial interspersed repeti- Presser K, Schwinge D, Wegmann M et al. Coex- tive- unit-variable-number tandem-repeat typing sys- pression of TGF-{beta}1 and IL-10 enables regula- tem combined with spoligotyping for population- tory T cells to completely suppress airway hyperre- based molecular epidemiology studies of tubercu- activity. J Immunol 2008; 181(11):7751-7758. losis. J Clin Microbiol. 2007; 45:691-7. Olak C, Muenter A, Andrä J, Brezesinski G. Inter- R facial properties and structural analysis of the antimicrobial peptide NK-2. J Pept Sci 2008;14:510-517. Raevsky OA, Schaper K-J. Unified physicochemical QSPR model of the partitioning and solubility of Wissenschaftlicher Jahresbericht 2007-2008 219 Publications Peer reviewed papers 2008 chemicals in the triple system ‘water-octanol-air’. Rodriguez-Sanchez B, Sanchez-Vizcaino JM, Ut- QSAR Comb Sci 2008; 27:347-356. tenthal A, Rasmussen TB, Hakhverdyan M, King Rampini SK, Selchow P, Keller C, Ehlers S, Böttger DP, Ferris NP, Ebert K, Reid SM, Kiss I, Brocchi E, EC, Sander P. LspA inactivation in Mycobacterium Cordioli P, Hjerner B, McMenamy M, McKillen J, tuberculosis results in attenuation without affecting Ahmed JS, Belak S. Improved Diagnosis for Nine Vi- phagosome maturation arrest. Microbiology. 2008 ral Diseases Considered as Notifiable By the World Oct;154(Pt 10):2991-3001. Organization for Animal Health. Transbound Emerg Ramu P, Lobo L, Kukkonen M, Bjur E, Suomalainen Dis 2008; 55:215-225. M, Raukola H, Miettinen M, Julkunen I, Holst O, Rodriguez B, Valdez H, Lange C, Assad R, Med- Rhen M, Korhonen T, Lähteenmäki K. Activation of vik K, Sieg S. In vitro T cell proliferation failure pre- pro-matrix metalloproteinase-9 and degradion of dicts poor post-immunization DTH responses to gelatin by the surface protease PgtE of Salmonella neoantigen, but not recall antigens in HIV-infection. enterica sv. Typhimurium. Int. J. Med. Microbiol. Clin Immunol. In press. 2008; 298:263-278. Rückert R, Brandt K, Marienfeld K, Ernst M, Cser- Reifenberg K, Lehr HA, Fan J, Koike T, Wiese E, nok E, Metzler C, Budagian V, Bulanova E, Paus R, Küpper I, Sagban TA, Schaefer SC, Zähringer U, Torzewski M, Lackner KJ, Bhakdi S. Endotoxin ac- Bulfone-Paus S. IL-15 stimulates macrophages to activate CD4+ T-cells: A role in the pathogenesis of celerates atherosclerosis independent of comple- rheumatoid arthritis. Immunol 2008; 120:63-73. ment activation. Thromb Res 2008, Aug 8. [Epub Rückert R, Bulfone-Paus S, Brandt K. Interleukin-21 ahead of print]. PMID:18692867. stimulates antigen uptake, protease activity, survival Reiling N, Ehlers S, Hölscher C. MyDths and un- and induction of CD4+ T-cell proliferation by murine TOLLed truths: sensor, instructive and effector immu- macrophages. Clin Exp Immunol 2008; 151:487-495 nity to tuberculosis. Immunol Lett. 2008; 116(1):15-23. Rüsch-Gerdes S, Hillemann D. [Modern laboratory Renneker S, Kullmann B, Gerber S, Dobschanski diagnostics J, Bakheit MA, Geysen D, Shiels B, Tait A, Ahmed 2008;62:533-40. Fo r s c h u n g s z e n t r u m Bo r s t e l for mycobacteria] Pneumologie. JS, Seitzer U. Development of a Competitive ELISA for Detection of Theileria annulata Infection. Trans- S bound Emerg Dis 2008; 55:249-256. Richter E, Rüsch-Gerdes S, Hillemann D. First line- Sadovski J, Kuchenbuch T, Ruppert C et al. Ker- zolid-resistant clinical isolates of Mycobacterium tu- atinocyte growth factor prevents intra-alveolar berculosis. Antimicrob Agents Chemother. 2007; oedema in experimental lung isografts. Eur Respir 51:1534-6. J 2008; 31(1):21-28. Richter E, Tortoli E, Fischer A, et al. Mycobacteri- Salih DA, Liu Z, Bakheit MA, Ali AM, El Hussein um alsiense, a novel, slowly growing species iso- AM, Unger H, Viljoen G, Seitzer U, Ahmed JS. De- lated from two patients with pulmonary disease. J velopment and Evaluation of a Loop-Mediated Clin Microbiol. 2007; 45:3837-9. Isothermal Amplification Method for Diagnosis of Riecken S, Lindner B, Petersen A, Jappe U, Becker Tropical Theileriosis. Transbound Emerg Dis 2008; WM. Purification and characterization of natural Ara h 55:238-243. 8, the Bet v 1 homologous allergen from peanut, pro- Sánchez-Gómez S, Lamata M, Leiva J, Blondelle vides a novel isoform. Biol Chem. 2008; 389: 415-23. SE, Jerala R, Andrä J, Brandenburg K, Lohner K, Riekenberg S, Farhat K, Debarry J, Heine H, Jung Moriyón I, and Martínez de Tejada G. Compara- G, Wiesmuller KH, Ulmer AJ. Regulators of G-protein tive analysis of selected methods for the assess- signalling are modulated by bacterial lipopeptides ment of antimicrobial and membrane-permeabiliz- and lipopolysaccharide. FEBS J 2008; 276(3):649-59. ing activity: a case study for lactoferricin derived Wissenschaftlicher Jahresbericht 2007-2008 220 Publications Peer reviewed papers 2008 peptides. BMC Microbiology.2008; 8:196. other CD4- lymphocytes during infection with Sal- Sarrazin H, Wilkinson KA, Andersson J, Rangaka monella enterica serovar Enteritidis and has a mild MX, Radler L, van Veen K, Lange C, Wilkinson RJ. effect in bacterial clearance. Int Immunol 2008; Relationship between tuberculin skin test reactivity, 20:1129-1138. memory CD4 subset and circulating FoxP3 express- Schulz SM, Köhler G, Schütze N, Knauer J, Straub- ing cells in HIV-infected persons. J Infect Dis. In inger RK, Chakerian AA, WitteE, Wolk K, Sabat R, press. Iwakura Y, Hölscher C, Müller U, Kastelein RA, Al- Schaaf B, Liebau C, Kurowski V, Droemann D, Dal- ber G. Protective immunity to systemic infection with hoff K. Hospital-acquired pneumonia with high-risk attenuated Salmonella enterica serovar Enteritidis bacteria is associated with increased pulmonary in the abscence of IL-12 is associated with IL-23-de- matrix metalloproteinase activity. BMC Pulm Med pendent IL-22 but not IL-17A. J Immunol 2008; 2008; 8: 12. 181:7891-7901. Schaefer M, Reiling N, Fessler C, Stephani J, Tani- Schweickert B, Goldenberg O, Richter E, et al. Oc- uchi I, Hatam F, Yildirim AO, Fehrenbach H, Wal- currence and clinical relevance of Mycobacterium ter K, Ruland J, Wagner H, Ehlers S, Sparwasser chimaera sp. nov., Germany. Emerg Infect Dis. T. Decreased pathology and prolonged survival of 2008;14:1443-6. human DC-SIGN transgenic mice during mycobac- Schweimer K, Petersen A, Suck R, Becker WM, terial infection. J Immunol. 2008; 180(10):6836-45. Rösch P, Matecko I. Solution structure of Phl p 3, a Schmidt V, Schneider S, Schlomer J, Krautwald- major allergen from timothy grass pollen. Biol Junghanns ME, Richter E. Transmission of tubercu- Chem. 2008; 389: 919-23. losis between men and pet birds: a case report. Scriba TJ, Kalsdorf B, Abrahams DA, Isaacs F, Avian Pathol. 2008;37:589-92. Hofmeister J, Black G, Hassan HY, Wilkinson RJ, Schmiedl A, Lempa T, Hoymann HG et al. Elas- Walzl G, Gelderbloem SJ, Mahomed H, Hussey tase-induced lung emphysema in rats is not reduced GD, Hanekom WA. Distinct, specific IL-17- and IL-22- by hematopoietic growth factors when applied pre- producing CD4+ T cell subsets contribute to the hu- ventionally. Virchows Arch 2008; 452(6):675-688. man anti-mycobacterial immune response. J Im- Schreiber O, Steinwede K, Ding N, Srivastava M, munol. 2008;180(3):1962-70. Maus R, Länger F, Prokein J,Ehlers S, Welte T, Seitzer U, Ahmed J. Attenuated vaccines against Gunn MD, Maus UA. Mice that overexpress CC animal diseases. Vaccine 2008; 26S6:G1-G3. chemokine ligand 2 in their lungs show increased Seitzer U, Ahmed J. Tropical theileriosis: Cytotoxic protective immunity to infection with Mycobacterium T-lymphocyte response to vaccination. Vaccine bovis bacilli Calmette-Guérin. J Infect Dis. 2008 Oct 2008; 26S6:G24-G28. 1;198(7):1044-54. Seitzer U, Beyer D, Kullmann B, Bakheit MA, Ahmed Schröder I, JS. Evaluation of Theileria annulata Recombinant Im- Nieswandt B, Orinska Z, Himmerkus N, Bleich M, J, Lüllmann-Rauch R, Pleines munodominant Proteins for the Development of Saftig P. Deficiency of the tretraspanin CD63/LIMP- ELISA. Transbound Emerg Dis 2008; 55:244-248. 1 associated kidney pathology but normal lysoso- Seitzer U, Liu Z, Yin H, Beyer D, Kullmann B, Mi- mal function. Mol Cell Biol 2008. In press. randa J, Ahmed JS. Immune response of Theileria Schultz H, Kähler D, Branscheid D, Vollmer E, sp. (China) infected sheep to recombinant Theileria Zabel P, Goldmann T. TKTL1 is overexpressed in a proteins. Ann NY Acad Sci USA 2008; 1149:186–190. large portion of non-small cell lung cancer speci- Sel S, Rost BR, Yildirim AO et al. Loss of classical mens. Diagn Pathol 2008; 3: 35. transient receptor potential 6 channel reduces al- Schulz SM, Köhler G, Hölscher C, Iwakura Y, Alber lergic airway response. Clin Exp Allergy 2008; G. IL-17A is produced by Th17 cells, γδT cells and 38(9):1548-1558. Wissenschaftlicher Jahresbericht 2007-2008 221 Publications Peer reviewed papers 2008 Fo r s c h u n g s z e n t r u m Bo r s t e l Sel S, Wegmann M, Dicke T et al. Effective prevention and therapy of experimental allergic asth- T ma using a GATA-3-specific DNAzyme. J Allergy Clin Thomas MM, Hinks TS, Raghuraman S, Rama- Immunol 2008; 121(4):910-916. lingam N, Ernst M, Nau R, Lange C, Kösters K, Shah NS, Wright A, Bai GH, et al. Worldwide emer- Gnanamuthu C, John GT, Marshall B, Lalvani A. gence of extensively drug-resistant tuberculosis. Rapid diagnosis of Mycobacterium tuberculosis Emerg Infect Dis. 2007;13:380-7. meningitis by enumeration of cerebrospinal fluid Shiow LR, Roadcap DW, Paris K, Watson SR, Grig- antigen-specific T-cells. Int J Tuberc Lung Dis. 2008 orova IL, Lebet T, An J, Xu Y, Jenne CN, Föger N, Jun;12(6):651-7. Sorensen RU, Goodnow CC, Bear JE, Puck JM, Cyster JG. The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a pa- U tient with severe combined immunodeficiency. Nat Ullrich E, Mignot G, Bonmort M, Jacobs B, Bosisio, Immunol 2008; 9:1307-1315. D, Sozzani S, Jalil A, Louache F, Geissman F, Ryf- Sonntag T, Kröger S, Akira S, Mossmann H, fel B, Chaput N, Bulfone-Paus, S, Zitvogel L. Trans- Kirschning CJ, Wagner H, Freudenberg M, Ehlers presentation of interleukin-15 dictates IKDC effector S. Containment of aerogenic Mycobacterium tuber- functions. J Immunol 2008; 180:7887-7897. culosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9 specimens. Diagn Pathol. 2008 Aug 12;3:35. V Sotgiu G, Ferrara G, Matteelli A, Richardson MA, van Ree R, Chapman MD, Ferreira F, Vieths S, Centis R, Ruesch-Gerdes S, Toungoussova O, Zell- Bryan D, Cromwell O, Villalba M, Durham SR, weger JP, Spanevello A, Cirillo D, Lange C, Becker WM, Aalbers M, André C, Barber D, Cis- Migliori GB. Epidemiology and clinical manage- tero Bahima A, Custovic A, Didierlaurent A, Dol- ment of XDR-TB: A systematic review by TBNET. Eur man C, Dorpema JW, Di Felice G, Eberhardt F, Fer- Respir J. In press. nandez Caldas E, Fernandez Rivas M, Fiebig H, Spiller S, Dreher S, Meng G, Grabiec A, Thomas Focke M, Fötisch K, Gadermaier G, Das RG, Gon- W, Hartung T et al. Cellular recognition of trimyris- zalez Mancebo E, Himly M, Kinaciyan T, Knulst AC, toylated peptide or enterobacterial lipopolysac- Kroon AM, Lepp U, Marco FM, Mari A, Moingeon charide via both TLR2 and TLR4. J Biol Chem 2007; P, Monsalve R, Neubauer A, Notten S, Ooievaar- 282(18):13190-13198. de Heer P, Pauli G, Pini C, Purohit A, Quiralte J, Strassburg A, Jafari C, Ernst M, Lotz W, Lange C. Rak S, Raulf-Heimsoth M, San Miguel Moncin MM, Rapid diagnosis of pulmonary TB by BAL enzyme- Simpson B, Tsay A, Vailes L, Wallner M, Weber B. linked immunospot assay in an immunocompro- The CREATE project: development of certified refer- mised host. Eur Respir J. 2008 May;31(5):1132-5. ence materials for allergenic products and valida- Strassburg A, Rupp J, Herth FJ, Magnussen H, tion of methods for their quantification. Allergy. Zabel P, Lange C. Infection diagnostics in pneu- 2008;63: 310-26. mology. Pneumologie 2008; 62: 730-743. Vogel K, Blümer N, Korthals M, Mittelstädt J, Garn Sürken M, Keller C, Röhker C, Ehlers S, Bange FC. H, Ege M, von Mutius E, Gatermann S, Bufe A, Anaerobic arginine metabolism of Mycobacterium Goldmann T, Schwaiger K, Renz H, Brandau S, tuberculosis is mediated by arginine deiminase (ar- Bauer J, Heine H, Holst O. Animal shed Bacillus cA), but is not essential for chronic persistence in an licheniformis spores possess allergy-protective as aerogenic mouse model of infection. Int J Med Mi- well as inflammatory properties. J Allergy Clin Im- crobiol. 2008 Oct; 298(7-8):657-61. munol 2008; 122:307-312. Wissenschaftlicher Jahresbericht 2007-2008 222 Publications W Wagner C, Isermann K, Fehrenbach H, Roeder T. Peer reviewed papers 2008 lation of the inflammatory response to Streptococcus pneumoniae in a model of acute lung tissue infection. Am J Respir Cell Mol Biol 2008; 39: 522-529. Molecular architecture of the fruit fly’s airway epithelial immune system. BMC Genomics 2008; 9:446. Y Wang H, Head J, Kosma P, Brade H, Muller-Loennies S, Sheikh S et al. Recognition of heptoses and Yildirim AO, Veith M, Rausch T et al. Keratinocyte the inner core of bacterial lipopolysaccharides by growth factor protects against Clara cell injury induced surfactant protein d. Biochemistry 2008; 47(2):710- by naphthalene. Eur Respir J 2008; 32(3):694-704. 720. Yu X, Gimsa U, Wester-Rosenlof L, Kanitz E, Otten Wang W, Sass HJ, Zähringer U*, Grzesiek S*. Structure and dynamics of 13C,15N-labeled lipopolysac- W, Kunz M, Ibrahim SM. Dissecting the effects of charides in a membrane mimetic (*contributed conplastic strains. Genome Res. In press. equally). Angew Chem Int Ed 2008;47:9870-9874. Yu X, Koczan D, Sulonen AM, Akkad DA, Kroner A, Wegmann M, Michen B, Luxbacher T, Fritsch J, Comabella M, Costa G, Corongiu D, Goertsches Graule T. Modification of ceramic microfilters with R, Camina-Tato M et al. mtDNA nt13708A variant colloidal zirconia to promote the adsorption of virus- increases the risk of multiple sclerosis. PLoS ONE es from water. Water Res 2008; 42(6-7):1726-1734. 2008; 3:e1530. Wegmann M. Animal models of chronic experi- Yu X, Teng H, Marques A, Ashgari F, Ibrahim SM. mental asthma – strategies for the identification of High resolution mapping of Cia3: a mouse arthritis new therapeutic targets. J Occup Med Toxicol 2008; QTL with homolgous in rat and human. J Immunol. 3 (Suppl 1):S4. In press. mtDNA variations on complex traits using mouse Werninghaus K, Babiak A, Groß O, Hölscher C, Dietrich H, Agger EM, Mages J, Mocsai A, Schoenen Z H, Finger K, Nimmerjahn F, Brown GD, Kirschning CJ, Heit A, Andersen P, Wagner H, Ruland J, Lang Zabel P. Bronchial asthma. Internist 2008; 49: 1293- R. Adjuvanticity of a synthetic cord factor analog for 1294. the subunit M. tuberculosis vaccination requires FcR Zahringer U, Lindner B, Inamura S, Heine H, – Syk-Card9-dependent innate immune activation. J Alexander C. TLR2 - promiscuous or specific? A crit- Exp Med. In press. ical re-evaluation of a receptor expressing appar- Wirth T, Hildebrand F, Allix-Beguec C, Wolbeling ent broad specificity. Immunobiology 2008; 213(3- F, Kubica T, Kremer K et al. Origin, spread and de- 4):205-224. mography of the Mycobacterium tuberculosis com- Zäuner S, Zähringer U, Lindner B, Warnecke D, plex. PLoS Pathog 2008; 4(9):e1000160. and Sperling P. Identification and functional char- Woller G, Brandt E, Mittelstädt J, Rybakowski C, acterization of the 2-hydroxy fatty acid N-acyl- 3(E)- Petersen F. Platelet factor 4/CXCL4-stimulated hu- desaturase from Fusarium graminearum. J Biol man monocytes induce apoptosis in endothelial Chem 2008;283:36734-36742. cells by the release of oxygen radicals. J Leukoc Bi- Zdorovenko EL, Vinogradov E, Wydra K, Lindner ol 2008; 83:936-945. B, Knirel YA. Structure of the oligosaccharide chain of the SR-type lipopolysaccharide of Ralstonia X solanacearum Toudk-2. Biomacromolecules 2008;9:2215-2220. Xu F, Droemann D, Rupp J, Shen H, Wu X, Goldmann T, Hippenstiel S, Zabel P, Dalhoff K. Modu- Wissenschaftlicher Jahresbericht 2005-2006 223 Publications Book Chapters and Reviews 2007 Fo r s c h u n g s z e n t r u m Bo r s t e l Book Chapters and Reviews 2007 G A Alexander C, Haylett R, Schromm A, Zähringer U, Garidel P, Andrä J, Howe J, Gutsmann T, Bran- Rink L. Pathogens in sepsis: Gram-positive bacteri- denburg K. Novel antiinflammatory and antiinfec- al PAMPs, PRRs and superantigens. In: Sepsis and tive agents. Antinfect Agents Med Chem 2007; non-infectious SIRS, Cavaillon JM, Adrie C, (eds.), 6:185-200. Wiley & Sons. In press. Greinert U, Lange C. Nicht-tuberkulöse Mykobak- Andrä J, Gutsmann T, Mueller M, and Schromm terien: In: Matthys H, Seeger W (Hrsg.). Klinische AB. Interactions between lipid A and serum pro- Pneumologie. 4. Auflage. In press. teins. In: Lipid A in cancer therapy. Jeannin, J.F, ed. Greinert U, Hillemann D, Lange C, Richter E. Anti- Landes Biosciences, Georgetown, USA; 2007. In biotic drug-resistant tuberculosis. Med Klin (Munich). press. 2007; 102:957-66. Review. Andrä J, Gutsmann T, Müller M, Schromm AB. In- Gutsmann T, Schromm AB, Brandenburg K. The teractions with lipid A and serum proteins. In: Jean- physicochemistry of endotoxins in relation to bioac- nin JF, ed. Lipid A in cancer therapies. Georgetown, tivity. Int J Med Microbiol 2007; 297(5):341-352. USA: Landes Bioscience; 2007. H B Hauber HP, Zabel P. Lung and autoimmune disea- Bade S, Frey A. Vaccines against transmissible ses—clinical aspects and diagnosis. Dtsch Med Wo- spongiform encephalopathies: An urgent need? Hu- chenschr 2007; Aug;132(31-32):1633-8. man Vaccines. In press. Hauber HP, Zabel P. Lung and autoimmune disea- Becker WM. Purification of the natural peanut al- se—therapy. lergen Ara h 1. In: Cellular and Molecular Targets Aug;132(33):1703-6. in Allergy and Clinical Immunology. Holgate S, Kay Heine H. Volume Editor: Innate Immunity of Plants, AB, Eds., Hogrefe & Huber Publishers, Göttingen, Animals and Humans; Springer-Verlag. Germany. In press. Hillemann D., Rüsch-Gerdes S. Epidemiology of tu- Brandenburg K, Howe J, Rössle M, Andrä J. Spec- berculosis - newer developments and trends. Med- troscopic investigations into inactivation of bacteri- ical Corps International, 2007. al virulence factors. In: Kneipp K, Aroca R, Kneipp Hillemann D, Richter E. 2007. Mykobakteriosen. In H, eds. New approaches in Biomedical Spec- Hofmann: Handbuch der Infektionskrankheiten. Epi- troscopy. Washington DC, USA: ACS; 2007. demiologie, Diagnostik, Therapie, Prophylaxe, Ge- Brandenburg K, Seydel U. Conformation and setzliche Regelungen. Ecomed Medizin, Verlags- supramolecular structure of lipid A, in ‘Lipid A in gruppe Hüthig Jehle Rehm GmbH. VIII – 1.32 1-13. Cancer Research’, J.M. Jeannin, ed. Landes Bio- Holst O, Müller-Loennies S. Microbial polysaccha- sciences; 2007. ride structures. In: Kamerling JP, ed. Comprehensive Brandt K, Singh PB, Bulfone-Paus S, Rückert R. In- Glycosciences, Elsevier, Amsterdam, 2007, pp. 123- terleukin-21: Effects on lymphoid and myeloid cells 179. and its relevance for immunity, infection and cancer. Holst O. The core region of enterobacterial Cytokine and Growth Factor Reviews 2007: 18(3- lipopolysaccharides - an update. FEMS Microbiol 4):223-32. Lett 2007; 271: 3-11. Dtsch Med Wochenschr. 2007 Wissenschaftlicher Jahresbericht 2007-2008 224 Publications Book Chapters and Reviews 2007 Lange C, Greinert U, Zabel P. Tuberkulose. In: Mat- Müller-Loennies S, Brade L, Brade H. Neutralizing thys H, Seeger W (Hrsg.). Klinische Pneumologie. 4. and cross-reactive antibodies against enterobacte- Auflage. In press. rial lipopolysaccharide. Int J Med Microbiol 2007; Lange C, Lederman MM. Infections Involving 297(5):321-340. Bones and Joints. In: Cecil´s Essentials of medicine 7th (Eds. Andreoli TE, Carpenter CJ, Loscalzo J, Müller-Quernheim J, Gaede KI, Prasse A, Zissel G. M L Chronic berylliosis. Pneumologie 2007; 61, 2:109-16. Griggs RC) Elsevier 2007, 965-969. Lange C, Lederman MM. Infections of the Head and Neck. In: Cecil´s Essentials of medicine 7th P (Eds. Andreoli TE, Carpenter CJ, Loscalzo J, Griggs Petersen A, Schramm G, Kramer A, Grobe K, RC) Elsevier 2007; 921-926. Becker WM. Epitope mapping and characterization Lange C, Lederman MM. Infections of the Lower of the binding specificity of monoclonal antibodies Respiratory Tract. In: Cecil´s Essentials of medicine 7th (Eds. Andreoli TE, Carpenter CJ, Loscalzo J, Grig- directed against allergens of grass group 1. In: Cel- gs RC) Elsevier 2007, 927-937. Immunology. Holgate S, Kay AB, Eds., Hogrefe & Hu- Lange C, Lederman MM. Infections of the Urinary ber Publishers, Göttingen, Germany. In press. lular and Molecular Targets in Allergy and Clinical Tract. In: Cecil´s Essentials of medicine 7th (Eds. Andreoli TE, Carpenter CJ, Loscalzo J, Griggs RC) 2007, R 970-973. Lange C, Lederman MM. Infectious Diarrhea. In: Cecil´s Essentials of medicine 7th (Eds. Andreoli TE, Reiling N, Ehlers S, Hölscher C. MYDths and un- Carpenter CJ, Loscalzo J, Griggs RC) Elsevier 2007, munity to tuberculosis. Immunology Letters. In press- 958-964. Röckendorf N, Helfmann J, Fujimoto N, Wehry K, Lange C, Lederman MM. Intra-Abdominal Abscess and Peritonitis. In: Cecil´s Essentials of medicine 7th Bürger M, Frey A. Peptide-based optical contrast (Eds. Andreoli TE, Carpenter CJ, Loscalzo J, Griggs Biophotonics 2007: Optics in Life Science; J. Popp, RC) Elsevier 2007, 953-957. G. von Bally, eds.; SPIE Press, Bellingham, USA, Lange C, Lederman MM. Skin and Soft Tissue Infections. In: Cecil´s Essentials of medicine 7th (Eds. 66332A. Andreoli TE, Carpenter CJ, Loscalzo J, Griggs RC) El- Hofmann: Handbuch der Infektionskrankheiten. Epi- sevier 2007, 947- 952. demiologie, Diagnostik, Therapie, Prophylaxe, Ge- Lange C. Highlights der Tuberkuloseliteratur 2006. setzliche Regelungen. Ecomed Medizin, Verlags- Pneumologie 2007; 61:518-21. gruppe Hüthig Jehle Rehm GmbH. VIII – 1.52 1-23. Lange CG, Schieferstein C, Toossi Z, Gori A. Tu- Rüsch-Gerdes S, Hillemann D. Extensiv resistente berculosis. In: HIVMEDICINE 2007 (eds. Hoffmann C, Tuberkulose (XDR-TB) – weltweit ein neues Problem. Kamps BS) Steinhäuser Verlag Wuppertal. Epidemiologisches Bulletin 2007; 11: 90-1. List J, Schromm AB. Kind oder Karriere – oder Kar- Schieferstein C, Lange CG. Tuberkulose. In: HIV.NET riere und Kind? Forschung & Lehre; 09/2007: 536- 2007 (eds. Hoffmann C, Kamps BS, Rockstroh J) 537. Steinhäuser Verlag Wuppertal. TOLLed truths: sensor, instructive and effector im- agents for targeting of intestinal malignancies. In: Rüsch-Gerdes S, Hillemann D. 2007. Tuberkulose. In Wissenschaftlicher Jahresbericht 2007-2008 225 Publications Book Chapters and Reviews 2007 Fo r s c h u n g s z e n t r u m Bo r s t e l S Schromm A, Alexander C, Gutsmann T, Andrä J, Stamme C. Pathogens in sepsis: Pathogens in Sepsis: Gram-negative bacterial PAMPs and PRRs. In: Sepsis and non-infectious SIRS, Cavaillon JM, Adrie C, (eds.), Wiley & Sons. In press. Stelekati E, Orinska Z, Bulfone-Paus S. Mast cells in allergy: Innate instructors of adaptive responses. Immunobiology 2007; 212:505-519. V von Hundelshausen P, Petersen F, Brandt E. Platelet-derived chemokines in vascular biology. Thromb Haemost 2007; 97:704-713. Z Zähringer U, Lindner B, Inamura S, Heine H, Alexander C. TLR2 – specific or promiscuous? Immunobiology. In press. Wissenschaftlicher Jahresbericht 2007-2008 226 Publications Book Chapters and Reviews 2008 Book Chapters and Reviews 2008 A ge C. Klinik und Diagnose der Tuberkulose. Pneumologie 2008, 62(5):2984-94 Alexander C, Haylett R, Schromm AB, Zähringer U, Rink L. Pathogens in sepsis: Gram-positive bacterial L PAMPs, PRRs and superantigens. In: Sepsis and noninfectious systemic inflammation. Cavaillon JM, Adrie Lange C, Greinert U, Zabel P. Tuberkulose. In: Mat- C (Eds.).Wiley-VCH, Weinheim, 2008, Germany. thys H, Seeger W (Hrsg.). Klinische Pneumologie. 4. Auflage 2008, 351-65. B Lange C, Grobusch M, Wagner D. XDR-Tuberkulose. Dtsch Med Wochenschr 2008; 133(8):374-6. Brombacher F, Arendse B, Peterson R, Hölscher A, Lange C, Mueller-Quernheim J. Transvertebral ven- Hölscher C. Analyzing classical and alternative tilation. Pneumologie 2008; 62:397-72. macrophage activation in macrophage/neutrophilspecific IL-4 receptor-alpha-deficient mice. In: M Macrophages and Dendritic Cells. Methods and Protocols. Methods in Molecular Biology. (ed. Reiner, N), Migliori GB, Centis R, Lange C, Matteelli A, Ciril- Springer Verlag, Heidelberg, Germany. In press. lo D, Tuberculosis, one disease, many faces. Monaldi Arch Chest Dis 2008; 69(1):2-4. G R Greinert U, Lange C. Nicht-tuberkulöse Mykobakterien: In: Matthys H, Seeger W (Hrsg.). Klinische Rüsch-Gerdes S., Hillemann D. Mycobacterium tu- Pneumologie. 4. Auflage 2008, 366-73. berculosis. In: Darai, Gholamreza; Handermann, Michaela; Sonntag, Hans-Günther (Hrsg.) Lexikon H Holst O. Occurrence and properties of glycolipids der Infektionskrankheiten des Menschen. Erreger, Symptome, Diagnose, Therapie, Prophylaxe - Springer Verlag 2008, ISBN-13: 9783540390053. in Nature. In: Glycoscience: Chemistry and chemical biology Vol. II. Fraser-Reid B, Tatsuta K, Thiem J, Eds, S Springer, Heidelberg, 2008:1603-1627. Schieferstein C, Lange C. Tuberkulose. In: HIV.NET J 2008 (eds. Hoffmann C, Kamps BS, Rockstroh J) Steinhäuser Verlag Wuppertal. Jafari C, Lange C. Sutton´s law: Local immunodi- Schromm AB, Alexander C, Gutsmann T, Andrae agnosis of tuberculosis. Infection 2008, 36: 510-14. J, Stamme C. Pathogens in Sepsis: Gram-negative Jafari C, Ernst M, Lange C. Reply to Barry et al. Local bacterial PAMPs and PRRs. In: Sepsis and non-in- immunodiagnosis of pulmonary TB: ELISPOT or flow cy- fectious systemic inflammation. Cavaillon JM, Adrie tometry, PPD or ESAT-6? Eur Resp J 2008; 32:532-33 C (Eds.).Wiley-VCH, Weinheim, 2008, Germany. Strassburg A, Rupp J, Herth FJF, Magnussen H, Za- K Kalsdorf B, Strassburg A, Greinert U, Lotz J, Lan- bel P, Lange C. Infektionsdiagnostik in der Pneumologie. Teil 1. Übersicht und Methoden. Pneumologie 2008, Sept 5 (epub ahead of print). Wissenschaftlicher Jahresbericht 2007-2008 227 Preise • Awards Ernennungen • Appointments Fo r s c h u n g s z e n t r u m Bo r s t e l Wissenschaftlicher Jahresbericht 2007-2008 228 Preise • Awards Ernennungen • Appointments Ernennungen • Auszeichnungen Appointments • Awards Wissenschaftlicher Jahresbericht 2007-2008 229 Preise 2007 Awards 2007 Fo r s c h u n g s z e n t r u m Bo r s t e l Preise 2007 Dipl.-Biol. Lena Heinbockel Diplompreis 2007 des Vereins zur Erforschung in- Dr. rer. nat. Steffen Bade fektiologischer und allergischer Prozesse. Posterpreis für den besten freien Vortrag 2. Gemeinsamer Deutscher Allergiekongress des Ärzteverbands Deutscher Allergologen e.V., der Dr. med. Barbara Kalsdorf Deutschen Gesellschaft für Allergologie und Kli- CFAR Travel Scholarship nische Immunologie und der Gesellschaft für Pä- Tuberculosis Research Unit, Case Western Re- diatrische Allergologie und Umweltmedizin. serve University, Cleveland, USA. Lübeck, September 2007. PD Dr. rer. nat. Frank Petersen Dr. rer. nat. Wolf-Meinhard Becker, Science Prize of the Signal Transduction Society Prof. Dr. rer. nat. Arnd Petersen (Acris Award) Forschungspreis der Stiftung Kanert für Allergie- for the Contribution “CXCL4 (Platelet factor 4) dif- forschung. ferentially regulates respiratory burst, survival, and differentiation of human monocytes by using distinct signaling pathways”. Weimar, November 2007. Dr. rer. nat. Dominik Rückerl Promotionspreis des Kreises Segeberg 2007. Dr. med. Alan Strassburg ERS/ELF Long Term Fellowship, Dr. rer. nat. Jenny Debarry Tuberculosis Immunology Unit, Imperial College, Promotionspreis des Krei- London. ses Segeberg 2007. Michael Weidhase Landesbester in der Ausbildung zum/r Biolaboranten/in, SchleswigHolstein. Nina-Christin Frank Landesbeste in der Ausbildung zum/r Tierpfleger/in, Schleswig-Holstein. 230 Wissenschaftlicher Jahresbericht 2007-2008 Preise 2008 Preise 2008 Awards 2008 PD Dr. rer. nat Norbert Reiling STS Science Award 2008 Dr. rer. nat. Steffen Bade Signal Transduction Society, Weimar 2008 3. Gemeinsamer Deutscher Allergiekongress des Ärzteverbands Deutscher Allergologen, der Deutschen Gesellschaft für Allergologie und Klinische Riecken S, Stratmann C, Fölster-Holst R, Petersen Immunologie und der Gesellschaft für Pädiatri- A, Becker W.-M. sche Allergologie und Umweltmedizin 3. Gemeinsamer Deutscher Allergiekongress des Posterpreis für den besten freien Vortrag, Sep- Ärzteverbands Deutscher Allergologen, der Deut- tember 2008, Erfurt. schen Gesellschaft für Allergologie und Klinische Immunologie und der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin Dr. rer. nat. Erwin Duitman Posterpreis, September 2008. OEGAI Joint annual Meeting of Immunology Posterpreis, September 2008. Kleinheinz A, Lepp U, Petersen A, Becker W.-M., Hausen B.M. 3. Gemeinsamer Deutscher Allergiekongress des Ärzteverbands Deutscher Allergologen, der Deutschen Gesellschaft für Allergologie und Klinische Dipl. Biol. Katharina Scholz Immunologie und der Gesellschaft für Pädiatri- Diplompreis 2008 des Ver- sche Allergologie und Umweltmedizin eins zur Erforschung infek- Posterpreis, September 2008. tiologischer und allergischer Prozesse. Maria Lammers Landesbeste in der Ausbildung zum/r Biolaboranten/in, Schleswig-Holstein. Dr. rer. nat. Kay Vogel Promotionspreis des Kreises Segeberg 2008. Dr. rer. nat. Christina Moulakakis Promotionspreis des Kreises Segeberg 2008. und American Thoracic Society Travel Award, September 2008. Wissenschaftlicher Jahresbericht 2007-2008 231 Ehrungen /Ernennungen 2007/2008 Berufungen 2007/2008 Fo r s c h u n g s z e n t r u m Bo r s t e l Ehrungen 2008 Berufungen 2007 Prof. Dr. med. Hans-Dieter Flad, Emeritus Prof. Dr. med. Stefan Ehlers Medal of Professor Ludwik Hirszfeld Ruf auf die W3-Professur XIIIth Congress of Polish Society of Experimental „Molekulare Entzündungs- and Clinical Immunology medizin“ Mai, 2008. Christian-Albrechts-Universität zu Kiel Oktober 2007 Ruf angenommen. Berufungen 2008 PD Dr. rer. nat. Thomas Gutsmann W3-Bionanomechanik Universität Ulm September 2008 Ruf abgelehnt Ernennungen 2007 Prof. Dr. rer. nat. Otto Holst wurde zum Präsident der European Carbohydrate Organisation ernannt. 232 Wissenschaftlicher Jahresbericht 2007-2008 Wissenschaftliche Veranstaltungen Colloquia and Symposia Fo r s c h u n g s z e n t r u m Bo r s t e l Wissenschaftlicher Jahresbericht 2007-2008 234 Wissenschaftliche Veranstaltungen Colloquia and Symposia Wissenschaftliche Veranstaltungen Colloquia and Symposia Wissenschaftlicher Jahresbericht 2007-2008 235 Seminare 2007 Colloquia 2007 Fo r s c h u n g s z e n t r u m Bo r s t e l Zentrumsseminare 2007 Prof. Dr. Jabbar Ahmed, Forschungszentrum Bor- Aik Bossing, M.D., Department of Pulmonary Dis- stel, LG Vet. Infektiologie und Immunologie, eases and Tuberculosis, Diakonessenhuis Utrecht, 12.06.2007 Niederlande, 23.10.2007 Theileria-transformierte Leukozyten als Modellsy- Use of the ELISPOT technique and Cross-spot tech- stem für Untersuchungen von Proliferation und nique to establish the diagnosis of tuberculosis. Apoptose. Prof. Dr. Helmut Brade, Forschungszentrum Borstel, Dr. Dirk Albrecht, Forschungszentrum Borstel, Me- LG Medizinische und Biochemische Mikrobiologie, dizinische Klinik, 24.05.2007 09.01.2007 Update zur nicht-invasiven Beatmung. Monoklonale Antikörper gegen Kohlenhydrate – Grundlagen und Anwendung. Dr. Sabine Anders, Forschungszentrum Borstel, Medizinische Klinik, 08.02.2007 PD Dr. Sven Brandau, Forschungszentrum Borstel, Vertrauen ist gut, Kontrolle ist besser. Controlling LG Immuntherapie, 13.02.2007 und Qualitätsmanagement im Krankenhaus. Interaktion von malignem Gewebe und Wirtsimmunität. Dipl. Biol. Ellen Andresen, Forschungszentrum Borstel, LG Klinische Infektiologie und Angeborene Im- Prof. Dr. Klaus Brandenburg/Dipl.-Phys. Jörg Ho- munologie, 05.04.2007 we, Forschungszentrum Borstel, LG Biophysik, Die Rolle antimikrobieller Peptide bei der COPD. 06.02.2007 Einsatz von Synchrotronstrahlung zur Strukturauf- Dr. Wolf-Meinhard Becker, Forschungszentrum Bor- klärung von Biomolekülen am Hamburger HASY- stel, LG Molekulare und Klinische Allergologie, LAB. Wie findet PETRA die Struktur der Moleküle? 10.04.2007 Prof. Dr. Thomas Brüning, Berufsgenossenschaftli- Erdnussallergie. ches Forschungsinstitut für Arbeitsmedizin (BGFA), Dr. Christoph Beisswenger, Department of Micro- Institut für Ruhr-Universität Bochum, 23.01.2007 biology and Pediatrics, University of Pennsylvania Die besondere Bedeutung des Biomonitorings in School of Medicine, Philadelphia, Pennsylvania, der arbeitsmedizinischen Vorsorge. USA, 04.09.2007 Transepithelial migration of invasive bacterial Prof. Dr. Petra Dersch, Institut für Mikrobiologie, TU pathogens. Braunschweig, 24.04.2007 Enteropathogenic Yersiniae: how to enter and ex- Prof. Dr. Rikard Blunck, Université de Montréal, GÉ- ploit human cells. PROM, Canada, 10.07.2007 Fluorescence spectroscopy of proteins in planar Dr. Daniel Drömann, Forschungszentrum Borstel, lipid bilayer. LG Klinische Immunpharmakologie, 08.05.2007 Infektionen im humanen Lungenmodell. Prof. Dr. Jan Born, Inst. f. Neuroendokrinologie, Universitätsklinikum Schleswig-Holstein, Campus Lü- Dr. med. Frank Eberhardt, Forschungszentrum Bor- beck, 18.01.2007 stel, Medizinische Klinik, 30.08.2007 Schlaf und Gedächtnisbildung. Therapie des NSCLC (Update vom ASCO 2007). 236 Wissenschaftlicher Jahresbericht 2007-2008 Seminare 2007 Colloquia 2007 Dr. Niko Föger, Institut für Immunologie, Otto-von- PD Dr. Thomas Jacobs, Bernhard-Nocht-Institut für Guericke Universität, Magdeburg, 05.06.2007 Tropenmedizin, Hamburg, 16.10.2007 Control of T-lymphocyte trafficking and cellular Regulation of T-cells during experimental malaria: homeostasis by the actin cytoskeleton. Protection versus Pathology. PD Dr. Andreas Frey, Forschungszentrum Borstel, Dr. Pernille Jensen, Imagnia AG, Malmö, Schwe- Medizinische Klinik, 09.10.2007 den, 30.03.2007 Peptid-basierte Targetingsysteme für die molekula- Signal enhancement of >10.000 times with hyper- re Bildgebung und Zelltyp-spezifische Antigenauf- polarized NMR for real time measurements of in vit- nahme. ro and in vivo metabolism. PD Dr. Karoline Gaede, Forschungszentrum Borstel, Dr. Stefan Kluge, Klinik für Intensivmedizin, Univer- LG Immunpharmakologie, 03.05.2007 sitätsklinikum Eppendorf, Hamburg, 01.02.2007 Chronische Berylliose – Risikofaktoren. Pulmonale Mykosen. Dr. med. Volker Geist, Segeberger Kliniken, Bad Se- Dr. Roland Lang, Technische Universität München, geberg, 06.09.2007 22.05.2007 pAVK: Aktuelle Diagnostik und Therapie. Balancing macrophage activation: from IL-10 to DUSP1. Delia Goletti M.D. Ph.D., National Institute for Infectious Diseases, Rom, Italien, 02.10.2007 PD Dr. Gerd Leimenstoll, Klinik für Allgemeine In- Immune diagnostic assays for the diagnosis of ac- nere Medizin, Universitätsklinikum Schleswig Hol- tive and latent tuberculosis infection. stein, Campus Kiel, 22.02.2007 Management der Niereninsuffizienz. Prof. Dr. Ernst Hempelmann, Witwatersrand University, Johannesburg, Südafrika, 25.09.2007 Prof. Dr. Helgo Magnussen, Krankenhaus Großhan- Malariaequipment: Die Achillesferse der Malaria- sdorf, 22.03.2007 parasiten. Phänotypisierung der COPD. Prof. Dr. Otto Holst, Forschungszentrum Borstel, LG Dr. Lauren Mashburn Warren, NMS Building, Uni- Strukturbiochemie, 11.12.2007 versity of Texas, Austin, USA, 19.06.2007 Allergy-protective cowsheds: a dirty story? Quorum sensing and insights into membrane vesicle formation. Prof. Dr. Christian G. Hübner, Institut für Physik, Universität zu Lübeck, 03.07.2007 Dr. Sebastian Meier, Institute of Molecular Biology, Intrinsic motions along an enzymatic reaction tra- University of Copenhagen, Denmark, 30.03.2007 jectory. Conformational landscapes of proteins: collective motions, unfolded states and fold evolution. Dr. Tamitake Itoh, National Institute of Advanced Industrial Science and Technology, Health Technolo- Dr. Markus Mohrs, Trudeau Institute, Saranac Lake, gy Research Center, Bio-Nano Analysis Team, Taka- USA, 26.06.2007 matsu, Japan, 01.10.2007 Interrogating immune responses with cytokine re- Surface-Enhanced Resonance Raman Scattering (SERS) porter mice. as an imaging tool for single molecular biomaterials. Wissenschaftlicher Jahresbericht 2007-2008 237 Seminare 2007 Colloquia 2007 Prof. Dr. Sergei Nedospasov, Engelhardt Institute Prof. Dr. Udo Schumacher, Universitätsklinikum Ep- of Molecular Biology, Moscow und Deutsches Rheu- pendorf, Hamburg, 13.03.2007 maforschungszentrum Berlin, 14.06.2007 Klinisch relevante Tiermodelle zur Tumormetasta- Distinct physiological functions of TNF may have dif- sierung. Fo r s c h u n g s z e n t r u m Bo r s t e l ferent physiological thresholds and are associated with production by distinct cell types. Dr. S. Schwarting, Dt. Gesellschaft Zahnärztliche Schlafmedizin, 19.04.2007 Prof. Dr. Joost Oppenheim, National Cancer Insti- Zahnschienen gegen Schnarchen und Schlafapnoe tute, Laboratory of Molecular Immunregulation, – Wirkungsweise, Leitlinien, klinische Anwendung. NIH, Bethesda, USA, 19.03.2007 Alarmins are a subset of danger signals. Dr. Silvano Sozzani, Section of General Pathology and Immunology, University of Brescia, Italien, 16.01.2007 Dr. Tobias Pukrop, Abt. Hämatologie/Onkologie, Role of LCCR in pulmonary dendritic cell migration. Universität Göttingen, 30.01.2007 Wnt5a signaling in tumor progression. Dr. med. Hendrik Treede, Universitätsklinikum Eppendorf, Hamburg, 13.09.2007 Prof. Dr. Hans-Reimer Rodewald, Institut für Immu- Lungentransplantation: Indikation, Technik und Prognose. nologie, Universitätskrankenhaus Ulm, 18.09.2007 Mechanism of a Mast Cell Protease-Mediated In- PD Dr. Thomas Tschernig, Functional and Applied nate Response. Anatomy, Medical School of Hannover, MHH, 06.03.2007 Dr. Philip Rosenstiel, Institut für Klinische Mole- MALP-2 stimulates the lung immune system. kuarbiologie, Christian-Albrechts-Universität, Kiel, 20.02.2007 Dr. Cornelis M. van Drunen, Head ENT Research Defence mechanisms at epithelial interfaces: les- Laboratory, Academic Medical Center, Amsterdam, sons from complex genetics. 06.11.2007 Primary nasal epithelium of house dust mite aller- Dr. Jan Rupp, Medizinische Klinik III, Universitätsklinikum Schleswig-Holstein, Campus gic individuals displays an activated state. Lübeck, 07.06.2007 PD Dr. Thomas Vogel, Institut für experimentelle Chlamydien und Mycoplasmen Pneumonien. Dermatologie, Universität Münster, 18.12.2007 MRP8 and MRP14 are novel endogenous ligands of PD Dr. Jan Rupp, Institut für Medizinische Mikro- Toll- like receptor 4 and promote lethal endotoxin - biologie und Hygiene, Universitätsklinikum Schles- induced shock. wig-Holstein, Campus Lübeck, 20.11.2007 C. pneumoniae interferes with immune regulatory Prof. Dr. Jürgen Westermann, Institut für Anatomie, mechanisms of antigen-presenting cells – is there a Universität zu Lübeck, 27.03.2007 functional role in the pathogenesis of asthma? CD4 memory T-cells on trial: Immunological memory without a memory T-cell. Prof. Dr. Axel Scheidig, ZBM, Christian-AlbrechtsUniversität zu Kiel, 27.02.2007 Prof. Dr. Barbara Wollenberg, HNO-Klinik, Univer- Insight into enzymatic reaction mechanisms by pro- sitätsklinikum Schleswig-Holstein, Campus Lübeck, tein crystallography. 28.06.2007 Akute und chronische Sinusitiden. 238 Wissenschaftlicher Jahresbericht 2007-2008 Seminare 2008 Colloquia 2008 Zentrumsseminare 2008 Dr. Kerstin Andrae Marobela, University of Functional genetics of multiple sclerosis using hu- Botswana, Gaborone, Botwana, 30.06.08 manised mice. Traditional medical knowledge and modern diseases. Prof. Dr. M. Gavrovi -Jankulovi , Faculty of Chemistry, University of Belgrade, 18.11.08 Prof. Dr. Ben Appelmelk, Dept. of Medical Micro- Modulation of T cell proliferation by mannose spe- biology, Vrije Universiteit Medical Center, Amster- cific banana lectin. dam, 21.10.08 DC-SIGN ligands on Mycobacterium tuberculosis Prof. Dr. Michael Glocker, Proteom-Zentrum Ro- and Heliobacter pylori and their interaction with the stock, Institut für Immunologie, Uni Rostock, 13.02.08 host. Peptidsignaturen beim Mamma-Carcinom: „Labelfree“ – Quantifizierung durch LC-MS im Vergleich zu PD Dr. Iris Bittmann, Pathologisches Institut, Diako- 2D Page – MALDI-TOF Peptide Mass Fingerprinting. niekrankenhaus Rotenburg (Wümme), 11.11.08 Muster des immunologisch getriggerten Lungen- Dr. Andrea Gómez-Zavaglia, Universidad de schadens. Buenos Aires, Argentinien, 22.01.08 Characterization of S-layer proteins from Lacto- Prof. Dr. Heimo Breiteneder, Institut für Pathophy- bacillus by FTIR spectroscopy. siologie, Zentrum für Physiologie, Pathophysiologie und Immunologie (CEPPI), Medizinische Universität Prof. Dr. Mathias Hornef, Institut für Med. Mikrobi- zu Wien, 04.03.08 ologie, Med. Hochschule Hannover, 05.02.08 Die Evolution der Allergenität. Innate recognition and response by the intestinal epithelium. Prof. Dr. Philip Calder, Professor of Nutritional Immunology, University of Southhampton, England, Dr. Birgit Jung und Dr. Detlef Stiller, Boehringer In- 28.10.08 gelheim Pharma, Biberach an der Riss, 21.04.08 Polyunsaturated fatty acids and inflammation: from Tiermodell in der COPD. the bench to bedside. Moderne Bildgebung in der Atemwegsforschung. Prof. Dr. André Fischer, Laboratory of Aging and Dr. Axel Kallies, The Walter and Eliza Hall Institute Cognitive Diseases, EURYI Research Group, Max of Medical Research, Parkville Victoria, Australia, Planck Society, Göttingen, 16.09.08 29.04.08 Epigenetic strategies to treat neurological diseases. Differentiation of mature effector lymphocytes depends on Blimp1. Prof. Dr. Wolfgang Fischer, Max Planck Institut für Biophysikalische Chemie, Göttingen, 23.09.08 Dr. Peter König, Institut für Anatomie, Universität Lü- Molecular analysis of histone modifications and beck, 11.03.08 chromatin domains. Mechanismen und Regulation des zilienvermittelten Partikeltransports in den Atemwegen. Dr. Manuel Friese, Institut für Neuroimmunologie und Klinische Multiple Sklerose Forschung, UKE, Prof. Dr. Paul Kosma, Dept. of Chemistry, Universi- 07.10.08 ty of Natural Resources and Applied Life Sciences, Wissenschaftlicher Jahresbericht 2007-2008 239 Seminare 2008 Colloquia 2008 Fo r s c h u n g s z e n t r u m Bo r s t e l Wien, 12.02.08 ical Sciences, Royal Institute of Medical Sciences, Chemical synthesis of nucleotide-activated hep- Royal Free and University College Medical School, toses and 4-aminoarabinose LPS epitopes. London, 01.04.08 Geographical variation in the priming of the im- Prof. Dr. Guido Kroemer, INSERM, Villejuif, Frankre- mune system: implications for the design of vac- ich, 25.11.08 cines for tuberculosis. Immunogenic cell death in anti-cancer chemotherDr. Günter Roth, Interfakultäres Institut für Zellbio- apy. logie, Eberhard-Karls-Universität, Tübingen, 20.05.08 Dr. Sabine Küsters, Director of European Opera- Softlithography and printing of microarrays. tions, Rules-Based Medicine Inc., Krefeld, Germany/Austin, Texas, USA, 18.06.08 Prof. Dr. Ruth Schmitz-Streit, Institut für Allgemeine High content immunoassays for biomarker profiling Mikrobiologie, Christian-Albrechts-Universität, Kiel, across species. 06.05.08 From nitrogen regulation in prokarya to gene min- Prof. Dr. Roland Martin, Institut für Neuroimmuno- ing of novel biocatalysts. logie und Klinische Multiple Sklerose Forschung, UKE, 27.05.08 Annette Schön, Brüsselbüro der Leibniz-Gemein- The role of T cells in multiple sclerosis. schaft, 26.02.08 Einführung in die EU-Forschungsförderung und Aus- Dr. Diana Mittag, Department of Immunology, blick auf die nächste Ausschreibung zum Thema 1 Monash University, Melbourne, 03.06.08 Gesundheit. Hitchhikers on ryegrass pollen shaping the T cell reProf. Dr. Yoichi Shinkai, Research Center for Infect. sponse – a T cell’s guide to the allergy. Diseases, Institute for Virus research, Kyoto UniverProf. Dr. Gunnar Pejler, Dept. of Anatomy, Physiol- sity, Japan, 19.05.08 ogy and Biochemistry, Swedish University of Agri- Function and regulation of histone lysine methyla- cultural Sciences, Uppsala, 15.04.08 tion. The role of mast cell chymase in inflammatory disDr. Alice Sijts, Dept. of Infectious Diseases and Im- ease. munology, Faculty of Veterinary Medicine, UniversiProf. Dr. Francesco Peri, Dept. of Biotechnology ty of Utrecht, 01.07.08 and Biosciences, University of Milano-Bicocca, Mi- How the antigen processing pathway regulates lano, 04.11.08 CD8 T cell responses to self and foreign antigens. Sugar-derived bioactive compounds: lipid A antagPD Dr. Christian Taube, 3. Med. Klinik, Univer- onist and Ras oncoprotein inhibitors. sitätsklinikum Mainz, 14.10.08 Prof. Dr. Satish Raina, Amrita Institute of Medical Regulation of allergic airway inflammation. Science, Cochin, Indien, 15.01.08 Signal transduction pathway in E. coli in response Prof. Dr. Diethard Tautz, Abteilung Evolutionsgene- to outer membrane alterations. tik, Max-Planck-Institut für Evolutionsbiologie, Plön, 29.01.08 Prof. Graham Rook, Centre for Infectious Diseases Tracing the genetics of adaptations in the house and International Health, Windeyer Institute of Med- mouse. 240 Wissenschaftlicher Jahresbericht 2007-2008 Seminare 2008 Colloquia 2008 Dr. Zhao–Qi Wang, Leibniz-Institut für Altersforschung – Fritz Lipmann Institut e.V. Jena, 19.02.08 DNA repair defects in human diseases: lessons from mouse models. Prof. Dr. Rainer Zawatzky, DKFZ Heidelberg, 17.06.08 The growing family of Interferon-induced genes: recent studies on a new member Wissenschaftlicher Jahresbericht 2007-2008 241 Weiterbildungseminare 2007 Colloquia 2007 Fo r s c h u n g s z e n t r u m Bo r s t e l Weiterbildungsseminare der Klinik 2007 Dr. Sven Hirschfeld Araujo, BUKH Boberg, Querschnittsgelähmten-Zentrum, 22.11.2007 Zwerchfellschrittmacher. Dr. Frank Eberhardt, Medizinische Klinik Borstel, 30.08.2007 Therapie des NSCLC. Dr. Volker Geist, Segeberger Kliniken, 6.09.2007 pAVK: Aktuelle Diagnostik und Therapie. PD Dr. Hans-Peter Hauber, Medizinische Klinik Borstel, 4.10.2007 Update GINA Guidelines. Klinisch-Pathologische Konferenz, 27.09.2007 Klinisch-Pathologische Konferenz, 1.11.2007 Klinisch-Pathologische Konferenz, 29.11.2007 Dr. Helgo Magnussen, KH Großhansdorf, 25.10.2007 Phänotypisierung der COPD. Dr. Hendrik Treede, UKE, Hamburg, 13.09.2007 Lungentransplantation: Indikation, Technik und Prognose. PD Dr. Gunther Wiest, Asklepios Klinik Harburg, 8.11.2007 Pulmonale Hypertonie: State of the art. 242 Wissenschaftlicher Jahresbericht 2007-2008 Weiterbildungseminare 2008 Colloquia 2008 Weiterbildungsseminare der Klinik 2008 Dr. Alexander Balling, Psychosomatische Klinik, Klinisch-Pathologische Konferenz, 23.10.2008 Bad Bramstedt, 19.06.2008 Morbide Adipositas: Behandlungsoptionen aus Klinisch-Pathologische Konferenz, 27.11.2008 psychosomatischer Sicht. Klinisch-Pathologische Konferenz, 18.12.2008 Dr. Hans-Jörg Baumann, II. Med. Klinik, UKE, Hamburg, 3.04.2008 Dr. Thomas Köhnlein, Abtl. Pneumologie, MHH, Die Buchstabensuppe der Beatmungsmodi. 4.12.2008 Alpha 1-Antitrypsin and COPD. Dr. Peter Buggisch, I. Medizinische Klinik, UKE, Hamburg, 15.05.2008 PD Dr. Christoph Lange, Medizinische Klinik Bor- Therapie der akuten und chronischen viralen He- stel, 5.06.2008 patitis. Exazerbation der COPD. PD Dr. Fabian Fehlauer, Strahlenzentrum Ham- Dr. Michael Melullis, Klinik f. Chirurgie, UKSH, Lü- burg Nord, 17.01.2008 beck, 7.02.2008 Strahlentherapie beim Bronchialkarzinom. Adipositaschirurgie: Indikation, Technik und Prognose. Dr. Volker Geist, Segeberger Kliniken, 24.01.2008 pAVK: Aktuelle Diagnostik und Therapie. PD Dr. Andreas Meyer, Krankenhaus Mariahilf, Mönchengladbach, 21.02.2008 PD Dr. Hans-Peter Hauber, Medizinische Klinik Nicht-medikamentöse Therapie von COPD und Borstel, 17.04.2008 Asthma. Update pulmonale Hypertonie. Dr. Ernst Müller, Medizinische Klinik Borstel, PD Dr. Hans-Peter Hauber, Medizinische Klinik 6.11.2008 Borstel, 18.09.2008 Nicht-kleinzelliges Bronchialkarzinom – State of the art. Neues vom ATS 2008. Dr. Thomas Nauert, LGASH, Kiel, 20.03.2008 Klinisch-Pathologische Konferenz, 31.01.2008. Asbestbedingte Berufskrankheiten. Klinisch-Pathologische Konferenz, 28.02.2008. Dr. Adriana Sorete Arbore, Lasi, Rumänien, 6.03.2008 Klinisch-Pathologische Konferenz, 27.03.2008. Tuberculosis in Romania. Klinisch-Pathologische Konferenz, 24.04.2008. Dr. Ulrich van Laak, Medizinische Klinik Borstel, 20.11.2008 Klinisch-Pathologische Konferenz, 29.05.2008. Apnoetauchen. Klinisch-Pathologische Konferenz, 27.06.2008. Prof. Dr. Robert J. Wilkinson, University Cape Town, South Africa, 8.07.2008 Klinisch-Pathologische Konferenz, 25.09.2008. HIV infection and XDR tuberculosis. Wissenschaftlicher Jahresbericht 2007-2008 243 Symposien und Workshops 2007 Symposia and Workshops 2007 Fo r s c h u n g s z e n t r u m Bo r s t e l Symposien und Workshops 2007 Meeting des Schistosomen-Ei-Konsortiums: Notting- SIICA 5th National Conference for the session ham – Cambridge – Leiden – Gießen – Borstel Cytokines and Inflammatory Mediators. Organisation: PD Dr. Helmut Haas, Dr. Gabriele Gruppo Regionale Immunologia, Immunologia Schramm Clinica e Allergologia (GRIICA-FVG) Forschungszentrum Borstel Vorsitz: Prof. Dr. Dr. Silvia Bulfone-Paus 27.-29. März 2007 Triest, Italien 6.-9. Juni 2007 EU-FP-6-ICTTD-3 Workshop „Attenuated Vaccines for Animal Diseases“ NGFN2-Abschlusssymposium „Umweltnetz” Organisation: Prof. Dr. Ulrike Seitzer, Prof. Dr. Co-Organisation: Prof. Dr. Stefan Ehlers Jabbar Ahmed Christian-Albrechts-Universität zu Kiel Forschungszentrum Borstel Juli 2007 16.-19. April 2007 EU-FP-6-ASEMDialog Meeting „The EU, China and EU-FP-6-ICTTD-3 Workshop „Isolation, cultivation South East Asia Dialog for the Development of Re- and monitoring techniques for the production search Areas in Animal Health of Mutual Interest“ and application of attenuated vaccines“ Organisation: Prof. Dr. Ulrike Seitzer, Prof. Dr. Jab- Organisation: Prof. Dr. Ulrike Seitzer, Prof. Dr. bar Ahmed Jabbar Ahmed Beijing, China Forschungszentrum Borstel 13.-15. August 2007 19.-24. April 2007 14th European Carbohydrate Symposium Arbeitskreis Infektiologie in Schleswig-Holstein Organisation: Forschungszentrum Borstel et al. Organisation: PD Dr. Christoph Lange Tagungspräsident: Prof. Dr. Otto Holst, FZB Kiel Lübeck 25. April 2.-7. September 2007 EU-FP-6-INCOME Meeting „Harmonisation and Dis- Workshop „Regulation of Cell Survival” tribution of Pathogen Detection and Differentiation 37. Annual Meeting of the German Society for Im- Tools“ munology Organisation: Prof. Dr. Ulrike Seitzer, Prof. Dr. Jab- Vorsitz: Prof. Dr. Dr. Silvia Bulfone-Paus bar Ahmed Heidelberg Losbon, Portugal 6.-7. September 2007 15.-18. Mai 2007 TBNET Meeting 20. Allergiekolloquium Co-Organisation: PD Dr. Christoph Lange „Aktuelles aus der Allergologie“ Stockholm, Schweden Organisation: Prof. Dr. Peter Zabel et al. 14.-15.September 2007 Forschungszentrum Borstel Mai 2007 244 Wissenschaftlicher Jahresbericht 2007-2008 Symposien und Workshops 2007 Symposia and Workshops 2007 EU-FP-6-ICTTD-3 „Asian Component Satellite Meeting“ Borsteler Bronchoskopiekurs Organisation: Prof. Dr. Ulrike Seitzer, Prof. Dr. Jab- Organisation: PD Dr. Christoph Lange, Dr. Ernst bar Ahmed Müller Sansibar, Afrika Forschungszentrum Borstel 26. September 2007 3. November 2007 2. Gemeinsamer Deutscher Allergiekongress 30. Arbeitstagung der Norddeutschen Immuno- der Deutschen Gesellschaft für Allergologie und logen klinische Immunologie, des Ärzteverbandes „Biology of Inflammation“ Deutscher Allergologen und der Gesellschaft für Organisation: Prof. Dr. Dr. Silvia Bulfone-Paus et Pädiatrische Allergologie und Umweltmedizin al. Co-Organisation: Forschungszentrum Borstel Forschungszentrum Borstel Tagungspräsident: Dr. Wolf-Meinhard Becker, FZB 16. November 2007 Lübeck 26.-29. September 2007 EU-FP-6-INCOME “Transboundary animal diseases & tick and tick-borne diseases” Scanning Probe Microscopies and Organic Ma- Organisation: Prof. Dr. Ulrike Seitzer, Prof. Dr. Jab- terials XVI bar Ahmed Organisation: PD Dr. Thomas Gutsmann RAZI Vaccine & Serum Research Institute, Hessa- Hamburg rak, Karaj, Iran September 2007 18.-22. November 2007 Treffen von deutschen (Glyko)Lipidforschern Arbeitskreis Infektiologie in Schleswig-Holstein Organisation: PD Dr. Thomas Gutsmann Organisation: PD Dr. Christoph Lange Hamburg Kiel September 2007 27. November 2007 Pneumocampus „Pneumologische Infektiologie“ Treffen der Norddeutschen Biophysiker Organisation: PD Dr. Christoph Lange Organisation: PD Dr. Thomas Gutsmann, PD Dr. Lübeck Andra Schromm 12.-13.Oktober 2007 Forschungszentrum Borstel 30. November 2007 SFB/TR22 Meeting Schloss Rauischholzhausen Steering Committee: Prof. Dr. Dr. Silvia Bulfone-Paus Statusseminar des Sonderforschungsbereichs Marburg 415 „Spezifität und Pathophysiologie von Signal- 24.-26. Oktober 2007 transduktionswegen“ Co-Organisation: Prof. Dr. Dr. Silvia Bulfone-Paus EU-FP-6-ConFluTech „Avian Influenza-Technology Forschungszentrum Borstel Transfer & Training“ 30. November - 1. Dezember 2007 Organisation: Prof. Dr. Ulrike Seitzer, Prof. Dr. Jabbar Ahmed Bucharest, Romania 29.-31. Oktober 2007 Wissenschaftlicher Jahresbericht 2007-2008 245 Symposien und Workshops 2008 Symposia and Workshops 2008 Fo r s c h u n g s z e n t r u m Bo r s t e l Symposien und Workshops 2008 12. Symposium “Infektion und Immunabwehr” Forschungszentrum Borstel der gemeinsamen Fachgruppe “Infektionsimmu- 25.-26. April 2008 nologie” der DGHM und DGfI Organisator: Prof. Dr. Christoph Hölscher Workshop “Technical workshop on epidemiologi- Burg Rothenfels cal tools” 7.-9. März 2008 Organisation, Durchführung: Prof. Dr. Ulrike Seitzer, Prof. Dr. Jabbar Ahmed Symposium der European Respiratory Society Duhok, Irak “State of the Art in Tuberculosis 2008 30. April–9. Mai 2008 und Treffen der Arbeitsgruppe Tuberkulosebera- Workshop „Technical workshop on molecular di- tungsstellen des ÖGD Schleswig-Holstein agnostic tools” Organisation: PD Dr. Christoph Lange, PD Dr. Organisation: Prof. Dr. Ulrike Seitzer, Prof. Dr. Stefan Niemann, Prof. Dr. Peter Zabel Jabbar Ahmed Forschungszentrum Borstel Berlin 9. April 2008 5.-9. Mai 2008 49. Kongress der Deutschen Gesellschaft für Workshop „Tierschutz und Versuchstiere in der Pneumologie und Beatmungsmedizin e.V. Forschung“ Tagungspräsident: Prof. Dr. Peter Zabel et al. Organisation: Dr. Ilka Monath Lübeck Forschungszentrum Borstel 9.-12. April 2008 8. Mai 2008 EU-funded Collaborative Networks Income and Workshop „Real Time PCR“ Lab-On-Site Organisation: PD Dr. Stefan Niemann “Technology Transfer of Molecular Diagnostic Forschungszentrum Borstel Tools” 14.-16. Mai 2008 Organisation, Durchführung: Prof. Dr. Ulrike Seitzer, Prof. Dr. Jabbar Ahmed Central European Workshop on “Application of Lanzhou, China Molecular genetic methods in veterinary diagnos- 14.-18. April 2008 tic virology” Organisation: Prof. Dr. Jabbar Ahmed 21. Allergie-Kolloquium Kosice, Slovak Republic „Update Allergologie“ 27.-29. Mai 2008 Organisation: Prof. Dr. Peter Zabel et al. Forschungszentrum Borstel EU-FP 6 INCOME Workshop „Bioinformatics“ 19. April 2008 Organisation: Prof. Dr. Ulrike Seitzer, Prof. Dr. Jabbar Ahmed SFB/TR 22 „Allergische Immunantwort der Lunge“ Forschungszentrum Borstel Retreat 8.-14. Juni 2008 Organisation: Prof. Dr. Dr. Silvia Bulfone-Paus, Prof. Dr. Harald Renz (Univ. Marburg) 246 Wissenschaftlicher Jahresbericht 2007-2008 Symposien und Workshops 2008 Symposia and Workshops 2008 Workshop, Arbeitskreis „Vakzine“ der Deutschen 5. Borsteler Herbstseminar für Pathologie und Gesellschaft für Immunologie Biomedizin Organisation: PD Dr. Andreas Frey et al. Organisation: Prof. Dr. Dr. Ekkehard Vollmer, PD Forschungszentrum Borstel Dr. Torsten Goldmann, Holger Schultz et al. 12. Juni 2008 Forschungszentrum Borstel 12.-13. September 2008 EU-FP 6 INCOME Workshop „Host-Pathogen-Interaction“ Regional Training Course on “Rapid Diagnosis of Organisation: Prof. Dr. Ulrike Seitzer, Prof. Dr. Avian Influenza (Bird Flu)” Jabbar Ahmed Organisation: Prof. Dr. Jabbar Ahmed Forschungszentrum Borstel Vladimir, Russian Federation 18. Juni 2008 15.-26. September 2008 Symposium der „Akademie der Wissenschaften SFB 415 „„Spezifität und Pathophysiologie von in Hamburg“ Signaltransduktionswegen” Organisation: Dr. Bettina Brand Status Quo Meeting Forschungszentrum Borstel Organisation: Prof. Dr. Dr. Silvia Bulfone-Paus, 21. Juni 2008 Prof. Dr. Dietrich Kablitz (Univ. Kiel) et al. Forschungszentrum Borstel Workshop „Moderne Wirkstoffforschung“ 19.-20. September 2008 Organisation: Dr. Hinrich Habeck, Ascenion; ScreeningPort GmbH Hamburg Workshop Fachgruppen “Microbial Systematics Forschungszentrum Borstel and Infection Epidemiology” 23. Juni 2008 60. Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie Conference of the Cluster of Excellence “Inflam- Organisation: PD Dr. Stefan Niemann mation at Interfaces” Dresden Organisation: PD Dr. Frank Petersen 21.-24. September 2008 Universität Lübeck 27.-28. Juni 2008 Ticks and Tick-borne Diseases VI Scientific Committee: Prof. Dr. Jabbar Ahmed 29th Annual Congress of the European Society of Buenos Aires, Argentinien Mycobacteriology 22.-26. September 2008 Steering Committee: PD Dr. Stefan Niemann Plovdiv, Bulgarien 13. Forum pneumologicum 6.-9. Juli 2008 „3 Jahre Zentrum für Klinische Infektiologie“ Organisation: Prof. Dr. Peter Zabel et al. Research in Swine Viral Diseases Forschungszentrum Borstel Organisation: Prof. Dr. Jabbar Ahmed 11. Oktober 2008 Shanghai 7.-9. Juli 2008 Wissenschaftlicher Jahresbericht 2007-2008 247 Symposien und Workshops 2008 Symposia and Workshops 2008 Fo r s c h u n g s z e n t r u m Bo r s t e l BMBF Verbund „Lungentuberkulose – Wirts- und National Training Course on Avian Influenza Diag- Erregerdeterminanten für Resistenz und Krank- nostics heitsausprägung” Organisation: Prof. Dr. Jabbar Ahmed Statusseminar Bucharest, Romania Organisation: Prof. Dr. Stefan Ehlers, PD Dr. Ka- 8.-9. Dezember 2008 roline Gaede Forschungszentrum Borstel National Training Course on Avian Influenza Diag- 30.-31. Oktober 2008 nostics Organisation: Prof. Dr. Jabbar Ahmed 31. Arbeitstagung der Norddeutschen Immunolo- Tbilisi, Georgien gen 15.-17. Dezember 2008 „Frontiers in Immunoregulation“ Organisation: Prof. Dr. Dr. Silvia Bulfone-Paus et al. National Training Course on Avian Influenza Diag- Forschungszentrum Borstel nostics 14. November 2008 Organisation: Prof. Dr. Jabbar Ahmed Istanbul, Turkey National Avian Influenza workshop for local exper- 15.-19. Dezember 2008 tise’s Organisation: Prof. Dr. Jabbar Ahmed Symposium: Deutsch-Ukrainische Partnerschaftsi- Athens, Griechenland nitiative 17.-19. November 2008 Organisation und Durchführung: Dr. Sabine Rüsch-Gerdes, PD Dr. Elivra Richter Workshop „Spiroergometrie“ Forschungszentrum Borstel Organisation: PD Dr. Hans-Peter Hauber et al. 18. Dezember 2008 Forschungszentrum Borstel 22. November 2008 GABRIEL – Workshop Organisation: Prof. Dr. Otto Holst et al. Forschungszentrum Borstel 27.-28. November 2008 SFB/TR 22 – Begutachtung Organisation: SFB/TR 22 Philipps-Universität Marburg 1.-2. Dezember 2008 World Vaccine Congress 2008 Scientific Advisory Board: Prof. Dr. Jabbar Ahmed Foshan, PRChina 1.-5. Dezember 2008 248 Wissenschaftlicher Jahresbericht 2007-2008 Lehre • Ausbildung Teaching • Training Fo r s c h u n g s z e n t r u m Bo r s t e l 250 Wissenschaftlicher Jahresbericht 2007-2008 Lehre • Ausbildung Teaching • Training Lehre • Ausbildung Teaching • Training Wissenschaftlicher Jahresbericht 2007-2008 251 Lehre 2007 - 2008 Teaching 2007 - 2008 Fo r s c h u n g s z e n t r u m Bo r s t e l Lehre Bulfone-Paus S, Brandt E, Gerdes J, Heine H, Petersen F, Seitzer U, Hölscher C, Reiling N. A Ausgewählte Themen der Immunologie und Zell- Ahmed JS. biologie Anleitung zum selbstständigen wissenschaftlichen Forschungszentrum Borstel WS 2006/2007, SS 2007, Arbeiten WS 2007/2008, SS 2008 Fachbereich Veterinärmedizin, FU Berlin, WS 2006/2007, SS 2007, WS 2007/2008, SS 2008 Bulfone-Paus S, Ulmer AJ, Petersen F, Ernst M, Haas H, Seitzer U, Reiling N, Heine H, Scholzen Andrä J. T, Petersen A, Schromm AB, Kasper B, Lee K-H. Vorlesung: Biochemie und Biophysik biologischer Neue Entwicklungen in der Immunologie für Natur- Membranen wissenschaftler und Mediziner Fachbereich Chemie, Universität Hamburg, WS Mathematisch-Naturwissenschaftliche Fakultät 2006/2007, SS 2007, WS2007/2008, SS 2008 Christian-Albrechts-Universität zu Kiel, WS 2006/2007, SS 2007, WS 2007/2008, SS 2008 Vorlesung, Biochemisch Analytik Fachbereich Chemie, Universität Hamburg, WS Bulfone-Paus S, Brandt E, Gerdes J, Ernst M, Pe- 2006/2007, SS 2007, WS 2007/2008, SS 2008 tersen F, Seitzer U. Anleitung zum selbstständigen wissenschaftlichen B Arbeiten Brade H, Ehlers S, Holst O, Zähringer U, Hölscher Universität zu Lübeck WS 2006/2007, SS 2007, WS C, Reiling N, Müller-Loennies S. 2007/2008, SS 2008 Immunchemisches Seminar Universität zu Lübeck, WS 2006/07, SS 2007, WS Bulfone-Paus S, Heine H, Ulmer AJ, Schromm AB, 2007/08, SS 2008 Petersen F mit wissenschaftlichen Mitarbeitern. Anleitung zum selbstständigen wissenschaftlichen Brade H, Holst O, Zähringer U, Müller-Loennies S, Arbeiten auf dem Gebiet der Immunologie und Schromm AB. Zellbiologie Anleitung zum wissenschaftlichen Arbeiten Mathematisch-Naturwissenschaftliche Fakultät Universität zu Lübeck, WS 2006/2007, SS 2007, WS Christian-Albrechts-Universität zu Kiel, WS 2007/2008, SS 2008 2006/2007, SS 2007, WS 2007/2008, SS 2008 Brandenburg K. Bulfone-Paus S, Ulmer A, Ernst M, Brandt E, Hei- Vorlesung, Physikalische Grundlagen des Lebens ne H, Petersen F, Seitzer U, Orinska Z, Scholzen Mathematisch-Naturwissenschaftliche Fakultät T, Reiling N, Kasper B, Petersen A, Hölscher C. Christian-Albrechts-Universität zu Kiel, WS Praktikum Immunologie für Naturwissenschaftler 2006/2007 und Mediziner am Forschungszentrum Borstel Vorlesung, Biophysik elektromagnetischer Strahlung Mathematisch-Naturwissenschaftliche Fakultät Mathematisch-Naturwissenschaftliche Fakultät Christian-Albrechts-Universität zu Kiel, SS 2007, SS Christian-Albrechts-Universität zu Kiel, SS 2007 2008 Praktikum Kernphysik und Radiochemie Fachhochschule Lübeck, WS 2006/2007 252 Wissenschaftlicher Jahresbericht 2007-2008 Lehre 2007 - 2008 Teaching 2007 - 2008 E Ehlers, Reiling N, Hölscher C, Niemann S. Gutsmann T, Andrä J, Brandenburg K. Infection Immunology Christian-Albrechts-Universität zu Kiel, WS Masterstudiengang Molecular Life Sciences 2006/2007, SS 2007, WS 2007/2008, SS 2008 Anleitung zum wissenschaftlichen Arbeiten Universität zu Lübeck, WS 2006/2007, WS 2007/2008 Gutsmann T. Vorlesung: Grundlagen der Biophysik Anleitung zum wissenschaftlichen Arbeiten Christian-Albrechts-Universität zu Kiel, WS Universität zu Lübeck, WS 2006/2007, SS 2007, WS 2006/2007, WS 2007/2008 2007/2008, SS 2008, Vorlesung: Membranbiophysik Ehlers S, Hölscher C, Reiling N, Laskay T, Christian-Albrechts-Universität zu Kiel, SS 2007, SS Schromm AB, Haas H, Niemann S. 2008 Seminar, Molekulare Infektiologie und Immunologie Universität zu Lübeck, WS 2006/2007, SS 2007, WS Fortgeschrittenen Praktikum Iii, Biophysik 2007/2008, SS 2008 Christian Albrechts-Universität zu Kiel, WS 2006/2007, WS 2007/2008 Ehlers S, Reiling N, Schramm G, Niemann S, G Richter E, Hillemann D, Müller-Loennies S, Goldmann T, Seitzer U. Haas H, Petersen A, Schramm G, Becker WM, FP II Praktikum Mikrobiologie für Studenten der Schocker F, Frey A. Biochemie/Molekularbiologie Aktuelle biochemische, molekulare und zelluläre Christian Albrechts-Universität zu Kiel, WS Aspekte der Allergieforschung 2006/2007, WS 2007/2008 Universität zu Lübeck, WS 2006/2007, SS 2007, WS 2007/2008, SS 2008 F Frey A. Hauber, H-P. Blockpraktikum Strukturbiologie: Herstellung von Einführung in die nicht-invasive Beatmung Biokonjugaten und ihre Anwendung in Analytik Universität zu Lübeck, WS 2007/2008, SS 2008 und Wirkstoff-Targeting. Masterstudiengang Molecular Life Sciences Heine H., Schromm AB, Bulfone-Paus S, Stamme Universität zu Lübeck, WS 2006/2007, WS C, Brade H, Zähringer U, Lindner B, Ernst M, 2007/2008 Baumann R, Reiling N, Vollmer E, Gutsmann T, Petersen F, G Gaede K, Goldmann T, Niemann S. Mentoring program for PhD and MD students Forschungszentrum Borstel WS 2006/2007, SS 2007 Molekularbiologische Methoden für Mediziner Universität zu Lübeck, WS 2006/2007, WS Hölscher C. 2007/2008 Praktikum, Transgene Expression in Mäusen Universität zu Lübeck, WS 2006/2007, WS Gutsmann T, Andrä J. 2007/2008 Vorlesung, Grundlagen der Membranphysik Universität zu Lübeck, SS 2007, SS 2008 Hölscher C, Niemann S. Praktikum, Molekulare Infektiologie und Immunologie Wissenschaftlicher Jahresbericht 2007-2008 253 Lehre 2007 - 2008 Teaching 2007 - 2008 Fo r s c h u n g s z e n t r u m Bo r s t e l Universität zu Lübeck, WS 2006/2007, SS 2007, WS Vorlesung, Physik der Sinne 2007/2008, SS 2008 Mathematisch-Naturwissenschaftliche Fakultät Christian-Albrechts-Universität zu Kiel, WS Hölscher C, Reiling N, Ehlers S, Niemann S, Holst 2006/2007, WS 2007/2008 O, Lange C, Goldmann T. Seminar, Aktuelle Ergebnisse der Tuberkuloseforschung Vorlesung, Einführung in die moderne Massen- Forschungszentrum Borstel, WS 2006/2007, SS spektrometrie 2007, WS 2007/2008, SS 2008 Mathematisch-Naturwissenschaftliche Fakultät Christian-Albrechts-Universität zu Kiel, SS 2007, SS 2008 Holst O. Vorlesung: Microbial toxins Universität Katowice, Polen, WS 2007/2008, SS Lindner B, Peters T, Mesters JR. 2008 Einführung in die Strukturanalytik Studiengang Molecular Life Sciences Holst O, Ehlers S, Mamat U, Goldmann T, Seitzer Universität zu Lübeck, SS 2007, SS 2008 U, Zähringer U, Reiling N, Niemann S, Hillemann D, Brade H, Vollmer E, Richter E, Schultz H. Lindner B, Zähringer U. Mentorenprogramm des Studiengangs Molecular Wahlpflichtveranstaltung Massenspektrometrie Life Science, Vorlesungen, Seminare Bachelor Studiengang Molecular Life Sciences Universität zu Lübeck, WS 2006/2007; SS 2007, WS Universität zu Lübeck, WS 2005/2006 2007/2008, SS 2008 M L Mamat U, Dalski A, Zühlke C. Lange C.Seminar Querschnittsbereich Infektiolo- Vorlesung, Praktikum, Genetik gie/Immunologie Bachelor Studiengang Molecular Life Sciences Universität zu Lübeck, WS 2006/2007, SS 2007, WS Universität zu Lübeck, SS 2007, SS 2008 2007/2008, SS 2008 P Seminar Themen aus der Inneren Medizin Petersen A. Universität zu Lübeck, WS 2006/2007, SS 2007, Ws Blockpraktikum Strukturbiologie: Untersuchungen 2007/2008, SS 2008 der RNase-Aktivität des Erdnussallergens Ara h8. Masterstudiengang Molecular Life Sciences, Uni- Laskay T, Rupp J, Knobloch J, Holst O, Ohgke H, versität zu Lübeck, WS 2007/2008 Niemann S. Vorlesung, Praktikum Mikrobiologie Petersen A, Flesch BK. Studiengang Molecular Life Sciences Elektrophoretisches Praktikum für Naturwissen- Universität zu Lübeck, WS 2006/2007, WS schaftler und Mediziner 2007/2008 Universität zu Lübeck und Christian-Albrechts-Universität zu Kiel, SS 2007, SS 2008 Lindner B. Physikalisches Praktikum Teil III: Biophysikalische R Arbeitsmethoden am Forschungszentrum Borstel, WS 2006/2007, WS Reiling N. 2007/2008 Vorlesung: Infektionsimmunologie der Tuberkulose 254 Wissenschaftlicher Jahresbericht 2007-2008 Lehre 2007 - 2008 Universität zu Lübeck, WS 2007/2008 Teaching 2007 - 2008 Universität zu Lübeck, WS 2006/2007, SS 2007, WS 2007/2008, SS 2008 S Stamme C. Zabel P, Lange C. Anleitung zum wissenschaftlichen Arbeiten Praktische Ausbildung in der Inneren Medizin Universität zu Lübeck, WS 2006/2007, SS 2007, WS Universität zu Lübeck, WS 2006/2007, SS 2007, WS 2007/2008, SS 2008 2007/2008, SS 2008 Repetitorium Zellbiologie Zabel P, Schunkert H, Fehm L, Gross W. et al. Universität zu Lübeck / Forschungszentrum Borstel, Vorlesung, Innere Medizin WS 2006/2007, SS 2007, WS 2007/2008, SS 2008 Universität zu Lübeck, SS 2007, SS 2008 V Vorlesung, Pathophysiologie der Inneren Medizin Vollmer E, Goldmann T, Schultz H. Universität zu Lübeck, WS 2006/2007, WS Anleitung zum wissenschaftlichen Arbeiten 2007/2008 Universität zu Lübeck, WS 2006/2007, SS 2007, WS 2007/2008, SS 2008 Blockpraktikum der Inneren Medizin Universität zu Lübeck, SS 2007, WS 2007/2008, SS Seminar, Ausgewählte Kapitel zur Tumorpatholo- 2008 gie Universität zu Lübeck, WS 2006/2007, SS 2007, WS 2007/2008, SS 2008 Vollmer E, Welker L, Schultz H. Klinisch-pathologische Konferenz Universität zu Lübeck, WS 2006/2007, SS 2007, WS 2007/2008, SS 2008 Vollmer E, Goldmann T, Niemann S, Drömann D, Schultz H. Komplexe Experimentalmodelle in der Pneumologie Universität zu Lübeck, WS 2006/2007, SS 2007, WS 2007/2008, SS2008 Z Zabel P. Vorlesung, Atemwegserkrankungen im Problemorientierten Lernen (POL) Universität zu Lübeck, SS 2007, WS 2007/2008, SS 2008 Zabel P, Petersen A, Haas H, Lange C, Frey A, Niemann S, Gaede KI, Hauber H-P. Anleitung zum wissenschaftlichen Arbeiten Wissenschaftlicher Jahresbericht 2007-2008 255 Ausbildung 2007 - 2008 Training 2007 - 2008 Fo r s c h u n g s z e n t r u m Bo r s t e l Ausbildung LEONARDO-DA-VINICI Programm Romina Pritzkow In 2007 und 2008 haben 26 Auszubildenden ihre berufliche Ausbildung erfolgreich abgeschlossen. „Wege entstehen dadurch, dass man sie geht und Chancen multiplizieren sich, wenn man sie er- Biolaboranten, 2007: Björn Adomeit, Jessica Dob- greift” schanski, David Gräser, Stefanie Heller, Marie-Luise Helms, Tjard Jörß, Kerstin Kopp, Stefan Kruse, Mit diesen Lebensweisheiten kann man wohl zu- Nadine Ruske, Ulrike Stein, Michael Weidhase, sammenfassend das ausdrücken, was uns 13 Aus- Doreen Weigel, Chrystin Wildgrube zubildenden für 4 Wochen geboten wurde. Wir durften teilnehmen am Leonardo - da - Vinci - Pro- Biolaboranten, 2008: Simon Berg, Franziska Da- jekt und 28 - 31 Tage lang, in einem EU - Land un- duna, Lisa Dost, Luisa Freese, Franziska Hillers, serer Wahl, Kultur, Sprache und Arbeit kennen ler- Maria Lammers, Linda Lang, Corinna Studt, So- nen. Ganz auf uns alleine gestellt, übten wir uns phie Weber, Birte Wegner, Kathleen Wilke in der englischen - und der jeweiligen Muttersprache, erfuhren neue Arbeitstechniken und er- Tierpfleger, 2007: Nina Frank lebten Kultur pur. Dieser Monat gab uns die Möglichkeit Einblicke in andere Länder zu gewinnen, Tierpfleger, 2008: Tina Lipski Erfahrungen sammeln zu können und Zukunftsperspektiven zu entwickeln. Ebenso lehrte uns der Aufenthalt Verantwortung LEONARDO-DA-VINICI Programm zu übernehmen und Selbstbewusstsein zu erlan- Das LEONARDO DA VINCI Programm der Eu- gen. Ganz besonderer Dank gilt der Ausbil- ropäischen Union ist im Bereich der beruflichen dungsleiterin vom FZ - Borstel, Fr. Dr. Zähringer, Aus- und Weiterbildung einzigartig. Es unterstützt die uns die Türen zur großen weiten Welt ein Stück die transnationale Zusammenarbeit zwischen weiter öffnete. den Akteuren in diesem Bereich, indem es Auslandsaufenthalte zum beruflichen Lernen fördert Danke – Thanks – Gracias – Hvala - Tack und in europäischen Partnerschaften innovative Lehr- und Lernmaterialien oder Zusatzqualifikationen entwickelt. Die Teilnahme des FZB an diesem Programm wurde 2004 durch die Leiterin der Ausbildung, Dr. Susanne Zähringer, initiiert. Für die Originalität der Antragstellung, Organisation und Zusammenarbeit mit den europäischen Partner wurde Dr. Zähringer in den letzten drei Jahren jeweils mit dem Qualitätsurteil „best practice“ ausgezeichnet – das allein spricht für sich! Hier einige Originalkommentare und Berichte der Auszubildenden mit eigenem Fotomaterial: 256 Alexander Börnhöft, Thore Masekowitz Universita degli Studi Napoli Federicoll, Neapel, Italien „... die Italiener sind nett und alles ist so crazy ...“ Wissenschaftlicher Jahresbericht 2007-2008 Ausbildung 2007 - 2008 Training 2007 - 2008 Katharina Langer, Ann-Kathrin Jarms University Clinic for Respiratory and Allergic Diseases Golnik, Bled, Slowenien „ ... klasse war die Gastfreundschaft der Slowenen – das geilste war das Paragliden ... ” Jan Demmer, Kai Treichel Instituto Zooprofilattico Sperimentale „A. Mirri“ della Sicilia, Italien „ ... afrikanische Kultur & Land sind sehr interessant ...“ Bericht über den Slowenien-Aufenthalt im Rahmen des Leonardo-Projektes 2008 Katharina Langer Im Rahmen des Leonardo-Projektes traten AnnKathrin Jarms und ich am 26.09.2008 unsere Reise nach Slowenien an. Gegen Abend des 27.09.2008 erreichten wir unser Apartment in BoFranziska Ganzert, Philip Wildgrube University Lund, Schweden „ ... Land, Leute und Arbeit waren einfach toll ... “ desce/Bled, hier bezogen wir ein 2-Zimmer Apartment mit Einbauküche und Bad in einem nett angelegten Bauernhaus. Am 29.09.2008 traten wir unseren ersten ArbeitsRomina Pritzkow, Melanie Röpcke, Svenja Schulz, Özge Kök Facultad de Ciencias de Quimicas de Moncloa, Madrid, Spanien „ ... wunderschöne Sehenswürdigkeiten & interessante neue Arbeitstechniken erlernt ...” tag in der „University Clinic of Respiratory and Allergic Diseases Golnik“ an. Unsere erste Arbeitswoche sollten wir in der Immunologie verbringen. Die immunologische Abteilung steht seit 2002 un- Wissenschaftlicher Jahresbericht 2007-2008 257 Ausbildung 2007 - 2008 Training 2007 - 2008 ter der Leitung von Dr. Peter Korosec, seine 5 Mit- Die Identifikation dieser Mykobakterienstämme arbeiter entwickeln standardisierbare immuno- soll später epidemiologischen Forschungen zur logische und genetisch diagnostische Tests für Verbreitung der verschiedenen Mykobakterien- Lungenerkrankungen und Allergien. Darüberhin- stämme in Slowenien dienen. Fo r s c h u n g s z e n t r u m Bo r s t e l aus werden hier Hypersensitivitäts-, immunologische, serologische und genetische Tests sowie Neben all der interessanten Arbeit blieb uns im- Tests zu Autoimmunerkrankungen durchgeführt. mer genügend Zeit, Slowenien kennen zu lernen. In dieser ersten Arbeitswoche war es unsere Auf- So hatten wir zum Beispiel die Gelegenheit, ein gabe, aus dem Vollblut von Patientenproben Wochenende in dem Apartment einer Arbeitskol- DNA zu Isolieren und die Konzentration der iso- legin in dem Hafenstädtchen Piran zu verbringen, lierten DNA fotometrisch zu messen. Hierbei fiel welches sich auf einer Landzunge in den Golf von auf, dass in sehr großem Maße auf die Sterilität Venedig erstreckt. Nachdem wir in den ersten geachtet wurde: So wurde z.B., entgegen unserer Wochen in Bled u. Umgebung. die schneebe- bisherigen Erfahrung, unter einer Cleanbench ge- deckten Kuppen 2000m hoher Berge bestaunt hat- arbeitet. Die Arbeit in dieser Abteilung war für ten, bot sich uns nun, nur 200km südwestlich, ein mich insofern sehr interessant, als dass mich an absolutes Kontrastprogramm: Mediterranes Kli- dem Leonardo-Projekt vor allem interessierte, wie ma mit Palmen, Olivenhainen und natürlich bereits bekannte Methoden in Laboratorien an- Strand- das alles bei ca. 28°C und Meerwasser derer Länder durchgeführt werden und dass es mit toller Badetemperatur. hier tatsächlich große Unterschiede zu vermerken gibt. Ein weiteres Highlight unseres Aufenthaltes war das Paragliden. Wie für so vieles hatte auch hier Am 09.10.2008 wechselten wir dann aus der Im- Manca Zolnir ihre Kontakte spielen lassen und ei- munologie in die Mykobakteriologie. Leiterin die- nen Tandemflug mit einem Paragliding-Piloten or- ser Abteilung ist seit 1995 Dr. Manca Zolnir-Dovc, ganisiert. Ich denke wer einmal frei wie ein Vogel für sie sind 6 Mitarbeiter tätig. Die Hauptaufga- über das traumhafte Panorama der julischen Al- ben dieses Labors liegen in der direkten mikro- pen geflogen ist, der wird diesen Eindruck sein skopischen Untersuchung von Patientenproben, Leben lang nicht mehr vergessen. bakteriologischen Kulturen und der Identifikation von Mykobakterien. All diese Untersuchungen dienen dazu, dem jeweiligen Patienten die richtige Diagnose zu stellen und geeignete Behandlungen zu entwickeln. Neben der Untersuchung von Patientenproben werden auch Forschungsprojekte, zum Beispiel im Bereich „molecular genotyping and molecular epidemiology of tubercle bacilli“, in dieser Abteilung durchgeführt. Unsere Aufgabe in diesem Labor war es zunächst, PCRs von isolierter DNA (aus Patientenproben aus dem Jahr 2007) durchzuführen. Diese amplifizierten Natürlich haben wir auch nahezu das komplette DNA-Proben wurden später von uns für eine Me- Programm touristischer Sehenswürdigkeiten Slo- thode namens Spoligotyping verwendet, mit wel- weniens „abgearbeitet“, wie z.B. die Tropfstein- cher verschiedene klinisch bedeutsame Myko- grotte „Postojnska Jama“, den Markt und die Alt- bakterienstämme identifiziert werden können. stadt von Ljubljana, eine Wanderung auf den 258 Wissenschaftlicher Jahresbericht 2007-2008 Ausbildung 2007 - 2008 Training 2007 - 2008 1500m hohen Gipfel des „Kriska Gora“, eine Wanderung entlang des Bohinj-Sees bis hin zum „Slap Savice“ (einem beeindruckenden Wasserfall) sowie eine Fahrt mit der Seilbahn auf den „Vogel“ auf ca. 1600m Höhe mit beeindruckendem Blick auf den Bohinj See. Zusammenfassend muss ich sagen, dass dieser Monat in Slowenien mit Sicherheit die tollste Auslandserfahrung war, die ich bisher gemacht habe. Auch, weil Slowenien ein Land ist, von dem ich bisher eine völlig falsche Vorstellung hatte, bin ich froh, gerade dieses Land gewählt zu haben und kann Slowenien und v.a. die Klinik Golnik jedem weiteren Auszubildenden, der in den Genuss der Leonardo-Teilnahme kommt, nur wärmstens empfehlen. Ich habe bisher nirgendwo in Europa eine solche Gastfreundschaft empfunden wie dort und bisher in keinem anderen Land so tiefe Einblicke in den Alltag der dort lebenden Menschen nehmen können. Alle Kolleginnen und Kollegen waren uns gegenüber sehr aufgeschlossen und interessiert, auch sprachlich gesehen gab es keine Schwierigkeiten, da fast alle über sehr gute Englischkenntnisse verfügten. Besonders hervorzuheben ist in diesem Zusammenhang erneut Manca Zolnir, die sich rührend um unser Wohlergehen kümmerte und uns sowohl in beruflichen wie auch die Freizeit betreffenden Fragen mit Rat und Tat zur Seite stand und viel Zeit für uns opferte. Ich hoffe, dass in den nächsten Jahren viele weitere Azubis ihre evtl. vorhandene Scheu gegenüber Slowenien ablegen und im Rahmen des Leonardo-Programms dorthin reisen werden. Ich, für meinen Teil, war absolut begeistert und froh, dass ich diese Gelegenheit genutzt habe. Wissenschaftlicher Jahresbericht 2007-2008 259 Chronik • Neue Entwicklungen • Haushaltsplan Chronicle • New Developments • Budget Fo r s c h u n g s z e n t r u m Bo r s t e l 260 Wissenschaftlicher Jahresbericht 2007-2008 Chronik • Neue Entwicklungen • Haushaltsplan Chronicle • New Developments • Budget Chronik • Neue Entwicklungen • Haushaltsplan Chronicle • New Developments • Budget Wissenschaftlicher Jahresbericht 2007-2008 261 Chronik 2007 Chronicle 2007 Fo r s c h u n g s z e n t r u m Bo r s t e l Chronik 2007 18. Juni 2007 Sitzung des Kuratoriums und der Stiftungsver- 13. Februar 2007 sammlung des Forschungszentrums Borstel. Besuch von Prof. Dr. Bernd Rohwer, Geschäftsführer der Industrie- und Handelskammer SchleswigHolstein, anlässlich einer Bereisung des Kreises 21. Juni 2007 Segeberg. Besuch des Ministerpräsidenten, Peter Harry Carstensen, mit diplomatischen Korps anlässlich der Kieler Woche und der damit verbundenen Reise 8. März 2007 ins Land. Besuch des FDP-Kreisverbandes Segeberg. 15. Juni 2007 „… wer den Mythos von Borstel, das Geheimnis dieses wunderbaren und im internationalen Wettbewerb so herausragend erfolgreichen Forschungszentrums für Medizin und Biowissenschaften ergründen will, der muss in das Herrenhaus, die Parkallee 1, eintreten, so wie Sie alle es getan haben, sich niederlassen – und dann schauen, hören, tasten und spüren. Sie werden sehen, dass die Schönheit des Gebäudes zeitlos 28. Juni / 26. Juli / 30. August 2007 ist, so zeitlos, wie die Schönheit der Wissenschaft. 800 Jahrfeier der Gemeinde Sülfeld. Anlässlich Das Klima dieses Hauses inspiriert die Fantasie, dieses Jubiläums veranstaltete das FZB eine an generiert neue Ideen und befördert die für die die Öffentlichkeit gerichtete Veranstaltungsreihe Wissenschaft alles entscheidende Kreativität. Das zum Thema „Gesundheit der Lunge“. Herrenhaus verkörpert mithin den genius loci Borstels …“. Zitat aus der Rede von Prof. Ernst Th. Rietschel, Präsident der Leibniz-Gemeinschaft, 19. Juli 2007 anlässlich des Festaktes zur Eröffnung des Wis- Besuch des Lions Club Henstedt-Ulzburg mit einer sens- und Kommunikationszentrums im Herren- Besichtigung des Herrenhauses und Diskussion haus Borstel. zum Thema „Allergie“. 27. Juli – 9. September 2007 Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation at NCI, NIH has visited the Research Center Borstel on his sabbatical leave. Dr. Oppenheim was a pioneer in identifying cytokines and chemokines such as IL-1, IL-8 and MCP-1, and in characterizing their function. This earned him the nickname “Father of Cytokines”. 262 Wissenschaftlicher Jahresbericht 2007-2008 Chronik 2007 Chronicle 2007 Dr. Oppenheim has contributed to the field with regionalen Wirtschaft und der IHK zum Thema well over 550 papers (includes books, chapters, Forschung/Entwicklung/Innovationsförderung. reprints and reviews). 12. Dezember 2007 Erste Weihnachtsfeier des FZB nach der Restaurierung des Herrenhauses und der Eröffnung des Wissens- und Kommunikationszentrums. Für ein stimmungsvolles Programm und die wunderschöne Dekoration des Hauses sorgten Ulrike Schroer und Grudrun Lehwark-Yvetot. 29. August 2007 Kühl war es auf dem Sommerfest 2007! Doch auch das Wetter konnte den Borstelern die gute Stimmung nicht vermiesen. Die zweite Borstel Band „ex vivo“ heizte richtig ein, genauso wir die härtesten Griller Norddeutschlands und alle weiteren Köstlichkeiten aus der inzwischen weltweit bekannten Küche des Zentrums. 7. November 2007 Besuch der Staatssekretärin Karin Wiedemann, Ministerium für Wissenschaft, Wirtschaft und Verkehr. 15. November 2007 Besuch der IHK Nord zum Thema „Forschung erforschen“. Wirtschaftgespräche im Kreis Segeberg, Informations- und Meinungsaustausch zwischen der Wissenschaftlicher Jahresbericht 2007-2008 263 Chronik 2008 Chronicle 2008 Fo r s c h u n g s z e n t r u m Bo r s t e l Chronik 2008 der Abteilung „Molekulare Infektiologie“ willkommen. 22. Mai 2008 Veranstaltungsreihe „Forschung erforschen!“ Zu Gast waren Teilnehmer der Innovationstour der Metropol-, Industrie- und Handelskammern, Norddeutschland. 4. Juni 2008 Sitzung des Beirats der Region Südwest, Projektgesellschaft Norderelbe. 12. Juni 2008 Besuch des Lions Club Henstedt-Ulzburg, der das 17. Oktober 2008 Schullabor am FZB durch Spenden finanziell un- Verleihung des Professor-Otto-Roth Preises, des terstützt. Durch diese Initiative hat der Lions Club Heinrich-Dräger-Wissenschaftspreises und des Fa- weiteren Schulen die Teilnahme am Projekt „For- kultätspreises der Gesellschaft der Freunde und schung und Schule“ ermöglicht. Förderer der Universität Lübeck im Herrenhaus Borstel. 14. November 2008 Verleihung des Nils-Ilja-Richter Preises der Deutschen Gesellschaft für Autoimmun-Erkrankungen im Rahmen der 31. Arbeitstagung der Norddeutschen Immunologen in Anwesenheit von Minister Dr. Werner Marnette. 9. Dezember 2008 Die traditionelle Weihnachtsfeier, wie immer im prächtig geschmückten Herrenhaus, konnte eine 28. August 2008 Amtseinführung des neuen Direktors, Prof. Dr. Ulrich Schaible. Geladene Gäste aus Universitäten und außeruniversitären Einrichtungen sowie Premiere verzeichnen. Der Borstel Chor hatte mit den zuständigen Ministerien hießen den Direktor einer Reihe von internationalen Weihnachtslie- 264 Wissenschaftlicher Jahresbericht 2007-2008 Chronik 2008 Chronicle 2008 dern seinen ersten Auftritt und erhielt dafür einen Riesenapplaus. Ansprachen, Musik, Preisverleihungen, kulinarische Köstlichkeiten und „Spitzen“ in Wort und Ton der Comedian Scientists sorgten für einen mehr als gelungenen und stimmungsvollen Abend. 18. Dezember 2008 Aufsichtsratssitzung der Norgenta, Norddeutsche Life Science Agentur. Wissenschaftlicher Jahresbericht 2007-2008 265 Neue Entwicklungen New Developments Neue Entwicklungen bioimaging, flow cytometric sorting capacity, BSL3 fa- Fo r s c h u n g s z e n t r u m Bo r s t e l cility upgrade). Two newly created structural W3 pro- Exzellenz-Cluster „Entzündung an Grenzflächen“ fessorships affiliated with the universities of Lübeck and Kiel (Experimental Pneumology, Heinz Fehrenbach; Molecular Inflammation Medicine, Stefan A proud founding pillar of the Cluster of Excellence in Inflammation Research Ehlers) and one Kiel-affiliated W1 junior professor- Stefan Ehlers, Member of the Executive Group frastructures and personnel in Borstel through Clus- ship (Mouse Model Systems for Microbe-Induced Inflammation, Guntram Grassl) receive support for in- ter funding. In addition, several independent young On October 19, 2007, the Cluster of Excellence “In- researcher and postdoctoral positions are funded flammation at Interfaces” was approved for funding via the molecular research pipelines on collagen VII, through 2012. The Cluster is a research consortium gp130 and NOD-like receptors and thus form an in- comprising five faculties of the universities of Kiel and tegral part of the interdisciplinary Cluster effort. Al- Lübeck, the Max-Planck-Institute for Evolution Biology together, approx. 20% of all Cluster funds (total of ⇔ in Plön and the Research Center Borstel. Research fo- 30 million over 5 years) have been acquired by Bors- cuses on human chronic inflammatory barrier disor- tel researchers. ders, such as Crohn disease, psoriasis and sarcoidosis. The aim of the Cluster is to re-structure the The Research Center Borstel is represented in the scientific landscape in Schleswig-Holstein into a high- Cluster Steering Committee by Silvia Bulfone-Paus ly matrixed field of interested scientists who, based and Ulrich Zähringer, and within the Cluster Executive on new genetic input concerning disease etiology, Group by Stefan Ehlers. Borstel will also participate predict structure information and describe multiple in- in a PhD program “Inflammation Research” to be tertwined pathways and pathophysiologies in mod- conducted by the newly recruited young professors el systems of barrier diseases in a highly parallel of the Cluster. Members of all three departments fashion. In its first year of existence, the Cluster has profit from the Cluster via its international visibility filled 3 W3 structural professorships as well as 12 W2 (e.g. monthly Cluster Lectures with high profile re- and 3 W1 strategic researcher positions at the uni- searchers), access to high-throughput and high-tech versities of Kiel and Lübeck, and has recruited 12 in- platforms (genome wide sequencing, DESY PETRA III dependent young scientists at the postdoctoral level beamline, population representative biobank pop- in the research pipelines focused around NOD-like re- gen), and free online access to the Elsevier Freedom ceptors, gp130 cytokines, and collagen VII. An infra- Collection and Nature Journal Series. Most impor- structural milestone will be the inauguration of the tantly, however, the successful application as an in- Comprehensive Center of Inflammation Medicine in tegral founding member of the Cluster is another April 2009 where patients will be diagnosed and proof of excellence for the disease-oriented molecu- treated based on an interdisciplinary clinical confer- lar research that is the centerpiece of the Research ence and where therapy and prevention studies will Concept in Borstel. be initiated with new anti-inflammatory agents and molecular nutrition. The Research Center Borstel provides access to its technological platforms (e.g. Literarisches zum Cluster biosafety level 2 and 3 facilities, advanced mass spectrometry, unique M. tuberculosis strain collec- Ein imaginäres Gespräch tions, certified infectious disease study center) and is Hans-Dieter Flad* rewarded by several infrastructural investments (e.g. Am 6. Dezember 1769 fand am Hof des Königs 266 Wissenschaftlicher Jahresbericht 2007-2008 Neue Entwicklungen New Developments Christian VII. von Dänemark ein Gespräch zwi- gnose gestellt habe („febris continua epidemica schen Johann Hartwig Ernst Graf von Bernstorff, maligna petechialis“) und, entgegen dem Rat an- dem allmächtigen Staatsminister und Handels- derer Ärzte, als Therapie „Lüftung der Kranken- minister, und Johann Friedrich Struensee, Leib- stuben, nicht zu warm zudecken, nicht zu stark hei- arzt des Königs, Physikus der Herrschaft von Pin- zen, kühlende Waschungen mit Wasser-verdünn- neberg und Altona und Landphysikus der Graf- tem Weinessig“ empfohlen habe. Damit eng ver- schaft Rantzau, statt. bunden sind auch Maßnahmen, die den Sanitätsdienst in unserem Lande betreffen. Struensee: Exzellenz, ich beabsichtige, einen Ver- Bernstorff: Struensee, ich bin mit Ihrem Vorschlag bund der medizinischen Diagnostik und der Pati- einverstanden. Was das Gebiet betrifft so sollte entenversorgung in Dänemark und Norddeutsch- dieses „Exzellenzcluster“, wie Sie das nennen, land zu gründen, ein sogenanntes Medizinisches ganz Norddeutschland einschließlich meinen Exzellenzcluster für das ganze Land. Stammsitz Borstel und weiter Hamburg und Alto- Bernstorff: Das klingt interessant, zumal es auch na umfassen. meinen Titel beinhaltet. Als Staatsminister, der für Struensee: Sehr richtig, Exzellenz. den Handel zuständig ist, habe ich natürlich ein Interesse daran, dass die Bevölkerung gesund ist Am 15. September 1770 wurde Bernstorff aus po- und vor Krankheiten geschützt werden kann. litischen Gründen unter Mithilfe von Struensee Aber: Was haben Sie vor? Sind Sie überhaupt für von König Christian dem VII. entlassen. Bernstorff ein solches Vorhaben qualifiziert? bemerkte hierzu: „Was ich erwartet habe, ist ge- Struensee: Ich denke schon, Exzellenz. Zunächst schehen. Ich habe eine Schlacht verloren. Die Op- einmal muss die Verhütung von Krankheiten, die position ist zu stark gewesen. … Ich bin es nun zu- Prophylaxe, verbessert werden. Ich bin, wie Sie frieden, ich ziehe bald nach Borstel, wo ich es gut wissen, ein Anhänger des Contagiums, d. h. der habe und gern sein mag.“ Aber in Borstel kann Übertragbarkeit von Krankheiten durch kleine Er- er nicht bleiben, weil seine Schwiegermutter we- reger, die, wie Leibniz propagiert, mit dem Mi- gen der Schmach der Entlassung ihn nicht auf- kroskop erkannt werden können. Krankheiten ent- nehmen will. Struensee wird am 17. Januar 1772 stehen nicht, wie die Humoralpathologie be- verhaftet und am 24. April zum Tode verurteilt. Sei- hauptet, als Folge einer Säfteverderbnis durch nen Feinden war es gelungen, ihm ein Verhältnis Ausdünstungen aus dem Boden. So habe ich be- zu Königin Caroline Mathilde nachzusagen. Seine obachtet, dass die Exkremente von Ruhr- und Reformen des Sanitätswesens und seine seu- Faulfieber-Kranken im Fleetwasser von Hamburg chenprophylaktischen Verdienste im Sinne einer ansteckend sind und Gesunde krankmachen, Exzellenzinitiative fielen der Vergangenheit zum während das Trinkwasser von Altona von besse- Opfer. Erst 235 Jahre später konnte seine Idee ei- rer Qualität ist und weniger neue Krankheitsfälle nes Exzellenzclusters in Norddeutschland inklusi- hervorruft. Weiterhin habe ich gute Erfahrung mit ve Borstel verwirklicht werden. Die wissenschaft- der Pockenimpfung. Ich sage immer: „So wie die lichen Grundlagen waren gelegt. Eigenschaft des Magneten durch Berührung aus vielen Eisenstücken übergehen kann, ebenso Die Mächtigen interagierten und kooperierten kann das Blatterngift von einem Kranken auf vie- miteinander. Ehefrauen und Schwiegermütter wur- le Gesunde, welche noch keine Blattern haben, den in das neue Konzept mit einbezogen. übertragen werden“. Auch dürfte Ihnen, Exzel- (Literatur beim Verfasser) lenz, bekannt sein, dass ich 1759 im Kreis Pinne- *Prof. Dr. med. Hans-Dieter Flad war 20 Jahre als Direktor der berg bei Fälle von Fleckfieber die richtige Dia- Abteilung „Immunologie und Zellbiologie“ am FZB tätig. Wissenschaftlicher Jahresbericht 2007-2008 267 Neue Entwicklungen New Developments Fo r s c h u n g s z e n t r u m Bo r s t e l Neues Gesicht am FZB Lötzer besonders wichtig, die Wissenschaftler dabei zu unterstützen, ihre Themenvorschläge bei EU-Forschungsreferat der EU-Kommission bekannt zu machen und star- Seit Oktober 2008 ist das EU-Forschungsreferat ke internationale Konsortien zu bilden. Die För- neu besetzt. Dr. rer. nat. Katharina Lötzer wech- derung von Forschungsprojekten durch die Eu- selte an das FZB, um die Wissenschaftler in allen ropäische Union ist nicht nur ein wichtiger Bau- Fragen der EU-Forschungsförderung zu unterstüt- stein zur Finanzierung relevanter Forschungsvor- zen. Frau Lötzer war zu- haben, sondern festigt auch die internationale vor als Wissenschaftlerin Akzeptanz des FZB und seiner Wissenschaftler. am Institut für Vaskuläre Medizin der FriedrichSchiller-Universität Jena Scientific Reinforcement im Bereich der Atherosklerose-Forschung tätig. Department Molecular Infection Biology Nach Abschluss ihrer In August 2008, Prof. Dr. rer. nat. Ulrich E. Schaible Promotion im Fach Zell- succeeded Ernst Rietschel in leading the Depart- biologie leitete sie die ment Immunochemistry and Biochemical Microbiol- Arbeitsgruppe Endothelzellbiologie und sammel- ogy renamed as Department of Molecular Infection te während dieser Tätigkeit umfangreiche Erfah- Biology. In addition he is holding the chair for Bio- rungen in Forschungsförderung und Projektma- chemical Mircobiology at the University of Lübeck. nagement. Erste Berührungen mit der Leibniz-Ge- Parts of his research team are still working at the meinschaft ergaben sich bereits während ihres London School of Hygiene & Tropical Medicine, In- Studiums der Ökotrophologie an der Christian- fectious and Tropical Diseases where he had a Albrechts-Universität zu Kiel bei einem einjähri- chair in immunology (2006-2008) and is now ap- gen Forschungsaufenthalt am Deutschen Institut pointed as a Honorary Professor. für Ernährungsforschung in Potsdam-Rehbrücke. Durch ihren Wechsel nach Borstel kann Frau Lötzer ihre Interessen im Bereich Wissenschaft, Wirtschaft und Organisation verbinden und für das FZB einsetzen. Sie hält engen Kontakt zu den Nationalen Kontaktstellen und dem Büro der LeibnizGemeinschaft in Brüssel, um die Borsteler Wissenschaftler und Entscheidungsträger stets auf dem aktuellen Stand halten zu können. Im Januar 2009 wird sie daher im Brüsseler Büro hospitieren, um vor Ort mit spezifischen Angelegenheiten der EU-Forschungsförderung bekannt zu werden. Hierzu gehört insbesondere das Knüpfen von Kontakten, etwa zu Vertretungen der Länder und Organisationen sowie zur Europäischen Kommission. Denn neben der Informationsvermittlung The Department of Molecular Infection Biology sowie der Unterstützung der Wissenschaftler von (MIB) combines research on the many facets of Projektidee und Antragstellung bis Vertragsver- bacterial infections to study them in their entirety. handlungen und Projektmanagement ist es Frau The research agenda covers from basic molecular 268 Wissenschaftlicher Jahresbericht 2007-2008 Neue Entwicklungen New Developments analysis of bacterial structures and their genetic basis, studies on pathogen and host interactions and the resulting immune responses as well as translational approaches in collaboration with the Clinical Department. The prime foci of MIB are on pulmonary pathogens, in particular those, which cause Tuberculosis and Cystic Fibrosis, but also on Chlamydia and other Gram-negative ones including environmental bacteria and their influence on lung immunity such as allergic reactions. Tuberculosis research comprises studies on host genetics, host cell/pathogen interactions and anti-tuberculo- tion and structural changes leading to a disease- sis immunity. Factors determining virulence and specific patho-physiology. The integrative research pathogenicity - primarily in infections with Gram- concept is based on the in vivo study of animal negative bacteria - are studied with respect to their models and comprises the seek for specific molec- structural, genetic and functional characteristics ular mechanisms linked to the development of lung with a focus on immune modulation by bacterial (dys)function and pathology. The central aim is the compounds and membrane biophysics of receptor- identification of novel therapeutic targets. ligand interactions. Severe asthma displays a complex clinical phenotype with chronic impairment of lung function periodically necessitating intensive care hospitalization and mechanical ventilation. Recent data suggest that chronic airway inflammation is different from the classical T helper 2 cell driven airway eosinophilia. It involves influx of neutrophils as well as a contribution of T helper 17 cells. However, the factors leading to the altered inflammatory response and ultimately to progression and aggravation of the asthmatic phenotype remain elusive. Work in the division utilizes several animal models together with extensive lung function assessment and state-of-the-art stereology in order to elucidate Experimental Pneumology the role of neutrophils and T helper 17 cells. In July 2008, Prof. Dr. rer. nat. Heinz Fehrenbach joined the Research Center Borstel to establish the Pulmonary emphysema is characterized by the section “Experimental Pneumology” which compris- loss of alveoli, which is considered to be irreversible es additional three research groups. Furthermore, with no curative therapy being available. Although he is holding the chair in Experimental Pneumology cigarette smoking is the most prominent cause of (W3) at the University of Lübeck. the disease, systemic effects are implicated in its pathogenesis. Increased interest in regenerative His division “Inflammation and Regeneration” will therapeutic approaches has been stimulated by re- focus on the genuine patho-physiological process- cent studies indicating that the lung possesses an es and the specific cell types, which link inflamma- endogenous regenerative capacity, which may be Wissenschaftlicher Jahresbericht 2007-2008 269 Neue Entwicklungen New Developments influenced by systemic factors. Several growth fac- chemokines, and receptors is evaluated. First ex- tors (HGF, KGF, VEGF, PDGF, TGFb) exerting cell periments have shown that very low tidal volumes type-specific effects are candidate key mediators in induce pulmonary inflammation. Most previous alveolar regeneration. Work in the division will fo- studies used animals with healthy lungs. It is not cus on the identification of the relative contribution clear whether so called protective ventilation strate- of these known as well as of still unknown pul- gies can be used in injured lungs. Therefore differ- monary and systemic pathways underlying such en- ent ventilation strategies are applied to mice with dogenous and potentially inducible regenerative injured lungs (bleomycin-induced fibrosis, elastase- processes, which may lead to the restoration of a induced emphysema; 2 hit model). Fo r s c h u n g s z e n t r u m Bo r s t e l proper lung structure and function. Work on granulomatous and fibrotic interstitial lung disease focuses on the mechanisms of disease susPathophysiology of Inflammation ceptibility. Using genome wide linkage analysis Head: PD Dr. Hans-Peter Hauber gene polymorphisms are identified that are linked with disease susceptibility. The group „Pathophysiology of Inflammation“ is interested in pathomechanisms of acute and chronic pulmonary inflammation and the resultant functional impairment. Work mainly focuses on COPD, bronchial asthma, pneumonia, and chronic granulomatous diseases (eg. Sarcoidosis, berylliosis). Moreover, ventilator-induced injury and ARDS are main topics of the group. One main area of research is the investigation of the mechanisms that lead to mucus hypersecretion in chronic inflammatory lung disease. Using a mod- Barrier Integrity el of explanted human mucosal tissue of the upper The Team: Ingmar Lautenschläger (head), Dr. airways stimulation of the mucosa with bacterial Heike Dombrowsky (scientific staff), Jürgen Sarau products (LPS, PAM3), living bacteria (Chlamydia, (technical staff). Pseudomonas aeruginosa), and Th2 type cytokines (IL-4, IL-9, IL-13) to mimik bacterial and allergic in- As a barrier organ, the intestine has the delicate flammation ex vivo can be achieved. By evaluating task of distinguishing between “friend and foe” on mechanisms of mucus hypersecretion new thera- a molecular basis, incorporating the former and peutic targets can be defined. tagging them harmless while warding off the latter. Failure of this barrier function may result in severe Another main area of research is the investigation illness. In close cooperation with the Department of of the pathophysiological mechanisms that are in- Anaesthesiology and Intensive Care Medicine at volved in the ventilator-induced lung injury. Several the University Medical Center Schleswig-Holstein, studies have demonstrated that both very high and Campus Kiel, and the Institute of Pharmacology and very low pressure can induce lung injury and may Toxicology at the RWTH Aachen University, the Di- affect the whole organism. Using a model of venti- vision of Barrier Integrity focuses in particular on elu- lated mice the effect of different ventilation strate- cidating mechanisms of interface disorders and im- gies on gene and protein expression of cytokines, mune responses in this organ. 270 Wissenschaftlicher Jahresbericht 2007-2008 Neue Entwicklungen New Developments Acute inflammatory diseases such as sepsis and at the interface between M. tuberculosis and its host multiple organ failure are accompanied by loss of cell, the macrophage. The detailed characterization endothelial and epithelial barrier functions with sub- of the interaction between mycobacteria and sequent edema formation. The impact of the intes- macrophages is the major focus of the division. We tine as an immunologically highly active surface or- use a variety of biochemical, immunological as well gan on this pathology is not well understood. Using as cell- and microbiological approaches to monitor a unique and complex isolated perfused small in- the infection in “real” cells, such as primary human testine model with real time access to all compart- and murine macrophages. We study the functional ments (vasculature, lumen, lymphatics and intestin- relevance of a distinct mediator or signaling path- al tissue), we will study the molecular mechanisms way analyzed in vitro experiments and if possible of intestinal edema formation caused by bacterial also in an in vivo infection situation. To come as components such as LPS and inflammatory media- close as possible to the natural infection situation tors. Comprehension of these mechanisms will en- we challenge immunocompetent and selectively able us to test novel therapeutic approaches, e.g. gene-deficient mice with M. tuberculosis via the immunonutrition or proteasome inhibition. aerosol route and analyze the course of infection by monitoring macrophage activation, bacterial bur- Allergic diseases, including food allergies, have den, as well as granuloma development. doubled in number within the past 25 years, affectaccess: Defining the M. tuberculo- ing now approximately 10-15% of the population in New industrialized countries. Failure of desensitization to- sis/macrophage interface wards food ingredients is noted with increased fre- M. tuberculosis actively blocks phagosome/lysosome quency resulting in impairment of everyday life and fusion and is able to survive and even replicate in even in life threatening events. In order to close this macrophages. Components of the mycobacterial cell therapeutic gap, we will, in collaboration with the wall, e.g. glycolipids and lipoproteins, modulate cel- Division of Mucosal Immunology and Diagnostics, lular functions so that the cell is not capable of erad- focus on the intestinal antigen absorption, process- icating the invading microorganism. However the ing and translocation, and examine food allergens question which signaling pathways are initiated in in the abovementioned isolated perfused intestine which compartment and at what time during M. tu- model. Of particular interest is the isolation and berculosis infection is far from being completely un- characterisation of allergen carrying components derstood. To tackle this issue we have developed a as well as factors modulating the immunogenicity of novel immunomagnetic technique which allows a allergens with the long-term goal of being able to rapid isolation of phagosomes from mycobacteria-in- induce immunological tolerance in allergic patients. fected primary macrophages. This enables us to perform a detailed biochemical characterization of the molecular processes occurring at the (intracellular) Microbial Interface Biology interface between mycobacteria and macrophages. Head: PD Dr. Norbert Reiling Novel responses: Deciphering the role of “To get it, all you have to do is breathe”- Tubercu- Wnt/Frizzled signaling in mycobacterial infections losis is acquired through inhalation of Mycobac- The contact between mycobacterial structures and terium tuberculosis. In the lung the bacteria get in- the macrophage elicits a variety of immunological to contact with alveolar macrophages. Whether responses: Depending on the mycobacterial strain, these cells are capable of killing the bacteria de- the cells produce a wide array of pro- and anti-in- pends on a number of processes which take place flammatory mediators. We have identified several Wissenschaftlicher Jahresbericht 2007-2008 271 Neue Entwicklungen New Developments Fo r s c h u n g s z e n t r u m Bo r s t e l members of the ics of bacterial recognition, uptake and phagoso- Wnt/Frizzled signal- mal processing by antigen presenting cells. In this ing cascade to be context the formation of receptor complexes, mem- involved in the reg- brane and intracellular trafficking as well as signal ulation of antimy- transduction pathways will be studied in detail. To cobacterial effector this end it is planned to utilize fluorescence-based functions the techniques such as FRAP (fluorescence recovery af- host. Both Toll and ter photobleaching), FRET (fluorescence resonance WNT energy transfer) and the photoactivation of fluores- of signaling pathways are evolutionarily cent protein tags. highly conserved and have only recently been found to intersect in Drosophila. A major focus of the group is the in-depth analysis of the novel functions of this signaling network, already well known for their roles in embryogenesis and cancer, in inflammation and infection. Service Unit Fluorescence Cytometry Head: Dr. Thomas Scholzen The service unit Fluorescence Cytometry offers scientists at the FZB and associated universities access to modern fluorescence-based techniques. These include flow cytometry, which allows to analyze large numbers of cells in a quantitative manner and, by utilizing FACS sorting, to obtain highly purified populations of living cells for subsequent experiments. However, to get additional information about the spatial distribution of components and the chronological sequence of events, complementary methods must be applied. In this regard high resolution live cell imaging is a key technique for the spatialtemporal analysis of complex processes. For this purpose the service unit provides state-of-the-art confocal and wide-field fluorescence microscopes. The Fluorescence Cytometry is scientifically associated with the division of Innate Immunity (Head PD. Dr. Holger Heine), working on allergy protection based on the immunomodulatory effects evoked by certain bacterial strains. The Fluorescence Cytometry unit contributes to this project by applying live cell imaging techniques to investigate the dynam- 272 Wissenschaftlicher Jahresbericht 2007-2008 Haushaltsplan Budget Haushaltsplan Institutioneller Hauhalt 2007: 16,96 Mio. Euro Eingeworbene Drittmittel 2007: 6,0 Mio. Euro Institutioneller Hauhalt 2008: 15,36 Mio Euro Eingeworbene Drittmittel 2008: 6,8 Mio. Euro Wissenschaftlicher Jahresbericht 2007-2008 273 Personenregister Register of Persons Fo r s c h u n g s z e n t r u m Bo r s t e l Personenregister Ahmed JS; 109, 118 Albrecht S; 47 Alexander C; 50-56 Ali AM; 113 Aly S; 64-65 Andrä J; 52-56 Andresen E; 125 Bade S; 184-187, 189, 230, 231 Bakheit MA; 113 Barths D; 181-182 Becker WM; 175-179, 230, 231 Behrends J; 66, 70 Billur M; 106-107 Böhling A; 55 Brade H; 32-35 Brade L; 32, 34 Brandenburg K; 52-55, 59 Brandt E; 102-105 Brandt K; 89 Brown J; 106 Budagian V; 88-89 Bulanova E; 88-89, 90 Bulfone-Paus S; 6-9, 80-91 Bullwinkel J; 106-107 Debarry J; 126-129, 230 Drömann D; 146 Duitman E; 88, 90, 231 Eberhardt F; 145 Ehlers S; 62-68, 232, 266 EkerB; 197 Ernst M; 99-101 Farhat K; 92-95 Fattakhova G; 97 Fehrenbach H; 269 Feuerriegel S; 169 Flad HD; 232, 266-267 Frey A; 184-190 Fujimoto N; 189, 190 Funk C; 46 Gaede K; 147-148 274 Schwartzkopff F; 100 Seitzer U; 109-118 Singh PB; 106-107 Sodenkamp J; 71 Mamat U; 36 Stamme C; 60, 74-76 Miranda J; 118 Stein K; 126-129 Mirghomizadeh F; 118 Steinhäuser C, 67 Mittelstädt J; 122 Moulakakis C; 60, 74-75, Stellmacher F; 149, 155 Strassburg A; 99, 100, 231 Müller-Loennies S; 32-35 191-193, 199-200, 230 Galle J; 155 Gerber S; 114 Gerdes J; 106-108 GhulamO; 103 Goldmann T; 149-156, 182 Grage-Griebnow E; 67 Greinert U; 99, 191-192, 193, 199 Gutsmann T; 52-58, 232 Liu Z; 113, 116-117 Loetzer K; 268 Haas H; 180-183 Haller D; 109 Hammer M; 53 Hanuszkiewicz A; 36-38, 40, 42-43 Hauber HP; 143-145, 270 Heine H; 125-129 Heinemann S; 144 Heitmann L; 60-70 Hessmann M; 70 Hillemann D; 159, 161-162 Hoerster R; 191 Hölscher C, 69-73 Holst O; 36-44, 232 Homolka S; 170, 172-173 Howe J; 52-53, 56-57, 59 Hübner G; 48 Ulmer AJ; 92-96 Nguyen XH; 97 Niemann S; 162, 164-171 Vogel K; 41, 231 Vollmer E; 149-156 Orinska Z; 88-89, 90 Jafari C; 99-100, 191-194 Kacynski Z; 38 Kähler D; 149, 154 Kalsdorf B; 99, 191-192, 195, 199, 230 Kasper B; 119-121 Keese S; 60 Keller C; 62, 63-64 Kirsten D; 99 Kondakova A; 49 Kubica T; 170-172 Lang DS; 149-152 Lange C; 99, 191-200 Lautenschläger I; 270 Lee KH; 97-98 Leonhardt L; 121, 123 Lindner B; 47-50 Petersen A; 175-179, 231 Petersen F; 119-124, 230 Plinke C; 169 Reiling N; 62, 65, 66-68, 271 Renneker S; 114 Reuter F; 184-186 Richter E; 159-163 Riecken S; 177, 178, 231 Riekenberg S; 92-94 Röckendorf N; 186-190 Romey R; 107 Röschmann K; 94-96 Rückerl D; 70, 230 Rückert R; 88,89 Rüsch-Gerdes S; 157163, 167-171 Walter K; 62-64, 66 Warmbold C; 95 Wehry K; 187, 189-190 Wittkowski M; 38 Wölbeling F; 172 Woller G; 121 Yu X; 124 Zabel P; 6-9, 132-148 Zähringer U; 45-51 Salih DA; 110, 111, 113, 116-117 Sarrazin H; 194 Schaible UE; 6-9, 16-30, 268 Schiemann F; 102-103 Schneider I; 108 Schocker F; 178 Scholzen T; 107, 272 Schramm G; 180-182 Schromm AB; 59-61 Schulmistrat J; 102, 104 Schultz H; 149-156 Schurek B; 98 Wissenschaftlicher Jahresbericht 2007-2008 Kiel B 404/A 21 A7 Bad Bramstedt Bad Segeberg B4 Bad Oldesloe B 433 B 75 Kaltenkirchen Borstel B 432 A1 Hamburg Fo r s c h u n g s z e n t r u m Bo r s t e l Parkallee 1-40 23845 Borstel Tel. +49 (0)4537.188 0 fzb@fz-borstel.de www.fz-borstel.de B 208 Lübeck Thomas Gutsmann, Leiter der Biophysik Thomas Gutsmann, Head of the Division of Biophysics Maria Lammers, Landesbeste in der Ausbildung zur Biolaborantin, Schleswig- Holstein Maria Lammers, the best trainee (lab assistant in biology) in Schleswig-Holstein Kay Vogel, Promotionspreis des Kreises Segeberg, 2008 Kay Vogel, laureate of the "Promotionspreis Kreis Segeberg", best graduation 2008 Fo r s c h u n g s z e n t r u m Bo r s t e l Parkallee 1-40 23845 Borstel fzb@fz-borstel.de www.fz-borstel.de